{"data_date":"2026-11-08","library_size":29380,"matched_against":"each record's title and abstract (summary field), case-insensitive","n":1354,"page":"https://alzhub.org/answers/amyloid-pet-scan-results","query":"title or abstract mentions \"amyloid PET\", \"amyloid imaging\", a tracer (florbetapir, florbetaben, flutemetamol, Pittsburgh compound B), \"Centiloid\", or \"amyloid-positive/negative\"","studies":[{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/clinical-validation-of-the-precivityad2-blood-test-a-mass-1b1b5bc0","doi":null,"journal":"Alzheimer's & Dementia","n_participants":583,"pmid":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/38491912/","study_design":"cross-sectional","title":"Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and A\u03b242/40 ratio to identify presence of brain amyloid","title_match":false,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/independent-validation-of-the-precivityad2-blood-test-to-identify-7d747d82","doi":null,"journal":"npj Dementia","n_participants":191,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12411272/","study_design":"cross-sectional","title":"Independent validation of the PrecivityAD2 blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/pittsburgh-plasma-p-tau217-classification-accuracies-for-autosomal-e4bc0f72","doi":null,"journal":"Alzheimer's & Dementia","n_participants":363,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12263344/","study_design":"cross-sectional","title":"Pittsburgh plasma p-tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the community","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/interim-biomarker-results-for-trontinemab-a-novel-brainshuttle-b9ea469a","doi":null,"journal":"Alzheimer's & Dementia (AAIC 2025 conference abstract)","n_participants":13,"pmid":null,"source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740797/","study_design":"phase-2-trial","title":"Interim biomarker results for trontinemab, a novel Brainshuttle antibody in development for the treatment of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-detecting-alzheimer-s-disease-pathology-in-41193403","doi":"10.1002/alz.70828","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":"41193403","source_url":"https://pubmed.ncbi.nlm.nih.gov/41193403/","study_design":"meta-analysis","title":"Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/updated-appropriate-use-criteria-for-amyloid-and-tau-pet-a-report-39776249","doi":"10.1002/alz.14338","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":"39776249","source_url":"https://pubmed.ncbi.nlm.nih.gov/39776249/","study_design":"systematic-review","title":"Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-for-detecting-amyloid-clearance-after-donanemab-in-42565262","doi":"10.1002/alz.71740","journal":"Alzheimer's & Dementia","n_participants":830,"pmid":"42565262","source_url":"https://pubmed.ncbi.nlm.nih.gov/42565262/","study_design":"phase-3-trial","title":"Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/prognostic-value-of-blood-based-p-tau217-levels-for-progression-to-42449500","doi":"10.1001/jama.2026.12556","journal":"JAMA","n_participants":2684,"pmid":"42449500","source_url":"https://pubmed.ncbi.nlm.nih.gov/42449500/","study_design":"cohort","title":"Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment","title_match":false,"year":2026},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/amyloid-pet-quantitation-and-centiloid-thresholds-in-the-diagnosis-of-42441390","doi":"10.1001/jama.2026.13116","journal":"JAMA","n_participants":49227,"pmid":"42441390","source_url":"https://pubmed.ncbi.nlm.nih.gov/42441390/","study_design":"meta-analysis","title":"Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis","title_match":true,"year":2026},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/sex-differences-in-p-tau217-tau-aggregation-and-cognitive-decline-41697669","doi":"10.1001/jamaneurol.2025.5670","journal":"JAMA neurology","n_participants":1292,"pmid":"41697669","source_url":"https://pubmed.ncbi.nlm.nih.gov/41697669/","study_design":"cohort","title":"Sex Differences in P-Tau217, Tau Aggregation, and Cognitive Decline","title_match":false,"year":2026},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/concurrent-changes-in-plasma-phosphorylated-tau-217-tau-pet-and-40853684","doi":"10.1001/jamaneurol.2025.2974","journal":"JAMA Neurology","n_participants":1707,"pmid":"40853684","source_url":"https://pubmed.ncbi.nlm.nih.gov/40853684/","study_design":"cohort","title":"Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-p-tau217-a42-p-tau217-and-a42-a40-biomarkers-by-40801297","doi":"10.1002/alz.70469","journal":"Alzheimer's & Dementia","n_participants":1135,"pmid":"40801297","source_url":"https://pubmed.ncbi.nlm.nih.gov/40801297/","study_design":"cross-sectional","title":"Comparison of plasma p-tau217/A\u03b242, p-tau217, and A\u03b242/A\u03b240 biomarkers by race to detect Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/quantitative-assessment-of-the-effect-of-chronic-kidney-disease-on-39823562","doi":"10.1212/WNL.0000000000210287","journal":"Neurology","n_participants":202,"pmid":"39823562","source_url":"https://pubmed.ncbi.nlm.nih.gov/39823562/","study_design":"cross-sectional","title":"Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/acceptable-performance-of-blood-biomarker-tests-of-amyloid-pathology-38866966","doi":"10.1038/s41582-024-00977-5","journal":"Nature Reviews Neurology","n_participants":null,"pmid":"38866966","source_url":"https://pubmed.ncbi.nlm.nih.gov/38866966/","study_design":null,"title":"Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-alzheimer-biomarkers-and-diagnostic-decision-making-in-memory-42593792","doi":"10.1001/jamanetworkopen.2026.28864","journal":"JAMA Network Open","n_participants":450,"pmid":"42593792","source_url":"https://pubmed.ncbi.nlm.nih.gov/42593792/","study_design":"cohort","title":"Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory Clinics","title_match":false,"year":2026},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/prognostic-value-of-plasma-glial-fibrillary-acidic-protein-in-41268784","doi":"10.1002/alz.70948","journal":"Alzheimer's & Dementia","n_participants":949,"pmid":"41268784","source_url":"https://pubmed.ncbi.nlm.nih.gov/41268784/","study_design":"cohort","title":"Prognostic value of plasma glial fibrillary acidic protein in cognitively unimpaired older adults: Results from the A4 study","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/diagnostic-performance-of-plasma-a42-40-ratio-p-tau181-gfap-and-nfl-40551285","doi":"10.1002/alz.14573","journal":"Alzheimer's & Dementia","n_participants":1298,"pmid":"40551285","source_url":"https://pubmed.ncbi.nlm.nih.gov/40551285/","study_design":"cross-sectional","title":"Diagnostic performance of plasma A\u03b242/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/estimation-of-the-value-based-price-of-a-blood-test-for-alzheimer-s-40494736","doi":"10.1016/j.tjpad.2025.100219","journal":"Journal of Prevention of Alzheimer's Disease","n_participants":null,"pmid":"40494736","source_url":"https://pubmed.ncbi.nlm.nih.gov/40494736/","study_design":"modelling","title":"Estimation of the value-based price of a blood test for Alzheimer's disease pathology in primary and specialty care in the U.S","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/apoe4-lowers-the-ptau217-threshold-for-tau-aggregation-and-spread-in-41410687","doi":"10.1093/brain/awaf463","journal":"Brain","n_participants":401,"pmid":"41410687","source_url":"https://pubmed.ncbi.nlm.nih.gov/41410687/","study_design":"cohort","title":"ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner","title_match":false,"year":2026},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/amyloid-associated-hyperconnectivity-drives-tau-spread-across-39841807","doi":"10.1126/scitranslmed.adp2564","journal":"Science Translational Medicine","n_participants":609,"pmid":"39841807","source_url":"https://pubmed.ncbi.nlm.nih.gov/39841807/","study_design":"cohort","title":"Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/glymphatic-system-dysfunction-predicts-amyloid-deposition-38501315","doi":"10.1002/alz.13789","journal":"Alzheimer's & Dementia","n_participants":419,"pmid":"38501315","source_url":"https://pubmed.ncbi.nlm.nih.gov/38501315/","study_design":"cohort","title":"Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/study-of-the-utility-and-impact-of-a-plasma-p-tau181-alzheimer-s-42254757","doi":"10.1002/trc2.70207","journal":"Alzheimer's & Dementia: Translational Research & Clinical Interventions","n_participants":100,"pmid":"42254757","source_url":"https://pubmed.ncbi.nlm.nih.gov/42254757/","study_design":"cohort","title":"Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE)","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/neuropathological-alterations-in-alzheimer-disease-22229116","doi":"10.1101/cshperspect.a006189","journal":"Cold Spring Harbor perspectives in medicine","n_participants":null,"pmid":"22229116","source_url":"https://pubmed.ncbi.nlm.nih.gov/22229116/","study_design":"cross-sectional","title":"Neuropathological alterations in Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/a-t-n-an-unbiased-descriptive-classification-scheme-for-alzheimer-27371494","doi":"10.1212/wnl.0000000000002923","journal":"Neurology","n_participants":null,"pmid":"27371494","source_url":"https://pubmed.ncbi.nlm.nih.gov/27371494/","study_design":null,"title":"A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","title_match":false,"year":2016},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/high-precision-plasma-amyloid-42-40-predicts-current-and-future-brain-31371569","doi":"10.1212/wnl.0000000000008081","journal":"Neurology","n_participants":null,"pmid":"31371569","source_url":"https://pubmed.ncbi.nlm.nih.gov/31371569/","study_design":null,"title":"High-precision plasma \u03b2-amyloid 42/40 predicts current and future brain amyloidosis","title_match":false,"year":2019},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/association-of-amyloid-and-tau-with-cognition-in-preclinical-31157827","doi":"10.1001/jamaneurol.2019.1424","journal":"JAMA neurology","n_participants":279,"pmid":"31157827","source_url":"https://pubmed.ncbi.nlm.nih.gov/31157827/","study_design":"cohort study","title":"Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","title_match":false,"year":2019},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/differences-between-plasma-and-cerebrospinal-fluid-glial-fibrillary-34661615","doi":"10.1001/jamaneurol.2021.3671","journal":"JAMA neurology","n_participants":300,"pmid":"34661615","source_url":"https://pubmed.ncbi.nlm.nih.gov/34661615/","study_design":"cross-sectional","title":"Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","title_match":false,"year":2021},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/prevalence-of-amyloid-pet-positivity-in-dementia-syndromes-a-meta-25988463","doi":"10.1001/jama.2015.4669","journal":"JAMA","n_participants":377,"pmid":"25988463","source_url":"https://pubmed.ncbi.nlm.nih.gov/25988463/","study_design":"meta-analysis","title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","title_match":true,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/an-operational-approach-to-national-institute-on-aging-alzheimer-s-22488240","doi":"10.1002/ana.22628","journal":"Annals of neurology","n_participants":null,"pmid":"22488240","source_url":"https://pubmed.ncbi.nlm.nih.gov/22488240/","study_design":"cross-sectional","title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/association-of-amyloid-positron-emission-tomography-with-subsequent-30938796","doi":"10.1001/jama.2019.2000","journal":"JAMA","n_participants":16,"pmid":"30938796","source_url":"https://pubmed.ncbi.nlm.nih.gov/30938796/","study_design":"longitudinal study","title":"Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia","title_match":true,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/appropriate-use-criteria-for-amyloid-pet-a-report-of-the-amyloid-23360977","doi":"10.1016/j.jalz.2013.01.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"23360977","source_url":"https://pubmed.ncbi.nlm.nih.gov/23360977/","study_design":null,"title":"Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association","title_match":true,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/csf-a42-a40-and-a42-a38-ratios-better-diagnostic-markers-of-alzheimer-27042676","doi":"10.1002/acn3.274","journal":"Annals of clinical and translational neurology","n_participants":1182,"pmid":"27042676","source_url":"https://pubmed.ncbi.nlm.nih.gov/27042676/","study_design":null,"title":"CSF A\u03b242/A\u03b240 and A\u03b242/A\u03b238 ratios: better diagnostic markers of Alzheimer disease","title_match":false,"year":2016},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/brain-amyloid-load-approaches-a-plateau-23446680","doi":"10.1212/wnl.0b013e3182840bbe","journal":"Neurology","n_participants":246,"pmid":"23446680","source_url":"https://pubmed.ncbi.nlm.nih.gov/23446680/","study_design":null,"title":"Brain \u03b2-amyloid load approaches a plateau","title_match":false,"year":2013},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/age-sex-and-apoe-4-effects-on-memory-brain-structure-and-amyloid-25775353","doi":"10.1001/jamaneurol.2014.4821","journal":"JAMA neurology","n_participants":1246,"pmid":"25775353","source_url":"https://pubmed.ncbi.nlm.nih.gov/25775353/","study_design":"cross-sectional","title":"Age, Sex, and APOE \u03b54 Effects on Memory, Brain Structure, and \u03b2-Amyloid Across the Adult Life Span","title_match":false,"year":2015},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/measurement-of-longitudinal-amyloid-change-with-18f-florbetapir-pet-25745095","doi":"10.2967/jnumed.114.148981","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":14,"pmid":"25745095","source_url":"https://pubmed.ncbi.nlm.nih.gov/25745095/","study_design":"longitudinal study","title":"Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","title_match":true,"year":2015},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/association-of-factors-with-elevated-amyloid-burden-in-clinically-32250387","doi":"10.1001/jamaneurol.2020.0387","journal":"JAMA neurology","n_participants":4486,"pmid":"32250387","source_url":"https://pubmed.ncbi.nlm.nih.gov/32250387/","study_design":"cross-sectional","title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","title_match":false,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/detailed-comparison-of-amyloid-pet-and-csf-biomarkers-for-identifying-26354982","doi":"10.1212/wnl.0000000000001991","journal":"Neurology","n_participants":122,"pmid":"26354982","source_url":"https://pubmed.ncbi.nlm.nih.gov/26354982/","study_design":"longitudinal study","title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","title_match":true,"year":2015},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/understanding-white-matter-disease-imaging-pathological-correlations-19064767","doi":"10.1161/strokeaha.108.537704","journal":"Stroke","n_participants":null,"pmid":"19064767","source_url":"https://pubmed.ncbi.nlm.nih.gov/19064767/","study_design":null,"title":"Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment","title_match":false,"year":2009},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/accuracy-of-tau-positron-emission-tomography-as-a-prognostic-marker-34180956","doi":"10.1001/jamaneurol.2021.1858","journal":"JAMA neurology","n_participants":1135,"pmid":"34180956","source_url":"https://pubmed.ncbi.nlm.nih.gov/34180956/","study_design":"cohort study","title":"Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging","title_match":true,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/associations-of-amyloid-tau-and-neurodegeneration-biomarker-profiles-31211344","doi":"10.1001/jama.2019.7437","journal":"JAMA","n_participants":480,"pmid":"31211344","source_url":"https://pubmed.ncbi.nlm.nih.gov/31211344/","study_design":"cohort study","title":"Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia","title_match":false,"year":2019},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/influence-of-tau-pet-amyloid-pet-and-hippocampal-volume-on-cognition-30068637","doi":"10.1212/wnl.0000000000006075","journal":"Neurology","n_participants":152,"pmid":"30068637","source_url":"https://pubmed.ncbi.nlm.nih.gov/30068637/","study_design":"longitudinal study","title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","title_match":true,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/prevalence-estimates-of-amyloid-abnormality-across-the-alzheimer-35099509","doi":"10.1001/jamaneurol.2021.5216","journal":"JAMA neurology","n_participants":97,"pmid":"35099509","source_url":"https://pubmed.ncbi.nlm.nih.gov/35099509/","study_design":"cross-sectional","title":"Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/brain-pet-in-the-diagnosis-of-alzheimer-s-disease-25199063","doi":"10.1097/rlu.0000000000000547","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"25199063","source_url":"https://pubmed.ncbi.nlm.nih.gov/25199063/","study_design":null,"title":"Brain PET in the diagnosis of Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/association-of-phosphorylated-tau-biomarkers-with-amyloid-positron-36508198","doi":"10.1001/jamaneurol.2022.4485","journal":"JAMA neurology","n_participants":609,"pmid":"36508198","source_url":"https://pubmed.ncbi.nlm.nih.gov/36508198/","study_design":"cross-sectional","title":"Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography","title_match":true,"year":2023},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/prevalence-of-biologically-vs-clinically-defined-alzheimer-spectrum-31305929","doi":"10.1001/jamaneurol.2019.1971","journal":"JAMA neurology","n_participants":4660,"pmid":"31305929","source_url":"https://pubmed.ncbi.nlm.nih.gov/31305929/","study_design":"cohort study","title":"Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework","title_match":false,"year":2019},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/csf-mtbr-tau243-is-a-specific-biomarker-of-tau-tangle-pathology-in-37443334","doi":"10.1038/s41591-023-02443-z","journal":"Nature medicine","n_participants":448,"pmid":"37443334","source_url":"https://pubmed.ncbi.nlm.nih.gov/37443334/","study_design":null,"title":"CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/association-of-donanemab-treatment-with-exploratory-plasma-biomarkers-36251300","doi":"10.1001/jamaneurol.2022.3392","journal":"JAMA neurology","n_participants":1955,"pmid":"36251300","source_url":"https://pubmed.ncbi.nlm.nih.gov/36251300/","study_design":null,"title":"Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial","title_match":false,"year":2022},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-phosphorylated-tau-species-with-amyloid-and-tau-34309632","doi":"10.1001/jamaneurol.2021.2293","journal":"JAMA neurology","n_participants":1329,"pmid":"34309632","source_url":"https://pubmed.ncbi.nlm.nih.gov/34309632/","study_design":null,"title":"Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/staging-amyloid-pathology-with-amyloid-positron-emission-tomography-31314895","doi":"10.1001/jamaneurol.2019.2214","journal":"JAMA neurology","n_participants":402,"pmid":"31314895","source_url":"https://pubmed.ncbi.nlm.nih.gov/31314895/","study_design":"cohort study","title":"Staging \u03b2-Amyloid Pathology With Amyloid Positron Emission Tomography","title_match":true,"year":2019},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-role-of-amyloid-pet-in-imaging-neurodegenerative-disorders-a-35649652","doi":"10.2967/jnumed.121.263195","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"35649652","source_url":"https://pubmed.ncbi.nlm.nih.gov/35649652/","study_design":null,"title":"The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review","title_match":true,"year":2022},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/validation-of-plasma-amyloid-42-40-for-detecting-alzheimer-disease-34906975","doi":"10.1212/wnl.0000000000013211","journal":"Neurology","n_participants":465,"pmid":"34906975","source_url":"https://pubmed.ncbi.nlm.nih.gov/34906975/","study_design":null,"title":"Validation of Plasma Amyloid-\u03b2 42/40 for Detecting Alzheimer Disease Amyloid Plaques","title_match":false,"year":2022},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/biomarker-based-staging-of-alzheimer-disease-rationale-and-clinical-38429551","doi":"10.1038/s41582-024-00942-2","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"38429551","source_url":"https://pubmed.ncbi.nlm.nih.gov/38429551/","study_design":null,"title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/atn-classification-and-clinical-progression-in-subjective-cognitive-32522798","doi":"10.1212/wnl.0000000000009724","journal":"Neurology","n_participants":385,"pmid":"32522798","source_url":"https://pubmed.ncbi.nlm.nih.gov/32522798/","study_design":null,"title":"ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/amyloid-first-and-neurodegeneration-first-profiles-characterize-24132377","doi":"10.1212/01.wnl.0000435556.21319.e4","journal":"Neurology","n_participants":207,"pmid":"24132377","source_url":"https://pubmed.ncbi.nlm.nih.gov/24132377/","study_design":null,"title":"Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity","title_match":true,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/av-1451-pet-imaging-of-tau-pathology-in-preclinical-alzheimer-disease-28756238","doi":"10.1016/j.neuroimage.2017.07.050","journal":"NeuroImage","n_participants":null,"pmid":"28756238","source_url":"https://pubmed.ncbi.nlm.nih.gov/28756238/","study_design":null,"title":"AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-27042902","doi":"10.1212/con.0000000000000307","journal":"Continuum (Minneapolis, Minn.)","n_participants":null,"pmid":"27042902","source_url":"https://pubmed.ncbi.nlm.nih.gov/27042902/","study_design":null,"title":"Alzheimer Disease","title_match":false,"year":2016},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/diagnostic-performance-of-plasma-ptau-sub-217-sub-ptau-sub-181-sub-a-38926773","doi":"10.1186/s13195-024-01513-9","journal":"Alzheimer's research & therapy","n_participants":130,"pmid":"38926773","source_url":"https://pubmed.ncbi.nlm.nih.gov/38926773/","study_design":null,"title":"Diagnostic performance of plasma pTau217, pTau181, A\u03b21-42 and A\u03b21-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease","title_match":false,"year":2024},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/diabetes-and-elevated-hemoglobin-a1c-levels-are-associated-with-brain-24652830","doi":"10.2967/jnumed.113.132647","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":749,"pmid":"24652830","source_url":"https://pubmed.ncbi.nlm.nih.gov/24652830/","study_design":"longitudinal study","title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","title_match":false,"year":2014},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/plasma-tau-and-neurofilament-light-in-frontotemporal-lobar-33199433","doi":"10.1212/wnl.0000000000011226","journal":"Neurology","n_participants":265,"pmid":"33199433","source_url":"https://pubmed.ncbi.nlm.nih.gov/33199433/","study_design":"cross-sectional","title":"Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/left-frontal-cortex-connectivity-underlies-cognitive-reserve-in-28188306","doi":"10.1212/wnl.0000000000003711","journal":"Neurology","n_participants":null,"pmid":"28188306","source_url":"https://pubmed.ncbi.nlm.nih.gov/28188306/","study_design":null,"title":"Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/astrocytosis-precedes-amyloid-plaque-deposition-in-alzheimer-appswe-25893384","doi":"10.1007/s00259-015-3047-0","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"25893384","source_url":"https://pubmed.ncbi.nlm.nih.gov/25893384/","study_design":null,"title":"Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-patients-with-mild-cognitive-impairment-a-2-21325653","doi":"10.1212/wnl.0b013e318212015e","journal":"Neurology","n_participants":null,"pmid":"21325653","source_url":"https://pubmed.ncbi.nlm.nih.gov/21325653/","study_design":null,"title":"Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study","title_match":true,"year":2011},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/defining-the-lowest-threshold-for-amyloid-pet-to-predict-future-33199430","doi":"10.1212/wnl.0000000000011214","journal":"Neurology","n_participants":342,"pmid":"33199430","source_url":"https://pubmed.ncbi.nlm.nih.gov/33199430/","study_design":null,"title":"Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation","title_match":true,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/assessment-of-a-plasma-amyloid-probability-score-to-estimate-amyloid-35446396","doi":"10.1001/jamanetworkopen.2022.8392","journal":"JAMA network open","n_participants":249,"pmid":"35446396","source_url":"https://pubmed.ncbi.nlm.nih.gov/35446396/","study_design":"cohort study","title":"Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment","title_match":true,"year":2022},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/association-between-in-vivo-fluorine-18-labeled-flutemetamol-amyloid-21747004","doi":"10.1001/archneurol.2011.153","journal":"Archives of neurology","n_participants":null,"pmid":"21747004","source_url":"https://pubmed.ncbi.nlm.nih.gov/21747004/","study_design":"cross-sectional","title":"Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology","title_match":true,"year":2011},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-i-apoe4-i-and-clinical-variability-in-alzheimer-33262228","doi":"10.1212/wnl.0000000000011270","journal":"Neurology","n_participants":119,"pmid":"33262228","source_url":"https://pubmed.ncbi.nlm.nih.gov/33262228/","study_design":null,"title":"Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET","title_match":true,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/racial-and-ethnic-differences-in-amyloid-pet-positivity-in-36190710","doi":"10.1001/jamaneurol.2022.3157","journal":"JAMA neurology","n_participants":3154,"pmid":"36190710","source_url":"https://pubmed.ncbi.nlm.nih.gov/36190710/","study_design":"cohort study","title":"Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study","title_match":true,"year":2022},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/association-of-amyloid-positron-emission-tomography-with-changes-in-29889941","doi":"10.1001/jamaneurol.2018.1346","journal":"JAMA neurology","n_participants":866,"pmid":"29889941","source_url":"https://pubmed.ncbi.nlm.nih.gov/29889941/","study_design":null,"title":"Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project","title_match":true,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/standardized-expression-of-18f-nav4694-and-11c-pib-amyloid-pet-26912446","doi":"10.2967/jnumed.115.171595","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26912446","source_url":"https://pubmed.ncbi.nlm.nih.gov/26912446/","study_design":null,"title":"Standardized Expression of 18F-NAV4694 and 11C-PiB \u03b2-Amyloid PET Results with the Centiloid Scale","title_match":true,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/tau-pet-uptake-regional-variation-in-average-suvr-and-impact-of-28138510","doi":"10.1016/j.dadm.2016.12.010","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":490,"pmid":"28138510","source_url":"https://pubmed.ncbi.nlm.nih.gov/28138510/","study_design":null,"title":"Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition","title_match":false,"year":2017},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/spatial-temporal-patterns-of-amyloid-accumulation-a-subtype-and-stage-35292558","doi":"10.1212/wnl.0000000000200148","journal":"Neurology","n_participants":1890,"pmid":"35292558","source_url":"https://pubmed.ncbi.nlm.nih.gov/35292558/","study_design":null,"title":"Spatial-Temporal Patterns of \u03b2-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis","title_match":false,"year":2022},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/rates-of-amyloid-accumulation-are-independent-of-hippocampal-24706010","doi":"10.1212/wnl.0000000000000386","journal":"Neurology","n_participants":252,"pmid":"24706010","source_url":"https://pubmed.ncbi.nlm.nih.gov/24706010/","study_design":null,"title":"Rates of \u03b2-amyloid accumulation are independent of hippocampal neurodegeneration","title_match":false,"year":2014},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/determining-amyloid-positivity-using-sup-18-sup-f-azd4694-pet-imaging-32737243","doi":"10.2967/jnumed.120.245209","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":22,"pmid":"32737243","source_url":"https://pubmed.ncbi.nlm.nih.gov/32737243/","study_design":null,"title":"Determining Amyloid-\u03b2 Positivity Using 18F-AZD4694 PET Imaging","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/mild-to-moderate-alzheimer-dementia-with-insufficient-24585367","doi":"10.1002/ana.24125","journal":"Annals of neurology","n_participants":null,"pmid":"24585367","source_url":"https://pubmed.ncbi.nlm.nih.gov/24585367/","study_design":null,"title":"Mild to moderate Alzheimer dementia with insufficient neuropathological changes","title_match":false,"year":2014},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-prediction-of-cognitive-and-functional-decline-in-39044488","doi":"10.14283/jpad.2024.122","journal":"The journal of prevention of Alzheimer's disease","n_participants":583,"pmid":"39044488","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044488/","study_design":"longitudinal study","title":"Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/correlation-of-amyloid-pet-ligand-florbetapir-f-18-binding-with-a-22354138","doi":"10.1097/wad.0b013e31821300bc","journal":"Alzheimer disease and associated disorders","n_participants":40,"pmid":"22354138","source_url":"https://pubmed.ncbi.nlm.nih.gov/22354138/","study_design":null,"title":"Correlation of amyloid PET ligand florbetapir F 18 binding with A\u03b2 aggregation and neuritic plaque deposition in postmortem brain tissue","title_match":true,"year":2012},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-implications-of-different-approaches-to-define-at-n-in-alzheimer-32398359","doi":"10.1212/wnl.0000000000009485","journal":"Neurology","n_participants":490,"pmid":"32398359","source_url":"https://pubmed.ncbi.nlm.nih.gov/32398359/","study_design":"longitudinal study","title":"The implications of different approaches to define AT(N) in Alzheimer disease","title_match":false,"year":2020},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/amyloid-pet-screening-for-enrichment-of-early-stage-alzheimer-disease-26885819","doi":"10.1097/wad.0000000000000144","journal":"Alzheimer disease and associated disorders","n_participants":278,"pmid":"26885819","source_url":"https://pubmed.ncbi.nlm.nih.gov/26885819/","study_design":null,"title":"Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial","title_match":true,"year":2016},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/association-between-ambient-air-pollution-and-amyloid-positron-33252608","doi":"10.1001/jamaneurol.2020.3962","journal":"JAMA neurology","n_participants":18,"pmid":"33252608","source_url":"https://pubmed.ncbi.nlm.nih.gov/33252608/","study_design":"cross-sectional","title":"Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment","title_match":true,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/association-of-sleep-and-amyloid-pathology-among-older-cognitively-34297074","doi":"10.1001/jamanetworkopen.2021.17573","journal":"JAMA network open","n_participants":null,"pmid":"34297074","source_url":"https://pubmed.ncbi.nlm.nih.gov/34297074/","study_design":"cross-sectional","title":"Association of Sleep and \u03b2-Amyloid Pathology Among Older Cognitively Unimpaired Adults","title_match":false,"year":2021},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/multitracer-model-for-staging-cortical-amyloid-deposition-using-pet-32675080","doi":"10.1212/wnl.0000000000010256","journal":"Neurology","n_participants":867,"pmid":"32675080","source_url":"https://pubmed.ncbi.nlm.nih.gov/32675080/","study_design":"longitudinal study","title":"Multitracer model for staging cortical amyloid deposition using PET imaging","title_match":false,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/csf-synaptic-biomarkers-in-the-preclinical-stage-of-alzheimer-disease-34556565","doi":"10.1212/wnl.0000000000012853","journal":"Neurology","n_participants":null,"pmid":"34556565","source_url":"https://pubmed.ncbi.nlm.nih.gov/34556565/","study_design":"cross-sectional","title":"CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-lewy-body-disorders-23831180","doi":"10.1016/j.jagp.2013.03.001","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":null,"pmid":"23831180","source_url":"https://pubmed.ncbi.nlm.nih.gov/23831180/","study_design":"longitudinal study","title":"Amyloid PET Imaging in Lewy body disorders","title_match":true,"year":2015},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/predicting-symptom-onset-in-sporadic-alzheimer-disease-with-amyloid-34504028","doi":"10.1212/wnl.0000000000012775","journal":"Neurology","n_participants":236,"pmid":"34504028","source_url":"https://pubmed.ncbi.nlm.nih.gov/34504028/","study_design":"longitudinal study","title":"Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/clinical-and-imaging-features-of-mixed-alzheimer-and-vascular-25722748","doi":"10.1186/s13195-015-0104-7","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"25722748","source_url":"https://pubmed.ncbi.nlm.nih.gov/25722748/","study_design":null,"title":"Clinical and imaging features of mixed Alzheimer and vascular pathologies","title_match":false,"year":2015},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-pet-and-neuropathology-in-dementia-with-lewy-bodies-31862783","doi":"10.1212/wnl.0000000000008818","journal":"Neurology","n_participants":39,"pmid":"31862783","source_url":"https://pubmed.ncbi.nlm.nih.gov/31862783/","study_design":null,"title":"\u03b2-Amyloid PET and neuropathology in dementia with Lewy bodies","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/associations-of-fully-automated-csf-and-novel-plasma-biomarkers-with-34266917","doi":"10.1212/wnl.0000000000012513","journal":"Neurology","n_participants":27,"pmid":"34266917","source_url":"https://pubmed.ncbi.nlm.nih.gov/34266917/","study_design":null,"title":"Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy","title_match":false,"year":2021},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/frequency-of-biologically-defined-alzheimer-disease-in-relation-to-33443136","doi":"10.1212/wnl.0000000000011416","journal":"Neurology","n_participants":166,"pmid":"33443136","source_url":"https://pubmed.ncbi.nlm.nih.gov/33443136/","study_design":"cohort study","title":"Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE \u03b54, and Cognitive Impairment","title_match":false,"year":2021},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/pet-approaches-for-diagnosis-of-dementia-23945233","doi":"10.3174/ajnr.a3695","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"23945233","source_url":"https://pubmed.ncbi.nlm.nih.gov/23945233/","study_design":null,"title":"PET approaches for diagnosis of dementia","title_match":false,"year":2014},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/validity-and-performance-of-blood-biomarkers-for-alzheimer-disease-to-36261295","doi":"10.1212/wnl.0000000000201479","journal":"Neurology","n_participants":357,"pmid":"36261295","source_url":"https://pubmed.ncbi.nlm.nih.gov/36261295/","study_design":"prospective cohort","title":"Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort","title_match":false,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/association-of-data-driven-white-matter-hyperintensity-spatial-36123127","doi":"10.1212/wnl.0000000000201186","journal":"Neurology","n_participants":null,"pmid":"36123127","source_url":"https://pubmed.ncbi.nlm.nih.gov/36123127/","study_design":"cross-sectional","title":"Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies","title_match":false,"year":2022},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/timing-of-biomarker-changes-in-sporadic-alzheimer-s-disease-in-38400792","doi":"10.1002/ana.26891","journal":"Annals of neurology","n_participants":118,"pmid":"38400792","source_url":"https://pubmed.ncbi.nlm.nih.gov/38400792/","study_design":"cross-sectional","title":"Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset","title_match":false,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/assessment-of-the-incremental-diagnostic-value-of-florbetapir-f-18-27802513","doi":"10.1001/jamaneurol.2016.3751","journal":"JAMA neurology","n_participants":228,"pmid":"27802513","source_url":"https://pubmed.ncbi.nlm.nih.gov/27802513/","study_design":null,"title":"Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study","title_match":true,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/finding-treatment-effects-in-alzheimer-trials-in-the-face-of-disease-34550903","doi":"10.1212/wnl.0000000000012022","journal":"Neurology","n_participants":302,"pmid":"34550903","source_url":"https://pubmed.ncbi.nlm.nih.gov/34550903/","study_design":null,"title":"Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/amyloid-pet-in-clinical-practice-its-place-in-the-multidimensional-24179802","doi":"10.1016/j.nicl.2013.03.014","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24179802","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179802/","study_design":"cross-sectional","title":"Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease","title_match":true,"year":2013},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/clinical-use-and-utility-of-amyloid-imaging-28818990","doi":"10.2967/jnumed.116.185017","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"28818990","source_url":"https://pubmed.ncbi.nlm.nih.gov/28818990/","study_design":null,"title":"Clinical Use and Utility of Amyloid Imaging","title_match":true,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/update-on-appropriate-use-criteria-for-amyloid-pet-imaging-dementia-23809369","doi":"10.1016/j.jalz.2013.06.001","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"23809369","source_url":"https://pubmed.ncbi.nlm.nih.gov/23809369/","study_design":null,"title":"Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging","title_match":true,"year":2013},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/rates-of-amyloid-imaging-positivity-in-patients-with-primary-29309493","doi":"10.1001/jamaneurol.2017.4309","journal":"JAMA neurology","n_participants":109,"pmid":"29309493","source_url":"https://pubmed.ncbi.nlm.nih.gov/29309493/","study_design":"longitudinal study","title":"Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia","title_match":true,"year":2018},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/signs-and-artifacts-in-amyloid-pet-30422768","doi":"10.1148/rg.2018180160","journal":"Radiographics : a review publication of the Radiological Society of North America, Inc","n_participants":null,"pmid":"30422768","source_url":"https://pubmed.ncbi.nlm.nih.gov/30422768/","study_design":null,"title":"Signs and Artifacts in Amyloid PET","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/generation-of-structural-mr-images-from-amyloid-pet-application-to-mr-29217736","doi":"10.2967/jnumed.117.199414","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"29217736","source_url":"https://pubmed.ncbi.nlm.nih.gov/29217736/","study_design":null,"title":"Generation of Structural MR Images from Amyloid PET: Application to MR-Less Quantification","title_match":true,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-bdnf-lt-sub-gt-val66met-lt-sub-gt-snp-modulates-the-association-30899092","doi":"10.1038/s41380-019-0404-6","journal":"Molecular psychiatry","n_participants":149,"pmid":"30899092","source_url":"https://pubmed.ncbi.nlm.nih.gov/30899092/","study_design":null,"title":"The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/association-of-serum-docosahexaenoic-acid-with-cerebral-amyloidosis-27532692","doi":"10.1001/jamaneurol.2016.1924","journal":"JAMA neurology","n_participants":61,"pmid":"27532692","source_url":"https://pubmed.ncbi.nlm.nih.gov/27532692/","study_design":"cross-sectional","title":"Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis","title_match":false,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/apoe4-and-connectivity-mediated-spreading-of-tau-pathology-at-lower-37930695","doi":"10.1001/jamaneurol.2023.4038","journal":"JAMA neurology","n_participants":237,"pmid":"37930695","source_url":"https://pubmed.ncbi.nlm.nih.gov/37930695/","study_design":"cohort study","title":"ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels","title_match":false,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/an-mri-measure-of-degenerative-and-cerebrovascular-pathology-in-30217936","doi":"10.1212/wnl.0000000000006310","journal":"Neurology","n_participants":1175,"pmid":"30217936","source_url":"https://pubmed.ncbi.nlm.nih.gov/30217936/","study_design":"cross-sectional","title":"An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease","title_match":false,"year":2018},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/beta-amyloid-deposition-is-not-associated-with-cognitive-impairment-31105633","doi":"10.3389/fneur.2019.00391","journal":"Frontiers in neurology","n_participants":23,"pmid":"31105633","source_url":"https://pubmed.ncbi.nlm.nih.gov/31105633/","study_design":"cross-sectional","title":"Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease","title_match":false,"year":2019},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/utilizing-semantic-intrusions-to-identify-amyloid-positivity-in-mild-30076274","doi":"10.1212/wnl.0000000000006128","journal":"Neurology","n_participants":null,"pmid":"30076274","source_url":"https://pubmed.ncbi.nlm.nih.gov/30076274/","study_design":null,"title":"Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/tau-pet-binding-distinguishes-patients-with-early-stage-posterior-28394771","doi":"10.1097/wad.0000000000000196","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"28394771","source_url":"https://pubmed.ncbi.nlm.nih.gov/28394771/","study_design":null,"title":"Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/practical-utility-of-amyloid-and-fdg-pet-in-an-academic-dementia-24353340","doi":"10.1212/wnl.0000000000000032","journal":"Neurology","n_participants":24,"pmid":"24353340","source_url":"https://pubmed.ncbi.nlm.nih.gov/24353340/","study_design":null,"title":"Practical utility of amyloid and FDG-PET in an academic dementia center","title_match":false,"year":2014},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/comparison-of-amyloid-burden-in-individuals-with-down-syndrome-versus-36517172","doi":"10.1016/s1474-4422(22)00408-2","journal":"The Lancet. Neurology","n_participants":216,"pmid":"36517172","source_url":"https://pubmed.ncbi.nlm.nih.gov/36517172/","study_design":"cross-sectional","title":"Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/large-multi-ethnic-genetic-analyses-of-amyloid-imaging-identify-new-37101235","doi":"10.1186/s40478-023-01563-4","journal":"Acta neuropathologica communications","n_participants":13409,"pmid":"37101235","source_url":"https://pubmed.ncbi.nlm.nih.gov/37101235/","study_design":null,"title":"Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease","title_match":true,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/use-of-amyloid-pet-to-determine-cutpoints-for-csf-markers-a-26468410","doi":"10.1212/wnl.0000000000002081","journal":"Neurology","n_participants":433,"pmid":"26468410","source_url":"https://pubmed.ncbi.nlm.nih.gov/26468410/","study_design":null,"title":"Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study","title_match":true,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/comprehension-of-an-elevated-amyloid-positron-emission-tomography-29059270","doi":"10.1001/jamaneurol.2017.2954","journal":"JAMA neurology","n_participants":80,"pmid":"29059270","source_url":"https://pubmed.ncbi.nlm.nih.gov/29059270/","study_design":null,"title":"Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults","title_match":true,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/partial-volume-effect-correction-improves-quantitative-analysis-of-26541776","doi":"10.2967/jnumed.115.161893","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26541776","source_url":"https://pubmed.ncbi.nlm.nih.gov/26541776/","study_design":null,"title":"Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben \u03b2-Amyloid PET Scans","title_match":true,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/update-on-appropriate-use-criteria-for-amyloid-pet-imaging-dementia-23753186","doi":"10.2967/jnumed.113.127068","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"23753186","source_url":"https://pubmed.ncbi.nlm.nih.gov/23753186/","study_design":null,"title":"Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education","title_match":true,"year":2013},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/the-spatial-temporal-ordering-of-amyloid-pathology-and-opportunities-31836683","doi":"10.2967/jnumed.119.235879","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"31836683","source_url":"https://pubmed.ncbi.nlm.nih.gov/31836683/","study_design":"cross-sectional","title":"The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-neurofilament-light-chain-is-a-marker-of-aging-35167933","doi":"10.1016/j.nbd.2022.105662","journal":"Neurobiology of disease","n_participants":71,"pmid":"35167933","source_url":"https://pubmed.ncbi.nlm.nih.gov/35167933/","study_design":null,"title":"Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/sex-related-differences-in-tau-positron-emission-tomography-pet-and-32520734","doi":"10.1097/wad.0000000000000393","journal":"Alzheimer disease and associated disorders","n_participants":148,"pmid":"32520734","source_url":"https://pubmed.ncbi.nlm.nih.gov/32520734/","study_design":"cross-sectional","title":"Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT)","title_match":false,"year":2021},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/autosomal-dominant-and-sporadic-late-onset-alzheimer-s-disease-share-35580594","doi":"10.1093/brain/awac181","journal":"Brain : a journal of neurology","n_participants":559,"pmid":"35580594","source_url":"https://pubmed.ncbi.nlm.nih.gov/35580594/","study_design":null,"title":"Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/dementia-with-lewy-bodies-association-of-alzheimer-pathology-with-34114602","doi":"10.1093/brain/awab218","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"34114602","source_url":"https://pubmed.ncbi.nlm.nih.gov/34114602/","study_design":null,"title":"Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/roles-of-vascular-and-metabolic-components-in-cognitive-dysfunction-24204343","doi":"10.3389/fnagi.2013.00064","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"24204343","source_url":"https://pubmed.ncbi.nlm.nih.gov/24204343/","study_design":null,"title":"Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors","title_match":false,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/application-of-the-national-institute-on-aging-alzheimer-s-23645596","doi":"10.1212/wnl.0b013e318295d6cf","journal":"Neurology","n_participants":211,"pmid":"23645596","source_url":"https://pubmed.ncbi.nlm.nih.gov/23645596/","study_design":null,"title":"Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI","title_match":false,"year":2013},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/sup-18-sup-f-f-ded-pet-imaging-of-reactive-astrogliosis-in-36906584","doi":"10.1186/s12974-023-02749-2","journal":"Journal of neuroinflammation","n_participants":null,"pmid":"36906584","source_url":"https://pubmed.ncbi.nlm.nih.gov/36906584/","study_design":"cross-sectional","title":"[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data","title_match":false,"year":2023},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/confidentiality-in-preclinical-alzheimer-disease-studies-when-24477112","doi":"10.1212/wnl.0000000000000153","journal":"Neurology","n_participants":null,"pmid":"24477112","source_url":"https://pubmed.ncbi.nlm.nih.gov/24477112/","study_design":null,"title":"Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinical-amyloid-imaging-27987555","doi":"10.1053/j.semnuclmed.2016.09.005","journal":"Seminars in nuclear medicine","n_participants":null,"pmid":"27987555","source_url":"https://pubmed.ncbi.nlm.nih.gov/27987555/","study_design":null,"title":"Clinical Amyloid Imaging","title_match":true,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-neuropathology-in-a-patient-previously-treated-with-35581440","doi":"10.1007/s00401-022-02433-4","journal":"Acta neuropathologica","n_participants":null,"pmid":"35581440","source_url":"https://pubmed.ncbi.nlm.nih.gov/35581440/","study_design":"case report","title":"Alzheimer disease neuropathology in a patient previously treated with aducanumab","title_match":false,"year":2022},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/impact-of-reference-and-target-region-selection-on-amyloid-pet-suv-29777003","doi":"10.2967/jnumed.118.209130","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"29777003","source_url":"https://pubmed.ncbi.nlm.nih.gov/29777003/","study_design":null,"title":"Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab","title_match":true,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/predictive-value-of-sup-18-sup-f-florbetapir-and-sup-18-sup-f-fdg-pet-31628215","doi":"10.2967/jnumed.119.230797","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":159,"pmid":"31628215","source_url":"https://pubmed.ncbi.nlm.nih.gov/31628215/","study_design":null,"title":"Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia","title_match":true,"year":2020},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/a-survey-of-knowledge-and-views-concerning-genetic-and-amyloid-pet-27019867","doi":"10.1016/j.trci.2015.12.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":207,"pmid":"27019867","source_url":"https://pubmed.ncbi.nlm.nih.gov/27019867/","study_design":null,"title":"A Survey of Knowledge and Views Concerning Genetic and Amyloid PET Status Disclosure","title_match":true,"year":2016},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/multimodality-imaging-of-alzheimer-disease-and-other-25413136","doi":"10.2967/jnumed.114.141416","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"25413136","source_url":"https://pubmed.ncbi.nlm.nih.gov/25413136/","study_design":null,"title":"Multimodality imaging of Alzheimer disease and other neurodegenerative dementias","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/amyloid-proteins-and-their-role-in-multiple-sclerosis-considerations-27065425","doi":"10.3389/fneur.2016.00053","journal":"Frontiers in neurology","n_participants":null,"pmid":"27065425","source_url":"https://pubmed.ncbi.nlm.nih.gov/27065425/","study_design":null,"title":"Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging","title_match":true,"year":2016},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-in-the-dian-tu-001-trial-of-36151869","doi":"10.1002/ana.26511","journal":"Annals of neurology","n_participants":52,"pmid":"36151869","source_url":"https://pubmed.ncbi.nlm.nih.gov/36151869/","study_design":"cross-sectional","title":"Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/topographic-distribution-of-amyloid-tau-and-atrophy-in-patients-with-33093220","doi":"10.1212/wnl.0000000000011081","journal":"Neurology","n_participants":15,"pmid":"33093220","source_url":"https://pubmed.ncbi.nlm.nih.gov/33093220/","study_design":null,"title":"Topographic Distribution of Amyloid-\u03b2, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/economic-impacts-of-introducing-diagnostics-for-mild-cognitive-31463360","doi":"10.1016/j.trci.2019.06.001","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"31463360","source_url":"https://pubmed.ncbi.nlm.nih.gov/31463360/","study_design":null,"title":"Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients","title_match":false,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/early-and-longitudinal-microglial-activation-but-not-amyloid-30262517","doi":"10.2967/jnumed.118.217703","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"30262517","source_url":"https://pubmed.ncbi.nlm.nih.gov/30262517/","study_design":"longitudinal study","title":"Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice","title_match":false,"year":2019},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effectiveness-of-florbetapir-pet-imaging-in-changing-patient-28787712","doi":"10.1159/000478007","journal":"Dementia and geriatric cognitive disorders","n_participants":618,"pmid":"28787712","source_url":"https://pubmed.ncbi.nlm.nih.gov/28787712/","study_design":null,"title":"Effectiveness of Florbetapir PET Imaging in Changing Patient Management","title_match":true,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/atrophy-rates-in-asymptomatic-amyloidosis-implications-for-alzheimer-23554933","doi":"10.1371/journal.pone.0058816","journal":"PloS one","n_participants":null,"pmid":"23554933","source_url":"https://pubmed.ncbi.nlm.nih.gov/23554933/","study_design":null,"title":"Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials","title_match":false,"year":2013},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/clinical-effect-of-early-vs-late-amyloid-positron-emission-tomography-37155177","doi":"10.1001/jamaneurol.2023.0997","journal":"JAMA neurology","n_participants":844,"pmid":"37155177","source_url":"https://pubmed.ncbi.nlm.nih.gov/37155177/","study_design":null,"title":"Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial","title_match":true,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/accuracy-of-biomarker-testing-for-neuropathologically-defined-32340038","doi":"10.7326/m19-3888","journal":"Annals of internal medicine","n_participants":null,"pmid":"32340038","source_url":"https://pubmed.ncbi.nlm.nih.gov/32340038/","study_design":"systematic review","title":"Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia","title_match":false,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/biomarker-pattern-of-aria-e-participants-in-phase-3-randomized-29429971","doi":"10.1212/wnl.0000000000005060","journal":"Neurology","n_participants":1512,"pmid":"29429971","source_url":"https://pubmed.ncbi.nlm.nih.gov/29429971/","study_design":"longitudinal study","title":"Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab","title_match":false,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/visual-versus-fully-automated-analyses-of-18f-fdg-and-amyloid-pet-for-26585056","doi":"10.2967/jnumed.115.163717","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26585056","source_url":"https://pubmed.ncbi.nlm.nih.gov/26585056/","study_design":null,"title":"Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment","title_match":true,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/amyloid-and-fdg-pet-study-of-logopenic-primary-progressive-aphasia-25860346","doi":"10.1007/s00415-015-7738-z","journal":"Journal of neurology","n_participants":16,"pmid":"25860346","source_url":"https://pubmed.ncbi.nlm.nih.gov/25860346/","study_design":null,"title":"Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/using-alzheimer-s-disease-blood-tests-to-accelerate-clinical-trial-35934777","doi":"10.1002/alz.12754","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35934777","source_url":"https://pubmed.ncbi.nlm.nih.gov/35934777/","study_design":null,"title":"Using Alzheimer's disease blood tests to accelerate clinical trial enrollment","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/independent-comparison-of-cogstate-computerized-testing-and-a-25458308","doi":"10.1016/j.jalz.2014.09.001","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"25458308","source_url":"https://pubmed.ncbi.nlm.nih.gov/25458308/","study_design":null,"title":"Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging","title_match":false,"year":2014},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/neuroimaging-predictors-of-brain-amyloidosis-in-mild-cognitive-23686534","doi":"10.1002/ana.23921","journal":"Annals of neurology","n_participants":62,"pmid":"23686534","source_url":"https://pubmed.ncbi.nlm.nih.gov/23686534/","study_design":null,"title":"Neuroimaging predictors of brain amyloidosis in mild cognitive impairment","title_match":false,"year":2013},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/analysis-of-psychological-symptoms-following-disclosure-of-amyloid-36637820","doi":"10.1001/jamanetworkopen.2022.50921","journal":"JAMA network open","n_participants":27,"pmid":"36637820","source_url":"https://pubmed.ncbi.nlm.nih.gov/36637820/","study_design":null,"title":"Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-of-dutch-type-hereditary-cerebral-amyloid-angiopathy-31361916","doi":"10.1002/ana.25560","journal":"Annals of neurology","n_participants":null,"pmid":"31361916","source_url":"https://pubmed.ncbi.nlm.nih.gov/31361916/","study_design":"longitudinal study","title":"Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers","title_match":true,"year":2019},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/potential-diagnostic-value-of-red-blood-cells-synuclein-30826968","doi":"10.1007/s12035-019-1531-4","journal":"Molecular neurobiology","n_participants":39,"pmid":"30826968","source_url":"https://pubmed.ncbi.nlm.nih.gov/30826968/","study_design":null,"title":"Potential Diagnostic Value of Red Blood Cells \u03b1-Synuclein Heteroaggregates in Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/csf-p-tau181-and-other-biomarkers-in-patients-with-neuronal-36517236","doi":"10.1212/wnl.0000000000201647","journal":"Neurology","n_participants":12,"pmid":"36517236","source_url":"https://pubmed.ncbi.nlm.nih.gov/36517236/","study_design":null,"title":"CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease","title_match":false,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/blood-derived-mitochondrial-dna-copy-number-is-associated-with-39444005","doi":"10.1186/s13195-024-01601-w","journal":"Alzheimer's research & therapy","n_participants":13799,"pmid":"39444005","source_url":"https://pubmed.ncbi.nlm.nih.gov/39444005/","study_design":null,"title":"Blood-derived mitochondrial DNA copy number is associated with Alzheimer disease, Alzheimer-related biomarkers and serum metabolites","title_match":false,"year":2024},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/fast-and-accurate-amyloid-brain-pet-quantification-without-mri-using-36328490","doi":"10.2967/jnumed.122.264414","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"36328490","source_url":"https://pubmed.ncbi.nlm.nih.gov/36328490/","study_design":null,"title":"Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/physical-activity-as-a-moderator-of-alzheimer-pathology-a-systematic-30873924","doi":"10.2174/1567205016666190315095151","journal":"Current Alzheimer research","n_participants":40,"pmid":"30873924","source_url":"https://pubmed.ncbi.nlm.nih.gov/30873924/","study_design":"systematic review","title":"Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies","title_match":false,"year":2019},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/real-space-navigation-testing-differentiates-between-amyloid-positive-31896617","doi":"10.1212/wnl.0000000000008758","journal":"Neurology","n_participants":null,"pmid":"31896617","source_url":"https://pubmed.ncbi.nlm.nih.gov/31896617/","study_design":null,"title":"Real-space navigation testing differentiates between amyloid-positive and -negative aMCI","title_match":true,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/impact-of-amyloid-and-tau-pet-on-changes-in-diagnosis-and-patient-36175151","doi":"10.1212/wnl.0000000000201389","journal":"Neurology","n_participants":40,"pmid":"36175151","source_url":"https://pubmed.ncbi.nlm.nih.gov/36175151/","study_design":null,"title":"Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management","title_match":false,"year":2023},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/association-of-dipeptidyl-peptidase-4-inhibitor-use-and-amyloid-34380754","doi":"10.1212/wnl.0000000000012534","journal":"Neurology","n_participants":70,"pmid":"34380754","source_url":"https://pubmed.ncbi.nlm.nih.gov/34380754/","study_design":"longitudinal study","title":"Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment","title_match":false,"year":2021},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/examining-cognitive-decline-across-black-and-white-participants-in-32417775","doi":"10.3233/jad-191291","journal":"Journal of Alzheimer's disease : JAD","n_participants":296,"pmid":"32417775","source_url":"https://pubmed.ncbi.nlm.nih.gov/32417775/","study_design":"longitudinal study","title":"Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/validation-of-noninvasive-tracer-kinetic-analysis-of-sup-18-sup-f-29175981","doi":"10.2967/jnumed.117.200964","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":20,"pmid":"29175981","source_url":"https://pubmed.ncbi.nlm.nih.gov/29175981/","study_design":"longitudinal study","title":"Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol","title_match":true,"year":2018},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/imaging-vascular-disease-and-amyloid-in-the-aging-brain-implications-25844350","doi":"10.14283/jpad.2015.47","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"25844350","source_url":"https://pubmed.ncbi.nlm.nih.gov/25844350/","study_design":null,"title":"Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment","title_match":false,"year":2015},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/concordance-between-amyloid-pet-quantification-and-real-world-visual-40720133","doi":"10.1001/jamaneurol.2025.2218","journal":"JAMA neurology","n_participants":294,"pmid":"40720133","source_url":"https://pubmed.ncbi.nlm.nih.gov/40720133/","study_design":"cross-sectional","title":"Concordance Between Amyloid-PET Quantification and Real-World Visual Reads","title_match":true,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/associations-of-stages-of-objective-memory-impairment-with-amyloid-35197359","doi":"10.1212/wnl.0000000000200046","journal":"Neurology","n_participants":null,"pmid":"35197359","source_url":"https://pubmed.ncbi.nlm.nih.gov/35197359/","study_design":null,"title":"Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/association-of-memory-impairment-with-concomitant-tau-pathology-in-33627498","doi":"10.1212/wnl.0000000000011745","journal":"Neurology","n_participants":39,"pmid":"33627498","source_url":"https://pubmed.ncbi.nlm.nih.gov/33627498/","study_design":"cross-sectional","title":"Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy","title_match":false,"year":2021},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-dynamics-disorders-relationship-to-alzheimer-31719134","doi":"10.1212/wnl.0000000000008616","journal":"Neurology","n_participants":684,"pmid":"31719134","source_url":"https://pubmed.ncbi.nlm.nih.gov/31719134/","study_design":null,"title":"Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition","title_match":false,"year":2019},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/a-pragmatic-data-driven-method-to-determine-cutoffs-for-csf-35970577","doi":"10.1212/wnl.0000000000200735","journal":"Neurology","n_participants":497,"pmid":"35970577","source_url":"https://pubmed.ncbi.nlm.nih.gov/35970577/","study_design":null,"title":"A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging","title_match":false,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/one-stop-shop-sup-18-sup-f-flortaucipir-pet-differentiates-amyloid-32620704","doi":"10.2967/jnumed.120.244061","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":35,"pmid":"32620704","source_url":"https://pubmed.ncbi.nlm.nih.gov/32620704/","study_design":null,"title":"One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases","title_match":true,"year":2021},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/resting-state-functional-connectivity-disruption-as-a-pathological-33430685","doi":"10.1089/brain.2020.0808","journal":"Brain connectivity","n_participants":171,"pmid":"33430685","source_url":"https://pubmed.ncbi.nlm.nih.gov/33430685/","study_design":"cross-sectional","title":"Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/regional-binding-of-tau-and-amyloid-pet-tracers-in-down-syndrome-33222700","doi":"10.1186/s13024-020-00414-3","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"33222700","source_url":"https://pubmed.ncbi.nlm.nih.gov/33222700/","study_design":null,"title":"Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue","title_match":true,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/better-stress-coping-associated-with-lower-tau-in-amyloid-positive-31964689","doi":"10.1212/wnl.0000000000008979","journal":"Neurology","n_participants":225,"pmid":"31964689","source_url":"https://pubmed.ncbi.nlm.nih.gov/31964689/","study_design":"cross-sectional","title":"Better stress coping associated with lower tau in amyloid-positive cognitively unimpaired older adults","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/challenges-in-a-biological-definition-of-alzheimer-disease-39353147","doi":"10.1212/wnl.0000000000209884","journal":"Neurology","n_participants":null,"pmid":"39353147","source_url":"https://pubmed.ncbi.nlm.nih.gov/39353147/","study_design":"longitudinal study","title":"Challenges in a Biological Definition of Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/brain-pet-imaging-frontotemporal-dementia-36442960","doi":"10.1016/j.cpet.2022.09.010","journal":"PET clinics","n_participants":null,"pmid":"36442960","source_url":"https://pubmed.ncbi.nlm.nih.gov/36442960/","study_design":null,"title":"Brain PET Imaging: Frontotemporal Dementia","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-pet-in-dementia-syndromes-a-chinese-multicenter-study-32385166","doi":"10.2967/jnumed.119.240325","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"32385166","source_url":"https://pubmed.ncbi.nlm.nih.gov/32385166/","study_design":null,"title":"Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study","title_match":true,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/canadian-consensus-guidelines-on-use-of-amyloid-imaging-in-canada-26916179","doi":"10.1017/cjn.2015.401","journal":"The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques","n_participants":null,"pmid":"26916179","source_url":"https://pubmed.ncbi.nlm.nih.gov/26916179/","study_design":null,"title":"Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada","title_match":true,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/regional-age-related-atrophy-after-screening-for-preclinical-34655980","doi":"10.1016/j.neurobiolaging.2021.09.010","journal":"Neurobiology of aging","n_participants":null,"pmid":"34655980","source_url":"https://pubmed.ncbi.nlm.nih.gov/34655980/","study_design":"cross-sectional","title":"Regional age-related atrophy after screening for preclinical alzheimer disease","title_match":false,"year":2022},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-candidates-may-focus-more-on-30094328","doi":"10.1016/j.dadm.2018.05.003","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":59,"pmid":"30094328","source_url":"https://pubmed.ncbi.nlm.nih.gov/30094328/","study_design":"randomized controlled trial","title":"Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure","title_match":true,"year":2018},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/18f-fdg-pet-improves-diagnosis-in-patients-with-focal-onset-dementias-26251415","doi":"10.2967/jnumed.115.161067","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":94,"pmid":"26251415","source_url":"https://pubmed.ncbi.nlm.nih.gov/26251415/","study_design":null,"title":"18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias","title_match":false,"year":2015},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/temporal-correlation-of-csf-and-neuroimaging-in-the-amyloid-tau-33931538","doi":"10.1212/wnl.0000000000012123","journal":"Neurology","n_participants":371,"pmid":"33931538","source_url":"https://pubmed.ncbi.nlm.nih.gov/33931538/","study_design":"longitudinal study","title":"Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-pet-quantification-via-end-to-end-training-of-a-deep-learning-31723364","doi":"10.1007/s13139-019-00610-0","journal":"Nuclear medicine and molecular imaging","n_participants":null,"pmid":"31723364","source_url":"https://pubmed.ncbi.nlm.nih.gov/31723364/","study_design":null,"title":"Amyloid PET Quantification Via End-to-End Training of a Deep Learning","title_match":true,"year":2019},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/blood-biomarkers-confirm-subjective-cognitive-decline-scd-as-a-40247130","doi":"10.1038/s41380-025-03021-0","journal":"Molecular psychiatry","n_participants":457,"pmid":"40247130","source_url":"https://pubmed.ncbi.nlm.nih.gov/40247130/","study_design":"longitudinal study","title":"Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer\u00b4s disease","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/predicting-cognitive-decline-in-amyloid-positive-patients-with-mild-38986053","doi":"10.1212/wnl.0000000000209605","journal":"Neurology","n_participants":961,"pmid":"38986053","source_url":"https://pubmed.ncbi.nlm.nih.gov/38986053/","study_design":"longitudinal study","title":"Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia","title_match":true,"year":2024},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/quantitative-brain-positron-emission-tomography-in-female-5xfad-34901060","doi":"10.3389/fmed.2021.745064","journal":"Frontiers in medicine","n_participants":null,"pmid":"34901060","source_url":"https://pubmed.ncbi.nlm.nih.gov/34901060/","study_design":null,"title":"Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations","title_match":false,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-angiopathy-pathology-and-its-association-with-34504022","doi":"10.1212/wnl.0000000000012770","journal":"Neurology","n_participants":null,"pmid":"34504022","source_url":"https://pubmed.ncbi.nlm.nih.gov/34504022/","study_design":null,"title":"Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-\u03b2 PET Signal","title_match":false,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-presubiculum-links-incipient-amyloid-and-tau-pathology-to-memory-32273431","doi":"10.1212/wnl.0000000000009362","journal":"Neurology","n_participants":127,"pmid":"32273431","source_url":"https://pubmed.ncbi.nlm.nih.gov/32273431/","study_design":null,"title":"The presubiculum links incipient amyloid and tau pathology to memory function in older persons","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/assessing-amyloid-pet-positivity-and-cognitive-function-in-down-38940611","doi":"10.1002/alz.14068","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38940611","source_url":"https://pubmed.ncbi.nlm.nih.gov/38940611/","study_design":"cross-sectional","title":"Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/quantitative-brain-amyloid-pet-38514082","doi":"10.2967/jnumed.123.265766","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"38514082","source_url":"https://pubmed.ncbi.nlm.nih.gov/38514082/","study_design":"longitudinal study","title":"Quantitative Brain Amyloid PET","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-rsna-qiba-profile-for-amyloid-pet-as-an-imaging-biomarker-for-36137760","doi":"10.2967/jnumed.122.264031","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"36137760","source_url":"https://pubmed.ncbi.nlm.nih.gov/36137760/","study_design":null,"title":"The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/novel-diagnostic-tools-for-identifying-cognitive-impairment-using-35260170","doi":"10.1186/s13195-022-00978-w","journal":"Alzheimer's research & therapy","n_participants":97,"pmid":"35260170","source_url":"https://pubmed.ncbi.nlm.nih.gov/35260170/","study_design":"open-label trial","title":"Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/microglial-activation-in-the-right-amygdala-entorhinal-hippocampal-33385560","doi":"10.1016/j.neuroimage.2020.117707","journal":"NeuroImage","n_participants":null,"pmid":"33385560","source_url":"https://pubmed.ncbi.nlm.nih.gov/33385560/","study_design":"cross-sectional","title":"Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in AppNL-G-F mice","title_match":false,"year":2021},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/vascular-endothelial-cadherin-as-a-marker-of-endothelial-injury-in-36342663","doi":"10.1002/acn3.51685","journal":"Annals of clinical and translational neurology","n_participants":700,"pmid":"36342663","source_url":"https://pubmed.ncbi.nlm.nih.gov/36342663/","study_design":null,"title":"Vascular endothelial-cadherin as a marker of endothelial injury in preclinical Alzheimer disease","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/in-vivo-assessment-of-lewy-body-and-beta-amyloid-copathologies-in-36071460","doi":"10.1186/s12987-022-00368-2","journal":"Fluids and barriers of the CNS","n_participants":null,"pmid":"36071460","source_url":"https://pubmed.ncbi.nlm.nih.gov/36071460/","study_design":null,"title":"In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/biomarkers-of-age-related-frailty-and-frailty-related-to-diseases-an-35718861","doi":"10.1007/s12603-022-1793-9","journal":"The journal of nutrition, health & aging","n_participants":1199,"pmid":"35718861","source_url":"https://pubmed.ncbi.nlm.nih.gov/35718861/","study_design":"cross-sectional","title":"Biomarkers of Age-Related Frailty and Frailty Related to Diseases: An Exploratory, Cross-Sectional Analysis from the MAPT Study","title_match":false,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/glitter-in-the-darkness-nonfibrillar-amyloid-plaque-components-34016733","doi":"10.2967/jnumed.120.261858","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"34016733","source_url":"https://pubmed.ncbi.nlm.nih.gov/34016733/","study_design":"longitudinal study","title":"Glitter in the Darkness? Nonfibrillar \u03b2-Amyloid Plaque Components Significantly Impact the \u03b2-Amyloid PET Signal in Mouse Models of Alzheimer Disease","title_match":true,"year":2022},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/onset-of-preclinical-alzheimer-disease-in-monozygotic-twins-33583080","doi":"10.1002/ana.26048","journal":"Annals of neurology","n_participants":126,"pmid":"33583080","source_url":"https://pubmed.ncbi.nlm.nih.gov/33583080/","study_design":null,"title":"Onset of Preclinical Alzheimer Disease in Monozygotic Twins","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-pet-fdg-pet-or-mri-the-power-of-different-imaging-biomarkers-31672138","doi":"10.1186/s12883-019-1498-9","journal":"BMC neurology","n_participants":null,"pmid":"31672138","source_url":"https://pubmed.ncbi.nlm.nih.gov/31672138/","study_design":"longitudinal study","title":"Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease","title_match":true,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/multimodal-pet-imaging-of-amyloid-and-tau-pathology-in-alzheimer-28576172","doi":"10.1016/j.cpet.2017.02.005","journal":"PET clinics","n_participants":null,"pmid":"28576172","source_url":"https://pubmed.ncbi.nlm.nih.gov/28576172/","study_design":null,"title":"Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias","title_match":false,"year":2017},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/amyloid-pet-ligands-for-dementia-27157482","doi":"10.1016/j.cpet.2009.12.008","journal":"PET clinics","n_participants":null,"pmid":"27157482","source_url":"https://pubmed.ncbi.nlm.nih.gov/27157482/","study_design":null,"title":"Amyloid PET Ligands for Dementia","title_match":true,"year":2010},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/identification-of-diabetes-related-dementia-longitudinal-perfusion-25573776","doi":"10.1016/j.jns.2014.12.023","journal":"Journal of the neurological sciences","n_participants":175,"pmid":"25573776","source_url":"https://pubmed.ncbi.nlm.nih.gov/25573776/","study_design":"longitudinal study","title":"Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies","title_match":true,"year":2015},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/diffusion-tensor-mri-structural-connectivity-and-pet-amyloid-burden-34636637","doi":"10.1148/radiol.2021210383","journal":"Radiology","n_participants":null,"pmid":"34636637","source_url":"https://pubmed.ncbi.nlm.nih.gov/34636637/","study_design":"cross-sectional","title":"Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort","title_match":true,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/tau-sup-iq-sup-a-canonical-image-based-algorithm-to-quantify-tau-pet-33517326","doi":"10.2967/jnumed.120.258962","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":615,"pmid":"33517326","source_url":"https://pubmed.ncbi.nlm.nih.gov/33517326/","study_design":"cross-sectional","title":"TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans","title_match":false,"year":2021},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/current-role-for-biomarkers-in-clinical-diagnosis-of-alzheimer-29134465","doi":"10.1007/s11940-017-0484-z","journal":"Current treatment options in neurology","n_participants":null,"pmid":"29134465","source_url":"https://pubmed.ncbi.nlm.nih.gov/29134465/","study_design":null,"title":"Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia","title_match":false,"year":2017},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/optimal-target-region-for-subject-classification-on-the-basis-of-26135108","doi":"10.2967/jnumed.115.158774","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26135108","source_url":"https://pubmed.ncbi.nlm.nih.gov/26135108/","study_design":null,"title":"Optimal Target Region for Subject Classification on the Basis of Amyloid PET Images","title_match":true,"year":2015},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/relationships-of-cognitive-measures-with-cerebrospinal-fluid-but-not-38038976","doi":"10.1002/ana.26838","journal":"Annals of neurology","n_participants":null,"pmid":"38038976","source_url":"https://pubmed.ncbi.nlm.nih.gov/38038976/","study_design":null,"title":"Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/investigating-heterogeneity-and-neuroanatomic-correlates-of-35483899","doi":"10.1212/wnl.0000000000200336","journal":"Neurology","n_participants":27,"pmid":"35483899","source_url":"https://pubmed.ncbi.nlm.nih.gov/35483899/","study_design":"case-control study","title":"Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/astrocyte-activation-imaging-with-11c-acetate-and-amyloid-pet-in-mild-34231519","doi":"10.1097/mnm.0000000000001460","journal":"Nuclear medicine communications","n_participants":null,"pmid":"34231519","source_url":"https://pubmed.ncbi.nlm.nih.gov/34231519/","study_design":"cross-sectional","title":"Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology","title_match":true,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-in-olmsted-county-evidence-of-2-subclasses-and-32591471","doi":"10.1212/wnl.0000000000009874","journal":"Neurology","n_participants":547,"pmid":"32591471","source_url":"https://pubmed.ncbi.nlm.nih.gov/32591471/","study_design":null,"title":"CSF biomarkers in Olmsted County: Evidence of 2 subclasses and associations with demographics","title_match":false,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/simultaneously-evaluating-the-effect-of-baseline-levels-and-30569014","doi":"10.1016/j.trci.2018.10.009","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":262,"pmid":"30569014","source_url":"https://pubmed.ncbi.nlm.nih.gov/30569014/","study_design":"longitudinal study","title":"Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/imaging-amyloidopathy-in-parkinson-disease-and-parkinsonian-dementia-25745616","doi":"10.1007/s40336-015-0104-4","journal":"Clinical and translational imaging","n_participants":null,"pmid":"25745616","source_url":"https://pubmed.ncbi.nlm.nih.gov/25745616/","study_design":null,"title":"Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes","title_match":false,"year":2015},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/association-of-the-informant-reported-memory-decline-with-cognitive-37085328","doi":"10.1212/wnl.0000000000207338","journal":"Neurology","n_participants":25,"pmid":"37085328","source_url":"https://pubmed.ncbi.nlm.nih.gov/37085328/","study_design":"cross-sectional","title":"Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum","title_match":false,"year":2023},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/amyloid-pet-a-questionable-single-primary-surrogate-efficacy-measure-36278356","doi":"10.3233/jad-220841","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"36278356","source_url":"https://pubmed.ncbi.nlm.nih.gov/36278356/","study_design":null,"title":"Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials","title_match":true,"year":2022},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/longitudinal-evaluation-of-neuroinflammation-and-oxidative-stress-in-35676734","doi":"10.1186/s13195-022-01016-5","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"35676734","source_url":"https://pubmed.ncbi.nlm.nih.gov/35676734/","study_design":"longitudinal study","title":"Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography","title_match":false,"year":2022},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/neuroticism-conscientiousness-and-in-vivo-alzheimer-pathologies-31985106","doi":"10.1111/pcn.12983","journal":"Psychiatry and clinical neurosciences","n_participants":397,"pmid":"31985106","source_url":"https://pubmed.ncbi.nlm.nih.gov/31985106/","study_design":null,"title":"Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI","title_match":true,"year":2020},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/plasma-glial-fibrillary-acid-protein-and-phosphorated-tau-181-39560478","doi":"10.1148/radiol.233019","journal":"Radiology","n_participants":50,"pmid":"39560478","source_url":"https://pubmed.ncbi.nlm.nih.gov/39560478/","study_design":null,"title":"Plasma Glial Fibrillary Acid Protein and Phosphorated Tau 181 Association with Presynaptic Density-Dependent Tau Pathology at 18F-SynVesT-1 Brain PET Imaging","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/protective-effects-of-sleep-duration-and-physical-activity-on-37379733","doi":"10.1016/j.nicl.2023.103460","journal":"NeuroImage. Clinical","n_participants":4322,"pmid":"37379733","source_url":"https://pubmed.ncbi.nlm.nih.gov/37379733/","study_design":"cross-sectional","title":"Protective effects of sleep duration and physical activity on cognitive performance are influenced by \u03b2-amyloid and brain volume but not tau burden among cognitively unimpaired older adults","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/adamts4-is-involved-in-the-production-of-the-alzheimer-disease-36721026","doi":"10.1038/s41380-023-01946-y","journal":"Molecular psychiatry","n_participants":null,"pmid":"36721026","source_url":"https://pubmed.ncbi.nlm.nih.gov/36721026/","study_design":null,"title":"ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711","title_match":false,"year":2023},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/added-value-of-cerebrospinal-fluid-multimarker-analysis-in-diagnosis-33236496","doi":"10.1111/ene.14658","journal":"European journal of neurology","n_participants":319,"pmid":"33236496","source_url":"https://pubmed.ncbi.nlm.nih.gov/33236496/","study_design":"longitudinal study","title":"Added value of cerebrospinal fluid multimarker analysis in diagnosis and progression of dementia","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/hippocampal-volume-loss-brain-amyloid-accumulation-and-apoe-status-in-31846965","doi":"10.1159/000504302","journal":"Neuro-degenerative diseases","n_participants":null,"pmid":"31846965","source_url":"https://pubmed.ncbi.nlm.nih.gov/31846965/","study_design":"longitudinal study","title":"Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects","title_match":false,"year":2019},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/high-sensitivity-plasma-proteomics-reveals-disease-specific-41250190","doi":"10.1186/s13024-025-00909-x","journal":"Molecular neurodegeneration","n_participants":3232,"pmid":"41250190","source_url":"https://pubmed.ncbi.nlm.nih.gov/41250190/","study_design":null,"title":"High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort","title_match":false,"year":2025},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/associations-between-changes-in-levels-of-phosphorylated-tau-and-40373247","doi":"10.1212/wnl.0000000000213676","journal":"Neurology","n_participants":431,"pmid":"40373247","source_url":"https://pubmed.ncbi.nlm.nih.gov/40373247/","study_design":"longitudinal study","title":"Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/amyloid-pet-predicts-longitudinal-functional-and-cognitive-40145384","doi":"10.1002/alz.70075","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40145384","source_url":"https://pubmed.ncbi.nlm.nih.gov/40145384/","study_design":null,"title":"Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort","title_match":true,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/machine-learning-models-of-polygenic-risk-for-enhanced-prediction-of-38250184","doi":"10.1212/nxg.0000000000200120","journal":"Neurology. Genetics","n_participants":1791,"pmid":"38250184","source_url":"https://pubmed.ncbi.nlm.nih.gov/38250184/","study_design":null,"title":"Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes","title_match":false,"year":2024},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/metabolite-signature-of-alzheimer-s-disease-in-adults-with-down-34309066","doi":"10.1002/ana.26178","journal":"Annals of neurology","n_participants":118,"pmid":"34309066","source_url":"https://pubmed.ncbi.nlm.nih.gov/34309066/","study_design":null,"title":"Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/optical-coherence-tomography-angiography-retinal-imaging-associations-39085998","doi":"10.1097/wno.0000000000002230","journal":"Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society","n_participants":41,"pmid":"39085998","source_url":"https://pubmed.ncbi.nlm.nih.gov/39085998/","study_design":null,"title":"Optical Coherence Tomography Angiography Retinal Imaging Associations With Burden of Small Vessel Disease and Amyloid Positivity in the Brain","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/spatial-extent-as-a-sensitive-amyloid-pet-metric-in-preclinical-38988055","doi":"10.1002/alz.14036","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38988055","source_url":"https://pubmed.ncbi.nlm.nih.gov/38988055/","study_design":null,"title":"Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer's disease","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/atrophy-patterns-in-cerebral-amyloid-angiopathy-with-and-without-29678935","doi":"10.1212/wnl.0000000000005524","journal":"Neurology","n_participants":27,"pmid":"29678935","source_url":"https://pubmed.ncbi.nlm.nih.gov/29678935/","study_design":null,"title":"Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/molecular-imaging-of-alzheimer-disease-pathology-24503555","doi":"10.3174/ajnr.a3847","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"24503555","source_url":"https://pubmed.ncbi.nlm.nih.gov/24503555/","study_design":"cohort study","title":"Molecular imaging of Alzheimer disease pathology","title_match":false,"year":2014},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-p-tau217-and-lt-sup-gt-18-lt-sup-gt-f-fdg-pet-39715476","doi":"10.1212/wnl.0000000000210211","journal":"Neurology","n_participants":81,"pmid":"39715476","source_url":"https://pubmed.ncbi.nlm.nih.gov/39715476/","study_design":null,"title":"Comparison of Plasma p-tau217 and [18F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/blood-synuclein-is-related-to-amyloid-pet-positivity-in-memory-clinic-37052206","doi":"10.1002/alz.13046","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":51,"pmid":"37052206","source_url":"https://pubmed.ncbi.nlm.nih.gov/37052206/","study_design":"longitudinal study","title":"Blood \u03b2-synuclein is related to amyloid PET positivity in memory clinic patients","title_match":true,"year":2023},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/differential-neurocognitive-network-perturbation-in-amnestic-and-31969462","doi":"10.1212/wnl.0000000000008960","journal":"Neurology","n_participants":14,"pmid":"31969462","source_url":"https://pubmed.ncbi.nlm.nih.gov/31969462/","study_design":null,"title":"Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/concordance-between-centiloid-quantification-and-visual-40101933","doi":"10.3174/ajnr.a8743","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"40101933","source_url":"https://pubmed.ncbi.nlm.nih.gov/40101933/","study_design":null,"title":"Concordance between Centiloid Quantification and Visual Interpretation of Amyloid PET Scans across the Alzheimer Disease Continuum","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/advanced-structural-brain-aging-in-preclinical-autosomal-dominant-38111006","doi":"10.1186/s13024-023-00688-3","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"38111006","source_url":"https://pubmed.ncbi.nlm.nih.gov/38111006/","study_design":null,"title":"Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/combined-connectomics-mapt-gene-expression-and-amyloid-deposition-to-37837382","doi":"10.1002/ana.26818","journal":"Annals of neurology","n_participants":1000,"pmid":"37837382","source_url":"https://pubmed.ncbi.nlm.nih.gov/37837382/","study_design":null,"title":"Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/psychosocial-and-behavioral-outcomes-for-persons-with-cognitive-37561950","doi":"10.1097/wad.0000000000000569","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"37561950","source_url":"https://pubmed.ncbi.nlm.nih.gov/37561950/","study_design":"systematic review","title":"Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-\u03b2 PET Scan Disclosure: A Systematic Review","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/fdg-pet-and-mri-for-monitoring-immunotherapy-in-alzheimer-disease-37314733","doi":"10.1097/rlu.0000000000004710","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"37314733","source_url":"https://pubmed.ncbi.nlm.nih.gov/37314733/","study_design":null,"title":"FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/focal-amyloid-and-asymmetric-tau-in-an-imaging-to-autopsy-case-of-35945628","doi":"10.1186/s40478-022-01412-w","journal":"Acta neuropathologica communications","n_participants":null,"pmid":"35945628","source_url":"https://pubmed.ncbi.nlm.nih.gov/35945628/","study_design":null,"title":"Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology","title_match":false,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/a-population-based-study-of-head-injury-cognitive-function-and-33694298","doi":"10.1002/acn3.51331","journal":"Annals of clinical and translational neurology","n_participants":502,"pmid":"33694298","source_url":"https://pubmed.ncbi.nlm.nih.gov/33694298/","study_design":null,"title":"A population-based study of head injury, cognitive function and pathological markers","title_match":false,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-cerebral-blood-flow-single-photon-emission-32388925","doi":"10.1111/imj.14890","journal":"Internal medicine journal","n_participants":126,"pmid":"32388925","source_url":"https://pubmed.ncbi.nlm.nih.gov/32388925/","study_design":null,"title":"Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and 18 F-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of Alzheimer disease","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/reshaping-the-amyloid-buildup-curve-in-alzheimer-disease-partial-32358089","doi":"10.2967/jnumed.119.238477","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"32358089","source_url":"https://pubmed.ncbi.nlm.nih.gov/32358089/","study_design":"longitudinal study","title":"Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data","title_match":true,"year":2020},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/neuroimaging-of-diseases-causing-dementia-31761062","doi":"10.1016/j.ncl.2019.08.003","journal":"Neurologic clinics","n_participants":null,"pmid":"31761062","source_url":"https://pubmed.ncbi.nlm.nih.gov/31761062/","study_design":null,"title":"Neuroimaging of Diseases Causing Dementia","title_match":false,"year":2020},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/integrating-plasma-p-tau217-and-digital-cognitive-assessments-for-40491259","doi":"10.1002/alz.70355","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":954,"pmid":"40491259","source_url":"https://pubmed.ncbi.nlm.nih.gov/40491259/","study_design":null,"title":"Integrating plasma p-tau217 and digital cognitive assessments for early detection in Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/late-life-depression-is-not-associated-with-alzheimer-type-tau-39107144","doi":"10.1016/j.jagp.2024.07.005","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":102,"pmid":"39107144","source_url":"https://pubmed.ncbi.nlm.nih.gov/39107144/","study_design":"cross-sectional","title":"Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/evidence-of-pericyte-damage-in-a-cognitively-normal-cohort-38752577","doi":"10.1097/wad.0000000000000623","journal":"Alzheimer disease and associated disorders","n_participants":null,"pmid":"38752577","source_url":"https://pubmed.ncbi.nlm.nih.gov/38752577/","study_design":"cross-sectional","title":"Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer Disease","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/deconstructing-pathological-tau-by-biological-process-in-early-stages-38552342","doi":"10.1016/j.ebiom.2024.105080","journal":"EBioMedicine","n_participants":null,"pmid":"38552342","source_url":"https://pubmed.ncbi.nlm.nih.gov/38552342/","study_design":"cross-sectional","title":"Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging","title_match":false,"year":2024},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/cognitive-impact-of-multidomain-intervention-and-omega-3-according-to-37872582","doi":"10.1186/s13195-023-01325-3","journal":"Alzheimer's research & therapy","n_participants":483,"pmid":"37872582","source_url":"https://pubmed.ncbi.nlm.nih.gov/37872582/","study_design":null,"title":"Cognitive impact of multidomain intervention and omega 3 according to blood A\u03b242/40 ratio: a subgroup analysis from the randomized MAPT trial","title_match":false,"year":2023},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/advanced-brain-imaging-for-the-diagnosis-of-alzheimer-disease-37639461","doi":"10.1097/wco.0000000000001198","journal":"Current opinion in neurology","n_participants":null,"pmid":"37639461","source_url":"https://pubmed.ncbi.nlm.nih.gov/37639461/","study_design":null,"title":"Advanced brain imaging for the diagnosis of Alzheimer disease","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-associations-of-obesity-with-tau-amyloid-pet-37574737","doi":"10.3233/jad-230466","journal":"Journal of Alzheimer's disease : JAD","n_participants":387,"pmid":"37574737","source_url":"https://pubmed.ncbi.nlm.nih.gov/37574737/","study_design":null,"title":"Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-biomarkers-may-aid-in-the-prognosis-of-mci-cases-31068481","doi":"10.1212/wnl.0000000000007609","journal":"Neurology","n_participants":757,"pmid":"31068481","source_url":"https://pubmed.ncbi.nlm.nih.gov/31068481/","study_design":null,"title":"Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal","title_match":false,"year":2019},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-amyloid-imaging-in-a-complex-case-of-corticobasal-26225355","doi":"10.4172/2329-6895.1000194","journal":"Journal of neurological disorders","n_participants":null,"pmid":"26225355","source_url":"https://pubmed.ncbi.nlm.nih.gov/26225355/","study_design":null,"title":"Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms","title_match":true,"year":2014},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-the-court-of-public-opinion-23966257","doi":"10.1212/wnl.0b013e3182a55fe3","journal":"Neurology","n_participants":null,"pmid":"23966257","source_url":"https://pubmed.ncbi.nlm.nih.gov/23966257/","study_design":null,"title":"Amyloid imaging: the court of public opinion","title_match":true,"year":2013},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/amyloid-pet-mri-in-the-differential-diagnosis-of-dementia-23856830","doi":"10.1097/rlu.0b013e31829b9e5f","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"23856830","source_url":"https://pubmed.ncbi.nlm.nih.gov/23856830/","study_design":null,"title":"Amyloid PET/MRI in the differential diagnosis of dementia","title_match":true,"year":2014},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/longitudinal-blood-based-biomarkers-and-clinical-progression-in-41335440","doi":"10.1001/jamanetworkopen.2025.45862","journal":"JAMA network open","n_participants":298,"pmid":"41335440","source_url":"https://pubmed.ncbi.nlm.nih.gov/41335440/","study_design":"cohort study","title":"Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/analytical-validation-and-performance-of-a-blood-based-p-tau217-39836199","doi":"10.1093/jalm/jfae155","journal":"The journal of applied laboratory medicine","n_participants":1091,"pmid":"39836199","source_url":"https://pubmed.ncbi.nlm.nih.gov/39836199/","study_design":null,"title":"Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/proteomic-clusters-underlie-heterogeneity-in-preclinical-alzheimer-s-36542469","doi":"10.1093/brain/awac484","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"36542469","source_url":"https://pubmed.ncbi.nlm.nih.gov/36542469/","study_design":"longitudinal study","title":"Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/csf-phosphorylated-tau-as-an-indicator-of-subsequent-tau-accumulation-35764037","doi":"10.1016/j.neurobiolaging.2022.02.015","journal":"Neurobiology of aging","n_participants":143,"pmid":"35764037","source_url":"https://pubmed.ncbi.nlm.nih.gov/35764037/","study_design":"longitudinal study","title":"CSF phosphorylated tau as an indicator of subsequent tau accumulation","title_match":false,"year":2022},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/neuropsychological-assessment-and-cerebral-vascular-disease-the-new-23999023","doi":"10.1016/j.neurol.2013.07.009","journal":"Revue neurologique","n_participants":null,"pmid":"23999023","source_url":"https://pubmed.ncbi.nlm.nih.gov/23999023/","study_design":null,"title":"Neuropsychological assessment and cerebral vascular disease: the new standards","title_match":false,"year":2013},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-217-and-amyloid-burden-in-older-adults-41324928","doi":"10.1001/jamaneurol.2025.4721","journal":"JAMA neurology","n_participants":7834,"pmid":"41324928","source_url":"https://pubmed.ncbi.nlm.nih.gov/41324928/","study_design":"systematic review","title":"Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/imaging-and-fluid-biomarkers-of-alzheimer-disease-complementation-40480828","doi":"10.2967/jnumed.125.270152","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"40480828","source_url":"https://pubmed.ncbi.nlm.nih.gov/40480828/","study_design":null,"title":"Imaging and Fluid Biomarkers of Alzheimer Disease: Complementation Rather Than Competition","title_match":false,"year":2025},{"alzhub_score":85,"alzhub_url":"https://alzhub.org/study/two-phase-3-trials-of-bapineuzumab-in-mild-to-moderate-alzheimer-s-24450891","doi":"10.1056/nejmoa1304839","journal":"The New England journal of medicine","n_participants":1090,"pmid":"24450891","source_url":"https://pubmed.ncbi.nlm.nih.gov/24450891/","study_design":"clinical trial","title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/prevalence-of-cerebral-amyloid-pathology-in-persons-without-dementia-25988462","doi":"10.1001/jama.2015.4668","journal":"JAMA","n_participants":2914,"pmid":"25988462","source_url":"https://pubmed.ncbi.nlm.nih.gov/25988462/","study_design":"meta-analysis","title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","title_match":false,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/imaging-beta-amyloid-burden-in-aging-and-dementia-17502554","doi":"10.1212/01.wnl.0000261919.22630.ea","journal":"Neurology","n_participants":null,"pmid":"17502554","source_url":"https://pubmed.ncbi.nlm.nih.gov/17502554/","study_design":"longitudinal study","title":"Imaging beta-amyloid burden in aging and dementia","title_match":false,"year":2007},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/apoe-predicts-amyloid-beta-but-not-tau-alzheimer-pathology-in-20186853","doi":"10.1002/ana.21843","journal":"Annals of neurology","n_participants":241,"pmid":"20186853","source_url":"https://pubmed.ncbi.nlm.nih.gov/20186853/","study_design":null,"title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","title_match":false,"year":2010},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/longitudinal-assessment-of-a-and-cognition-in-aging-and-alzheimer-21280088","doi":"10.1002/ana.22248","journal":"Annals of neurology","n_participants":206,"pmid":"21280088","source_url":"https://pubmed.ncbi.nlm.nih.gov/21280088/","study_design":null,"title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":75,"alzhub_url":"https://alzhub.org/study/association-between-midlife-vascular-risk-factors-and-estimated-brain-28399252","doi":"10.1001/jama.2017.3090","journal":"JAMA","n_participants":20,"pmid":"28399252","source_url":"https://pubmed.ncbi.nlm.nih.gov/28399252/","study_design":"cohort study","title":"Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition","title_match":false,"year":2017},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/conversion-of-amyloid-positive-and-negative-mci-to-ad-over-3-years-an-19587325","doi":"10.1212/wnl.0b013e3181b23564","journal":"Neurology","n_participants":null,"pmid":"19587325","source_url":"https://pubmed.ncbi.nlm.nih.gov/19587325/","study_design":null,"title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","title_match":true,"year":2009},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/amyloid-burden-in-healthy-aging-regional-distribution-and-cognitive-22302550","doi":"10.1212/wnl.0b013e318245d295","journal":"Neurology","n_participants":137,"pmid":"22302550","source_url":"https://pubmed.ncbi.nlm.nih.gov/22302550/","study_design":null,"title":"\u03b2-Amyloid burden in healthy aging: regional distribution and cognitive consequences","title_match":false,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-association-of-global-amyloid-and-regional-tau-30715078","doi":"10.1001/jamaneurol.2018.4693","journal":"JAMA neurology","n_participants":89,"pmid":"30715078","source_url":"https://pubmed.ncbi.nlm.nih.gov/30715078/","study_design":"cross-sectional","title":"Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults","title_match":false,"year":2019},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/assessment-of-racial-disparities-in-biomarkers-for-alzheimer-disease-30615028","doi":"10.1001/jamaneurol.2018.4249","journal":"JAMA neurology","n_participants":1255,"pmid":"30615028","source_url":"https://pubmed.ncbi.nlm.nih.gov/30615028/","study_design":"cross-sectional","title":"Assessment of Racial Disparities in Biomarkers for Alzheimer Disease","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/accuracy-of-brain-amyloid-detection-in-clinical-practice-using-25155658","doi":"10.1001/jamaneurol.2014.1358","journal":"JAMA neurology","n_participants":118,"pmid":"25155658","source_url":"https://pubmed.ncbi.nlm.nih.gov/25155658/","study_design":"cross-sectional","title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-amyloid 42: a cross-validation study against amyloid positron emission tomography","title_match":true,"year":2014},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/using-positron-emission-tomography-and-florbetapir-f18-to-image-21747008","doi":"10.1001/archneurol.2011.150","journal":"Archives of neurology","n_participants":46,"pmid":"21747008","source_url":"https://pubmed.ncbi.nlm.nih.gov/21747008/","study_design":null,"title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","title_match":true,"year":2011},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/asymmetry-and-heterogeneity-of-alzheimer-s-and-frontotemporal-24574501","doi":"10.1093/brain/awu024","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"24574501","source_url":"https://pubmed.ncbi.nlm.nih.gov/24574501/","study_design":null,"title":"Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia","title_match":false,"year":2014},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/suspected-non-alzheimer-disease-pathophysiology-concept-and-26782335","doi":"10.1038/nrneurol.2015.251","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"26782335","source_url":"https://pubmed.ncbi.nlm.nih.gov/26782335/","study_design":null,"title":"Suspected non-Alzheimer disease pathophysiology--concept and controversy","title_match":false,"year":2016},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/longitudinal-tau-accumulation-and-atrophy-in-aging-and-alzheimer-30597624","doi":"10.1002/ana.25406","journal":"Annals of neurology","n_participants":null,"pmid":"30597624","source_url":"https://pubmed.ncbi.nlm.nih.gov/30597624/","study_design":"longitudinal study","title":"Longitudinal tau accumulation and atrophy in aging and alzheimer disease","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/longitudinal-cerebrospinal-fluid-biomarker-changes-in-preclinical-26147946","doi":"10.1001/jamaneurol.2015.1285","journal":"JAMA neurology","n_participants":169,"pmid":"26147946","source_url":"https://pubmed.ncbi.nlm.nih.gov/26147946/","study_design":"cohort study","title":"Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age","title_match":false,"year":2015},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/mild-hypercholesterolemia-is-an-early-risk-factor-for-the-development-12874399","doi":"10.1212/01.wnl.0000070182.02537.84","journal":"Neurology","n_participants":null,"pmid":"12874399","source_url":"https://pubmed.ncbi.nlm.nih.gov/12874399/","study_design":null,"title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","title_match":false,"year":2003},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/pet-amyloid-ligand-11c-pib-uptake-is-increased-in-mild-cognitive-17485647","doi":"10.1212/01.wnl.0000260969.94695.56","journal":"Neurology","n_participants":13,"pmid":"17485647","source_url":"https://pubmed.ncbi.nlm.nih.gov/17485647/","study_design":null,"title":"PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment","title_match":true,"year":2007},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/association-of-short-and-long-sleep-duration-with-amyloid-burden-and-34459862","doi":"10.1001/jamaneurol.2021.2876","journal":"JAMA neurology","n_participants":2618,"pmid":"34459862","source_url":"https://pubmed.ncbi.nlm.nih.gov/34459862/","study_design":"cross-sectional","title":"Association of Short and Long Sleep Duration With Amyloid-\u03b2 Burden and Cognition in Aging","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/clinical-syndromes-associated-with-posterior-atrophy-early-age-at-19901249","doi":"10.1212/wnl.0b013e3181c0d427","journal":"Neurology","n_participants":30,"pmid":"19901249","source_url":"https://pubmed.ncbi.nlm.nih.gov/19901249/","study_design":null,"title":"Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum","title_match":false,"year":2009},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/effect-of-apoe-genotype-on-amyloid-plaque-load-and-gray-matter-volume-19339712","doi":"10.1212/wnl.0b013e3181a2e8d0","journal":"Neurology","n_participants":null,"pmid":"19339712","source_url":"https://pubmed.ncbi.nlm.nih.gov/19339712/","study_design":null,"title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","title_match":false,"year":2009},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/cognitive-and-neuroimaging-features-and-brain-amyloidosis-in-29500152","doi":"10.1016/s1474-4422(18)30029-2","journal":"The Lancet. Neurology","n_participants":318,"pmid":"29500152","source_url":"https://pubmed.ncbi.nlm.nih.gov/29500152/","study_design":null,"title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study","title_match":false,"year":2018},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/prevalence-of-amyloid-pathology-in-distinct-variants-of-primary-30255971","doi":"10.1002/ana.25333","journal":"Annals of neurology","n_participants":443,"pmid":"30255971","source_url":"https://pubmed.ncbi.nlm.nih.gov/30255971/","study_design":"meta-analysis","title":"Prevalence of amyloid-\u03b2 pathology in distinct variants of primary progressive aphasia","title_match":false,"year":2018},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/arterial-stiffness-and-dementia-pathology-atherosclerosis-risk-in-29549223","doi":"10.1212/wnl.0000000000005259","journal":"Neurology","n_participants":null,"pmid":"29549223","source_url":"https://pubmed.ncbi.nlm.nih.gov/29549223/","study_design":"cross-sectional","title":"Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study","title_match":false,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/indicators-of-amyloid-burden-in-a-population-based-study-of-22972644","doi":"10.1212/wnl.0b013e31826e2696","journal":"Neurology","n_participants":100,"pmid":"22972644","source_url":"https://pubmed.ncbi.nlm.nih.gov/22972644/","study_design":null,"title":"Indicators of amyloid burden in a population-based study of cognitively normal elderly","title_match":false,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/effect-of-lifestyle-activities-on-alzheimer-disease-biomarkers-and-23280791","doi":"10.1002/ana.23665","journal":"Annals of neurology","n_participants":515,"pmid":"23280791","source_url":"https://pubmed.ncbi.nlm.nih.gov/23280791/","study_design":null,"title":"Effect of lifestyle activities on Alzheimer disease biomarkers and cognition","title_match":false,"year":2012},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/sex-driven-modifiers-of-alzheimer-risk-a-multimodality-brain-imaging-32580974","doi":"10.1212/wnl.0000000000009781","journal":"Neurology","n_participants":null,"pmid":"32580974","source_url":"https://pubmed.ncbi.nlm.nih.gov/32580974/","study_design":null,"title":"Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/genetic-susceptibility-for-alzheimer-disease-neuritic-plaque-pathology-23836404","doi":"10.1001/jamaneurol.2013.2815","journal":"JAMA neurology","n_participants":114,"pmid":"23836404","source_url":"https://pubmed.ncbi.nlm.nih.gov/23836404/","study_design":null,"title":"Genetic susceptibility for Alzheimer disease neuritic plaque pathology","title_match":false,"year":2013},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/incidence-of-cerebral-microbleeds-in-preclinical-alzheimer-disease-24623839","doi":"10.1212/wnl.0000000000000285","journal":"Neurology","n_participants":null,"pmid":"24623839","source_url":"https://pubmed.ncbi.nlm.nih.gov/24623839/","study_design":"longitudinal study","title":"Incidence of cerebral microbleeds in preclinical Alzheimer disease","title_match":false,"year":2014},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/odor-identification-and-alzheimer-disease-biomarkers-in-clinically-25934852","doi":"10.1212/wnl.0000000000001614","journal":"Neurology","n_participants":null,"pmid":"25934852","source_url":"https://pubmed.ncbi.nlm.nih.gov/25934852/","study_design":"cross-sectional","title":"Odor identification and Alzheimer disease biomarkers in clinically normal elderly","title_match":false,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/amyloid-11c-pib-pet-imaging-results-from-2-randomized-bapineuzumab-26208959","doi":"10.1212/wnl.0000000000001877","journal":"Neurology","n_participants":115,"pmid":"26208959","source_url":"https://pubmed.ncbi.nlm.nih.gov/26208959/","study_design":"clinical trial","title":"Amyloid-\u03b2 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","title_match":true,"year":2015},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/plasma-apolipoprotein-e-and-alzheimer-disease-risk-the-aibl-study-of-21422459","doi":"10.1212/wnl.0b013e318211c352","journal":"Neurology","n_participants":1079,"pmid":"21422459","source_url":"https://pubmed.ncbi.nlm.nih.gov/21422459/","study_design":"cross-sectional","title":"Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging","title_match":false,"year":2011},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/relationship-of-regional-brain-amyloid-to-gait-speed-26643548","doi":"10.1212/wnl.0000000000002235","journal":"Neurology","n_participants":null,"pmid":"26643548","source_url":"https://pubmed.ncbi.nlm.nih.gov/26643548/","study_design":"cross-sectional","title":"Relationship of regional brain \u03b2-amyloid to gait speed","title_match":false,"year":2016},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-biomarkers-and-clinical-phenotype-in-dementia-with-32989106","doi":"10.1212/wnl.0000000000010943","journal":"Neurology","n_participants":417,"pmid":"32989106","source_url":"https://pubmed.ncbi.nlm.nih.gov/32989106/","study_design":null,"title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/temporal-dynamics-of-amyloid-accumulation-in-aging-and-alzheimer-33408147","doi":"10.1212/wnl.0000000000011524","journal":"Neurology","n_participants":475,"pmid":"33408147","source_url":"https://pubmed.ncbi.nlm.nih.gov/33408147/","study_design":null,"title":"Temporal Dynamics of \u03b2-Amyloid Accumulation in Aging and Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/shapes-of-the-trajectories-of-5-major-biomarkers-of-alzheimer-disease-22409939","doi":"10.1001/archneurol.2011.3405","journal":"Archives of neurology","n_participants":343,"pmid":"22409939","source_url":"https://pubmed.ncbi.nlm.nih.gov/22409939/","study_design":"cross-sectional","title":"Shapes of the trajectories of 5 major biomarkers of Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/regional-amyloid-accumulation-and-cognitive-decline-in-initially-30305451","doi":"10.1212/wnl.0000000000006469","journal":"Neurology","n_participants":null,"pmid":"30305451","source_url":"https://pubmed.ncbi.nlm.nih.gov/30305451/","study_design":null,"title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","title_match":true,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/differential-effect-of-apoe-genotype-on-amyloid-load-and-glucose-23255822","doi":"10.1212/wnl.0b013e31827f0889","journal":"Neurology","n_participants":null,"pmid":"23255822","source_url":"https://pubmed.ncbi.nlm.nih.gov/23255822/","study_design":null,"title":"Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia","title_match":false,"year":2013},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/genetic-risk-for-alzheimer-disease-is-distinct-from-genetic-risk-for-31199530","doi":"10.1002/ana.25530","journal":"Annals of neurology","n_participants":null,"pmid":"31199530","source_url":"https://pubmed.ncbi.nlm.nih.gov/31199530/","study_design":null,"title":"Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition","title_match":false,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/vascular-risk-and-amyloid-are-synergistically-associated-with-30565287","doi":"10.1002/ana.25399","journal":"Annals of neurology","n_participants":null,"pmid":"30565287","source_url":"https://pubmed.ncbi.nlm.nih.gov/30565287/","study_design":null,"title":"Vascular Risk and \u03b2-Amyloid Are Synergistically Associated with Cortical Tau","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/associations-of-the-top-20-alzheimer-disease-risk-variants-with-brain-29340569","doi":"10.1001/jamaneurol.2017.4198","journal":"JAMA neurology","n_participants":977,"pmid":"29340569","source_url":"https://pubmed.ncbi.nlm.nih.gov/29340569/","study_design":null,"title":"Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis","title_match":false,"year":2018},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/increased-midlife-triglycerides-predict-brain-amyloid-and-tau-29196581","doi":"10.1212/wnl.0000000000004749","journal":"Neurology","n_participants":134,"pmid":"29196581","source_url":"https://pubmed.ncbi.nlm.nih.gov/29196581/","study_design":"cohort study","title":"Increased midlife triglycerides predict brain \u03b2-amyloid and tau pathology 20 years later","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e-genotype-and-the-diagnostic-accuracy-of-25162367","doi":"10.1001/jamapsychiatry.2014.1060","journal":"JAMA psychiatry","n_participants":105,"pmid":"25162367","source_url":"https://pubmed.ncbi.nlm.nih.gov/25162367/","study_design":null,"title":"Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease","title_match":false,"year":2014},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/nonlinear-association-between-cerebrospinal-fluid-and-florbetapir-f-25822737","doi":"10.1001/jamaneurol.2014.4829","journal":"JAMA neurology","n_participants":820,"pmid":"25822737","source_url":"https://pubmed.ncbi.nlm.nih.gov/25822737/","study_design":"cohort study","title":"Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 \u03b2-Amyloid Measures Across the Spectrum of Alzheimer Disease","title_match":true,"year":2015},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/dissociable-influences-of-i-apoe-i-4-and-polygenic-risk-of-ad-29592889","doi":"10.1212/wnl.0000000000005415","journal":"Neurology","n_participants":702,"pmid":"29592889","source_url":"https://pubmed.ncbi.nlm.nih.gov/29592889/","study_design":"longitudinal study","title":"Dissociable influences of APOE \u03b54 and polygenic risk of AD dementia on amyloid and cognition","title_match":false,"year":2018},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-brain-amyloid-with-slow-gait-in-elderly-individuals-27842173","doi":"10.1001/jamaneurol.2016.3474","journal":"JAMA neurology","n_participants":183,"pmid":"27842173","source_url":"https://pubmed.ncbi.nlm.nih.gov/27842173/","study_design":"cross-sectional","title":"Association of Brain Amyloid-\u03b2 With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E \u03b54 Genotype","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/myo-inositol-changes-precede-amyloid-pathology-and-relate-to-apoe-27164711","doi":"10.1212/wnl.0000000000002672","journal":"Neurology","n_participants":null,"pmid":"27164711","source_url":"https://pubmed.ncbi.nlm.nih.gov/27164711/","study_design":"cross-sectional","title":"Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/association-of-hypometabolism-and-amyloid-levels-in-aging-normal-24793183","doi":"10.1212/wnl.0000000000000467","journal":"Neurology","n_participants":null,"pmid":"24793183","source_url":"https://pubmed.ncbi.nlm.nih.gov/24793183/","study_design":"cross-sectional","title":"Association of hypometabolism and amyloid levels in aging, normal subjects","title_match":false,"year":2014},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/precuneus-amyloid-burden-is-associated-with-reduced-cholinergic-21700583","doi":"10.1212/wnl.0b013e3182231419","journal":"Neurology","n_participants":null,"pmid":"21700583","source_url":"https://pubmed.ncbi.nlm.nih.gov/21700583/","study_design":null,"title":"Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/mechanism-of-amyloid-removal-in-patients-with-alzheimer-disease-21987394","doi":"10.1001/archneurol.2011.1538","journal":"Archives of neurology","n_participants":null,"pmid":"21987394","source_url":"https://pubmed.ncbi.nlm.nih.gov/21987394/","study_design":null,"title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","title_match":false,"year":2012},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/targeting-prodromal-alzheimer-disease-with-avagacestat-a-randomized-26414022","doi":"10.1001/jamaneurol.2015.0607","journal":"JAMA neurology","n_participants":263,"pmid":"26414022","source_url":"https://pubmed.ncbi.nlm.nih.gov/26414022/","study_design":"randomized controlled trial","title":"Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial","title_match":false,"year":2015},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/short-term-psychological-outcomes-of-disclosing-amyloid-imaging-32777010","doi":"10.1001/jamaneurol.2020.2734","journal":"JAMA neurology","n_participants":1167,"pmid":"32777010","source_url":"https://pubmed.ncbi.nlm.nih.gov/32777010/","study_design":"cohort study","title":"Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment","title_match":true,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/effects-of-liraglutide-on-neurodegeneration-blood-flow-and-cognition-23158895","doi":null,"journal":"Danish medical journal","n_participants":20,"pmid":"23158895","source_url":"https://pubmed.ncbi.nlm.nih.gov/23158895/","study_design":null,"title":"Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer\u00b4s disease - protocol for a controlled, randomized double-blinded trial","title_match":false,"year":2012},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/a-phase-ii-randomized-double-blind-placebo-controlled-study-of-safety-27589523","doi":"10.3233/jad-160369","journal":"Journal of Alzheimer's disease : JAD","n_participants":146,"pmid":"27589523","source_url":"https://pubmed.ncbi.nlm.nih.gov/27589523/","study_design":null,"title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/association-of-sleep-disordered-breathing-and-medial-temporal-lobe-37258299","doi":"10.1212/wnl.0000000000207421","journal":"Neurology","n_participants":122,"pmid":"37258299","source_url":"https://pubmed.ncbi.nlm.nih.gov/37258299/","study_design":"randomized controlled trial","title":"Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/low-dose-whole-brain-radiation-therapy-for-alzheimer-s-dementia-36935024","doi":"10.1016/j.ijrobp.2023.03.044","journal":"International journal of radiation oncology, biology, physics","n_participants":null,"pmid":"36935024","source_url":"https://pubmed.ncbi.nlm.nih.gov/36935024/","study_design":null,"title":"Low-Dose Whole Brain Radiation Therapy for Alzheimer's Dementia: Results From a Pilot Trial in Humans","title_match":false,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/relationship-between-brain-amyloid-deposition-and-instrumental-30207586","doi":"10.1111/jgs.15497","journal":"Journal of the American Geriatrics Society","n_participants":269,"pmid":"30207586","source_url":"https://pubmed.ncbi.nlm.nih.gov/30207586/","study_design":"randomized controlled trial","title":"Relationship Between Brain Amyloid Deposition and Instrumental Activities of Daily Living in Older Adults: A Longitudinal Study from the Multidomain Alzheimer Prevention Trial","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-effects-of-low-dose-radiation-therapy-in-patients-with-mild-to-37403351","doi":"10.3857/roj.2023.00052","journal":"Radiation oncology journal","n_participants":null,"pmid":"37403351","source_url":"https://pubmed.ncbi.nlm.nih.gov/37403351/","study_design":"randomized controlled trial","title":"The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study","title_match":false,"year":2023},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/pulse-pressure-as-a-predictor-of-alzheimer-s-disease-biomarkers-and-40908201","doi":"10.1016/j.tjpad.2025.100363","journal":"The journal of prevention of Alzheimer's disease","n_participants":1690,"pmid":"40908201","source_url":"https://pubmed.ncbi.nlm.nih.gov/40908201/","study_design":"cohort study","title":"Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE \u03b54","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/changes-in-daily-functioning-in-association-with-tau-and-amyloid-40440591","doi":"10.1212/wnl.0000000000213775","journal":"Neurology","n_participants":434,"pmid":"40440591","source_url":"https://pubmed.ncbi.nlm.nih.gov/40440591/","study_design":"randomized controlled trial","title":"Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/protocol-for-a-randomized-phase-ii-iii-double-blind-placebo-40434891","doi":"10.1097/wad.0000000000000677","journal":"Alzheimer disease and associated disorders","n_participants":326,"pmid":"40434891","source_url":"https://pubmed.ncbi.nlm.nih.gov/40434891/","study_design":null,"title":"Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/association-between-lifestyle-at-different-life-periods-and-brain-39919257","doi":"10.1212/wnl.0000000000213347","journal":"Neurology","n_participants":null,"pmid":"39919257","source_url":"https://pubmed.ncbi.nlm.nih.gov/39919257/","study_design":"randomized controlled trial","title":"Association Between Lifestyle at Different Life Periods and Brain Integrity in Older Adults","title_match":false,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/digital-memory-assessments-and-plasma-ptau217-enable-efficient-41653883","doi":"10.1016/j.tjpad.2026.100503","journal":"The journal of prevention of Alzheimer's disease","n_participants":818,"pmid":"41653883","source_url":"https://pubmed.ncbi.nlm.nih.gov/41653883/","study_design":null,"title":"Digital memory assessments and plasma pTau217 enable efficient preclinical Alzheimer's trials","title_match":false,"year":2026},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/interactive-associations-of-vascular-risk-and-amyloid-burden-with-29799986","doi":"10.1001/jamaneurol.2018.1123","journal":"JAMA neurology","n_participants":223,"pmid":"29799986","source_url":"https://pubmed.ncbi.nlm.nih.gov/29799986/","study_design":"longitudinal study","title":"Interactive Associations of Vascular Risk and \u03b2-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study","title_match":false,"year":2018},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/prevalence-and-outcomes-of-amyloid-positivity-among-persons-without-29710225","doi":"10.1001/jamaneurol.2018.0629","journal":"JAMA neurology","n_participants":3894,"pmid":"29710225","source_url":"https://pubmed.ncbi.nlm.nih.gov/29710225/","study_design":null,"title":"Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting","title_match":true,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/florbetapir-pet-analysis-of-amyloid-deposition-in-the-presenilin-1-23137949","doi":"10.1016/s1474-4422(12)70227-2","journal":"The Lancet. Neurology","n_participants":null,"pmid":"23137949","source_url":"https://pubmed.ncbi.nlm.nih.gov/23137949/","study_design":"cross-sectional","title":"Florbetapir PET analysis of amyloid-\u03b2 deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study","title_match":true,"year":2012},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/predicting-alzheimer-disease-with-amyloid-imaging-results-from-the-24448836","doi":"10.1002/ana.24040","journal":"Annals of neurology","n_participants":87,"pmid":"24448836","source_url":"https://pubmed.ncbi.nlm.nih.gov/24448836/","study_design":null,"title":"Predicting Alzheimer disease with \u03b2-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing","title_match":true,"year":2013},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/white-matter-hyperintensities-and-cerebral-amyloidosis-necessary-and-23420027","doi":"10.1001/jamaneurol.2013.1321","journal":"JAMA neurology","n_participants":20,"pmid":"23420027","source_url":"https://pubmed.ncbi.nlm.nih.gov/23420027/","study_design":null,"title":"White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pet-amyloid-beta-imaging-in-preclinical-alzheimer-s-disease-22108203","doi":"10.1016/j.bbadis.2011.11.005","journal":"Biochimica et biophysica acta","n_participants":null,"pmid":"22108203","source_url":"https://pubmed.ncbi.nlm.nih.gov/22108203/","study_design":null,"title":"PET amyloid-beta imaging in preclinical Alzheimer's disease","title_match":true,"year":2012},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/multi-method-investigation-of-factors-influencing-amyloid-onset-and-35856240","doi":"10.1093/brain/awac213","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"35856240","source_url":"https://pubmed.ncbi.nlm.nih.gov/35856240/","study_design":"longitudinal study","title":"Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts","title_match":false,"year":2022},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/nutrient-patterns-and-brain-biomarkers-of-alzheimer-s-disease-in-25809805","doi":"10.1007/s12603-014-0534-0","journal":"The journal of nutrition, health & aging","n_participants":null,"pmid":"25809805","source_url":"https://pubmed.ncbi.nlm.nih.gov/25809805/","study_design":"cross-sectional","title":"Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals","title_match":false,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/i-apoe-i-genotype-and-early-amyloid-accumulation-in-older-adults-28794245","doi":"10.1212/wnl.0000000000004336","journal":"Neurology","n_participants":325,"pmid":"28794245","source_url":"https://pubmed.ncbi.nlm.nih.gov/28794245/","study_design":"longitudinal study","title":"APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia","title_match":false,"year":2017},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-26921134","doi":"10.1016/s0140-6736(15)01124-1","journal":"Lancet (London, England)","n_participants":null,"pmid":"26921134","source_url":"https://pubmed.ncbi.nlm.nih.gov/26921134/","study_design":null,"title":"Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/inverse-relation-between-in-vivo-amyloid-imaging-load-and-16372280","doi":"10.1002/ana.20730","journal":"Annals of neurology","n_participants":null,"pmid":"16372280","source_url":"https://pubmed.ncbi.nlm.nih.gov/16372280/","study_design":null,"title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","title_match":true,"year":2006},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/tau-positron-emission-tomographic-imaging-in-aging-and-early-26505746","doi":"10.1002/ana.24546","journal":"Annals of neurology","n_participants":null,"pmid":"26505746","source_url":"https://pubmed.ncbi.nlm.nih.gov/26505746/","study_design":null,"title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","title_match":false,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/use-of-florbetapir-pet-for-imaging-beta-amyloid-pathology-21245183","doi":"10.1001/jama.2010.2008","journal":"JAMA","n_participants":35,"pmid":"21245183","source_url":"https://pubmed.ncbi.nlm.nih.gov/21245183/","study_design":null,"title":"Use of florbetapir-PET for imaging beta-amyloid pathology","title_match":true,"year":2011},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/plasma-phospholipids-identify-antecedent-memory-impairment-in-older-24608097","doi":"10.1038/nm.3466","journal":"Nature medicine","n_participants":null,"pmid":"24608097","source_url":"https://pubmed.ncbi.nlm.nih.gov/24608097/","study_design":null,"title":"Plasma phospholipids identify antecedent memory impairment in older adults","title_match":false,"year":2014},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/cerebral-pet-with-florbetapir-compared-with-neuropathology-at-autopsy-22749065","doi":"10.1016/s1474-4422(12)70142-4","journal":"The Lancet. Neurology","n_participants":59,"pmid":"22749065","source_url":"https://pubmed.ncbi.nlm.nih.gov/22749065/","study_design":null,"title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","title_match":true,"year":2012},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-217-and-phosphorylated-tau-181-as-34418401","doi":"10.1016/s1474-4422(21)00214-3","journal":"The Lancet. Neurology","n_participants":15,"pmid":"34418401","source_url":"https://pubmed.ncbi.nlm.nih.gov/34418401/","study_design":null,"title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","title_match":false,"year":2021},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-pet-with-florbetaben-18f-in-patients-with-alzheimer-21481640","doi":"10.1016/s1474-4422(11)70077-1","journal":"The Lancet. Neurology","n_participants":81,"pmid":"21481640","source_url":"https://pubmed.ncbi.nlm.nih.gov/21481640/","study_design":"clinical trial","title":"Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study","title_match":true,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/brain-imaging-in-alzheimer-disease-22474610","doi":"10.1101/cshperspect.a006213","journal":"Cold Spring Harbor perspectives in medicine","n_participants":null,"pmid":"22474610","source_url":"https://pubmed.ncbi.nlm.nih.gov/22474610/","study_design":null,"title":"Brain imaging in Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/comparison-of-multiple-tau-pet-measures-as-biomarkers-in-aging-and-28587897","doi":"10.1016/j.neuroimage.2017.05.058","journal":"NeuroImage","n_participants":null,"pmid":"28587897","source_url":"https://pubmed.ncbi.nlm.nih.gov/28587897/","study_design":null,"title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/existing-pittsburgh-compound-b-positron-emission-tomography-25953778","doi":"10.1093/brain/awv112","journal":"Brain : a journal of neurology","n_participants":50,"pmid":"25953778","source_url":"https://pubmed.ncbi.nlm.nih.gov/25953778/","study_design":null,"title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","title_match":true,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/drug-treatments-in-alzheimer-s-disease-27251914","doi":"10.7861/clinmedicine.16-3-247","journal":"Clinical medicine (London, England)","n_participants":null,"pmid":"27251914","source_url":"https://pubmed.ncbi.nlm.nih.gov/27251914/","study_design":null,"title":"Drug treatments in Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/amyloid-pet-and-sup-18-sup-f-fdg-pet-in-the-diagnostic-investigation-33098804","doi":"10.1016/s1474-4422(20)30314-8","journal":"The Lancet. Neurology","n_participants":null,"pmid":"33098804","source_url":"https://pubmed.ncbi.nlm.nih.gov/33098804/","study_design":null,"title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/relationships-between-biomarkers-in-aging-and-dementia-19822868","doi":"10.1212/wnl.0b013e3181bc010c","journal":"Neurology","n_participants":34,"pmid":"19822868","source_url":"https://pubmed.ncbi.nlm.nih.gov/19822868/","study_design":null,"title":"Relationships between biomarkers in aging and dementia","title_match":false,"year":2009},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-as-a-clinical-biological-construct-an-international-39483064","doi":"10.1001/jamaneurol.2024.3770","journal":"JAMA neurology","n_participants":null,"pmid":"39483064","source_url":"https://pubmed.ncbi.nlm.nih.gov/39483064/","study_design":null,"title":"Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/pet-imaging-of-amyloid-in-alzheimer-s-disease-15324720","doi":"10.1016/s1474-4422(04)00853-1","journal":"The Lancet. Neurology","n_participants":null,"pmid":"15324720","source_url":"https://pubmed.ncbi.nlm.nih.gov/15324720/","study_design":null,"title":"PET imaging of amyloid in Alzheimer's disease","title_match":false,"year":2004},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/clinicopathologic-and-11c-pittsburgh-compound-b-implications-of-thal-25805643","doi":"10.1093/brain/awv050","journal":"Brain : a journal of neurology","n_participants":3618,"pmid":"25805643","source_url":"https://pubmed.ncbi.nlm.nih.gov/25805643/","study_design":null,"title":"Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum","title_match":true,"year":2015},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/the-use-of-pet-in-alzheimer-disease-20139997","doi":"10.1038/nrneurol.2009.217","journal":"Nature reviews. Neurology","n_participants":null,"pmid":"20139997","source_url":"https://pubmed.ncbi.nlm.nih.gov/20139997/","study_design":null,"title":"The use of PET in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-drug-development-pipeline-2017-29067343","doi":"10.1016/j.trci.2017.05.002","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":54073,"pmid":"29067343","source_url":"https://pubmed.ncbi.nlm.nih.gov/29067343/","study_design":null,"title":"Alzheimer's disease drug development pipeline: 2017","title_match":false,"year":2017},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-angiopathy-emerging-concepts-25692104","doi":"10.5853/jos.2015.17.1.17","journal":"Journal of stroke","n_participants":null,"pmid":"25692104","source_url":"https://pubmed.ncbi.nlm.nih.gov/25692104/","study_design":null,"title":"Cerebral amyloid angiopathy: emerging concepts","title_match":false,"year":2015},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-with-18-f-florbetaben-in-alzheimer-disease-and-other-21764791","doi":"10.2967/jnumed.111.089730","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":20,"pmid":"21764791","source_url":"https://pubmed.ncbi.nlm.nih.gov/21764791/","study_design":null,"title":"Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias","title_match":true,"year":2011},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/phase-3-trial-of-flutemetamol-labeled-with-radioactive-fluorine-18-25622185","doi":"10.1001/jamaneurol.2014.4144","journal":"JAMA neurology","n_participants":176,"pmid":"25622185","source_url":"https://pubmed.ncbi.nlm.nih.gov/25622185/","study_design":"open-label trial","title":"Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","title_match":true,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/11c-pib-in-a-nondemented-population-potential-antecedent-marker-of-16894106","doi":"10.1212/01.wnl.0000228230.26044.a4","journal":"Neurology","n_participants":null,"pmid":"16894106","source_url":"https://pubmed.ncbi.nlm.nih.gov/16894106/","study_design":"longitudinal study","title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","title_match":false,"year":2006},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-tau-beta-amyloid-42-ratio-as-a-prediction-of-17210801","doi":"10.1001/archneur.64.3.noc60123","journal":"Archives of neurology","n_participants":139,"pmid":"17210801","source_url":"https://pubmed.ncbi.nlm.nih.gov/17210801/","study_design":"longitudinal study","title":"Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","title_match":false,"year":2007},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/18f-flutemetamol-amyloid-imaging-in-alzheimer-disease-and-mild-20687209","doi":"10.1002/ana.22068","journal":"Annals of neurology","n_participants":null,"pmid":"20687209","source_url":"https://pubmed.ncbi.nlm.nih.gov/20687209/","study_design":null,"title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","title_match":true,"year":2010},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/association-between-elevated-brain-amyloid-and-subsequent-cognitive-28609533","doi":"10.1001/jama.2017.6669","journal":"JAMA","n_participants":243,"pmid":"28609533","source_url":"https://pubmed.ncbi.nlm.nih.gov/28609533/","study_design":"longitudinal study","title":"Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/evidence-for-astrocytosis-in-prodromal-alzheimer-disease-provided-by-22213821","doi":"10.2967/jnumed.110.087031","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"22213821","source_url":"https://pubmed.ncbi.nlm.nih.gov/22213821/","study_design":null,"title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG","title_match":true,"year":2012},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/pittsburgh-compound-b-imaging-and-prediction-of-progression-from-20008650","doi":"10.1001/archneurol.2009.269","journal":"Archives of neurology","n_participants":null,"pmid":"20008650","source_url":"https://pubmed.ncbi.nlm.nih.gov/20008650/","study_design":"cohort study","title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/longitudinal-change-in-csf-biomarkers-in-autosomal-dominant-alzheimer-24598588","doi":"10.1126/scitranslmed.3007901","journal":"Science translational medicine","n_participants":null,"pmid":"24598588","source_url":"https://pubmed.ncbi.nlm.nih.gov/24598588/","study_design":"cross-sectional","title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/sex-differences-in-alzheimer-risk-brain-imaging-of-endocrine-vs-28855400","doi":"10.1212/wnl.0000000000004425","journal":"Neurology","n_participants":null,"pmid":"28855400","source_url":"https://pubmed.ncbi.nlm.nih.gov/28855400/","study_design":null,"title":"Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging","title_match":false,"year":2017},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/associations-between-tau-a-and-cortical-thickness-with-cognition-in-30626656","doi":"10.1212/wnl.0000000000006875","journal":"Neurology","n_participants":106,"pmid":"30626656","source_url":"https://pubmed.ncbi.nlm.nih.gov/30626656/","study_design":"cross-sectional","title":"Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease","title_match":false,"year":2019},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/19f-and-1h-mri-detection-of-amyloid-beta-plaques-in-vivo-15768036","doi":"10.1038/nn1422","journal":"Nature neuroscience","n_participants":null,"pmid":"15768036","source_url":"https://pubmed.ncbi.nlm.nih.gov/15768036/","study_design":"longitudinal study","title":"19F and 1H MRI detection of amyloid beta plaques in vivo","title_match":false,"year":2005},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/magnetic-resonance-images-implicate-that-glymphatic-alterations-36214568","doi":"10.1002/ana.26516","journal":"Annals of neurology","n_participants":50,"pmid":"36214568","source_url":"https://pubmed.ncbi.nlm.nih.gov/36214568/","study_design":null,"title":"Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease","title_match":false,"year":2023},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/type-2-diabetes-mellitus-and-biomarkers-of-neurodegeneration-26333802","doi":"10.1212/wnl.0000000000001982","journal":"Neurology","n_participants":816,"pmid":"26333802","source_url":"https://pubmed.ncbi.nlm.nih.gov/26333802/","study_design":"cross-sectional","title":"Type 2 diabetes mellitus and biomarkers of neurodegeneration","title_match":false,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/subtypes-of-progressive-aphasia-application-of-the-international-21908392","doi":"10.1093/brain/awr216","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"21908392","source_url":"https://pubmed.ncbi.nlm.nih.gov/21908392/","study_design":null,"title":"Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using \u03b2-amyloid imaging","title_match":true,"year":2011},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/tau-pet-in-alzheimer-disease-and-mild-cognitive-impairment-27358341","doi":"10.1212/wnl.0000000000002892","journal":"Neurology","n_participants":20,"pmid":"27358341","source_url":"https://pubmed.ncbi.nlm.nih.gov/27358341/","study_design":null,"title":"Tau PET in Alzheimer disease and mild cognitive impairment","title_match":false,"year":2016},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/disease-modifying-therapies-for-alzheimer-disease-challenges-to-early-17938373","doi":"10.1212/01.wnl.0000295996.54210.69","journal":"Neurology","n_participants":null,"pmid":"17938373","source_url":"https://pubmed.ncbi.nlm.nih.gov/17938373/","study_design":null,"title":"Disease-modifying therapies for Alzheimer disease: challenges to early intervention","title_match":false,"year":2007},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/short-term-clinical-outcomes-for-stages-of-nia-aa-preclinical-22551733","doi":"10.1212/wnl.0b013e3182563bbe","journal":"Neurology","n_participants":null,"pmid":"22551733","source_url":"https://pubmed.ncbi.nlm.nih.gov/22551733/","study_design":null,"title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","title_match":false,"year":2012},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-and-csf-biomarkers-in-predicting-cognitive-impairment-23576620","doi":"10.1212/wnl.0b013e3182918ca6","journal":"Neurology","n_participants":201,"pmid":"23576620","source_url":"https://pubmed.ncbi.nlm.nih.gov/23576620/","study_design":"longitudinal study","title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","title_match":true,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/automated-quantification-of-18f-flutemetamol-pet-activity-for-25146124","doi":"10.2967/jnumed.114.142109","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":68,"pmid":"25146124","source_url":"https://pubmed.ncbi.nlm.nih.gov/25146124/","study_design":null,"title":"Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads","title_match":true,"year":2014},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/beta-amyloid-burden-in-the-temporal-neocortex-is-related-to-20065247","doi":"10.1212/wnl.0b013e3181c918b5","journal":"Neurology","n_participants":32,"pmid":"20065247","source_url":"https://pubmed.ncbi.nlm.nih.gov/20065247/","study_design":null,"title":"Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia","title_match":false,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/brain-volume-decline-in-aging-evidence-for-a-relation-between-18195148","doi":"10.1001/archneurol.2007.27","journal":"Archives of neurology","n_participants":null,"pmid":"18195148","source_url":"https://pubmed.ncbi.nlm.nih.gov/18195148/","study_design":"cross-sectional","title":"Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve","title_match":false,"year":2008},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/amyloid-deposition-in-parkinson-s-disease-and-cognitive-impairment-a-25879534","doi":"10.1002/mds.26191","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"25879534","source_url":"https://pubmed.ncbi.nlm.nih.gov/25879534/","study_design":"systematic review","title":"Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review","title_match":false,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/physical-activity-attenuates-age-related-biomarker-alterations-in-25298312","doi":"10.1212/wnl.0000000000000964","journal":"Neurology","n_participants":186,"pmid":"25298312","source_url":"https://pubmed.ncbi.nlm.nih.gov/25298312/","study_design":"cross-sectional","title":"Physical activity attenuates age-related biomarker alterations in preclinical AD","title_match":false,"year":2014},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/clinical-validation-of-18f-azd4694-an-amyloid-specific-pet-radioligand-22323782","doi":"10.2967/jnumed.111.094029","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"22323782","source_url":"https://pubmed.ncbi.nlm.nih.gov/22323782/","study_design":null,"title":"Clinical validation of 18F-AZD4694, an amyloid-\u03b2-specific PET radioligand","title_match":false,"year":2012},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/imaging-markers-for-alzheimer-disease-which-vs-how-23897875","doi":"10.1212/wnl.0b013e31829d86e8","journal":"Neurology","n_participants":null,"pmid":"23897875","source_url":"https://pubmed.ncbi.nlm.nih.gov/23897875/","study_design":null,"title":"Imaging markers for Alzheimer disease: which vs how","title_match":false,"year":2013},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/absence-of-pittsburgh-compound-b-detection-of-cerebral-amyloid-beta-20008664","doi":"10.1001/archneurol.2009.279","journal":"Archives of neurology","n_participants":null,"pmid":"20008664","source_url":"https://pubmed.ncbi.nlm.nih.gov/20008664/","study_design":"case report","title":"Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","title_match":true,"year":2009},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/apolipoprotein-e-4-and-age-effects-on-florbetapir-positron-emission-22633529","doi":"10.1016/j.neurobiolaging.2012.04.017","journal":"Neurobiology of aging","n_participants":245,"pmid":"22633529","source_url":"https://pubmed.ncbi.nlm.nih.gov/22633529/","study_design":null,"title":"Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","title_match":true,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-between-amyloid-and-tau-accumulation-in-young-adults-with-29435558","doi":"10.1001/jamaneurol.2017.4907","journal":"JAMA neurology","n_participants":24,"pmid":"29435558","source_url":"https://pubmed.ncbi.nlm.nih.gov/29435558/","study_design":"cross-sectional","title":"Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease","title_match":false,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/soluble-trem2-in-csf-and-its-association-with-other-biomarkers-and-35305339","doi":"10.1016/s1474-4422(22)00027-8","journal":"The Lancet. Neurology","n_participants":155,"pmid":"35305339","source_url":"https://pubmed.ncbi.nlm.nih.gov/35305339/","study_design":"longitudinal study","title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/age-vascular-health-and-alzheimer-disease-biomarkers-in-an-elderly-29023983","doi":"10.1002/ana.25071","journal":"Annals of neurology","n_participants":430,"pmid":"29023983","source_url":"https://pubmed.ncbi.nlm.nih.gov/29023983/","study_design":"longitudinal study","title":"Age, vascular health, and Alzheimer disease biomarkers in an elderly sample","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-brain-atrophy-subtypes-are-associated-with-29070667","doi":"10.1212/wnl.0000000000004670","journal":"Neurology","n_participants":229,"pmid":"29070667","source_url":"https://pubmed.ncbi.nlm.nih.gov/29070667/","study_design":null,"title":"Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline","title_match":false,"year":2017},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/comparison-of-analytical-platforms-for-cerebrospinal-fluid-measures-21555603","doi":"10.1001/archneurol.2011.105","journal":"Archives of neurology","n_participants":103,"pmid":"21555603","source_url":"https://pubmed.ncbi.nlm.nih.gov/21555603/","study_design":null,"title":"Comparison of analytical platforms for cerebrospinal fluid measures of \u03b2-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology","title_match":false,"year":2011},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/sup-18-sup-f-flortaucipir-tau-positron-emission-tomography-28980714","doi":"10.1002/ana.25060","journal":"Annals of neurology","n_participants":33,"pmid":"28980714","source_url":"https://pubmed.ncbi.nlm.nih.gov/28980714/","study_design":null,"title":"18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-11c-pib-and-18f-azd4694-nav4694-for-23575995","doi":"10.2967/jnumed.112.114785","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"23575995","source_url":"https://pubmed.ncbi.nlm.nih.gov/23575995/","study_design":null,"title":"Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for \u03b2-amyloid imaging in aging and dementia","title_match":true,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/identification-of-pure-subcortical-vascular-dementia-using-11c-21593437","doi":"10.1212/wnl.0b013e318221acee","journal":"Neurology","n_participants":45,"pmid":"21593437","source_url":"https://pubmed.ncbi.nlm.nih.gov/21593437/","study_design":null,"title":"Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B","title_match":true,"year":2011},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/low-pib-pet-retention-in-presence-of-pathologic-csf-biomarkers-in-22700814","doi":"10.1212/wnl.0b013e31825fdf18","journal":"Neurology","n_participants":null,"pmid":"22700814","source_url":"https://pubmed.ncbi.nlm.nih.gov/22700814/","study_design":null,"title":"Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers","title_match":true,"year":2012},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-and-3-year-alzheimer-brain-biomarker-changes-in-29653991","doi":"10.1212/wnl.0000000000005527","journal":"Neurology","n_participants":34,"pmid":"29653991","source_url":"https://pubmed.ncbi.nlm.nih.gov/29653991/","study_design":null,"title":"Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/accelerated-cortical-atrophy-in-cognitively-normal-elderly-with-high-22302548","doi":"10.1212/wnl.0b013e318246d67a","journal":"Neurology","n_participants":null,"pmid":"22302548","source_url":"https://pubmed.ncbi.nlm.nih.gov/22302548/","study_design":null,"title":"Accelerated cortical atrophy in cognitively normal elderly with high \u03b2-amyloid deposition","title_match":false,"year":2012},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/pathogenesis-of-cerebral-microbleeds-in-vivo-imaging-of-amyloid-and-23495089","doi":"10.1002/ana.23845","journal":"Annals of neurology","n_participants":226,"pmid":"23495089","source_url":"https://pubmed.ncbi.nlm.nih.gov/23495089/","study_design":null,"title":"Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/visinin-like-protein-1-diagnostic-and-prognostic-biomarker-in-21823155","doi":"10.1002/ana.22448","journal":"Annals of neurology","n_participants":211,"pmid":"21823155","source_url":"https://pubmed.ncbi.nlm.nih.gov/21823155/","study_design":null,"title":"Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/longitudinal-amyloid-imaging-using-11c-pib-methodologic-considerations-23940304","doi":"10.2967/jnumed.112.113654","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"23940304","source_url":"https://pubmed.ncbi.nlm.nih.gov/23940304/","study_design":"longitudinal study","title":"Longitudinal amyloid imaging using 11C-PiB: methodologic considerations","title_match":true,"year":2013},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/in-vivo-amyloid-imaging-in-autopsy-confirmed-parkinson-disease-with-20038776","doi":"10.1212/wnl.0b013e3181c7da8e","journal":"Neurology","n_participants":null,"pmid":"20038776","source_url":"https://pubmed.ncbi.nlm.nih.gov/20038776/","study_design":null,"title":"In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia","title_match":true,"year":2010},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/glial-activation-and-glucose-metabolism-in-a-transgenic-amyloid-mouse-26912428","doi":"10.2967/jnumed.115.167858","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26912428","source_url":"https://pubmed.ncbi.nlm.nih.gov/26912428/","study_design":null,"title":"Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study","title_match":false,"year":2016},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/cerebral-amyloid-angiopathy-burden-associated-with-leukoaraiosis-a-23424091","doi":"10.1002/ana.23830","journal":"Annals of neurology","n_participants":null,"pmid":"23424091","source_url":"https://pubmed.ncbi.nlm.nih.gov/23424091/","study_design":null,"title":"Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study","title_match":false,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-pathology-and-axonal-injury-after-brain-trauma-26843562","doi":"10.1212/wnl.0000000000002413","journal":"Neurology","n_participants":null,"pmid":"26843562","source_url":"https://pubmed.ncbi.nlm.nih.gov/26843562/","study_design":null,"title":"Amyloid pathology and axonal injury after brain trauma","title_match":false,"year":2016},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/association-of-age-at-menopause-and-hormone-therapy-use-with-tau-and-37010830","doi":"10.1001/jamaneurol.2023.0455","journal":"JAMA neurology","n_participants":null,"pmid":"37010830","source_url":"https://pubmed.ncbi.nlm.nih.gov/37010830/","study_design":"cross-sectional","title":"Association of Age at Menopause and Hormone Therapy Use With Tau and \u03b2-Amyloid Positron Emission Tomography","title_match":true,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/effect-of-off-target-binding-on-sup-18-sup-f-flortaucipir-variability-30877180","doi":"10.2967/jnumed.118.224113","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":139,"pmid":"30877180","source_url":"https://pubmed.ncbi.nlm.nih.gov/30877180/","study_design":null,"title":"Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/resting-bold-fmri-differentiates-dementia-with-lewy-bodies-vs-21525427","doi":"10.1212/wnl.0b013e31821ccc83","journal":"Neurology","n_participants":88,"pmid":"21525427","source_url":"https://pubmed.ncbi.nlm.nih.gov/21525427/","study_design":"longitudinal study","title":"Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/dynamic-lt-sup-gt-11-lt-sup-gt-c-pib-pet-shows-cerebrospinal-fluid-30850505","doi":"10.2967/jnumed.118.223834","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"30850505","source_url":"https://pubmed.ncbi.nlm.nih.gov/30850505/","study_design":null,"title":"Dynamic 11C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis","title_match":true,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/functional-network-integrity-presages-cognitive-decline-in-28592457","doi":"10.1212/wnl.0000000000004059","journal":"Neurology","n_participants":237,"pmid":"28592457","source_url":"https://pubmed.ncbi.nlm.nih.gov/28592457/","study_design":"longitudinal study","title":"Functional network integrity presages cognitive decline in preclinical Alzheimer disease","title_match":false,"year":2017},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/brain-amyloid-imaging-21917849","doi":"10.2967/jnumed.110.076315","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"21917849","source_url":"https://pubmed.ncbi.nlm.nih.gov/21917849/","study_design":null,"title":"Brain amyloid imaging","title_match":true,"year":2011},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/small-molecule-pet-tracers-for-imaging-proteinopathies-28826526","doi":"10.1053/j.semnuclmed.2017.06.003","journal":"Seminars in nuclear medicine","n_participants":null,"pmid":"28826526","source_url":"https://pubmed.ncbi.nlm.nih.gov/28826526/","study_design":null,"title":"Small-molecule PET Tracers for Imaging Proteinopathies","title_match":false,"year":2017},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/brain-amyloid-imaging-23396994","doi":"10.2967/jnumed.110.076315","journal":"Journal of nuclear medicine technology","n_participants":null,"pmid":"23396994","source_url":"https://pubmed.ncbi.nlm.nih.gov/23396994/","study_design":null,"title":"Brain amyloid imaging","title_match":true,"year":2013},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/follow-up-of-11c-pib-uptake-and-brain-volume-in-patients-with-19726751","doi":"10.1212/wnl.0b013e3181bacf1b","journal":"Neurology","n_participants":null,"pmid":"19726751","source_url":"https://pubmed.ncbi.nlm.nih.gov/19726751/","study_design":null,"title":"Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls","title_match":false,"year":2009},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/potential-impact-of-amyloid-imaging-on-diagnosis-and-intended-23203162","doi":"10.1097/wad.0b013e318279d02a","journal":"Alzheimer disease and associated disorders","n_participants":229,"pmid":"23203162","source_url":"https://pubmed.ncbi.nlm.nih.gov/23203162/","study_design":null,"title":"Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline","title_match":true,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cerebral-microhemorrhage-and-brain-amyloid-in-aging-and-alzheimer-21700585","doi":"10.1212/wnl.0b013e318221ad36","journal":"Neurology","n_participants":28,"pmid":"21700585","source_url":"https://pubmed.ncbi.nlm.nih.gov/21700585/","study_design":"cross-sectional","title":"Cerebral microhemorrhage and brain \u03b2-amyloid in aging and Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/microglial-activation-in-early-alzheimer-trajectory-is-associated-30796139","doi":"10.1212/wnl.0000000000007133","journal":"Neurology","n_participants":55,"pmid":"30796139","source_url":"https://pubmed.ncbi.nlm.nih.gov/30796139/","study_design":"longitudinal study","title":"Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume","title_match":false,"year":2019},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/imaging-and-cerebrospinal-fluid-biomarkers-in-early-preclinical-27398953","doi":"10.1002/ana.24719","journal":"Annals of neurology","n_participants":164,"pmid":"27398953","source_url":"https://pubmed.ncbi.nlm.nih.gov/27398953/","study_design":"longitudinal study","title":"Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-as-a-biomarker-for-cerebral-amyloidosis-and-risk-22078170","doi":"10.1016/j.neurobiolaging.2011.09.006","journal":"Neurobiology of aging","n_participants":null,"pmid":"22078170","source_url":"https://pubmed.ncbi.nlm.nih.gov/22078170/","study_design":"longitudinal study","title":"Amyloid imaging as a biomarker for cerebral \u03b2-amyloidosis and risk prediction for Alzheimer dementia","title_match":true,"year":2011},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/association-of-enlarged-perivascular-spaces-and-measures-of-small-33046608","doi":"10.1212/wnl.0000000000011046","journal":"Neurology","n_participants":240,"pmid":"33046608","source_url":"https://pubmed.ncbi.nlm.nih.gov/33046608/","study_design":null,"title":"Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/synergistic-effects-of-ischemia-and-amyloid-burden-on-cognitive-24554306","doi":"10.1001/jamapsychiatry.2013.4506","journal":"JAMA psychiatry","n_participants":95,"pmid":"24554306","source_url":"https://pubmed.ncbi.nlm.nih.gov/24554306/","study_design":"cross-sectional","title":"Synergistic effects of ischemia and \u03b2-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment","title_match":false,"year":2014},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/in-vivo-fibrillar-beta-amyloid-detected-using-11c-pib-positron-21320990","doi":"10.1001/archneurol.2010.357","journal":"Archives of neurology","n_participants":null,"pmid":"21320990","source_url":"https://pubmed.ncbi.nlm.nih.gov/21320990/","study_design":"longitudinal study","title":"In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults","title_match":false,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/etiology-of-white-matter-hyperintensities-in-autosomal-dominant-and-37843849","doi":"10.1001/jamaneurol.2023.3618","journal":"JAMA neurology","n_participants":1141,"pmid":"37843849","source_url":"https://pubmed.ncbi.nlm.nih.gov/37843849/","study_design":"cohort study","title":"Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease","title_match":false,"year":2023},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/vascular-risk-and-a-interact-to-reduce-cortical-thickness-in-ad-24907234","doi":"10.1212/wnl.0000000000000550","journal":"Neurology","n_participants":null,"pmid":"24907234","source_url":"https://pubmed.ncbi.nlm.nih.gov/24907234/","study_design":null,"title":"Vascular risk and A\u03b2 interact to reduce cortical thickness in AD vulnerable brain regions","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-semiautomated-method-for-quantification-of-f-18-florbetapir-pet-26338898","doi":"10.2967/jnumed.114.153494","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"26338898","source_url":"https://pubmed.ncbi.nlm.nih.gov/26338898/","study_design":null,"title":"A Semiautomated Method for Quantification of F 18 Florbetapir PET Images","title_match":true,"year":2015},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/serum-albumin-and-beta-amyloid-deposition-in-the-human-brain-32690787","doi":"10.1212/wnl.0000000000010005","journal":"Neurology","n_participants":396,"pmid":"32690787","source_url":"https://pubmed.ncbi.nlm.nih.gov/32690787/","study_design":null,"title":"Serum albumin and beta-amyloid deposition in the human brain","title_match":false,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/association-of-digital-clock-drawing-with-pet-amyloid-and-tau-33589537","doi":"10.1212/wnl.0000000000011697","journal":"Neurology","n_participants":300,"pmid":"33589537","source_url":"https://pubmed.ncbi.nlm.nih.gov/33589537/","study_design":null,"title":"Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults","title_match":true,"year":2021},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/comparing-sup-18-sup-f-av-1451-with-csf-t-tau-and-p-tau-for-diagnosis-29321235","doi":"10.1212/wnl.0000000000004887","journal":"Neurology","n_participants":14,"pmid":"29321235","source_url":"https://pubmed.ncbi.nlm.nih.gov/29321235/","study_design":null,"title":"Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease","title_match":false,"year":2018},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/longitudinal-amyloid-imaging-in-mouse-brain-with-11c-pib-comparison-23833271","doi":"10.2967/jnumed.112.110163","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"23833271","source_url":"https://pubmed.ncbi.nlm.nih.gov/23833271/","study_design":"longitudinal study","title":"Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease","title_match":true,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/default-mode-network-functional-connectivity-in-early-and-late-mild-26840545","doi":"10.1097/wad.0000000000000143","journal":"Alzheimer disease and associated disorders","n_participants":130,"pmid":"26840545","source_url":"https://pubmed.ncbi.nlm.nih.gov/26840545/","study_design":null,"title":"Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative","title_match":false,"year":2016},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/effect-of-intellectual-enrichment-on-ad-biomarker-trajectories-26911640","doi":"10.1212/wnl.0000000000002490","journal":"Neurology","n_participants":393,"pmid":"26911640","source_url":"https://pubmed.ncbi.nlm.nih.gov/26911640/","study_design":"longitudinal study","title":"Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study","title_match":false,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/early-11c-pib-frames-and-18f-fdg-pet-measures-are-comparable-a-study-21233181","doi":"10.2967/jnumed.110.082057","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"21233181","source_url":"https://pubmed.ncbi.nlm.nih.gov/21233181/","study_design":null,"title":"Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients","title_match":false,"year":2011},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/tau-positron-emission-tomography-for-predicting-dementia-in-38857029","doi":"10.1001/jamaneurol.2024.1612","journal":"JAMA neurology","n_participants":110,"pmid":"38857029","source_url":"https://pubmed.ncbi.nlm.nih.gov/38857029/","study_design":"cohort study","title":"Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment","title_match":false,"year":2024},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/alzheimer-related-cerebrovascular-disease-in-down-syndrome-32944999","doi":"10.1002/ana.25905","journal":"Annals of neurology","n_participants":138,"pmid":"32944999","source_url":"https://pubmed.ncbi.nlm.nih.gov/32944999/","study_design":"cross-sectional","title":"Alzheimer-Related Cerebrovascular Disease in Down Syndrome","title_match":false,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/multimodal-brain-age-estimates-relate-to-alzheimer-disease-biomarkers-36607335","doi":"10.7554/elife.81869","journal":"eLife","n_participants":null,"pmid":"36607335","source_url":"https://pubmed.ncbi.nlm.nih.gov/36607335/","study_design":null,"title":"Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study","title_match":false,"year":2023},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/formula-see-text-practice-effects-and-longitudinal-cognitive-change-27724156","doi":"10.1080/13854046.2016.1241303","journal":"The Clinical neuropsychologist","n_participants":null,"pmid":"27724156","source_url":"https://pubmed.ncbi.nlm.nih.gov/27724156/","study_design":"longitudinal study","title":"[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status","title_match":false,"year":2017},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-alzheimer-s-disease-33720637","doi":"10.1056/nejmoa2100708","journal":"The New England journal of medicine","n_participants":257,"pmid":"33720637","source_url":"https://pubmed.ncbi.nlm.nih.gov/33720637/","study_design":"clinical trial","title":"Donanemab in Early Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/dissecting-phenotypic-traits-linked-to-human-resilience-to-alzheimer-23824488","doi":"10.1093/brain/awt171","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"23824488","source_url":"https://pubmed.ncbi.nlm.nih.gov/23824488/","study_design":null,"title":"Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/imaging-amyloid-deposition-in-lewy-body-diseases-18794492","doi":"10.1212/01.wnl.0000326146.60732.d6","journal":"Neurology","n_participants":null,"pmid":"18794492","source_url":"https://pubmed.ncbi.nlm.nih.gov/18794492/","study_design":null,"title":"Imaging amyloid deposition in Lewy body diseases","title_match":false,"year":2008},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/neuronal-dysfunction-and-disconnection-of-cortical-hubs-in-non-21490054","doi":"10.1093/brain/awr066","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"21490054","source_url":"https://pubmed.ncbi.nlm.nih.gov/21490054/","study_design":null,"title":"Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden","title_match":false,"year":2011},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/in-vivo-radioligand-binding-to-translocator-protein-correlates-with-23775979","doi":"10.1093/brain/awt145","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"23775979","source_url":"https://pubmed.ncbi.nlm.nih.gov/23775979/","study_design":"longitudinal study","title":"In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/face-name-associative-memory-performance-is-related-to-amyloid-burden-21689670","doi":"10.1016/j.neuropsychologia.2011.06.006","journal":"Neuropsychologia","n_participants":45,"pmid":"21689670","source_url":"https://pubmed.ncbi.nlm.nih.gov/21689670/","study_design":null,"title":"Face-name associative memory performance is related to amyloid burden in normal elderly","title_match":false,"year":2011},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/white-matter-hyperintensities-relationship-to-amyloid-and-tau-burden-31199475","doi":"10.1093/brain/awz162","journal":"Brain : a journal of neurology","n_participants":434,"pmid":"31199475","source_url":"https://pubmed.ncbi.nlm.nih.gov/31199475/","study_design":null,"title":"White matter hyperintensities: relationship to amyloid and tau burden","title_match":false,"year":2019},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/florbetapir-f18-av-45-pet-to-assess-amyloid-burden-in-alzheimer-s-23375563","doi":"10.1016/j.jalz.2012.10.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":184,"pmid":"23375563","source_url":"https://pubmed.ncbi.nlm.nih.gov/23375563/","study_design":"clinical trial","title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging","title_match":true,"year":2013},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-higher-cortical-amyloid-burden-with-loneliness-in-27806159","doi":"10.1001/jamapsychiatry.2016.2657","journal":"JAMA psychiatry","n_participants":25,"pmid":"27806159","source_url":"https://pubmed.ncbi.nlm.nih.gov/27806159/","study_design":"cross-sectional","title":"Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults","title_match":false,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/tau-positron-emission-tomographic-imaging-in-the-lewy-body-diseases-27654968","doi":"10.1001/jamaneurol.2016.3338","journal":"JAMA neurology","n_participants":null,"pmid":"27654968","source_url":"https://pubmed.ncbi.nlm.nih.gov/27654968/","study_design":"cross-sectional","title":"Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases","title_match":false,"year":2016},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/quantification-of-amyloid-pet-for-future-clinical-use-a-state-of-the-35389071","doi":"10.1007/s00259-022-05784-y","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"35389071","source_url":"https://pubmed.ncbi.nlm.nih.gov/35389071/","study_design":null,"title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","title_match":true,"year":2022},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-and-cognitive-reserve-variation-of-education-effect-19001165","doi":"10.1001/archneur.65.11.1467","journal":"Archives of neurology","n_participants":161,"pmid":"19001165","source_url":"https://pubmed.ncbi.nlm.nih.gov/19001165/","study_design":null,"title":"Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake","title_match":true,"year":2008},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/double-blind-placebo-controlled-proof-of-concept-trial-of-bexarotene-26822146","doi":"10.1186/s13195-016-0173-2","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"26822146","source_url":"https://pubmed.ncbi.nlm.nih.gov/26822146/","study_design":null,"title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/pulse-wave-velocity-is-associated-with-amyloid-deposition-in-the-24132374","doi":"10.1212/01.wnl.0000435301.64776.37","journal":"Neurology","n_participants":91,"pmid":"24132374","source_url":"https://pubmed.ncbi.nlm.nih.gov/24132374/","study_design":null,"title":"Pulse wave velocity is associated with \u03b2-amyloid deposition in the brains of very elderly adults","title_match":false,"year":2013},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/amyloid-is-linked-to-cognitive-decline-in-patients-with-parkinson-23243071","doi":"10.1212/wnl.0b013e31827b1a07","journal":"Neurology","n_participants":46,"pmid":"23243071","source_url":"https://pubmed.ncbi.nlm.nih.gov/23243071/","study_design":"cohort study","title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","title_match":false,"year":2013},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-aric-pet-amyloid-imaging-study-brain-amyloid-differences-by-age-27371485","doi":"10.1212/wnl.0000000000002914","journal":"Neurology","n_participants":329,"pmid":"27371485","source_url":"https://pubmed.ncbi.nlm.nih.gov/27371485/","study_design":"longitudinal study","title":"The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE","title_match":true,"year":2016},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/pittsburgh-compound-b-imaging-and-cerebrospinal-fluid-amyloid-in-a-27401520","doi":"10.1093/brain/aww160","journal":"Brain : a journal of neurology","n_participants":243,"pmid":"27401520","source_url":"https://pubmed.ncbi.nlm.nih.gov/27401520/","study_design":null,"title":"Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study","title_match":true,"year":2016},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/episodic-memory-loss-is-related-to-hippocampal-mediated-beta-amyloid-19042931","doi":"10.1093/brain/awn320","journal":"Brain : a journal of neurology","n_participants":20,"pmid":"19042931","source_url":"https://pubmed.ncbi.nlm.nih.gov/19042931/","study_design":null,"title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","title_match":false,"year":2009},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-in-alzheimer-s-disease-and-vascular-disease-27241045","doi":"10.1038/srep26801","journal":"Scientific reports","n_participants":719,"pmid":"27241045","source_url":"https://pubmed.ncbi.nlm.nih.gov/27241045/","study_design":null,"title":"Plasma \u03b2-amyloid in Alzheimer's disease and vascular disease","title_match":false,"year":2016},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/a-phase-iii-randomized-trial-of-gantenerumab-in-prodromal-alzheimer-s-29221491","doi":"10.1186/s13195-017-0318-y","journal":"Alzheimer's research & therapy","n_participants":3089,"pmid":"29221491","source_url":"https://pubmed.ncbi.nlm.nih.gov/29221491/","study_design":null,"title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-positron-emission-20451870","doi":"10.1016/j.jalz.2010.03.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":100,"pmid":"20451870","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451870/","study_design":"longitudinal study","title":"The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core","title_match":false,"year":2010},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/in-vivo-staging-of-regional-amyloid-deposition-29046362","doi":"10.1212/wnl.0000000000004643","journal":"Neurology","n_participants":667,"pmid":"29046362","source_url":"https://pubmed.ncbi.nlm.nih.gov/29046362/","study_design":"cross-sectional","title":"In vivo staging of regional amyloid deposition","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/the-importance-of-appropriate-partial-volume-correction-for-pet-21336694","doi":"10.1007/s00259-011-1745-9","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"21336694","source_url":"https://pubmed.ncbi.nlm.nih.gov/21336694/","study_design":null,"title":"The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease","title_match":false,"year":2011},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/gut-microbiota-composition-is-related-to-ad-pathology-35173707","doi":"10.3389/fimmu.2021.794519","journal":"Frontiers in immunology","n_participants":170,"pmid":"35173707","source_url":"https://pubmed.ncbi.nlm.nih.gov/35173707/","study_design":null,"title":"Gut Microbiota Composition Is Related to AD Pathology","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/classification-and-clinicoradiologic-features-of-primary-progressive-26103600","doi":"10.1016/j.cortex.2015.05.013","journal":"Cortex; a journal devoted to the study of the nervous system and behavior","n_participants":null,"pmid":"26103600","source_url":"https://pubmed.ncbi.nlm.nih.gov/26103600/","study_design":null,"title":"Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/a-blood-based-predictor-for-neocortical-a-burden-in-alzheimer-s-23628985","doi":"10.1038/mp.2013.40","journal":"Molecular psychiatry","n_participants":273,"pmid":"23628985","source_url":"https://pubmed.ncbi.nlm.nih.gov/23628985/","study_design":null,"title":"A blood-based predictor for neocortical A\u03b2 burden in Alzheimer's disease: results from the AIBL study","title_match":false,"year":2014},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/use-of-multimodality-imaging-and-artificial-intelligence-for-29352978","doi":"10.1016/j.trsl.2018.01.001","journal":"Translational research : the journal of laboratory and clinical medicine","n_participants":null,"pmid":"29352978","source_url":"https://pubmed.ncbi.nlm.nih.gov/29352978/","study_design":"longitudinal study","title":"Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/modifiable-risk-factors-for-dementia-and-dementia-risk-profiling-a-34635138","doi":"10.1186/s13195-021-00895-4","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"34635138","source_url":"https://pubmed.ncbi.nlm.nih.gov/34635138/","study_design":null,"title":"Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/mri-predictors-of-amyloid-pathology-results-from-the-emif-ad-30261928","doi":"10.1186/s13195-018-0428-1","journal":"Alzheimer's research & therapy","n_participants":337,"pmid":"30261928","source_url":"https://pubmed.ncbi.nlm.nih.gov/30261928/","study_design":null,"title":"MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/identifying-incipient-dementia-individuals-using-machine-learning-and-28756942","doi":"10.1016/j.neurobiolaging.2017.06.027","journal":"Neurobiology of aging","n_participants":null,"pmid":"28756942","source_url":"https://pubmed.ncbi.nlm.nih.gov/28756942/","study_design":null,"title":"Identifying incipient dementia individuals using machine learning and amyloid imaging","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/a-combination-model-of-ad-biomarkers-revealed-by-machine-learning-35668045","doi":"10.1002/alz.12700","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":411,"pmid":"35668045","source_url":"https://pubmed.ncbi.nlm.nih.gov/35668045/","study_design":null,"title":"A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study","title_match":false,"year":2023},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/life-course-genetic-and-neuropathological-associations-with-brain-age-36102775","doi":"10.1016/s2666-7568(22)00167-2","journal":"The lancet. Healthy longevity","n_participants":456,"pmid":"36102775","source_url":"https://pubmed.ncbi.nlm.nih.gov/36102775/","study_design":null,"title":"Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/dissociation-of-down-syndrome-and-alzheimer-s-disease-effects-with-28642933","doi":"10.1016/j.trci.2016.02.004","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"28642933","source_url":"https://pubmed.ncbi.nlm.nih.gov/28642933/","study_design":null,"title":"Dissociation of Down syndrome and Alzheimer's disease effects with imaging","title_match":false,"year":2016},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/independent-replication-of-advanced-brain-age-in-mild-cognitive-35974140","doi":"10.1038/s41380-022-01728-y","journal":"Molecular psychiatry","n_participants":757,"pmid":"35974140","source_url":"https://pubmed.ncbi.nlm.nih.gov/35974140/","study_design":null,"title":"Independent replication of advanced brain age in mild cognitive impairment and dementia: detection of future cognitive dysfunction","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/the-effects-of-normal-aging-on-amyloid-deposition-in-nondemented-26079411","doi":"10.1016/j.jalz.2015.05.013","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"26079411","source_url":"https://pubmed.ncbi.nlm.nih.gov/26079411/","study_design":null,"title":"The effects of normal aging on amyloid-\u03b2 deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B","title_match":true,"year":2016},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/early-striatal-amyloid-deposition-distinguishes-down-syndrome-and-29477284","doi":"10.1016/j.jalz.2018.01.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"29477284","source_url":"https://pubmed.ncbi.nlm.nih.gov/29477284/","study_design":null,"title":"Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition","title_match":false,"year":2018},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/using-positron-emission-tomography-and-carbon-11-labeled-pittsburgh-21403005","doi":"10.1001/archneurol.2011.36","journal":"Archives of neurology","n_participants":null,"pmid":"21403005","source_url":"https://pubmed.ncbi.nlm.nih.gov/21403005/","study_design":null,"title":"Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar \u03b2-amyloid in adults with down syndrome: safety, acceptability, and feasibility","title_match":true,"year":2011},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/positron-emission-tomography-and-neuropathologic-estimates-of-22084131","doi":"10.1001/archneurol.2011.535","journal":"Archives of neurology","n_participants":null,"pmid":"22084131","source_url":"https://pubmed.ncbi.nlm.nih.gov/22084131/","study_design":null,"title":"Positron emission tomography and neuropathologic estimates of fibrillar amyloid-\u03b2 in a patient with Down syndrome and Alzheimer disease","title_match":false,"year":2011},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/down-syndrome-age-dependence-of-pib-binding-in-postmortem-frontal-28385551","doi":"10.1016/j.neurobiolaging.2017.03.005","journal":"Neurobiology of aging","n_participants":25,"pmid":"28385551","source_url":"https://pubmed.ncbi.nlm.nih.gov/28385551/","study_design":null,"title":"Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-related-altered-white-matter-microstructural-integrity-in-33204811","doi":"10.1002/dad2.12040","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"33204811","source_url":"https://pubmed.ncbi.nlm.nih.gov/33204811/","study_design":null,"title":"Alzheimer-related altered white matter microstructural integrity in Down syndrome: A model for sporadic AD?","title_match":false,"year":2020},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/plasma-p-tau212-as-a-biomarker-of-sporadic-and-down-syndrome-40275833","doi":"10.1002/alz.70172","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":245,"pmid":"40275833","source_url":"https://pubmed.ncbi.nlm.nih.gov/40275833/","study_design":null,"title":"Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/the-striatum-is-an-early-accurate-indicator-of-amyloid-burden-using-40189783","doi":"10.1002/alz.70141","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":175,"pmid":"40189783","source_url":"https://pubmed.ncbi.nlm.nih.gov/40189783/","study_design":"longitudinal study","title":"The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers","title_match":false,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/longitudinal-trajectories-of-amyloid-deposition-cortical-thickness-31909173","doi":"10.1016/j.dadm.2019.04.006","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"31909173","source_url":"https://pubmed.ncbi.nlm.nih.gov/31909173/","study_design":"longitudinal study","title":"Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report","title_match":false,"year":2019},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/the-tau-biomarker-cascade-is-condensed-in-down-syndrome-compared-with-41240365","doi":"10.1093/brain/awaf428","journal":"Brain : a journal of neurology","n_participants":198,"pmid":"41240365","source_url":"https://pubmed.ncbi.nlm.nih.gov/41240365/","study_design":"longitudinal study","title":"The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-impact-of-congenital-heart-disease-on-the-timing-of-alzheimer-s-41561734","doi":"10.1002/dad2.70257","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":82,"pmid":"41561734","source_url":"https://pubmed.ncbi.nlm.nih.gov/41561734/","study_design":null,"title":"The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-head-to-head-comparison-of-multiple-amyloid-pet-radiotracers-for-8ec63439","doi":"10.1101/2025.03.18.25324200","journal":"medRxiv","n_participants":237,"pmid":null,"source_url":"https://doi.org/10.1101/2025.03.18.25324200","study_design":"longitudinal study","title":"A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials","title_match":true,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/the-striatum-is-an-early-accurate-indicator-of-amyloid-burden-using-c829b099","doi":"10.1101/2024.12.04.24318526","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":175,"pmid":null,"source_url":"https://doi.org/10.1101/2024.12.04.24318526","study_design":"longitudinal study","title":"The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: comparison of two radiotracers","title_match":false,"year":2024},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/amyloid-age-and-tau-pet-timeline-to-symptomatic-alzheimers-disease-in-f00bce0d","doi":"10.1101/2024.08.08.24311702","journal":"medRxiv","n_participants":167,"pmid":null,"source_url":"https://doi.org/10.1101/2024.08.08.24311702","study_design":"cohort study","title":"Amyloid age and tau PET timeline to symptomatic Alzheimer\u2019s disease in Down syndrome","title_match":false,"year":2024},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/regional-binding-of-tau-and-amyloid-pet-tracers-in-down-syndrome-a970244c","doi":"10.21203/rs.3.rs-48040/v2","journal":"Molecular neurodegeneration","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-48040/v2","study_design":null,"title":"Regional binding of tau and amyloid PET tracers in Down Syndrome autopsy brain tissue","title_match":true,"year":2020},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-of-alzheimer-s-disease-concord-with-amyloid-pet-and-29499171","doi":"10.1016/j.jalz.2018.01.010","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":277,"pmid":"29499171","source_url":"https://pubmed.ncbi.nlm.nih.gov/29499171/","study_design":null,"title":"CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","title_match":false,"year":2018},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/in-vivo-cortical-spreading-pattern-of-tau-and-amyloid-in-the-27323247","doi":"10.1002/ana.24711","journal":"Annals of neurology","n_participants":195,"pmid":"27323247","source_url":"https://pubmed.ncbi.nlm.nih.gov/27323247/","study_design":null,"title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","title_match":false,"year":2016},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-pet-positive-cognitively-unimpaired-individuals-are-36357681","doi":"10.1038/s41591-022-02049-x","journal":"Nature medicine","n_participants":1325,"pmid":"36357681","source_url":"https://pubmed.ncbi.nlm.nih.gov/36357681/","study_design":null,"title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-progress-report-and-20451868","doi":"10.1016/j.jalz.2010.03.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"20451868","source_url":"https://pubmed.ncbi.nlm.nih.gov/20451868/","study_design":null,"title":"The Alzheimer's disease neuroimaging initiative: progress report and future plans","title_match":false,"year":2010},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/brain-beta-amyloid-measures-and-magnetic-resonance-imaging-atrophy-20935035","doi":"10.1093/brain/awq277","journal":"Brain : a journal of neurology","n_participants":165,"pmid":"20935035","source_url":"https://pubmed.ncbi.nlm.nih.gov/20935035/","study_design":null,"title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-3-continued-27931796","doi":"10.1016/j.jalz.2016.10.006","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"27931796","source_url":"https://pubmed.ncbi.nlm.nih.gov/27931796/","study_design":null,"title":"The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement","title_match":false,"year":2017},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/regional-profiles-of-the-candidate-tau-pet-ligand-18f-av-1451-26936940","doi":"10.1093/brain/aww023","journal":"Brain : a journal of neurology","n_participants":14,"pmid":"26936940","source_url":"https://pubmed.ncbi.nlm.nih.gov/26936940/","study_design":null,"title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","title_match":false,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/a-review-on-neuroimaging-based-classification-studies-and-associated-28414186","doi":"10.1016/j.neuroimage.2017.03.057","journal":"NeuroImage","n_participants":null,"pmid":"28414186","source_url":"https://pubmed.ncbi.nlm.nih.gov/28414186/","study_design":null,"title":"A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages","title_match":false,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/microglial-activation-correlates-in-vivo-with-both-tau-and-amyloid-in-30052812","doi":"10.1093/brain/awy188","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"30052812","source_url":"https://pubmed.ncbi.nlm.nih.gov/30052812/","study_design":null,"title":"Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/a-data-driven-model-of-biomarker-changes-in-sporadic-alzheimer-s-25012224","doi":"10.1093/brain/awu176","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"25012224","source_url":"https://pubmed.ncbi.nlm.nih.gov/25012224/","study_design":null,"title":"A data-driven model of biomarker changes in sporadic Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/diverging-longitudinal-changes-in-astrocytosis-and-amyloid-pet-in-26813969","doi":"10.1093/brain/awv404","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"26813969","source_url":"https://pubmed.ncbi.nlm.nih.gov/26813969/","study_design":"longitudinal study","title":"Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease","title_match":true,"year":2016},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/early-stages-of-tau-pathology-and-its-associations-with-functional-33725124","doi":"10.1093/brain/awab114","journal":"Brain : a journal of neurology","n_participants":215,"pmid":"33725124","source_url":"https://pubmed.ncbi.nlm.nih.gov/33725124/","study_design":null,"title":"Early stages of tau pathology and its associations with functional connectivity, atrophy and memory","title_match":false,"year":2021},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/independent-information-from-cerebrospinal-fluid-amyloid-and-25541191","doi":"10.1093/brain/awu367","journal":"Brain : a journal of neurology","n_participants":769,"pmid":"25541191","source_url":"https://pubmed.ncbi.nlm.nih.gov/25541191/","study_design":null,"title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/regional-dynamics-of-amyloid-deposition-in-healthy-elderly-mild-22628162","doi":"10.1093/brain/aws125","journal":"Brain : a journal of neurology","n_participants":32,"pmid":"22628162","source_url":"https://pubmed.ncbi.nlm.nih.gov/22628162/","study_design":"longitudinal study","title":"Regional dynamics of amyloid-\u03b2 deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study","title_match":true,"year":2012},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/factors-affecting-a-plasma-levels-and-their-utility-as-biomarkers-in-21805181","doi":"10.1007/s00401-011-0861-8","journal":"Acta neuropathologica","n_participants":715,"pmid":"21805181","source_url":"https://pubmed.ncbi.nlm.nih.gov/21805181/","study_design":"longitudinal study","title":"Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI","title_match":false,"year":2011},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/tau-pet-and-in-vivo-braak-staging-as-prognostic-markers-of-future-34384484","doi":"10.1186/s13195-021-00880-x","journal":"Alzheimer's research & therapy","n_participants":396,"pmid":"34384484","source_url":"https://pubmed.ncbi.nlm.nih.gov/34384484/","study_design":"longitudinal study","title":"Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals","title_match":false,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/impact-of-molecular-imaging-on-the-diagnostic-process-in-a-memory-23164552","doi":"10.1016/j.jalz.2012.07.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":39,"pmid":"23164552","source_url":"https://pubmed.ncbi.nlm.nih.gov/23164552/","study_design":null,"title":"Impact of molecular imaging on the diagnostic process in a memory clinic","title_match":false,"year":2013},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/a-european-multicentre-pet-study-of-fibrillar-amyloid-in-alzheimer-s-22961445","doi":"10.1007/s00259-012-2237-2","journal":"European journal of nuclear medicine and molecular imaging","n_participants":97,"pmid":"22961445","source_url":"https://pubmed.ncbi.nlm.nih.gov/22961445/","study_design":null,"title":"A European multicentre PET study of fibrillar amyloid in Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/obstructive-sleep-apnea-and-longitudinal-alzheimer-s-disease-30794315","doi":"10.1093/sleep/zsz048","journal":"Sleep","n_participants":516,"pmid":"30794315","source_url":"https://pubmed.ncbi.nlm.nih.gov/30794315/","study_design":"longitudinal study","title":"Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes","title_match":false,"year":2019},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/electromagnetic-signatures-of-the-preclinical-and-prodromal-stages-of-29522156","doi":"10.1093/brain/awy044","journal":"Brain : a journal of neurology","n_participants":17,"pmid":"29522156","source_url":"https://pubmed.ncbi.nlm.nih.gov/29522156/","study_design":null,"title":"Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/choroid-plexus-volume-is-associated-with-levels-of-csf-proteins-32107064","doi":"10.1016/j.neurobiolaging.2020.01.005","journal":"Neurobiology of aging","n_participants":509,"pmid":"32107064","source_url":"https://pubmed.ncbi.nlm.nih.gov/32107064/","study_design":null,"title":"Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease","title_match":false,"year":2020},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/plasma-a42-40-ratio-detects-early-stages-of-alzheimer-s-disease-and-30569084","doi":"10.14283/jpad.2018.41","journal":"The journal of prevention of Alzheimer's disease","n_participants":145,"pmid":"30569084","source_url":"https://pubmed.ncbi.nlm.nih.gov/30569084/","study_design":null,"title":"Plasma A\u03b242/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study","title_match":false,"year":2019},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/carbon-11-labeled-pittsburgh-compound-b-and-carbon-11-labeled-r-19139300","doi":"10.1001/archneurol.2008.511","journal":"Archives of neurology","n_participants":null,"pmid":"19139300","source_url":"https://pubmed.ncbi.nlm.nih.gov/19139300/","study_design":null,"title":"Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/eeg-spectral-analysis-as-a-putative-early-prognostic-biomarker-in-28646686","doi":"10.1016/j.neurobiolaging.2017.05.017","journal":"Neurobiology of aging","n_participants":205,"pmid":"28646686","source_url":"https://pubmed.ncbi.nlm.nih.gov/28646686/","study_design":null,"title":"EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects","title_match":true,"year":2017},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-profiled-by-fluid-and-imaging-markers-tau-pet-34593971","doi":"10.1038/s41380-021-01263-2","journal":"Molecular psychiatry","n_participants":282,"pmid":"34593971","source_url":"https://pubmed.ncbi.nlm.nih.gov/34593971/","study_design":"longitudinal study","title":"Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/alzheimer-s-retinopathy-seeing-disease-in-the-eyes-33041751","doi":"10.3389/fnins.2020.00921","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"33041751","source_url":"https://pubmed.ncbi.nlm.nih.gov/33041751/","study_design":null,"title":"Alzheimer's Retinopathy: Seeing Disease in the Eyes","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/pet-staging-of-amyloidosis-using-striatum-29792874","doi":"10.1016/j.jalz.2018.04.011","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1433,"pmid":"29792874","source_url":"https://pubmed.ncbi.nlm.nih.gov/29792874/","study_design":null,"title":"PET staging of amyloidosis using striatum","title_match":false,"year":2018},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/the-accumulation-rate-of-tau-aggregates-is-higher-in-females-and-33439987","doi":"10.1093/brain/awaa327","journal":"Brain : a journal of neurology","n_participants":157,"pmid":"33439987","source_url":"https://pubmed.ncbi.nlm.nih.gov/33439987/","study_design":"cohort study","title":"The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects","title_match":true,"year":2020},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/subjective-cognitive-impairment-cohort-science-study-design-and-first-30081935","doi":"10.1186/s13195-018-0390-y","journal":"Alzheimer's research & therapy","n_participants":114,"pmid":"30081935","source_url":"https://pubmed.ncbi.nlm.nih.gov/30081935/","study_design":"cohort study","title":"Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results","title_match":false,"year":2018},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-in-aging-and-dementia-testing-the-amyloid-hypothesis-19847050","doi":"10.3233/ben-2009-0232","journal":"Behavioural neurology","n_participants":null,"pmid":"19847050","source_url":"https://pubmed.ncbi.nlm.nih.gov/19847050/","study_design":null,"title":"Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo","title_match":true,"year":2009},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-of-lewy-body-associated-disorders-20922808","doi":"10.1002/mds.23393","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"20922808","source_url":"https://pubmed.ncbi.nlm.nih.gov/20922808/","study_design":"longitudinal study","title":"Amyloid imaging of Lewy body-associated disorders","title_match":true,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/self-rated-and-informant-rated-everyday-function-in-comparison-to-25449531","doi":"10.1016/j.jalz.2014.09.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1080,"pmid":"25449531","source_url":"https://pubmed.ncbi.nlm.nih.gov/25449531/","study_design":null,"title":"Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/japanese-and-north-american-alzheimer-s-disease-neuroimaging-29753531","doi":"10.1016/j.jalz.2018.03.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":75,"pmid":"29753531","source_url":"https://pubmed.ncbi.nlm.nih.gov/29753531/","study_design":null,"title":"Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/integration-and-relative-value-of-biomarkers-for-prediction-of-mci-to-24371799","doi":"10.1016/j.nicl.2013.11.010","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24371799","source_url":"https://pubmed.ncbi.nlm.nih.gov/24371799/","study_design":null,"title":"Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers","title_match":false,"year":2014},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/dynamic-changes-in-pet-amyloid-and-fdg-imaging-at-different-stages-of-20688420","doi":"10.1016/j.neurobiolaging.2010.06.015","journal":"Neurobiology of aging","n_participants":null,"pmid":"20688420","source_url":"https://pubmed.ncbi.nlm.nih.gov/20688420/","study_design":null,"title":"Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease","title_match":true,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/associations-between-biomarkers-and-age-in-the-presenilin-1-e280a-25580592","doi":"10.1001/jamaneurol.2014.3314","journal":"JAMA neurology","n_participants":null,"pmid":"25580592","source_url":"https://pubmed.ncbi.nlm.nih.gov/25580592/","study_design":"cross-sectional","title":"Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study","title_match":false,"year":2015},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/high-striatal-amyloid-beta-peptide-deposition-across-different-20008660","doi":"10.1001/archneurol.2009.285","journal":"Archives of neurology","n_participants":30,"pmid":"20008660","source_url":"https://pubmed.ncbi.nlm.nih.gov/20008660/","study_design":null,"title":"High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types","title_match":false,"year":2009},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/microglial-activation-protects-against-accumulation-of-tau-aggregates-37118533","doi":"10.1038/s43587-022-00310-z","journal":"Nature aging","n_participants":null,"pmid":"37118533","source_url":"https://pubmed.ncbi.nlm.nih.gov/37118533/","study_design":"longitudinal study","title":"Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology","title_match":false,"year":2022},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/increase-of-trem2-during-aging-of-an-alzheimer-s-disease-mouse-model-28197095","doi":"10.3389/fnagi.2017.00008","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"28197095","source_url":"https://pubmed.ncbi.nlm.nih.gov/28197095/","study_design":"cross-sectional","title":"Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/soluble-trem2-levels-associate-with-conversion-from-mild-cognitive-36519540","doi":"10.1172/jci158708","journal":"The Journal of clinical investigation","n_participants":null,"pmid":"36519540","source_url":"https://pubmed.ncbi.nlm.nih.gov/36519540/","study_design":null,"title":"Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/strem2-is-associated-with-amyloid-related-p-tau-increases-and-glucose-36620941","doi":"10.15252/emmm.202216987","journal":"EMBO molecular medicine","n_participants":70,"pmid":"36620941","source_url":"https://pubmed.ncbi.nlm.nih.gov/36620941/","study_design":"cross-sectional","title":"sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/relationship-of-cerebrospinal-fluid-markers-to-11c-pib-and-18f-fddnp-19690025","doi":"10.2967/jnumed.109.064360","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":37,"pmid":"19690025","source_url":"https://pubmed.ncbi.nlm.nih.gov/19690025/","study_design":null,"title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding","title_match":false,"year":2009},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-biomarkers-are-associated-with-body-mass-index-22105948","doi":"10.1212/wnl.0b013e318238eec1","journal":"Neurology","n_participants":101,"pmid":"22105948","source_url":"https://pubmed.ncbi.nlm.nih.gov/22105948/","study_design":"cross-sectional","title":"Alzheimer disease biomarkers are associated with body mass index","title_match":false,"year":2011},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/sequence-of-alzheimer-disease-biomarker-changes-in-cognitively-normal-32873693","doi":"10.1212/wnl.0000000000010747","journal":"Neurology","n_participants":null,"pmid":"32873693","source_url":"https://pubmed.ncbi.nlm.nih.gov/32873693/","study_design":"cross-sectional","title":"Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study","title_match":false,"year":2020},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/association-of-csf-gap-43-with-the-rate-of-cognitive-decline-and-36192174","doi":"10.1212/wnl.0000000000201417","journal":"Neurology","n_participants":786,"pmid":"36192174","source_url":"https://pubmed.ncbi.nlm.nih.gov/36192174/","study_design":null,"title":"Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals","title_match":true,"year":2023},{"alzhub_score":65,"alzhub_url":"https://alzhub.org/study/accelerated-longitudinal-changes-and-ordering-of-alzheimer-disease-35925685","doi":"10.1093/brain/awac238","journal":"Brain : a journal of neurology","n_participants":2609,"pmid":"35925685","source_url":"https://pubmed.ncbi.nlm.nih.gov/35925685/","study_design":"longitudinal study","title":"Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/association-of-early-amyloid-accumulation-and-neuroinflammation-33514647","doi":"10.1212/wnl.0000000000011612","journal":"Neurology","n_participants":null,"pmid":"33514647","source_url":"https://pubmed.ncbi.nlm.nih.gov/33514647/","study_design":null,"title":"Association of Early \u03b2-Amyloid Accumulation and Neuroinflammation Measured With [11C]PBR28 in Elderly Individuals Without Dementia","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/amyloid-pet-correlation-with-cerebrospinal-fluid-biomarkers-and-31430334","doi":"10.1371/journal.pone.0221365","journal":"PloS one","n_participants":64,"pmid":"31430334","source_url":"https://pubmed.ncbi.nlm.nih.gov/31430334/","study_design":null,"title":"Amyloid-\u03b2 PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer\u00b4s disease diagnosis in a memory clinic","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/the-validation-of-multifactor-model-of-plasma-a-sub-i-42-i-sub-and-32792940","doi":"10.3389/fnagi.2020.00212","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"32792940","source_url":"https://pubmed.ncbi.nlm.nih.gov/32792940/","study_design":null,"title":"The Validation of Multifactor Model of Plasma A\u03b2 42 and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease","title_match":false,"year":2020},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/longitudinal-relationships-of-white-matter-hyperintensities-and-37202169","doi":"10.1212/wnl.0000000000207378","journal":"Neurology","n_participants":null,"pmid":"37202169","source_url":"https://pubmed.ncbi.nlm.nih.gov/37202169/","study_design":"longitudinal study","title":"Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/prognostic-value-of-atn-alzheimer-biomarkers-60-month-follow-up-32490138","doi":"10.1002/dad2.12026","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"32490138","source_url":"https://pubmed.ncbi.nlm.nih.gov/32490138/","study_design":null,"title":"Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-amyloid-and-tau-biomarker-changes-across-the-40638114","doi":"10.1001/jamanetworkopen.2025.19919","journal":"JAMA network open","n_participants":197,"pmid":"40638114","source_url":"https://pubmed.ncbi.nlm.nih.gov/40638114/","study_design":"cohort study","title":"Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/clinical-relevance-of-sup-18-sup-f-florbetaben-and-sup-18-sup-f-fdg-33652938","doi":"10.3390/molecules26051282","journal":"Molecules (Basel, Switzerland)","n_participants":40,"pmid":"33652938","source_url":"https://pubmed.ncbi.nlm.nih.gov/33652938/","study_design":null,"title":"Clinical Relevance of [18F]Florbetaben and [18F]FDG PET/CT Imaging on the Management of Patients with Dementia","title_match":true,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/association-between-herpes-simplex-virus-infection-and-alzheimer-s-39825066","doi":"10.1038/s41598-024-84583-x","journal":"Scientific reports","n_participants":58,"pmid":"39825066","source_url":"https://pubmed.ncbi.nlm.nih.gov/39825066/","study_design":null,"title":"Association between herpes simplex virus infection and Alzheimer's disease biomarkers: analysis within the MAPT trial","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/association-of-years-to-parent-s-sporadic-onset-and-risk-factors-with-32737076","doi":"10.1212/wnl.0000000000010527","journal":"Neurology","n_participants":290,"pmid":"32737076","source_url":"https://pubmed.ncbi.nlm.nih.gov/32737076/","study_design":null,"title":"Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer biomarkers","title_match":false,"year":2020},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/news-on-blood-biomarker-based-early-diagnosis-of-the-preliminary-41197657","doi":"10.1055/a-2698-5992","journal":"Fortschritte der Neurologie-Psychiatrie","n_participants":null,"pmid":"41197657","source_url":"https://pubmed.ncbi.nlm.nih.gov/41197657/","study_design":null,"title":"[News on blood biomarker-based early diagnosis of the preliminary stages of Alzheimer's dementia]","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/cognitive-stability-among-plasma-p-tau-181-negative-individuals-a-5-40383731","doi":"10.1093/gerona/glaf113","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":null,"pmid":"40383731","source_url":"https://pubmed.ncbi.nlm.nih.gov/40383731/","study_design":"longitudinal study","title":"Cognitive Stability Among Plasma p-tau 181 Negative Individuals: A 5-year Analysis of the Multidomain Alzheimer Prevention Trial Study","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/clinical-significance-of-the-plasma-biomarker-panels-in-amyloid-38891795","doi":"10.3390/ijms25115607","journal":"International journal of molecular sciences","n_participants":55,"pmid":"38891795","source_url":"https://pubmed.ncbi.nlm.nih.gov/38891795/","study_design":null,"title":"Clinical Significance of the Plasma Biomarker Panels in Amyloid-Negative and Tau PET-Positive Amnestic Patients: Comparisons with Alzheimer's Disease and Unimpaired Cognitive Controls","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/lecanemab-in-symptomatic-psen1-p-met233val-early-onset-alzheimer-s-42676462","doi":"10.1002/dad2.70468","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"42676462","source_url":"https://pubmed.ncbi.nlm.nih.gov/42676462/","study_design":"longitudinal study","title":"Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer's disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkers","title_match":true,"year":2026},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/prognostic-significance-of-cerebrospinal-fluid-tau-biomarkers-in-42585284","doi":"10.1177/13872877261476236","journal":"Journal of Alzheimer's disease : JAD","n_participants":1280,"pmid":"42585284","source_url":"https://pubmed.ncbi.nlm.nih.gov/42585284/","study_design":"cohort study","title":"Prognostic significance of cerebrospinal fluid tau biomarkers in amyloid-negative A-T\u2009+\u2009N\u2009+\u2009neurodegeneration: A retrospective cohort study","title_match":true,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/evaluation-of-small-animal-pet-outcome-measures-to-detect-disease-28611242","doi":"10.2967/jnumed.116.187625","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"28611242","source_url":"https://pubmed.ncbi.nlm.nih.gov/28611242/","study_design":null,"title":"Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease","title_match":false,"year":2017},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/commentary-aducanumab-related-aria-paean-or-lament-35543641","doi":"10.1097/rlu.0000000000004252","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"35543641","source_url":"https://pubmed.ncbi.nlm.nih.gov/35543641/","study_design":null,"title":"Commentary: Aducanumab-Related ARIA: Paean or Lament?","title_match":false,"year":2022},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/aducanumab-related-amyloid-related-imaging-abnormalities-paean-or-35452007","doi":"10.1097/rlu.0000000000004250","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"35452007","source_url":"https://pubmed.ncbi.nlm.nih.gov/35452007/","study_design":null,"title":"Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?","title_match":false,"year":2022},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/re-aducanumab-related-aria-paean-or-lament-36607365","doi":"10.1097/rlu.0000000000004490","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"36607365","source_url":"https://pubmed.ncbi.nlm.nih.gov/36607365/","study_design":null,"title":"Re: Aducanumab-Related ARIA: Paean or Lament?","title_match":false,"year":2023},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/trial-of-solanezumab-for-mild-dementia-due-to-alzheimer-s-disease-29365294","doi":"10.1056/nejmoa1705971","journal":"The New England journal of medicine","n_participants":2129,"pmid":"29365294","source_url":"https://pubmed.ncbi.nlm.nih.gov/29365294/","study_design":"clinical trial","title":"Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/microglia-amyloid-and-glucose-metabolism-in-parkinson-s-disease-with-23303049","doi":"10.1038/npp.2012.255","journal":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","n_participants":null,"pmid":"23303049","source_url":"https://pubmed.ncbi.nlm.nih.gov/23303049/","study_design":null,"title":"Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia","title_match":false,"year":2013},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/amyloid-assessed-by-florbetapir-f-18-pet-and-18-month-cognitive-22786606","doi":"10.1212/wnl.0b013e3182661f74","journal":"Neurology","n_participants":51,"pmid":"22786606","source_url":"https://pubmed.ncbi.nlm.nih.gov/22786606/","study_design":"longitudinal study","title":"Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","title_match":true,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/florbetapir-f-18-amyloid-pet-and-36-month-cognitive-decline-a-24614494","doi":"10.1038/mp.2014.9","journal":"Molecular psychiatry","n_participants":null,"pmid":"24614494","source_url":"https://pubmed.ncbi.nlm.nih.gov/24614494/","study_design":null,"title":"Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study","title_match":true,"year":2014},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/mood-changes-in-cognitively-normal-older-adults-are-linked-to-27426238","doi":"10.1016/j.jagp.2016.04.004","journal":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","n_participants":118,"pmid":"27426238","source_url":"https://pubmed.ncbi.nlm.nih.gov/27426238/","study_design":"longitudinal study","title":"Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels","title_match":false,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-and-cerebrospinal-fluid-results-30231896","doi":"10.1186/s13195-018-0424-5","journal":"Alzheimer's research & therapy","n_participants":26,"pmid":"30231896","source_url":"https://pubmed.ncbi.nlm.nih.gov/30231896/","study_design":null,"title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)","title_match":true,"year":2018},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/tilavonemab-in-early-alzheimer-s-disease-results-from-a-phase-2-36730056","doi":"10.1093/brain/awad024","journal":"Brain : a journal of neurology","n_participants":108,"pmid":"36730056","source_url":"https://pubmed.ncbi.nlm.nih.gov/36730056/","study_design":"clinical trial","title":"Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study","title_match":false,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/cortical-pib-binding-in-lewy-body-disease-is-associated-with-19162186","doi":"10.1016/j.nbd.2008.12.008","journal":"Neurobiology of disease","n_participants":null,"pmid":"19162186","source_url":"https://pubmed.ncbi.nlm.nih.gov/19162186/","study_design":null,"title":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics","title_match":false,"year":2009},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/neuropsychiatric-and-cognitive-symptoms-across-the-alzheimer-disease-34413181","doi":"10.1212/wnl.0000000000012598","journal":"Neurology","n_participants":520,"pmid":"34413181","source_url":"https://pubmed.ncbi.nlm.nih.gov/34413181/","study_design":"longitudinal study","title":"Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations","title_match":false,"year":2021},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-analysis-detects-cerebral-amyloid-accumulation-26936941","doi":"10.1093/brain/aww015","journal":"Brain : a journal of neurology","n_participants":437,"pmid":"26936941","source_url":"https://pubmed.ncbi.nlm.nih.gov/26936941/","study_design":"longitudinal study","title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography","title_match":false,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/left-lateralized-cerebral-glucose-metabolism-declines-in-amyloid-30101060","doi":"10.1016/j.nicl.2018.07.016","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"30101060","source_url":"https://pubmed.ncbi.nlm.nih.gov/30101060/","study_design":"longitudinal study","title":"Left lateralized cerebral glucose metabolism declines in amyloid-\u03b2 positive persons with mild cognitive impairment","title_match":false,"year":2018},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/data-driven-fdg-pet-subtypes-of-alzheimer-s-disease-related-33608059","doi":"10.1186/s13195-021-00785-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"33608059","source_url":"https://pubmed.ncbi.nlm.nih.gov/33608059/","study_design":null,"title":"Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration","title_match":false,"year":2021},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/genome-wide-interaction-study-of-brain-beta-amyloid-burden-and-27021820","doi":"10.1038/mp.2016.35","journal":"Molecular psychiatry","n_participants":678,"pmid":"27021820","source_url":"https://pubmed.ncbi.nlm.nih.gov/27021820/","study_design":"meta-analysis","title":"Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/rpop-robust-pet-only-processing-of-community-acquired-heterogeneous-34890793","doi":"10.1016/j.neuroimage.2021.118775","journal":"NeuroImage","n_participants":740,"pmid":"34890793","source_url":"https://pubmed.ncbi.nlm.nih.gov/34890793/","study_design":null,"title":"rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data","title_match":true,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/association-of-brain-amyloidosis-with-the-incidence-and-frequency-of-31857304","doi":"10.1136/bmjopen-2019-031947","journal":"BMJ open","n_participants":null,"pmid":"31857304","source_url":"https://pubmed.ncbi.nlm.nih.gov/31857304/","study_design":null,"title":"Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study","title_match":false,"year":2019},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/maternal-family-history-is-associated-with-alzheimer-s-disease-22669011","doi":"10.3233/jad-2012-120676","journal":"Journal of Alzheimer's disease : JAD","n_participants":99,"pmid":"22669011","source_url":"https://pubmed.ncbi.nlm.nih.gov/22669011/","study_design":"cross-sectional","title":"Maternal family history is associated with Alzheimer's disease biomarkers","title_match":false,"year":2012},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/associations-between-neuropsychiatric-symptoms-and-cerebral-amyloid-26484900","doi":"10.3233/jad-150181","journal":"Journal of Alzheimer's disease : JAD","n_participants":657,"pmid":"26484900","source_url":"https://pubmed.ncbi.nlm.nih.gov/26484900/","study_design":null,"title":"Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People","title_match":false,"year":2016},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/comparison-of-csf-markers-and-semi-quantitative-amyloid-pet-in-28441967","doi":"10.1186/s13195-017-0260-z","journal":"Alzheimer's research & therapy","n_participants":677,"pmid":"28441967","source_url":"https://pubmed.ncbi.nlm.nih.gov/28441967/","study_design":"cross-sectional","title":"Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database","title_match":true,"year":2017},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-amyloid-csf-pet-discordance-and-tau-load-5-years-later-32913020","doi":"10.1212/wnl.0000000000010739","journal":"Neurology","n_participants":318,"pmid":"32913020","source_url":"https://pubmed.ncbi.nlm.nih.gov/32913020/","study_design":"longitudinal study","title":"Association of amyloid-\u03b2 CSF/PET discordance and tau load 5 years later","title_match":false,"year":2020},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/differential-associations-of-apoe-2-and-apoe-4-alleles-with-pet-33521872","doi":"10.1007/s00259-021-05192-8","journal":"European journal of nuclear medicine and molecular imaging","n_participants":156,"pmid":"33521872","source_url":"https://pubmed.ncbi.nlm.nih.gov/33521872/","study_design":"cross-sectional","title":"Differential associations of APOE-\u03b52 and APOE-\u03b54 alleles with PET-measured amyloid-\u03b2 and tau deposition in older individuals without dementia","title_match":false,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/mild-behavioral-impairment-correlates-of-cognitive-impairments-in-34759274","doi":"10.1038/s41398-021-01675-2","journal":"Translational psychiatry","n_participants":1129,"pmid":"34759274","source_url":"https://pubmed.ncbi.nlm.nih.gov/34759274/","study_design":"longitudinal study","title":"Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology","title_match":false,"year":2021},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/amyloid-deposition-hypometabolism-and-longitudinal-cognitive-decline-23109153","doi":"10.1002/ana.23650","journal":"Annals of neurology","n_participants":null,"pmid":"23109153","source_url":"https://pubmed.ncbi.nlm.nih.gov/23109153/","study_design":"cross-sectional","title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","title_match":false,"year":2012},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/in-vivo-imaging-of-amyloid-deposition-in-alzheimer-disease-using-the-20501908","doi":"10.2967/jnumed.109.069088","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":16,"pmid":"20501908","source_url":"https://pubmed.ncbi.nlm.nih.gov/20501908/","study_design":"open-label trial","title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","title_match":true,"year":2010},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/molecular-imaging-with-pittsburgh-compound-b-confirmed-at-autopsy-a-17353389","doi":"10.1001/archneur.64.3.431","journal":"Archives of neurology","n_participants":null,"pmid":"17353389","source_url":"https://pubmed.ncbi.nlm.nih.gov/17353389/","study_design":null,"title":"Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report","title_match":true,"year":2007},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/early-and-protective-microglial-activation-in-alzheimer-s-disease-a-26984188","doi":"10.1093/brain/aww017","journal":"Brain : a journal of neurology","n_participants":38,"pmid":"26984188","source_url":"https://pubmed.ncbi.nlm.nih.gov/26984188/","study_design":null,"title":"Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging","title_match":false,"year":2016},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/microglial-activation-and-amyloid-deposition-in-mild-cognitive-19122031","doi":"10.1212/01.wnl.0000338622.27876.0d","journal":"Neurology","n_participants":null,"pmid":"19122031","source_url":"https://pubmed.ncbi.nlm.nih.gov/19122031/","study_design":null,"title":"Microglial activation and amyloid deposition in mild cognitive impairment: a PET study","title_match":false,"year":2009},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/influence-of-microglial-activation-on-neuronal-function-in-alzheimer-25239737","doi":"10.1016/j.jalz.2014.06.016","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"25239737","source_url":"https://pubmed.ncbi.nlm.nih.gov/25239737/","study_design":null,"title":"Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia","title_match":false,"year":2015},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/a-multimodal-machine-learning-model-for-predicting-dementia-38806509","doi":"10.1038/s41598-024-60134-2","journal":"Scientific Reports","n_participants":196,"pmid":"38806509","source_url":"https://pubmed.ncbi.nlm.nih.gov/38806509/","study_design":null,"title":"A multimodal machine learning model for predicting dementia conversion in Alzheimer\u2019s disease","title_match":false,"year":2024},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/f40105-racial-and-ethnic-differences-in-amyloid-pet-positivity-in-the-107a9626","doi":"10.1016/j.jalz.2019.06.4717","journal":"Alzheimer s & Dementia","n_participants":18550,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2019.06.4717","study_design":null,"title":"F4\u201001\u201005: RACIAL AND ETHNIC DIFFERENCES IN AMYLOID PET POSITIVITY IN THE IDEAS STUDY","title_match":true,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/a-comprehensive-communityengaged-recruitment-strategy-to-increase-132dce04","doi":"10.1002/alz.080558","journal":"Alzheimer s & Dementia","n_participants":4524,"pmid":null,"source_url":"https://doi.org/10.1002/alz.080558","study_design":"cohort study","title":"A Comprehensive, Community\u2010Engaged Recruitment Strategy to Increase Minority Representation in New IDEAS \u2013 an Amyloid Imaging Study","title_match":true,"year":2023},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/association-of-residential-neighborhood-disadvantage-with-amyloid-pet-4e49a7d2","doi":"10.17615/0g36-z486","journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.17615/0g36-z486","study_design":null,"title":"Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals","title_match":true,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/association-of-residential-neighborhood-disadvantage-with-amyloid-pet-41816196","doi":"10.1002/bsa3.70058","journal":"Alzheimer s & Dementia Behavior & Socioeconomics of Aging","n_participants":null,"pmid":"41816196","source_url":"https://pubmed.ncbi.nlm.nih.gov/41816196/","study_design":null,"title":"Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals","title_match":true,"year":2026},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/health-and-aging-brain-studyhealth-disparities-habshd-methods-and-40799724","doi":"10.1002/trc2.70140","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":null,"pmid":"40799724","source_url":"https://pubmed.ncbi.nlm.nih.gov/40799724/","study_design":null,"title":"Health and Aging Brain Study\u2013Health Disparities (HABS\u2010HD) methods and partner characteristics","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/residential-neighborhood-disadvantage-and-amyloid-positivity-findings-765dd107","doi":"10.1002/alz.091995","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.091995","study_design":null,"title":"Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS","title_match":true,"year":2024},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/residential-neighborhood-disadvantage-and-amyloid-positivity-findings-23bc1148","doi":"10.1002/alz.094017","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.094017","study_design":null,"title":"Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS","title_match":true,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/impact-of-race-ethnicity-and-area-deprivation-index-on-alzheimers-32ecf47a","doi":"10.1002/alz.089954","journal":"Alzheimer s & Dementia","n_participants":644,"pmid":null,"source_url":"https://doi.org/10.1002/alz.089954","study_design":null,"title":"Impact of race/ethnicity and area deprivation index on Alzheimer\u2019s disease and related disorders biomarkers in the POINTER Cohort","title_match":false,"year":2024},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/can-integration-of-alzheimers-plasma-biomarkers-with-mri-39291164","doi":"10.1093/braincomms/fcae300","journal":"Brain Communications","n_participants":1185,"pmid":"39291164","source_url":"https://pubmed.ncbi.nlm.nih.gov/39291164/","study_design":"cross-sectional","title":"Can integration of Alzheimer\u2019s plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction?","title_match":false,"year":2024},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/association-of-neighborhood-disadvantage-with-alzheimer-s-disease-41285652","doi":"10.1016/j.tjpad.2025.100445","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":755,"pmid":"41285652","source_url":"https://pubmed.ncbi.nlm.nih.gov/41285652/","study_design":"cohort study","title":"Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/differences-in-amyloid-pet-positivity-based-on-ethnoracial-group-and-42200449","doi":"10.1002/alz.71406","journal":"Alzheimer s & Dementia","n_participants":5757,"pmid":"42200449","source_url":"https://pubmed.ncbi.nlm.nih.gov/42200449/","study_design":null,"title":"Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study","title_match":true,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/differences-in-amyloid-pet-positivity-based-on-ethnoracial-group-and-8139bdf8","doi":"10.17615/agh3-gz31","journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","n_participants":5757,"pmid":null,"source_url":"https://doi.org/10.17615/agh3-gz31","study_design":null,"title":"Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS study","title_match":true,"year":2026},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/evaluating-plasma-p-tau217-as-an-endpoint-for-alzheimer-disease-41364889","doi":"10.1212/wnl.0000000000214441","journal":"Neurology","n_participants":716,"pmid":"41364889","source_url":"https://pubmed.ncbi.nlm.nih.gov/41364889/","study_design":"longitudinal study","title":"Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/association-of-plasma-biomarkers-of-alzheimer-disease-and-39889254","doi":"10.1212/wnl.0000000000210271","journal":"Neurology","n_participants":421,"pmid":"39889254","source_url":"https://pubmed.ncbi.nlm.nih.gov/39889254/","study_design":"longitudinal study","title":"Association of Plasma Biomarkers of Alzheimer Disease and Neurodegeneration With Longitudinal Intra-Network Functional Brain Connectivity","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/validation-of-blood-biomarkers-for-alzheimer-disease-in-thai-cohort-41452241","doi":"10.1002/alz70856_102473","journal":"Alzheimer s & Dementia","n_participants":51,"pmid":"41452241","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12742333/","study_design":null,"title":"Validation of blood biomarkers for Alzheimer Disease in Thai Cohort","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/prior-traumatic-brain-injury-and-alzheimer-disease-blood-biomarkers-42371653","doi":"10.1001/jamaneurol.2026.2042","journal":"JAMA Neurology","n_participants":272,"pmid":"42371653","source_url":"https://pubmed.ncbi.nlm.nih.gov/42371653/","study_design":"cohort study","title":"Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers","title_match":false,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-pet-signal-reduction-in-prior-aria-e-regions-after-41260674","doi":"10.3174/ajnr.a9111","journal":"American Journal of Neuroradiology","n_participants":null,"pmid":"41260674","source_url":"https://pubmed.ncbi.nlm.nih.gov/41260674/","study_design":null,"title":"\u03b2-Amyloid PET Signal Reduction in Prior ARIA-E Regions after Antiamyloid Therapy for Alzheimer Disease","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/added-value-of-amyloid-pet-quantification-with-the-centiloid-scale-in-40968015","doi":"10.3174/ajnr.a8850","journal":"American Journal of Neuroradiology","n_participants":null,"pmid":"40968015","source_url":"https://pubmed.ncbi.nlm.nih.gov/40968015/","study_design":null,"title":"Added Value of Amyloid PET Quantification with the Centiloid Scale in Clinical Practice","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/combination-of-a40-a42-and-tau-plasma-levels-to-distinguish-amyloid-40091634","doi":"10.5607/en25008","journal":"Experimental Neurobiology","n_participants":53,"pmid":"40091634","source_url":"https://pubmed.ncbi.nlm.nih.gov/40091634/","study_design":null,"title":"Combination of A\u03b240, A\u03b242, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls","title_match":true,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/centiloids-in-amyloid-pet-a-practical-guide-to-quantitation-41667282","doi":"10.2967/jnmt.125.271823","journal":"Journal of Nuclear Medicine Technology","n_participants":null,"pmid":"41667282","source_url":"https://pubmed.ncbi.nlm.nih.gov/41667282/","study_design":"longitudinal study","title":"Centiloids in Amyloid PET: A Practical Guide to Quantitation Interpretation","title_match":true,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/promising-clinical-tools-for-specific-alzheimer-disease-diagnosis-40348819","doi":"10.1038/s41598-025-01511-3","journal":"Scientific Reports","n_participants":134,"pmid":"40348819","source_url":"https://pubmed.ncbi.nlm.nih.gov/40348819/","study_design":null,"title":"Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unit","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/brain-amyloid-plaque-levels-affect-clinical-progression-in-alzheimer-41543367","doi":"10.1002/psp4.70173","journal":"CPT Pharmacometrics & Systems Pharmacology","n_participants":null,"pmid":"41543367","source_url":"https://pubmed.ncbi.nlm.nih.gov/41543367/","study_design":"clinical trial","title":"Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR \u2010 SB Utilizing Semi\u2010Mechanistic Model","title_match":true,"year":2026},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/combination-of-amyloid-and-fdg-pet-for-the-prediction-of-short-term-40257609","doi":"10.1007/s00259-025-07275-2","journal":"European Journal of Nuclear Medicine and Molecular Imaging","n_participants":145,"pmid":"40257609","source_url":"https://pubmed.ncbi.nlm.nih.gov/40257609/","study_design":null,"title":"Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer\u00b4s disease in the clinical practice","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/lecanemab-in-diad-6month-amyloid-pet-results-from-the-diantu001-trial-41447716","doi":"10.1002/alz70859_105303","journal":"Alzheimer s & Dementia","n_participants":97,"pmid":"41447716","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740335/","study_design":null,"title":"Lecanemab in DIAD: 6\u2010Month Amyloid PET Results from the DIAN\u2010TU\u2010001 Trial","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pet-imaging-in-alzheimer-disease-in-the-era-of-antiamyloid-therapy-in-41667280","doi":"10.2967/jnmt.125.271835","journal":"Journal of Nuclear Medicine Technology","n_participants":null,"pmid":"41667280","source_url":"https://pubmed.ncbi.nlm.nih.gov/41667280/","study_design":null,"title":"PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape","title_match":false,"year":2026},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/cognitive-and-brain-reserve-as-modifiers-of-early-alzheimer-41980229","doi":"10.1212/wnl.0000000000214833","journal":"Neurology","n_participants":621,"pmid":"41980229","source_url":"https://pubmed.ncbi.nlm.nih.gov/41980229/","study_design":"cross-sectional","title":"Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease\u2013Related Cognitive Vulnerability","title_match":false,"year":2026},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/association-of-polygenic-risk-score-for-5-diseases-with-alzheimer-39836940","doi":"10.1212/wnl.0000000000210250","journal":"Neurology","n_participants":752,"pmid":"39836940","source_url":"https://pubmed.ncbi.nlm.nih.gov/39836940/","study_design":"prospective cohort","title":"Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/quantitative-amyloid-brain-imaging-a-literature-review-of-the-41667284","doi":"10.2967/jnmt.125.271678","journal":"Journal of Nuclear Medicine Technology","n_participants":null,"pmid":"41667284","source_url":"https://pubmed.ncbi.nlm.nih.gov/41667284/","study_design":"longitudinal study","title":"Quantitative Amyloid Brain Imaging: A Literature Review of the Centiloid Scale in Alzheimer Disease Evaluation","title_match":true,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/comparative-prognostic-performance-of-hippocampal-volume-and-plasma-42683796","doi":"10.3988/jcn.2025.0659","journal":"Journal of Clinical Neurology","n_participants":null,"pmid":"42683796","source_url":"https://pubmed.ncbi.nlm.nih.gov/42683796/","study_design":null,"title":"Comparative Prognostic Performance of Hippocampal Volume and Plasma Biomarkers in Amyloid-Negative Subjective Cognitive Decline: A Four-Year Follow-up","title_match":true,"year":2026},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/clinical-evaluation-of-the-revised-biological-and-clinical-staging-42314105","doi":"10.1212/wnl.0000000000218184","journal":"Neurology","n_participants":1214,"pmid":"42314105","source_url":"https://pubmed.ncbi.nlm.nih.gov/42314105/","study_design":null,"title":"Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China","title_match":false,"year":2026},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/inflammatory-alterations-and-multidomain-cognition-in-alzheimer-41288277","doi":"10.1097/wad.0000000000000706","journal":"Alzheimer Disease & Associated Disorders","n_participants":21,"pmid":"41288277","source_url":"https://pubmed.ncbi.nlm.nih.gov/41288277/","study_design":"cross-sectional","title":"Inflammatory Alterations and Multidomain Cognition in Alzheimer Disease and Related Dementias","title_match":false,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/brain-pet-in-the-era-of-anti-amyloid-antibody-therapy-for-alzheimer-42033565","doi":"10.1007/s11604-026-01998-4","journal":"Japanese Journal of Radiology","n_participants":null,"pmid":"42033565","source_url":"https://pubmed.ncbi.nlm.nih.gov/42033565/","study_design":"narrative review","title":"Brain PET in the era of anti-amyloid-\u03b2 antibody therapy for Alzheimer disease","title_match":false,"year":2026},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/effects-of-lowintensity-ultrasound-on-amyloid-clearance-in-earlystage-c42da504","doi":"10.1155/ane/1538313","journal":"Acta Neurologica Scandinavica","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1155/ane/1538313","study_design":null,"title":"Effects of Low\u2010Intensity Ultrasound on Amyloid\u2010 \u03b2 Clearance in Early\u2010Stage Alzheimer\u2032s Disease: A Potential Role of Glymphatic Activity","title_match":false,"year":2026},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/correlation-and-interchangeability-of-amyloid-tau-and-glucose-41440067","doi":"10.3390/brainsci15121271","journal":"Brain Sciences","n_participants":58,"pmid":"41440067","source_url":"https://pubmed.ncbi.nlm.nih.gov/41440067/","study_design":null,"title":"Correlation and Interchangeability of Amyloid, Tau, and Glucose Metabolism PET in Mild Cognitive Impairment and Alzheimer: A Review","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/predicting-onset-of-alzheimer-disease-symptoms-with-a-plasma-ptau217-41442191","doi":"10.1002/alz70856_099674","journal":"Alzheimer s & Dementia","n_participants":420,"pmid":"41442191","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12732562/","study_design":"longitudinal study","title":"Predicting onset of Alzheimer disease symptoms with a plasma %p\u2010tau217 clock","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-pet-quantitation-and-centiloid-thresholds-in-the-diagnosis-of-9fe17487","doi":"10.17863/cam.132978","journal":"Apollo (University of Cambridge)","n_participants":48,"pmid":null,"source_url":"https://doi.org/10.17863/cam.132978","study_design":"meta-analysis","title":"Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis","title_match":true,"year":2026},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/clinical-validation-of-a-plasma-p-tau217-immunoassay-and-evaluation-41433690","doi":"10.1002/alz70861_108683","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41433690","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12725193/","study_design":null,"title":"Clinical validation of a plasma p \u2010tau217 immunoassay and evaluation of the impact of kidney function","title_match":false,"year":2025},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/fast-ai-based-amyloid-pet-reporting-can-nuclear-medicine-handle-the-2096c5f9","doi":"10.1055/s-0045-1804387","journal":"Nuklearmedizin - NuclearMedicine","n_participants":20,"pmid":null,"source_url":"https://doi.org/10.1055/s-0045-1804387","study_design":null,"title":"Fast AI Based Amyloid PET Reporting \u2013 can Nuclear Medicine Handle the Expected Workload in Alzheimers Diagnostics?","title_match":true,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/amyloid-pet-signal-reduction-in-regions-with-aria-e-following-anti-cc666680","doi":"10.1212/wnl.0000000000215645","journal":"Neurology","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1212/wnl.0000000000215645","study_design":null,"title":"\u03b2-amyloid PET Signal Reduction in Regions with ARIA-E Following Anti-amyloid Therapy for Alzheimer Disease (P1-12.010)","title_match":true,"year":2026},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/the-economic-value-of-plasma-p-tau217-testing-for-patients-presenting-41433569","doi":"10.1002/alz70861_108060","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41433569","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12725601/","study_design":null,"title":"The economic value of plasma p \u2010tau217 testing for patients presenting with cognitive impairment in the United States","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-for-neocortical-tau-burden-42573994","doi":"10.1001/jamaneurol.2026.2650","journal":"JAMA Neurology","n_participants":431,"pmid":"42573994","source_url":"https://pubmed.ncbi.nlm.nih.gov/42573994/","study_design":"cohort study","title":"Plasma Biomarkers for Neocortical Tau Burden","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/prediction-of-continuous-amyloid-positron-emission-tomography-with-41326715","doi":"10.1038/s44321-025-00348-7","journal":"EMBO Molecular Medicine","n_participants":1053,"pmid":"41326715","source_url":"https://pubmed.ncbi.nlm.nih.gov/41326715/","study_design":null,"title":"Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and \u03b2-amyloid","title_match":true,"year":2025},{"alzhub_score":34,"alzhub_url":"https://alzhub.org/study/cross-platform-concordance-of-quantitative-amyloid-pet-z-scores-in-a-41986146","doi":"10.3174/ajnr.a9354","journal":"American Journal of Neuroradiology","n_participants":null,"pmid":"41986146","source_url":"https://pubmed.ncbi.nlm.nih.gov/41986146/","study_design":null,"title":"Cross-Platform Concordance of Quantitative Amyloid PET Z-Scores in a Real-World Clinical Cohort of Patients with Cognitive Impairment and Suspected Alzheimer Disease","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-plasma-biomarker-assays-across-platforms-42633973","doi":"10.1016/j.scib.2026.08.018","journal":"\u4e2d\u56fd\u79d1\u5b66\u901a\u62a5\uff1a\u82f1\u6587\u7248","n_participants":431,"pmid":"42633973","source_url":"https://pubmed.ncbi.nlm.nih.gov/42633973/","study_design":"cross-sectional","title":"Head-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohort","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/determining-eligibility-for-antiamyloid-treatments-using-blood-41442134","doi":"10.1002/alz70856_097511","journal":"Alzheimer s & Dementia","n_participants":4000,"pmid":"41442134","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12732564/","study_design":null,"title":"Determining eligibility for anti\u2010amyloid treatments using blood biomarkers","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/adaptation-of-a-protocol-for-disclosure-of-amyloid-pet-results-for-41448156","doi":"10.1002/alz70858_100947","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41448156","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740482/","study_design":"longitudinal study","title":"Adaptation of a Protocol for Disclosure of Amyloid PET Results for Adults with Down Syndrome and Their Caregivers","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/t1-mapping-in-alzheimers-disease-a-quantitative-mri-study-with-42766053","doi":"10.1186/s41747-026-00792-1","journal":"European Radiology Experimental","n_participants":16,"pmid":"42766053","source_url":"https://pubmed.ncbi.nlm.nih.gov/42766053/","study_design":null,"title":"T1 mapping in Alzheimer\u2019s disease: a quantitative MRI study with amyloid-PET correlation","title_match":true,"year":2026},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/long-term-impact-of-disclosing-amyloid-pet-results-to-individuals-41896998","doi":"10.1186/s13195-026-02026-3","journal":"Alzheimer s Research & Therapy","n_participants":17,"pmid":"41896998","source_url":"https://pubmed.ncbi.nlm.nih.gov/41896998/","study_design":null,"title":"Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline","title_match":true,"year":2026},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/differing-network-patterns-of-functional-connectivity-and-amyloid-pet-41434143","doi":"10.1002/alz70862_109964","journal":"Alzheimer s & Dementia","n_participants":690,"pmid":"41434143","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12726122/","study_design":null,"title":"Differing network patterns of functional connectivity and amyloid PET between tau PET subtypes","title_match":true,"year":2025},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/racial-and-ethnic-differences-in-amyloid-pet-positivity-in-d1b2aa44","doi":"10.17615/aekj-fb35","journal":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","n_participants":3154,"pmid":null,"source_url":"https://doi.org/10.17615/aekj-fb35","study_design":"cohort study","title":"Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia","title_match":true,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/differing-network-patterns-of-functional-connectivity-and-amyloid-pet-41442473","doi":"10.1002/alz70856_097884","journal":"Alzheimer s & Dementia","n_participants":690,"pmid":"41442473","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12734641/","study_design":null,"title":"Differing network patterns of functional connectivity and amyloid PET between tau PET subtypes","title_match":true,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/additive-value-of-early-phase-amyloid-pet-for-the-differential-41690259","doi":"10.1016/j.nicl.2026.103963","journal":"NeuroImage Clinical","n_participants":379,"pmid":"41690259","source_url":"https://pubmed.ncbi.nlm.nih.gov/41690259/","study_design":null,"title":"Additive value of early-phase \u03b2-Amyloid-PET for the differential diagnosis of non-Alzheimer\u2019s disease dementia","title_match":true,"year":2026},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/failure-of-18f-florbetapir-amyloid-pet-imaging-after-injection-with-41632579","doi":"10.1097/rlu.0000000000006273","journal":"Clinical Nuclear Medicine","n_participants":null,"pmid":"41632579","source_url":"https://pubmed.ncbi.nlm.nih.gov/41632579/","study_design":null,"title":"Failure of 18F-florbetapir Amyloid PET Imaging after Injection With an Automated Injector Using an Air-vent Filter for FDG Injection","title_match":true,"year":2026},{"alzhub_score":29,"alzhub_url":"https://alzhub.org/study/pet-imaging-in-alzheimer-disease-diagnostic-and-prognostic-05f30011","doi":"10.66590/ijcmr2026030107","journal":"International Journal of Clinical and Medical Research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.66590/ijcmr2026030107","study_design":null,"title":"PET Imaging in Alzheimer Disease: Diagnostic and Prognostic Applications","title_match":false,"year":2026},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/alzheimer-mimicry-late-and-part-40164861","doi":"10.1007/s00702-025-02916-0","journal":"Journal of Neural Transmission","n_participants":null,"pmid":"40164861","source_url":"https://pubmed.ncbi.nlm.nih.gov/40164861/","study_design":null,"title":"Alzheimer mimicry: LATE and PART","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-and-apoe-genotype-disclosure-and-short-term-41910973","doi":"10.1001/jamanetworkopen.2026.3845","journal":"JAMA Network Open","n_participants":1184,"pmid":"41910973","source_url":"https://pubmed.ncbi.nlm.nih.gov/41910973/","study_design":"cohort study","title":"Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress","title_match":true,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cell-weighted-polygenic-risk-scores-are-associated-with-amyloid-and-41040848","doi":"10.1093/braincomms/fcaf353","journal":"Brain Communications","n_participants":734,"pmid":"41040848","source_url":"https://pubmed.ncbi.nlm.nih.gov/41040848/","study_design":null,"title":"Cell-weighted polygenic risk scores are associated with \u03b2-amyloid and tau biomarkers in Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/lecanemab-use-for-early-alzheimer-disease-in-canada-42373113","doi":"10.1503/cmaj.260193","journal":"Canadian Medical Association Journal","n_participants":null,"pmid":"42373113","source_url":"https://pubmed.ncbi.nlm.nih.gov/42373113/","study_design":null,"title":"Lecanemab use for early Alzheimer disease in Canada","title_match":false,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/lecanemab-aducanumab-and-donanemab-bind-the-same-human-alzheimer-41435407","doi":"10.1002/alz70855_099914","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41435407","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12726945/","study_design":null,"title":"Lecanemab, aducanumab, and donanemab bind the same human Alzheimer disease A\u03b2 aggregates at different epitopes","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/realworld-eligibility-for-antiamyloid-treatment-in-a-tertiary-memory-40506692","doi":"10.1002/alz.70375","journal":"Alzheimer s & Dementia","n_participants":1309,"pmid":"40506692","source_url":"https://pubmed.ncbi.nlm.nih.gov/40506692/","study_design":null,"title":"\u201cReal\u2010world\u201d eligibility for anti\u2010amyloid treatment in a tertiary memory clinic setting","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/dampening-of-microglial-activation-with-nasal-foralumab-40359013","doi":"10.1097/rlu.0000000000005955","journal":"Clinical Nuclear Medicine","n_participants":null,"pmid":"40359013","source_url":"https://pubmed.ncbi.nlm.nih.gov/40359013/","study_design":null,"title":"Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer\u2019s Disease Dementia","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/anti-amyloid-immunotherapies-for-alzheimers-disease-old-people-972a008a","doi":"10.62581/revgeri.21682","journal":"\u0098La \u009cRevue de g\u00e9riatrie","n_participants":726,"pmid":null,"source_url":"https://doi.org/10.62581/revgeri.21682","study_design":"clinical trial","title":"Anti-amyloid immunotherapies for Alzheimer\u2019s disease old people: eligibility and real life in a geriatric memory clinic in Lille (France)","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/rates-of-alzheimer-disease-biomarker-positivity-stratified-by-by-sex-d8ce6554","doi":"10.1002/alz70856_105627","journal":"Alzheimer s & Dementia","n_participants":4000,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_105627","study_design":null,"title":"Rates of Alzheimer disease biomarker positivity stratified by by sex and race in a specialty memory clinic","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/antiamyloid-therapy-and-cerebral-blood-flow-changes-on-mri-a-39805666","doi":"10.3174/ajnr.a8654","journal":"American Journal of Neuroradiology","n_participants":null,"pmid":"39805666","source_url":"https://pubmed.ncbi.nlm.nih.gov/39805666/","study_design":"longitudinal study","title":"Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response?","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/amyloid-spatial-extent-with-florbetapir-pet-for-early-detection-of-41830758","doi":"10.1016/j.tjpad.2026.100529","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"41830758","source_url":"https://pubmed.ncbi.nlm.nih.gov/41830758/","study_design":"cross-sectional","title":"Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer\u2019s disease","title_match":true,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/imagingneuropathology-evaluation-of-amyloid-related-imaging-41517928","doi":"10.1002/alz70856_107139","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41517928","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12789816/","study_design":"longitudinal study","title":"Imaging\u2010neuropathology evaluation of Amyloid Related Imaging Abnormality sulcal effusion in a DIAN\u2010TU\u2010001 participant treated with gantenerumab","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/imagingneuropathology-evaluation-of-amyloid-related-imaging-41433752","doi":"10.1002/alz70862_110062","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41433752","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12725136/","study_design":"longitudinal study","title":"Imaging\u2010neuropathology evaluation of Amyloid Related Imaging Abnormality sulcal effusion in a DIAN\u2010TU\u2010001 participant treated with gantenerumab","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/tabletbased-cognitive-assessment-tool-tabcat-in-a-multisite-study-of-41395729","doi":"10.1002/alz.71012","journal":"Alzheimer s & Dementia","n_participants":146,"pmid":"41395729","source_url":"https://pubmed.ncbi.nlm.nih.gov/41395729/","study_design":"longitudinal study","title":"Tablet\u2010based Cognitive Assessment Tool (TabCAT) in a multisite study of early\u2010onset Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/comparing-offtarget-meningeal-and-skull-signal-in-headtohead-mk6240-41447668","doi":"10.1002/alz70856_101657","journal":"Alzheimer s & Dementia","n_participants":42,"pmid":"41447668","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740264/","study_design":null,"title":"Comparing Off\u2010Target Meningeal and Skull Signal in Head\u2010to\u2010Head MK\u20106240 and AV\u20101451 Tau PET","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/neuroimaging-compendium-of-microglia-amyloid-tau-and-41288284","doi":"10.1097/wad.0000000000000707","journal":"Alzheimer Disease & Associated Disorders","n_participants":null,"pmid":"41288284","source_url":"https://pubmed.ncbi.nlm.nih.gov/41288284/","study_design":"longitudinal study","title":"Neuroimaging Compendium of Microglia, Amyloid, Tau, and Neurodegeneration Across Clinical Variants of Alzheimer Disease","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/decoupling-alzheimer-disease-pathologic-abnormalities-at-pet-with-41944723","doi":"10.1148/radiol.252321","journal":"Radiology","n_participants":7457,"pmid":"41944723","source_url":"https://pubmed.ncbi.nlm.nih.gov/41944723/","study_design":"longitudinal study","title":"Decoupling Alzheimer Disease Pathologic Abnormalities at PET with Improved Clinical Relevance by Interpretable Adversarial Decomposition Learning","title_match":false,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-probability-in-alzheimer-disease-from-plasma-cerebrospinal-6f44c1d3","doi":"10.1038/s44400-026-00109-4","journal":"npj Dementia","n_participants":320,"pmid":null,"source_url":"https://doi.org/10.1038/s44400-026-00109-4","study_design":"cross-sectional","title":"Amyloid probability in Alzheimer disease from plasma, cerebrospinal fluid, and amyloid imaging","title_match":true,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/tau-pet-imaging-in-black-and-latino-participants-with-and-without-41513292","doi":"10.1002/alz70856_106309","journal":"Alzheimer s & Dementia","n_participants":83,"pmid":"41513292","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12788947/","study_design":"longitudinal study","title":"Tau PET imaging in Black and Latino participants with and without cognitive impairment","title_match":false,"year":2025},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/amyloid-und-tau-pet-im-real-world-setting-vergleich-von-visueller-b32f9fa9","doi":"10.1055/s-0046-1818194","journal":"Nuklearmedizin - NuclearMedicine","n_participants":201,"pmid":null,"source_url":"https://doi.org/10.1055/s-0046-1818194","study_design":null,"title":"Amyloid- und Tau-PET im Real-World-Setting: Vergleich von visueller Beurteilung und Quantifizierung mit Liquor-Biomarkern zur Optimierung der Alzheimer-Diagnostik","title_match":false,"year":2026},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/using-ca1-rather-than-the-whole-hippocampus-to-capture-tau-pet-braak-42448890","doi":"10.1007/s00259-026-08074-z","journal":"European Journal of Nuclear Medicine and Molecular Imaging","n_participants":null,"pmid":"42448890","source_url":"https://pubmed.ncbi.nlm.nih.gov/42448890/","study_design":"longitudinal study","title":"Using CA1 rather than the whole hippocampus to capture tau-PET Braak stage II","title_match":false,"year":2026},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/18f-ro948-tau-pet-imaging-and-plasma-biomarkers-in-part-and-late-1419fb90","doi":"10.1002/alz70856_107395","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_107395","study_design":null,"title":"[18F] RO948 Tau PET imaging and plasma biomarkers in PART and LATE patients compared with sporadic Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/comparing-offtarget-meningeal-and-skull-signal-in-headtohead-mk6240-41433453","doi":"10.1002/alz70862_109929","journal":"Alzheimer s & Dementia","n_participants":42,"pmid":"41433453","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12724746/","study_design":null,"title":"Comparing Off\u2010Target Meningeal and Skull Signal in Head\u2010to\u2010Head MK\u20106240 and AV\u20101451 Tau PET","title_match":false,"year":2025},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau-for-the-diagnosis-of-alzheimer-disease-42201264","doi":"10.1093/clinchem/hvag048","journal":"Clinical Chemistry","n_participants":null,"pmid":"42201264","source_url":"https://pubmed.ncbi.nlm.nih.gov/42201264/","study_design":null,"title":"Blood Phosphorylated Tau for the Diagnosis of Alzheimer Disease","title_match":false,"year":2026},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/role-of-radio-diagnosis-in-early-detection-of-alzheimers-disease-a-792511ca","doi":"10.21474/ijar01/20861","journal":"International Journal of Advanced Research","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21474/ijar01/20861","study_design":"systematic review","title":"ROLE OF RADIO DIAGNOSIS IN EARLY DETECTION OF ALZHEIMERS DISEASE:A SYSTEMATIC REVIEW","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/neuroimaging-markers-of-dementia-across-race-ethnicity-and-sex-gender-40990061","doi":"10.1002/alz.70733","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"40990061","source_url":"https://pubmed.ncbi.nlm.nih.gov/40990061/","study_design":null,"title":"Neuroimaging markers of dementia across race/ethnicity and sex/gender using an intersectional approach within the HABS\u2010HD cohort","title_match":false,"year":2025},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/targeted-proteomic-biomarker-profiling-using-nulisa-in-a-cohort-40318118","doi":"10.1002/alz.70166","journal":"Alzheimer s & Dementia","n_participants":252,"pmid":"40318118","source_url":"https://pubmed.ncbi.nlm.nih.gov/40318118/","study_design":"cross-sectional","title":"Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementias","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/machine-learning-models-for-dementia-screening-to-classify-brain-39838434","doi":"10.1186/s13195-024-01650-1","journal":"Alzheimer s Research & Therapy","n_participants":15,"pmid":"39838434","source_url":"https://pubmed.ncbi.nlm.nih.gov/39838434/","study_design":null,"title":"Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/machine-learning-model-for-predicting-amyloid-positivity-and-40594040","doi":"10.1038/s41598-025-00743-7","journal":"Scientific Reports","n_participants":176,"pmid":"40594040","source_url":"https://pubmed.ncbi.nlm.nih.gov/40594040/","study_design":null,"title":"Machine learning model for predicting Amyloid-\u03b2 positivity and cognitive status using early-phase 18F-Florbetaben PET and clinical features","title_match":true,"year":2025},{"alzhub_score":33,"alzhub_url":"https://alzhub.org/study/machine-learningenhanced-screening-funnel-for-clinical-trials-in-40276322","doi":"10.1002/trc2.70084","journal":"Alzheimer s & Dementia Translational Research & Clinical Interventions","n_participants":null,"pmid":"40276322","source_url":"https://pubmed.ncbi.nlm.nih.gov/40276322/","study_design":null,"title":"Machine learning\u2013enhanced screening funnel for clinical trials in Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/factors-associated-with-atypical-cognitive-trajectories-in-older-41449092","doi":"10.1002/alz70857_105703","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41449092","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12740825/","study_design":"longitudinal study","title":"Factors Associated with Atypical Cognitive Trajectories in Older Adults with Down Syndrome","title_match":false,"year":2025},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/b31-13-circadian-rest-activity-rhythm-and-alzheimers-disease-02ad0ff8","doi":"10.1093/ajrccm/aamag162.6475","journal":"American Journal of Respiratory and Critical Care Medicine","n_participants":29,"pmid":null,"source_url":"https://doi.org/10.1093/ajrccm/aamag162.6475","study_design":"cross-sectional","title":"B31-13 Circadian Rest-Activity Rhythm and Alzheimer\u2019s Disease Biomarkers in Adults With Down Syndrome","title_match":false,"year":2026},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/correlating-antemortem-amyloid-pet-burden-postmortem-mri-volumes-with-41453185","doi":"10.1002/alz70856_103737","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"41453185","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12742906/","study_design":null,"title":"Correlating antemortem amyloid PET burden, postmortem MRI volumes, with neuropathological measures: Insights from Down syndrome and Alzheimer's disease cohorts","title_match":true,"year":2025},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/distinct-sensitivity-of-mri-versus-18-f-fdgpet-to-detect-cerebral-294a9f95","doi":"10.1002/alz70856_107114","journal":"Alzheimer s & Dementia","n_participants":29,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_107114","study_design":null,"title":"Distinct Sensitivity of MRI Versus [ 18 F]FDG\u2010PET To Detect Cerebral Changes Across the Alzheimer's Continuum in Down Syndrome: A Multimodal Imaging Study","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/changes-in-dti-alps-index-and-its-associations-with-neuronal-damage-40921114","doi":"10.1016/j.parkreldis.2025.108014","journal":"Parkinsonism & Related Disorders","n_participants":32,"pmid":"40921114","source_url":"https://pubmed.ncbi.nlm.nih.gov/40921114/","study_design":"longitudinal study","title":"Changes in DTI-ALPS index and its associations with neuronal damage in Lewy body disease","title_match":false,"year":2025},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/the-patient-pathway-for-mild-cognitive-impairment-due-to-alzheimers-40483260","doi":"10.1016/j.tjpad.2025.100215","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":31,"pmid":"40483260","source_url":"https://pubmed.ncbi.nlm.nih.gov/40483260/","study_design":null,"title":"The patient pathway for mild cognitive impairment due to Alzheimer\u2019s disease in Asia: Current practices, barriers, and expert recommendations for optimization","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau217a-pivotal-plasma-biomarker-for-predicting-42117479","doi":"10.1080/13803395.2026.2671206","journal":"Journal of Clinical and Experimental Neuropsychology","n_participants":47,"pmid":"42117479","source_url":"https://pubmed.ncbi.nlm.nih.gov/42117479/","study_design":"longitudinal study","title":"Plasma Phosphorylated Tau217\u2013A Pivotal Plasma Biomarker for Predicting the Progression of Mild Cognitive Impairment to Alzheimer\u2019s Disease: A Reanalysis of ADNI Data","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/profiling-characteristics-of-plasma-exosomal-mirnas-across-cognitive-40630682","doi":"10.1039/d5ra02993g","journal":"RSC Advances","n_participants":null,"pmid":"40630682","source_url":"https://pubmed.ncbi.nlm.nih.gov/40630682/","study_design":null,"title":"Profiling characteristics of plasma exosomal miRNAs across cognitive stages: from normalcy to mild cognitive impairment and Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/integrated-amyloid-neurodegeneration-and-vascular-biomarkers-estimate-42159446","doi":"10.1177/13872877261445623","journal":"Journal of Alzheimer s Disease","n_participants":58,"pmid":"42159446","source_url":"https://pubmed.ncbi.nlm.nih.gov/42159446/","study_design":"longitudinal study","title":"Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment","title_match":false,"year":2026},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/longitudinal-analysis-of-amyloid-pet-and-brain-mri-for-predicting-40137577","doi":"10.3390/tomography11030037","journal":"Tomography","n_participants":180,"pmid":"40137577","source_url":"https://pubmed.ncbi.nlm.nih.gov/40137577/","study_design":"longitudinal study","title":"Longitudinal Analysis of Amyloid PET and Brain MRI for Predicting Conversion from Mild Cognitive Impairment to Alzheimer\u2019s Disease: Findings from the ADNI Cohort","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/statistical-method-for-identification-of-alzheimer-s-disease-in-mild-40678096","doi":"10.32598/bcn.2024.2034.7","journal":"Basic and Clinical Neuroscience Journal","n_participants":487,"pmid":"40678096","source_url":"https://pubmed.ncbi.nlm.nih.gov/40678096/","study_design":null,"title":"Statistical Method for Identification of Alzheimer's Disease in Mild Cognitive Impairment with Multimodal Predictive Markers","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/moderating-role-of-triglycerides-in-the-relationship-between-amyloid-40918735","doi":"10.3389/fnagi.2025.1592341","journal":"Frontiers in Aging Neuroscience","n_participants":null,"pmid":"40918735","source_url":"https://pubmed.ncbi.nlm.nih.gov/40918735/","study_design":null,"title":"Moderating role of triglycerides in the relationship between amyloid-\u03b2, hippocampal atrophy, and cognitive decline in mild cognitive impairment and early Alzheimer\u2019s disease","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/genetic-drivers-of-hippocampal-atrophy-highlight-the-role-of-apoe-41092763","doi":"10.1016/j.nicl.2025.103889","journal":"NeuroImage Clinical","n_participants":1051,"pmid":"41092763","source_url":"https://pubmed.ncbi.nlm.nih.gov/41092763/","study_design":"longitudinal study","title":"Genetic drivers of hippocampal atrophy highlight the role of APOE functional variants and AD polygenicity in Mild Cognitive Impairment","title_match":false,"year":2025},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/growth-associated-protein-43-is-associated-with-faster-functional-40063372","doi":"10.1037/neu0000981","journal":"Neuropsychology","n_participants":null,"pmid":"40063372","source_url":"https://pubmed.ncbi.nlm.nih.gov/40063372/","study_design":null,"title":"Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/ginkgo-biloba-and-longitudinal-changes-in-amyloid-pet-and-plasma-41984497","doi":"10.1177/13872877261441816","journal":"Journal of Alzheimer s Disease","n_participants":21,"pmid":"41984497","source_url":"https://pubmed.ncbi.nlm.nih.gov/41984497/","study_design":"cohort study","title":"Ginkgo biloba and longitudinal changes in amyloid PET and plasma amyloid-\u03b2 oligomerization in amyloid-positive mild cognitive impairment: A retrospective analysis","title_match":true,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/contribution-of-genetic-and-lifestyle-factors-in-resistance-and-41447325","doi":"10.1002/alz70856_101525","journal":"Alzheimer s & Dementia","n_participants":529,"pmid":"41447325","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12739984/","study_design":"longitudinal study","title":"Contribution of genetic and lifestyle factors in resistance\u2010 and resilience\u2010related variability in longitudinal pathologic and neurodegeneration trajectory in Dominantly Inherited Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/a-positive-tau-biomarker-negative-cognitive-impairment-is-associated-256d8475","doi":"10.1002/alz70856_104812","journal":"Alzheimer s & Dementia","n_participants":77,"pmid":null,"source_url":"https://doi.org/10.1002/alz70856_104812","study_design":null,"title":"A\u03b2 positive, tau biomarker negative cognitive impairment is associated with significant non\u2010Alzheimer's disease neuropathologies","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-relationship-of-18-f-fdg-pet-to-other-common-biomarkers-of-40290782","doi":"10.1177/25424823251314392","journal":"Journal of Alzheimer s Disease Reports","n_participants":90,"pmid":"40290782","source_url":"https://pubmed.ncbi.nlm.nih.gov/40290782/","study_design":null,"title":"The relationship of 18 F-FDG-PET to other common biomarkers of dementia in a clinical cohort with memory deficits","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/real-world-clinical-practice-of-lecanemab-at-pumch-dementia-cohort-41520099","doi":"10.1186/s13195-025-01943-z","journal":"Alzheimer s Research & Therapy","n_participants":42,"pmid":"41520099","source_url":"https://pubmed.ncbi.nlm.nih.gov/41520099/","study_design":null,"title":"Real world clinical practice of lecanemab at PUMCH dementia cohort: focus on dynamic imaging and biomarker evolution","title_match":false,"year":2026},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/donanemab-in-early-symptomatic-alzheimers-disease-results-from-the-41330788","doi":"10.1016/j.tjpad.2025.100446","journal":"The Journal of Prevention of Alzheimer s Disease","n_participants":null,"pmid":"41330788","source_url":"https://pubmed.ncbi.nlm.nih.gov/41330788/","study_design":null,"title":"Donanemab in early symptomatic Alzheimer\u2019s disease: results from the TRAILBLAZER-ALZ 2 long-term extension","title_match":false,"year":2025},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pet-and-blood-biomarkers-as-predictors-of-shortterm-progression-in-41447122","doi":"10.1002/alz70856_100227","journal":"Alzheimer s & Dementia","n_participants":42,"pmid":"41447122","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12739722/","study_design":null,"title":"PET and Blood Biomarkers as Predictors of Short\u2010Term Progression in MCI and Mild Dementia: Prospective Insights from a Southeast Asian Middle\u2010Income Country","title_match":false,"year":2025},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/livermetabolic-stress-apolipoprotein-e-4-and-cognition-and-amyloid-41890209","doi":"10.3389/fnagi.2026.1773977","journal":"Frontiers in Aging Neuroscience","n_participants":507,"pmid":"41890209","source_url":"https://pubmed.ncbi.nlm.nih.gov/41890209/","study_design":"longitudinal study","title":"Liver\u2013metabolic stress, apolipoprotein E \u03b54, and cognition and amyloid burden: findings from the dementia platform Korea trial-ready registry","title_match":false,"year":2026},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/sex-differences-in-amyloid-pet-in-a-large-realworld-sample-from-the-40415175","doi":"10.1002/alz.70304","journal":"Alzheimer s & Dementia","n_participants":10361,"pmid":"40415175","source_url":"https://pubmed.ncbi.nlm.nih.gov/40415175/","study_design":null,"title":"Sex differences in amyloid PET in a large, real\u2010world sample from the Imaging Dementia\u2013Evidence for Amyloid Scanning (IDEAS) Study","title_match":true,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/tdp-43-pathology-is-associated-with-divergent-protein-profiles-in-als-40826370","doi":"10.1186/s40478-025-02084-y","journal":"Acta Neuropathologica Communications","n_participants":16,"pmid":"40826370","source_url":"https://pubmed.ncbi.nlm.nih.gov/40826370/","study_design":null,"title":"TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/trajectory-of-plasma-lipidome-associated-with-the-risk-of-late-onset-40592256","doi":"10.1016/j.ebiom.2025.105826","journal":"EBioMedicine","n_participants":1393,"pmid":"40592256","source_url":"https://pubmed.ncbi.nlm.nih.gov/40592256/","study_design":"cross-sectional","title":"Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer's disease: a longitudinal cohort study","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/growth-associated-protein-43-gap-43-predicts-brain-amyloidosis-in-40170060","doi":"10.1186/s12883-025-04140-5","journal":"BMC Neurology","n_participants":1639,"pmid":"40170060","source_url":"https://pubmed.ncbi.nlm.nih.gov/40170060/","study_design":null,"title":"Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer\u2019s dementia continuum: an [18 F] AV-45 study","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/cognitive-dispersion-is-associated-with-white-matter-hyperintensities-41138063","doi":"10.1080/13854046.2025.2570301","journal":"The Clinical Neuropsychologist","n_participants":819,"pmid":"41138063","source_url":"https://pubmed.ncbi.nlm.nih.gov/41138063/","study_design":null,"title":"Cognitive dispersion is associated with white matter hyperintensities in amyloid positive older adults","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/white-matter-hyperintensities-contribute-to-early-cortical-thinning-40712373","doi":"10.1016/j.neurobiolaging.2025.07.007","journal":"Neurobiology of Aging","n_participants":551,"pmid":"40712373","source_url":"https://pubmed.ncbi.nlm.nih.gov/40712373/","study_design":"cross-sectional","title":"White matter hyperintensities contribute to early cortical thinning in addition to tau in aging","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/amyloid-pet-pipeline-choice-influences-classification-of-preclinical-82e86751","doi":"10.64898/2026.08.14.26360465","journal":"medRxiv (preprint)","n_participants":433,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.14.26360465","study_design":"longitudinal study","title":"Amyloid-PET pipeline choice influences classification of preclinical Alzheimers disease","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/mri-derived-brain-aging-trajectories-across-the-alzheimer-s-continuum-ad82dff0","doi":"10.64898/2026.08.19.26360525","journal":"medRxiv (preprint)","n_participants":202,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.19.26360525","study_design":"longitudinal study","title":"MRI-derived brain aging trajectories across the Alzheimer's continuum: links to cognition, pathology and lifestyle risk factors","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/region-specific-cerebral-blood-flow-differentiates-cognitively-79f3be3a","doi":"10.64898/2026.08.22.26361093","journal":"medRxiv (preprint)","n_participants":500,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.22.26361093","study_design":"cohort study","title":"Region-specific cerebral blood flow differentiates cognitively impaired and unimpaired individuals with core Alzheimer's disease pathology","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/a-data-driven-regional-amyloid-pet-score-predicts-cognitive-decline-b90b0bb3","doi":"10.64898/2026.08.26.26360248","journal":"medRxiv (preprint)","n_participants":71,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.26.26360248","study_design":"meta-analysis","title":"A data-driven regional amyloid PET score predicts cognitive decline beyond Centiloid","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/analytical-validation-and-amyloid-status-discrimination-of-a-high-fa2a3d2c","doi":"10.64898/2026.08.31.26361836","journal":"medRxiv (preprint)","n_participants":449,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.31.26361836","study_design":null,"title":"Analytical validation and amyloid-status discrimination of a high-throughput, research-use-only plasma p-Tau217 immunoassay","title_match":false,"year":2026},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/a-two-stage-plasma-biomarker-algorithm-reduces-amyloid-pet-use-and-7da4a6e3","doi":"10.64898/2026.02.03.26345302","journal":"Annals of clinical and translational neurology","n_participants":630,"pmid":null,"source_url":"https://doi.org/10.64898/2026.02.03.26345302","study_design":null,"title":"A Two-Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p-Tau217 Gray Zone","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/physiological-variability-in-key-alzheimer-s-biomarkers-in-amyloid-281c7577","doi":"10.64898/2026.09.18.26363412","journal":"medRxiv (preprint)","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.18.26363412","study_design":null,"title":"Physiological variability in key Alzheimer's biomarkers in amyloid-positive clinical trial cohorts and the mechanistic basis of biomarker ratios","title_match":true,"year":2026},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/comparison-of-expert-reads-versus-local-clinical-reads-of-amyloid-pet-42722444","doi":"10.2967/jnumed.126.272571","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"42722444","source_url":"https://pubmed.ncbi.nlm.nih.gov/42722444/","study_design":null,"title":"Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study","title_match":true,"year":2026},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/biomarker-based-diagnosis-and-care-pathways-for-alzheimer-s-disease-42538752","doi":"10.1111/ene.70668","journal":"European journal of neurology","n_participants":null,"pmid":"42538752","source_url":"https://pubmed.ncbi.nlm.nih.gov/42538752/","study_design":null,"title":"Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/comparison-of-a-multi-analyte-algorithmic-immunoassay-blood-test-with-42434607","doi":"10.1002/dad2.70420","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":192,"pmid":"42434607","source_url":"https://pubmed.ncbi.nlm.nih.gov/42434607/","study_design":"cross-sectional","title":"Comparison of a multi-analyte algorithmic immunoassay blood test with immunoprecipitation mass spectrometry for the detection of amyloid pathology","title_match":false,"year":2026},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/implementation-and-service-impact-of-anti-amyloid-therapy-in-a-42019137","doi":"10.1016/j.genhosppsych.2026.04.006","journal":"General hospital psychiatry","n_participants":null,"pmid":"42019137","source_url":"https://pubmed.ncbi.nlm.nih.gov/42019137/","study_design":null,"title":"Implementation and service impact of anti-amyloid therapy in a psychiatry-led dementia care program: Real-world evidence from a Japanese regional dementia center","title_match":false,"year":2026},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/genetic-validation-of-abi3-p-ser209phe-variant-and-its-effects-on-41709289","doi":"10.1186/s13195-026-01984-y","journal":"Alzheimer's research & therapy","n_participants":500000,"pmid":"41709289","source_url":"https://pubmed.ncbi.nlm.nih.gov/41709289/","study_design":null,"title":"Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals","title_match":false,"year":2026},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/real-world-lecanemab-adoption-in-japan-1-year-after-launch-insights-41114448","doi":"10.1002/alz.70652","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":6000,"pmid":"41114448","source_url":"https://pubmed.ncbi.nlm.nih.gov/41114448/","study_design":null,"title":"Real-world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/is-us-residence-a-risk-factor-for-alzheimer-s-disease-40611639","doi":"10.1177/13872877251356682","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"40611639","source_url":"https://pubmed.ncbi.nlm.nih.gov/40611639/","study_design":null,"title":"Is US residence a risk factor for Alzheimer's disease?","title_match":false,"year":2025},{"alzhub_score":37,"alzhub_url":"https://alzhub.org/study/the-status-of-neuroimaging-with-spect-and-pet-in-germany-results-from-40233814","doi":"10.1055/a-2566-1487","journal":"Nuklearmedizin. Nuclear medicine","n_participants":null,"pmid":"40233814","source_url":"https://pubmed.ncbi.nlm.nih.gov/40233814/","study_design":null,"title":"The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023","title_match":false,"year":2025},{"alzhub_score":35,"alzhub_url":"https://alzhub.org/study/experiences-from-clinical-research-and-routine-use-of-florbetaben-39770490","doi":"10.3390/ph17121648","journal":"Pharmaceuticals (Basel, Switzerland)","n_participants":null,"pmid":"39770490","source_url":"https://pubmed.ncbi.nlm.nih.gov/39770490/","study_design":null,"title":"Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights","title_match":true,"year":2024},{"alzhub_score":30,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-update-how-the-amyloid-landscape-is-changing-in-light-39532491","doi":"10.2967/jnmt.124.268329","journal":"Journal of nuclear medicine technology","n_participants":null,"pmid":"39532491","source_url":"https://pubmed.ncbi.nlm.nih.gov/39532491/","study_design":null,"title":"Amyloid Imaging Update: How the Amyloid Landscape Is Changing in Light of the Recent Food and Drug Administration Approval of Antiamyloid Therapeutics","title_match":true,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/current-diagnostic-pathways-for-alzheimer-s-disease-a-cross-sectional-37483324","doi":"10.3233/ADR230007","journal":"Journal of Alzheimer's disease reports","n_participants":6744,"pmid":"37483324","source_url":"https://pubmed.ncbi.nlm.nih.gov/37483324/","study_design":"cross-sectional","title":"Current Diagnostic Pathways for Alzheimer's Disease: A Cross-Sectional Real-World Study Across Six Countries","title_match":false,"year":2023},{"alzhub_score":32,"alzhub_url":"https://alzhub.org/study/the-cost-of-early-diagnosis-of-cognitive-decline-in-german-memory-35858613","doi":"10.1055/a-1871-9889","journal":"Fortschritte der Neurologie-Psychiatrie","n_participants":null,"pmid":"35858613","source_url":"https://pubmed.ncbi.nlm.nih.gov/35858613/","study_design":null,"title":"[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]","title_match":false,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/neighborhood-socioeconomic-deprivation-is-associated-with-worse-41674810","doi":"10.21203/rs.3.rs-8546338/v1","journal":"NPJ dementia","n_participants":1110,"pmid":"41674810","source_url":"https://pubmed.ncbi.nlm.nih.gov/41674810/","study_design":null,"title":"Neighborhood Socioeconomic Deprivation is Associated with Worse Cognitive Performance and in vivo Amyloid Accumulation","title_match":false,"year":2026},{"alzhub_score":31,"alzhub_url":"https://alzhub.org/study/relationship-between-serum-tsh-level-and-alzheimer-disease-pathology-fa86d36f","doi":"10.1002/alz.041210","journal":"Alzheimer's & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/alz.041210","study_design":null,"title":"Relationship between serum TSH level and Alzheimer disease pathology","title_match":false,"year":2020},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/imaging-brain-amyloid-in-alzheimer-s-disease-with-pittsburgh-compoundb-14991808","doi":"10.1002/ana.20009","journal":"Annals of Neurology","n_participants":16,"pmid":"14991808","source_url":"https://pubmed.ncbi.nlm.nih.gov/14991808/","study_design":null,"title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound\u2010B","title_match":true,"year":2004},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/clinical-and-biomarker-changes-in-dominantly-inherited-alzheimer-s-22784036","doi":"10.1056/nejmoa1202753","journal":"New England Journal of Medicine","n_participants":128,"pmid":"22784036","source_url":"https://pubmed.ncbi.nlm.nih.gov/22784036/","study_design":"cross-sectional","title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease","title_match":false,"year":2012},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/the-centiloid-project-standardizing-quantitative-amyloid-plaque-25443857","doi":"10.1016/j.jalz.2014.07.003","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"25443857","source_url":"https://pubmed.ncbi.nlm.nih.gov/25443857/","study_design":null,"title":"The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET","title_match":true,"year":2014},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-amyloid-hypothesis-of-alzheimer-s-disease-at-25-years-27025652","doi":"10.15252/emmm.201606210","journal":"EMBO Molecular Medicine","n_participants":null,"pmid":"27025652","source_url":"https://pubmed.ncbi.nlm.nih.gov/27025652/","study_design":null,"title":"The amyloid hypothesis of Alzheimer's disease at 25 years","title_match":false,"year":2016},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-results-from-the-australian-imaging-biomarkers-and-20472326","doi":"10.1016/j.neurobiolaging.2010.04.007","journal":"Neurobiology of Aging","n_participants":null,"pmid":"20472326","source_url":"https://pubmed.ncbi.nlm.nih.gov/20472326/","study_design":null,"title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","title_match":true,"year":2010},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/defining-imaging-biomarker-cut-points-for-brain-aging-and-alzheimer-s-27697430","doi":"10.1016/j.jalz.2016.08.005","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"27697430","source_url":"https://pubmed.ncbi.nlm.nih.gov/27697430/","study_design":null,"title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/post-mortem-correlates-of-in-vivo-pib-pet-amyloid-imaging-in-a-18339640","doi":"10.1093/brain/awn016","journal":"Brain","n_participants":null,"pmid":"18339640","source_url":"https://pubmed.ncbi.nlm.nih.gov/18339640/","study_design":null,"title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","title_match":true,"year":2008},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/recommendations-for-the-use-of-pet-imaging-biomarkers-in-the-26099942","doi":"10.1016/j.remn.2015.03.002","journal":"Revista espanola de medicina nuclear e imagen molecular","n_participants":null,"pmid":"26099942","source_url":"https://pubmed.ncbi.nlm.nih.gov/26099942/","study_design":"systematic review","title":"Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus","title_match":false,"year":2015},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/phase-3-randomized-clinical-trials-of-simufilam-in-mild-to-moderate-41500915","doi":"10.1016/j.tjpad.2025.100469","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"41500915","source_url":"https://pubmed.ncbi.nlm.nih.gov/41500915/","study_design":"post-hoc analysis","title":"Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/prepandemic-alzheimer-disease-biomarkers-and-anxious-depressive-35918160","doi":"10.1212/wnl.0000000000200948","journal":"Neurology","n_participants":921,"pmid":"35918160","source_url":"https://pubmed.ncbi.nlm.nih.gov/35918160/","study_design":null,"title":"Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/sup-18-sup-f-thk5351-pet-positivity-and-longitudinal-changes-in-35184428","doi":"10.3349/ymj.2022.63.3.259","journal":"Yonsei medical journal","n_participants":25,"pmid":"35184428","source_url":"https://pubmed.ncbi.nlm.nih.gov/35184428/","study_design":"clinical trial","title":"18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in \u03b2-Amyloid-Negative Amnestic Mild Cognitive Impairment","title_match":true,"year":2022},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/high-performance-plasma-amyloid-biomarkers-for-alzheimers-disease-29420472","doi":"10.1038/nature25456","journal":"Nature","n_participants":null,"pmid":"29420472","source_url":"https://pubmed.ncbi.nlm.nih.gov/29420472/","study_design":null,"title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","title_match":false,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/frequent-amyloid-deposition-without-significant-cognitive-impairment-19001171","doi":"10.1001/archneur.65.11.1509","journal":"Archives of Neurology","n_participants":null,"pmid":"19001171","source_url":"https://pubmed.ncbi.nlm.nih.gov/19001171/","study_design":null,"title":"Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly","title_match":false,"year":2008},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/molecular-structural-and-functional-characterization-of-alzheimer-s-16120771","doi":"10.1523/jneurosci.2177-05.2005","journal":"Journal of Neuroscience","n_participants":null,"pmid":"16120771","source_url":"https://pubmed.ncbi.nlm.nih.gov/16120771/","study_design":null,"title":"Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory","title_match":false,"year":2005},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/beta-amyloid-imaging-and-memory-in-non-demented-individuals-evidence-fae1d136","doi":"10.1093/brain/awm238","journal":"Brain","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1093/brain/awm238","study_design":null,"title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","title_match":true,"year":2007},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-in-amyloid-modifying-21784348","doi":"10.1016/j.jalz.2011.05.2351","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"21784348","source_url":"https://pubmed.ncbi.nlm.nih.gov/21784348/","study_design":null,"title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","title_match":false,"year":2011},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/fibrillar-amyloid-burden-in-cognitively-normal-people-at-3-levels-of-19346482","doi":"10.1073/pnas.0900345106","journal":"Proceedings of the National Academy of Sciences","n_participants":null,"pmid":"19346482","source_url":"https://pubmed.ncbi.nlm.nih.gov/19346482/","study_design":null,"title":"Fibrillar amyloid-\u03b2 burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/performance-of-plasma-phosphorylated-tau-181-and-217-in-the-community-35618838","doi":"10.1038/s41591-022-01822-2","journal":"Nature Medicine","n_participants":null,"pmid":"35618838","source_url":"https://pubmed.ncbi.nlm.nih.gov/35618838/","study_design":null,"title":"Performance of plasma phosphorylated tau 181 and 217 in the community","title_match":false,"year":2022},{"alzhub_score":58,"alzhub_url":"https://alzhub.org/study/the-cortical-signature-of-alzheimer-s-disease-regionally-specific-18632739","doi":"10.1093/cercor/bhn113","journal":"Cerebral Cortex","n_participants":null,"pmid":"18632739","source_url":"https://pubmed.ncbi.nlm.nih.gov/18632739/","study_design":null,"title":"The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals","title_match":true,"year":2008},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/plasma-phosphotau181-increases-with-alzheimer-s-disease-clinical-29626426","doi":"10.1016/j.jalz.2018.02.013","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"29626426","source_url":"https://pubmed.ncbi.nlm.nih.gov/29626426/","study_design":null,"title":"Plasma phospho\u2010tau181 increases with Alzheimer's disease clinical severity and is associated with tau\u2010 and amyloid\u2010positron emission tomography","title_match":false,"year":2018},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/kinetic-modeling-of-amyloid-binding-in-humans-using-pet-imaging-and-15944649","doi":"10.1038/sj.jcbfm.9600146","journal":"Journal of Cerebral Blood Flow & Metabolism","n_participants":null,"pmid":"15944649","source_url":"https://pubmed.ncbi.nlm.nih.gov/15944649/","study_design":null,"title":"Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B","title_match":true,"year":2005},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/earliest-accumulation-of-amyloid-occurs-within-the-default-mode-29089479","doi":"10.1038/s41467-017-01150-x","journal":"Nature Communications","n_participants":null,"pmid":"29089479","source_url":"https://pubmed.ncbi.nlm.nih.gov/29089479/","study_design":null,"title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","title_match":false,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/clinical-and-biomarker-changes-of-alzheimer-s-disease-in-adults-with-32593336","doi":"10.1016/s0140-6736(20)30689-9","journal":"The Lancet","n_participants":null,"pmid":"32593336","source_url":"https://pubmed.ncbi.nlm.nih.gov/32593336/","study_design":null,"title":"Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study","title_match":false,"year":2020},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/simplified-quantification-of-pittsburgh-compound-b-amyloid-imaging-16330558","doi":null,"journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"16330558","source_url":"https://pubmed.ncbi.nlm.nih.gov/16330558/","study_design":null,"title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.","title_match":true,"year":2005},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/imaging-of-amyloid-burden-and-distribution-in-cerebral-amyloid-17683091","doi":"10.1002/ana.21164","journal":"Annals of Neurology","n_participants":null,"pmid":"17683091","source_url":"https://pubmed.ncbi.nlm.nih.gov/17683091/","study_design":null,"title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","title_match":false,"year":2007},{"alzhub_score":51,"alzhub_url":"https://alzhub.org/study/two-year-follow-up-of-amyloid-deposition-in-patients-with-alzheimer-s-16854944","doi":"10.1093/brain/awl178","journal":"Brain","n_participants":null,"pmid":"16854944","source_url":"https://pubmed.ncbi.nlm.nih.gov/16854944/","study_design":null,"title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","title_match":false,"year":2006},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/11c-pib-pet-assessment-of-change-in-fibrillar-amyloid-load-in-20189881","doi":"10.1016/s1474-4422(10)70043-0","journal":"The Lancet Neurology","n_participants":null,"pmid":"20189881","source_url":"https://pubmed.ncbi.nlm.nih.gov/20189881/","study_design":null,"title":"11C-PiB PET assessment of change in fibrillar amyloid-\u03b2 load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","title_match":true,"year":2010},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/florbetaben-pet-imaging-to-detect-amyloid-beta-plaques-in-alzheimer-s-25824567","doi":"10.1016/j.jalz.2015.02.004","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"25824567","source_url":"https://pubmed.ncbi.nlm.nih.gov/25824567/","study_design":null,"title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study","title_match":true,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/performance-characteristics-of-amyloid-pet-with-florbetapir-f-18-in-22331215","doi":"10.2967/jnumed.111.090340","journal":"Journal of Nuclear Medicine","n_participants":null,"pmid":"22331215","source_url":"https://pubmed.ncbi.nlm.nih.gov/22331215/","study_design":null,"title":"Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects","title_match":true,"year":2012},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-with-pittsburgh-compound-b-and-florbetapir-comparing-23166389","doi":"10.2967/jnumed.112.109009","journal":"Journal of Nuclear Medicine","n_participants":null,"pmid":"23166389","source_url":"https://pubmed.ncbi.nlm.nih.gov/23166389/","study_design":null,"title":"Amyloid-\u03b2 Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods","title_match":true,"year":2012},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/multisite-study-of-the-relationships-between-antemortem-11-c-pibpet-30347188","doi":"10.1016/j.jalz.2018.09.001","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"30347188","source_url":"https://pubmed.ncbi.nlm.nih.gov/30347188/","study_design":null,"title":"Multisite study of the relationships between antemortem [ 11 C]PIB\u2010PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology","title_match":true,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/quantitative-analysis-of-pib-pet-with-freesurfer-rois-24223109","doi":"10.1371/journal.pone.0073377","journal":"PLoS ONE","n_participants":null,"pmid":"24223109","source_url":"https://pubmed.ncbi.nlm.nih.gov/24223109/","study_design":null,"title":"Quantitative Analysis of PiB-PET with FreeSurfer ROIs","title_match":true,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/clinical-factors-associated-with-discordant-plasma-p-tau217-and-42821845","doi":"10.1212/wnl.0000000000218591","journal":"Neurology","n_participants":706,"pmid":"42821845","source_url":"https://pubmed.ncbi.nlm.nih.gov/42821845/","study_design":null,"title":"Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers","title_match":false,"year":2026},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/11-c-pbr28-binding-to-translocator-protein-increases-with-progression-27318133","doi":"10.1016/j.neurobiolaging.2016.04.011","journal":"Neurobiology of aging","n_participants":null,"pmid":"27318133","source_url":"https://pubmed.ncbi.nlm.nih.gov/27318133/","study_design":"longitudinal study","title":"(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease","title_match":false,"year":2016},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/imaging-of-tau-pathology-in-a-tauopathy-mouse-model-and-in-alzheimer-24050400","doi":"10.1016/j.neuron.2013.07.037","journal":"Neuron","n_participants":null,"pmid":"24050400","source_url":"https://pubmed.ncbi.nlm.nih.gov/24050400/","study_design":null,"title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","title_match":false,"year":2013},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/assessing-synaptic-density-in-alzheimer-disease-with-synaptic-vesicle-30014145","doi":"10.1001/jamaneurol.2018.1836","journal":"JAMA neurology","n_participants":null,"pmid":"30014145","source_url":"https://pubmed.ncbi.nlm.nih.gov/30014145/","study_design":"cross-sectional","title":"Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/quantitative-synaptic-alterations-in-the-human-neocortex-during-8423884","doi":"10.1212/wnl.43.1_part_1.192","journal":"Neurology","n_participants":25,"pmid":"8423884","source_url":"https://pubmed.ncbi.nlm.nih.gov/8423884/","study_design":null,"title":"Quantitative synaptic alterations in the human neocortex during normal aging","title_match":false,"year":1993},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/sup-18-sup-f-flortaucipir-av-1451-tau-pet-in-frontotemporal-dementia-30704514","doi":"10.1186/s13195-019-0470-7","journal":"Alzheimer's research & therapy","n_participants":45,"pmid":"30704514","source_url":"https://pubmed.ncbi.nlm.nih.gov/30704514/","study_design":null,"title":"18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes","title_match":false,"year":2019},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/neurobiology-of-alzheimer-s-disease-integrated-molecular-26412218","doi":"10.2174/1567205012666150701103107","journal":"Current Alzheimer research","n_participants":null,"pmid":"26412218","source_url":"https://pubmed.ncbi.nlm.nih.gov/26412218/","study_design":null,"title":"Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/in-vivo-tau-pathology-is-associated-with-synaptic-loss-and-altered-33546722","doi":"10.1186/s13195-021-00772-0","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"33546722","source_url":"https://pubmed.ncbi.nlm.nih.gov/33546722/","study_design":null,"title":"In vivo tau pathology is associated with synaptic loss and altered synaptic function","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/depression-is-associated-with-tau-and-not-amyloid-positron-emission-32144985","doi":"10.3233/jad-191078","journal":"Journal of Alzheimer's disease : JAD","n_participants":301,"pmid":"32144985","source_url":"https://pubmed.ncbi.nlm.nih.gov/32144985/","study_design":null,"title":"Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults","title_match":true,"year":2020},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/tauopathy-pet-and-amyloid-pet-in-the-diagnosis-of-chronic-traumatic-25226550","doi":"10.1038/tp.2014.91","journal":"Translational psychiatry","n_participants":null,"pmid":"25226550","source_url":"https://pubmed.ncbi.nlm.nih.gov/25226550/","study_design":null,"title":"Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury","title_match":true,"year":2014},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/evaluation-of-early-phase-sup-18-sup-f-florbetaben-pet-acquisition-in-28138429","doi":"10.1016/j.nicl.2016.10.005","journal":"NeuroImage. Clinical","n_participants":33,"pmid":"28138429","source_url":"https://pubmed.ncbi.nlm.nih.gov/28138429/","study_design":null,"title":"Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases","title_match":true,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-adherence-and-rate-of-cerebral-a-amyloid-30375373","doi":"10.1038/s41398-018-0293-5","journal":"Translational psychiatry","n_participants":77,"pmid":"30375373","source_url":"https://pubmed.ncbi.nlm.nih.gov/30375373/","study_design":null,"title":"Mediterranean diet adherence and rate of cerebral A\u03b2-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing","title_match":false,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/mediterranean-diet-its-components-and-amyloid-imaging-biomarkers-29889074","doi":"10.3233/jad-171121","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29889074","source_url":"https://pubmed.ncbi.nlm.nih.gov/29889074/","study_design":"cross-sectional","title":"Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers","title_match":true,"year":2018},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/change-in-caide-dementia-risk-score-and-neuroimaging-biomarkers-33970268","doi":"10.1093/gerona/glab130","journal":"The journals of gerontology. Series A, Biological sciences and medical sciences","n_participants":112,"pmid":"33970268","source_url":"https://pubmed.ncbi.nlm.nih.gov/33970268/","study_design":"post-hoc analysis","title":"Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis","title_match":false,"year":2021},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/27-hydroxycholesterol-cognition-and-brain-imaging-markers-in-the-33676572","doi":"10.1186/s13195-021-00790-y","journal":"Alzheimer's research & therapy","n_participants":47,"pmid":"33676572","source_url":"https://pubmed.ncbi.nlm.nih.gov/33676572/","study_design":"cross-sectional","title":"27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/synergistic-interaction-between-amyloid-and-tau-predicts-the-28024995","doi":"10.1016/j.jalz.2016.11.005","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"28024995","source_url":"https://pubmed.ncbi.nlm.nih.gov/28024995/","study_design":null,"title":"Synergistic interaction between amyloid and tau predicts the progression\u00a0to dementia","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/amyloid-associated-cortical-thinning-in-clinically-normal-elderly-21437929","doi":"10.1002/ana.22333","journal":"Annals of neurology","n_participants":32,"pmid":"21437929","source_url":"https://pubmed.ncbi.nlm.nih.gov/21437929/","study_design":null,"title":"Amyloid-\u03b2 associated cortical thinning in clinically normal elderly","title_match":false,"year":2011},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/structural-tract-alterations-predict-downstream-tau-accumulation-in-29403032","doi":"10.1038/s41593-018-0070-z","journal":"Nature neuroscience","n_participants":null,"pmid":"29403032","source_url":"https://pubmed.ncbi.nlm.nih.gov/29403032/","study_design":"longitudinal study","title":"Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals","title_match":true,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/cognitive-decline-and-brain-volume-loss-as-signatures-of-cerebral-20008651","doi":"10.1001/archneurol.2009.272","journal":"Archives of neurology","n_participants":135,"pmid":"20008651","source_url":"https://pubmed.ncbi.nlm.nih.gov/20008651/","study_design":"cross-sectional","title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","title_match":true,"year":2009},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/increased-alzheimer-s-risk-during-the-menopause-transition-a-3-year-30540774","doi":"10.1371/journal.pone.0207885","journal":"PloS one","n_participants":41,"pmid":"30540774","source_url":"https://pubmed.ncbi.nlm.nih.gov/30540774/","study_design":null,"title":"Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/magnetic-resonance-imaging-evidence-for-presymptomatic-change-in-23539189","doi":"10.1093/brain/awt065","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"23539189","source_url":"https://pubmed.ncbi.nlm.nih.gov/23539189/","study_design":null,"title":"Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/associations-between-alzheimer-disease-biomarkers-neurodegeneration-24166579","doi":"10.1001/jamaneurol.2013.4013","journal":"JAMA neurology","n_participants":29,"pmid":"24166579","source_url":"https://pubmed.ncbi.nlm.nih.gov/24166579/","study_design":"cross-sectional","title":"Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people","title_match":false,"year":2013},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/memory-decline-accompanies-subthreshold-amyloid-accumulation-29572282","doi":"10.1212/wnl.0000000000005354","journal":"Neurology","n_participants":13,"pmid":"29572282","source_url":"https://pubmed.ncbi.nlm.nih.gov/29572282/","study_design":"longitudinal study","title":"Memory decline accompanies subthreshold amyloid accumulation","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/objective-subtle-cognitive-difficulties-predict-future-amyloid-31888974","doi":"10.1212/wnl.0000000000008838","journal":"Neurology","n_participants":747,"pmid":"31888974","source_url":"https://pubmed.ncbi.nlm.nih.gov/31888974/","study_design":null,"title":"Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration","title_match":false,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/in-vivo-evaluation-of-a-novel-tau-imaging-tracer-for-alzheimer-s-24514874","doi":"10.1007/s00259-013-2681-7","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"24514874","source_url":"https://pubmed.ncbi.nlm.nih.gov/24514874/","study_design":null,"title":"In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-neurodegenerative-biomarkers-are-associated-with-23536070","doi":"10.1523/jneurosci.4409-12.2013","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"23536070","source_url":"https://pubmed.ncbi.nlm.nih.gov/23536070/","study_design":null,"title":"Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not \u03b2-amyloid in cognitively normal older individuals","title_match":false,"year":2013},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/apoe-genotype-and-neuroimaging-markers-of-alzheimer-s-disease-24838911","doi":"10.1136/jnnp-2014-307719","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":1628,"pmid":"24838911","source_url":"https://pubmed.ncbi.nlm.nih.gov/24838911/","study_design":"systematic review","title":"APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/cognitive-and-brain-profiles-associated-with-current-neuroimaging-26203136","doi":"10.1523/jneurosci.0150-15.2015","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"26203136","source_url":"https://pubmed.ncbi.nlm.nih.gov/26203136/","study_design":null,"title":"Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/3d-pib-and-csf-biomarker-associations-with-hippocampal-atrophy-in-20538372","doi":"10.1016/j.neurobiolaging.2010.05.003","journal":"Neurobiology of aging","n_participants":98,"pmid":"20538372","source_url":"https://pubmed.ncbi.nlm.nih.gov/20538372/","study_design":null,"title":"3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects","title_match":false,"year":2010},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/nilotinib-effects-on-safety-tolerability-and-biomarkers-in-alzheimer-32468646","doi":"10.1002/ana.25775","journal":"Annals of neurology","n_participants":37,"pmid":"32468646","source_url":"https://pubmed.ncbi.nlm.nih.gov/32468646/","study_design":"clinical trial","title":"Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/associations-between-serum-cholesterol-levels-and-cerebral-amyloidosis-24378418","doi":"10.1001/jamaneurol.2013.5390","journal":"JAMA neurology","n_participants":33,"pmid":"24378418","source_url":"https://pubmed.ncbi.nlm.nih.gov/24378418/","study_design":"cross-sectional","title":"Associations between serum cholesterol levels and cerebral amyloidosis","title_match":false,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/a-deposition-is-associated-with-increases-in-soluble-and-32426454","doi":"10.1126/sciadv.aaz2387","journal":"Science advances","n_participants":null,"pmid":"32426454","source_url":"https://pubmed.ncbi.nlm.nih.gov/32426454/","study_design":null,"title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-measured-by-elecsys-assays-compared-to-29501462","doi":"10.1016/j.jalz.2018.01.013","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":200,"pmid":"29501462","source_url":"https://pubmed.ncbi.nlm.nih.gov/29501462/","study_design":null,"title":"Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging","title_match":true,"year":2018},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/lecanemab-in-patients-with-early-alzheimer-s-disease-detailed-results-36544184","doi":"10.1186/s13195-022-01124-2","journal":"Alzheimer's research & therapy","n_participants":856,"pmid":"36544184","source_url":"https://pubmed.ncbi.nlm.nih.gov/36544184/","study_design":"open-label trial","title":"Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-leading-blood-tests-for-alzheimer-s-39394841","doi":"10.1002/alz.14315","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39394841","source_url":"https://pubmed.ncbi.nlm.nih.gov/39394841/","study_design":null,"title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","title_match":false,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/differential-levels-of-plasma-biomarkers-of-neurodegeneration-in-lewy-35078917","doi":"10.1136/jnnp-2021-327788","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":300,"pmid":"35078917","source_url":"https://pubmed.ncbi.nlm.nih.gov/35078917/","study_design":"longitudinal study","title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/detecting-amyloid-positivity-in-early-alzheimer-s-disease-using-34151519","doi":"10.1002/alz.12395","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":591,"pmid":"34151519","source_url":"https://pubmed.ncbi.nlm.nih.gov/34151519/","study_design":null,"title":"Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma A\u03b242/A\u03b240 and p-tau","title_match":true,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/equivalence-of-plasma-p-tau217-with-cerebrospinal-fluid-in-the-37078495","doi":"10.1002/alz.13026","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":174,"pmid":"37078495","source_url":"https://pubmed.ncbi.nlm.nih.gov/37078495/","study_design":null,"title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/predicting-amyloid-pet-and-tau-pet-stages-with-plasma-biomarkers-36789483","doi":"10.1093/brain/awad042","journal":"Brain : a journal of neurology","n_participants":1136,"pmid":"36789483","source_url":"https://pubmed.ncbi.nlm.nih.gov/36789483/","study_design":null,"title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","title_match":true,"year":2023},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/plasma-a42-a40-and-phospho-tau217-concentration-ratios-increase-the-37932961","doi":"10.1002/alz.13542","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"37932961","source_url":"https://pubmed.ncbi.nlm.nih.gov/37932961/","study_design":null,"title":"Plasma A\u03b242/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-accuracy-and-robustness-of-plasma-biomarker-models-for-amyloid-35130933","doi":"10.1186/s13195-021-00942-0","journal":"Alzheimer's research & therapy","n_participants":50,"pmid":"35130933","source_url":"https://pubmed.ncbi.nlm.nih.gov/35130933/","study_design":null,"title":"The accuracy and robustness of plasma biomarker models for amyloid PET positivity","title_match":true,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-217-in-preclinical-alzheimer-s-disease-37013174","doi":"10.1093/braincomms/fcad057","journal":"Brain communications","n_participants":165,"pmid":"37013174","source_url":"https://pubmed.ncbi.nlm.nih.gov/37013174/","study_design":"cohort study","title":"Plasma phosphorylated tau 217 in preclinical Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":81,"alzhub_url":"https://alzhub.org/study/the-fda-approved-anti-amyloid-monoclonal-antibodies-for-the-treatment-38017568","doi":"10.1186/s40001-023-01512-w","journal":"European journal of medical research","n_participants":4471,"pmid":"38017568","source_url":"https://pubmed.ncbi.nlm.nih.gov/38017568/","study_design":"systematic review","title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/comparison-of-two-plasma-p-tau217-assays-to-detect-and-monitor-38471397","doi":"10.1016/j.ebiom.2024.105046","journal":"EBioMedicine","n_participants":294,"pmid":"38471397","source_url":"https://pubmed.ncbi.nlm.nih.gov/38471397/","study_design":null,"title":"Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer's pathology","title_match":false,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/longitudinal-changes-in-alzheimer-s-related-plasma-biomarkers-and-37216632","doi":"10.1002/alz.13157","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":199,"pmid":"37216632","source_url":"https://pubmed.ncbi.nlm.nih.gov/37216632/","study_design":"longitudinal study","title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/optimizing-cutpoints-for-clinical-interpretation-of-brain-amyloid-39030981","doi":"10.1002/alz.14140","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":427,"pmid":"39030981","source_url":"https://pubmed.ncbi.nlm.nih.gov/39030981/","study_design":null,"title":"Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/the-cerebrospinal-fluid-a1-42-a1-40-ratio-improves-concordance-with-28869470","doi":"10.3233/jad-170327","journal":"Journal of Alzheimer's disease : JAD","n_participants":17,"pmid":"28869470","source_url":"https://pubmed.ncbi.nlm.nih.gov/28869470/","study_design":"longitudinal study","title":"The Cerebrospinal Fluid A\u03b21-42/A\u03b21-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting","title_match":true,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/detection-and-staging-of-alzheimer-s-disease-by-plasma-ptau217-on-a-39437657","doi":"10.1016/j.ebiom.2024.105405","journal":"EBioMedicine","n_participants":388,"pmid":"39437657","source_url":"https://pubmed.ncbi.nlm.nih.gov/39437657/","study_design":null,"title":"Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-brain-barrier-opening-of-the-default-mode-network-in-alzheimer-36694943","doi":"10.1093/brain/awac459","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"36694943","source_url":"https://pubmed.ncbi.nlm.nih.gov/36694943/","study_design":null,"title":"Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-and-p-tau217-a1-42-are-effective-biomarkers-for-39887504","doi":"10.1002/alz.14536","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39887504","source_url":"https://pubmed.ncbi.nlm.nih.gov/39887504/","study_design":null,"title":"Plasma p-tau217 and p-tau217/A\u03b21-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: Insights for research and clinical practice","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-181-predicts-amyloid-status-and-conversion-37012068","doi":"10.1136/jnnp-2022-330540","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"37012068","source_url":"https://pubmed.ncbi.nlm.nih.gov/37012068/","study_design":null,"title":"Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function","title_match":false,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau181-as-a-predictive-biomarker-for-alzheimer-34775468","doi":"10.1038/s41398-021-01709-9","journal":"Translational psychiatry","n_participants":1189,"pmid":"34775468","source_url":"https://pubmed.ncbi.nlm.nih.gov/34775468/","study_design":"cross-sectional","title":"Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status","title_match":false,"year":2021},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/p-tau217-as-a-reliable-blood-based-marker-of-alzheimer-s-disease-39200300","doi":"10.3390/biomedicines12081836","journal":"Biomedicines","n_participants":null,"pmid":"39200300","source_url":"https://pubmed.ncbi.nlm.nih.gov/39200300/","study_design":"narrative review","title":"P-tau217 as a Reliable Blood-Based Marker of Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-bio-hermes-study-biomarker-database-developed-to-investigate-38415908","doi":"10.1002/alz.13722","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":417,"pmid":"38415908","source_url":"https://pubmed.ncbi.nlm.nih.gov/38415908/","study_design":null,"title":"The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-alzheimer-s-disease-towards-clinical-34838239","doi":"10.1016/s1474-4422(21)00361-6","journal":"The Lancet. Neurology","n_participants":null,"pmid":"34838239","source_url":"https://pubmed.ncbi.nlm.nih.gov/34838239/","study_design":null,"title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-and-csf-neurofilament-light-relation-to-longitudinal-31182505","doi":"10.1212/wnl.0000000000007767","journal":"Neurology","n_participants":null,"pmid":"31182505","source_url":"https://pubmed.ncbi.nlm.nih.gov/31182505/","study_design":"cross-sectional","title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","title_match":false,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/combination-of-plasma-amyloid-beta-1-42-1-40-and-glial-fibrillary-32988409","doi":"10.1186/s13195-020-00682-7","journal":"Alzheimer's research & therapy","n_participants":176,"pmid":"32988409","source_url":"https://pubmed.ncbi.nlm.nih.gov/32988409/","study_design":null,"title":"Combination of plasma amyloid beta (1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","title_match":false,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/a-review-of-fluid-biomarkers-for-alzheimer-s-disease-moving-from-csf-28733960","doi":"10.1007/s40120-017-0073-9","journal":"Neurology and therapy","n_participants":null,"pmid":"28733960","source_url":"https://pubmed.ncbi.nlm.nih.gov/28733960/","study_design":"longitudinal study","title":"A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood","title_match":false,"year":2017},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/untangling-the-association-of-amyloid-and-tau-with-synaptic-and-33279949","doi":"10.1093/brain/awaa395","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"33279949","source_url":"https://pubmed.ncbi.nlm.nih.gov/33279949/","study_design":null,"title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/tau-positron-emission-tomography-in-former-national-football-league-30969506","doi":"10.1056/nejmoa1900757","journal":"The New England journal of medicine","n_participants":26,"pmid":"30969506","source_url":"https://pubmed.ncbi.nlm.nih.gov/30969506/","study_design":null,"title":"Tau Positron-Emission Tomography in Former National Football League Players","title_match":false,"year":2019},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-a42-40-corresponds-better-than-a42-to-amyloid-pet-27792012","doi":"10.3233/jad-160722","journal":"Journal of Alzheimer's disease : JAD","n_participants":200,"pmid":"27792012","source_url":"https://pubmed.ncbi.nlm.nih.gov/27792012/","study_design":null,"title":"Cerebrospinal Fluid A\u03b242/40 Corresponds Better than A\u03b242 to Amyloid PET in Alzheimer's Disease","title_match":true,"year":2017},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/a-blood-based-diagnostic-test-incorporating-plasma-a42-40-ratio-apoe-33933117","doi":"10.1186/s13024-021-00451-6","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"33933117","source_url":"https://pubmed.ncbi.nlm.nih.gov/33933117/","study_design":null,"title":"A blood-based diagnostic test incorporating plasma A\u03b242/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/clinical-validation-of-the-lumipulse-g-cerebrospinal-fluid-assays-for-31759396","doi":"10.1186/s13195-019-0550-8","journal":"Alzheimer's research & therapy","n_participants":80,"pmid":"31759396","source_url":"https://pubmed.ncbi.nlm.nih.gov/31759396/","study_design":null,"title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/plasma-markers-predict-changes-in-amyloid-tau-atrophy-and-cognition-34077494","doi":"10.1093/brain/awab163","journal":"Brain : a journal of neurology","n_participants":123,"pmid":"34077494","source_url":"https://pubmed.ncbi.nlm.nih.gov/34077494/","study_design":"longitudinal study","title":"Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects","title_match":false,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/plasma-a-but-not-tau-is-related-to-brain-pib-retention-in-early-25054847","doi":"10.1021/cn500101j","journal":"ACS chemical neuroscience","n_participants":25,"pmid":"25054847","source_url":"https://pubmed.ncbi.nlm.nih.gov/25054847/","study_design":null,"title":"Plasma A\u03b2 but not tau is related to brain PiB retention in early Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-beta-levels-are-associated-with-cerebral-amyloid-and-31384662","doi":"10.1016/j.dadm.2019.05.007","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"31384662","source_url":"https://pubmed.ncbi.nlm.nih.gov/31384662/","study_design":null,"title":"Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition","title_match":false,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/associations-between-air-pollution-and-biomarkers-of-alzheimer-s-34537521","doi":"10.1016/j.envint.2021.106864","journal":"Environment international","n_participants":156,"pmid":"34537521","source_url":"https://pubmed.ncbi.nlm.nih.gov/34537521/","study_design":null,"title":"Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/p-tau-a42-and-a42-40-ratios-in-csf-are-equally-predictive-of-amyloid-34027020","doi":"10.1002/dad2.12190","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":150,"pmid":"34027020","source_url":"https://pubmed.ncbi.nlm.nih.gov/34027020/","study_design":null,"title":"P-tau/A\u03b242 and A\u03b242/40 ratios in CSF are equally predictive of amyloid PET status","title_match":true,"year":2021},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/elecsys-csf-biomarker-immunoassays-demonstrate-concordance-with-32234072","doi":"10.1186/s13195-020-00595-5","journal":"Alzheimer's research & therapy","n_participants":202,"pmid":"32234072","source_url":"https://pubmed.ncbi.nlm.nih.gov/32234072/","study_design":null,"title":"Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging","title_match":true,"year":2020},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/performance-of-a-fully-automated-lumipulse-plasma-phospho-tau181-36371232","doi":"10.1186/s13195-022-01116-2","journal":"Alzheimer's research & therapy","n_participants":463,"pmid":"36371232","source_url":"https://pubmed.ncbi.nlm.nih.gov/36371232/","study_design":"longitudinal study","title":"Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/comparative-analytical-performance-of-multiple-plasma-a42-and-a40-35820077","doi":"10.1002/alz.12697","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"35820077","source_url":"https://pubmed.ncbi.nlm.nih.gov/35820077/","study_design":null,"title":"Comparative analytical performance of multiple plasma A\u03b242 and A\u03b240 assays and their ability to predict positron emission tomography amyloid positivity","title_match":true,"year":2023},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/diagnostic-biomarkers-of-amyloid-and-tau-pathology-in-alzheimer-s-37357283","doi":"10.14283/jpad.2023.43","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"37357283","source_url":"https://pubmed.ncbi.nlm.nih.gov/37357283/","study_design":null,"title":"Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer's Disease: An Overview of Tests for Clinical Practice in the United States and Europe","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/chemically-treated-plasma-a-is-a-potential-blood-based-biomarker-for-28330509","doi":"10.1186/s13195-017-0248-8","journal":"Alzheimer's research & therapy","n_participants":353,"pmid":"28330509","source_url":"https://pubmed.ncbi.nlm.nih.gov/28330509/","study_design":"cross-sectional","title":"Chemically treated plasma A\u03b2 is a potential blood-based biomarker for screening cerebral amyloid deposition","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/the-cerebrospinal-fluid-biomarker-ratio-a42-40-identifies-amyloid-35473631","doi":"10.1186/s13195-022-01003-w","journal":"Alzheimer's research & therapy","n_participants":44,"pmid":"35473631","source_url":"https://pubmed.ncbi.nlm.nih.gov/35473631/","study_design":null,"title":"The cerebrospinal fluid biomarker ratio A\u03b242/40 identifies amyloid positron emission tomography positivity better than A\u03b242 alone in a heterogeneous memory clinic cohort","title_match":true,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-a42-40-ratio-alone-or-combined-with-fdg-pet-can-accurately-31787105","doi":"10.1186/s13195-019-0549-1","journal":"Alzheimer's research & therapy","n_participants":39,"pmid":"31787105","source_url":"https://pubmed.ncbi.nlm.nih.gov/31787105/","study_design":null,"title":"Plasma A\u03b242/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study","title_match":true,"year":2019},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/combining-plasma-phospho-tau-and-accessible-measures-to-evaluate-35351181","doi":"10.1186/s13195-022-00990-0","journal":"Alzheimer's research & therapy","n_participants":110,"pmid":"35351181","source_url":"https://pubmed.ncbi.nlm.nih.gov/35351181/","study_design":null,"title":"Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients","title_match":false,"year":2022},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/population-based-blood-screening-for-preclinical-alzheimer-s-disease-33479777","doi":"10.1093/brain/awaa403","journal":"Brain : a journal of neurology","n_participants":502,"pmid":"33479777","source_url":"https://pubmed.ncbi.nlm.nih.gov/33479777/","study_design":null,"title":"Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70","title_match":false,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-blood-biomarker-detects-alzheimer-s-disease-29626112","doi":"10.15252/emmm.201708763","journal":"EMBO molecular medicine","n_participants":null,"pmid":"29626112","source_url":"https://pubmed.ncbi.nlm.nih.gov/29626112/","study_design":"cross-sectional","title":"Amyloid blood biomarker detects Alzheimer's disease","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/oligomeric-forms-of-amyloid-protein-in-plasma-as-a-potential-blood-29246249","doi":"10.1186/s13195-017-0324-0","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"29246249","source_url":"https://pubmed.ncbi.nlm.nih.gov/29246249/","study_design":null,"title":"Oligomeric forms of amyloid-\u03b2 protein in plasma as a potential blood-based biomarker for Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/novel-plasma-biomarker-surrogating-cerebral-amyloid-deposition-25391320","doi":"10.2183/pjab.90.353","journal":"Proceedings of the Japan Academy. Series B, Physical and biological sciences","n_participants":null,"pmid":"25391320","source_url":"https://pubmed.ncbi.nlm.nih.gov/25391320/","study_design":null,"title":"Novel plasma biomarker surrogating cerebral amyloid deposition","title_match":false,"year":2014},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/association-of-plasma-glial-fibrillary-acidic-protein-gfap-with-35252538","doi":"10.1002/dad2.12291","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":200,"pmid":"35252538","source_url":"https://pubmed.ncbi.nlm.nih.gov/35252538/","study_design":"cross-sectional","title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/plasma-glial-fibrillary-acidic-protein-in-autosomal-dominant-36576155","doi":"10.1002/alz.12879","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36576155","source_url":"https://pubmed.ncbi.nlm.nih.gov/36576155/","study_design":null,"title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A\u03b2-PET, neurodegeneration, and cognition","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-neurofilament-light-associates-with-alzheimer-s-disease-31673598","doi":"10.1016/j.dadm.2019.08.002","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"31673598","source_url":"https://pubmed.ncbi.nlm.nih.gov/31673598/","study_design":"cross-sectional","title":"Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals","title_match":true,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/ultrasensitive-detection-of-plasma-amyloid-as-a-biomarker-for-31424403","doi":"10.3233/jad-190533","journal":"Journal of Alzheimer's disease : JAD","n_participants":32,"pmid":"31424403","source_url":"https://pubmed.ncbi.nlm.nih.gov/31424403/","study_design":null,"title":"Ultrasensitive Detection of Plasma Amyloid-\u03b2 as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/effect-of-renal-function-on-the-diagnostic-performance-of-plasma-37009461","doi":"10.3389/fnagi.2023.1150510","journal":"Frontiers in aging neuroscience","n_participants":645,"pmid":"37009461","source_url":"https://pubmed.ncbi.nlm.nih.gov/37009461/","study_design":"cross-sectional","title":"Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-217-exhibits-sex-specific-prognostication-37639492","doi":"10.1002/alz.13454","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":163,"pmid":"37639492","source_url":"https://pubmed.ncbi.nlm.nih.gov/37639492/","study_design":"longitudinal study","title":"Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults","title_match":false,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-progression-of-glucose-metabolism-dysfunction-37121979","doi":"10.1038/s12276-023-00993-3","journal":"Experimental & molecular medicine","n_participants":181,"pmid":"37121979","source_url":"https://pubmed.ncbi.nlm.nih.gov/37121979/","study_design":"cross-sectional","title":"Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/blood-based-biomarker-candidates-of-cerebral-amyloid-using-pib-pet-in-27031486","doi":"10.3233/jad-151155","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27031486","source_url":"https://pubmed.ncbi.nlm.nih.gov/27031486/","study_design":"longitudinal study","title":"Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly","title_match":true,"year":2016},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/timing-of-changes-in-alzheimer-s-disease-plasma-biomarkers-as-40539416","doi":"10.1002/ana.27285","journal":"Annals of neurology","n_participants":784,"pmid":"40539416","source_url":"https://pubmed.ncbi.nlm.nih.gov/40539416/","study_design":"longitudinal study","title":"Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/racial-and-ethnic-differences-in-plasma-biomarker-eligibility-for-a-38629508","doi":"10.1002/alz.13803","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":4905,"pmid":"38629508","source_url":"https://pubmed.ncbi.nlm.nih.gov/38629508/","study_design":null,"title":"Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/identification-of-cathepsin-d-as-a-plasma-biomarker-for-alzheimer-s-33445607","doi":"10.3390/cells10010138","journal":"Cells","n_participants":null,"pmid":"33445607","source_url":"https://pubmed.ncbi.nlm.nih.gov/33445607/","study_design":null,"title":"Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/plasma-dyrk1a-as-a-novel-risk-factor-for-alzheimer-s-disease-25116835","doi":"10.1038/tp.2014.61","journal":"Translational psychiatry","n_participants":26,"pmid":"25116835","source_url":"https://pubmed.ncbi.nlm.nih.gov/25116835/","study_design":null,"title":"Plasma DYRK1A as a novel risk factor for Alzheimer's disease","title_match":false,"year":2014},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-as-a-blood-biomarker-for-alzheimer-s-disease-a-review-of-31868667","doi":"10.3233/jad-190714","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"31868667","source_url":"https://pubmed.ncbi.nlm.nih.gov/31868667/","study_design":null,"title":"Amyloid-\u03b2 as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature","title_match":false,"year":2020},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/the-computerized-cognitive-composite-c3-in-an-alzheimer-s-disease-33336226","doi":"10.14283/jpad.2020.38","journal":"The journal of prevention of Alzheimer's disease","n_participants":4486,"pmid":"33336226","source_url":"https://pubmed.ncbi.nlm.nih.gov/33336226/","study_design":"cross-sectional","title":"The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/episodic-memory-decline-predicts-cortical-amyloid-status-in-community-21876253","doi":"10.3233/jad-2011-110818","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"21876253","source_url":"https://pubmed.ncbi.nlm.nih.gov/21876253/","study_design":null,"title":"Episodic memory decline predicts cortical amyloid status in community-dwelling older adults","title_match":false,"year":2011},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/amyloid-accumulation-in-the-human-brain-after-one-night-of-sleep-29632177","doi":"10.1073/pnas.1721694115","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"29632177","source_url":"https://pubmed.ncbi.nlm.nih.gov/29632177/","study_design":null,"title":"\u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation","title_match":false,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/apoe-and-bche-as-modulators-of-cerebral-amyloid-deposition-a-23419831","doi":"10.1038/mp.2013.19","journal":"Molecular psychiatry","n_participants":555,"pmid":"23419831","source_url":"https://pubmed.ncbi.nlm.nih.gov/23419831/","study_design":null,"title":"APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study","title_match":true,"year":2014},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/prospective-longitudinal-atrophy-in-alzheimer-s-disease-correlates-31894103","doi":"10.1126/scitranslmed.aau5732","journal":"Science translational medicine","n_participants":32,"pmid":"31894103","source_url":"https://pubmed.ncbi.nlm.nih.gov/31894103/","study_design":"longitudinal study","title":"Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET","title_match":false,"year":2020},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/relationships-between-flortaucipir-pet-tau-binding-and-amyloid-burden-28077397","doi":"10.1093/brain/aww334","journal":"Brain : a journal of neurology","n_participants":217,"pmid":"28077397","source_url":"https://pubmed.ncbi.nlm.nih.gov/28077397/","study_design":"cross-sectional","title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","title_match":false,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/functional-brain-architecture-is-associated-with-the-rate-of-tau-31953405","doi":"10.1038/s41467-019-14159-1","journal":"Nature communications","n_participants":null,"pmid":"31953405","source_url":"https://pubmed.ncbi.nlm.nih.gov/31953405/","study_design":"cross-sectional","title":"Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/phases-of-hyperconnectivity-and-hypoconnectivity-in-the-default-mode-28314821","doi":"10.1523/jneurosci.3263-16.2017","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"28314821","source_url":"https://pubmed.ncbi.nlm.nih.gov/28314821/","study_design":null,"title":"Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals","title_match":false,"year":2017},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-impact-of-amyloid-beta-and-tau-on-prospective-cognitive-decline-30549303","doi":"10.1002/ana.25395","journal":"Annals of neurology","n_participants":null,"pmid":"30549303","source_url":"https://pubmed.ncbi.nlm.nih.gov/30549303/","study_design":null,"title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","title_match":false,"year":2019},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/the-relationships-between-neuroinflammation-beta-amyloid-and-tau-32375809","doi":"10.1186/s12974-020-01820-6","journal":"Journal of neuroinflammation","n_participants":null,"pmid":"32375809","source_url":"https://pubmed.ncbi.nlm.nih.gov/32375809/","study_design":"longitudinal study","title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/functional-connectivity-associated-with-tau-levels-in-ageing-30770704","doi":"10.1093/brain/awz026","journal":"Brain : a journal of neurology","n_participants":55,"pmid":"30770704","source_url":"https://pubmed.ncbi.nlm.nih.gov/30770704/","study_design":null,"title":"Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-and-tau-imaging-biomarkers-explain-cognitive-decline-from-31886494","doi":"10.1093/brain/awz378","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"31886494","source_url":"https://pubmed.ncbi.nlm.nih.gov/31886494/","study_design":"cross-sectional","title":"Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age","title_match":false,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/av-1451-tau-and-amyloid-positron-emission-tomography-imaging-in-27863444","doi":"10.1002/ana.24825","journal":"Annals of neurology","n_participants":19,"pmid":"27863444","source_url":"https://pubmed.ncbi.nlm.nih.gov/27863444/","study_design":null,"title":"AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with Lewy bodies","title_match":true,"year":2017},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/in-vivo-quantification-of-neurofibrillary-tangles-with-18-f-mk-6240-30064520","doi":"10.1186/s13195-018-0402-y","journal":"Alzheimer's research & therapy","n_participants":14,"pmid":"30064520","source_url":"https://pubmed.ncbi.nlm.nih.gov/30064520/","study_design":null,"title":"In vivo quantification of neurofibrillary tangles with [ 18 F]MK-6240","title_match":false,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/in-vivo-tau-amyloid-and-gray-matter-profiles-in-the-aging-brain-27413148","doi":"10.1523/jneurosci.0639-16.2016","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"27413148","source_url":"https://pubmed.ncbi.nlm.nih.gov/27413148/","study_design":null,"title":"In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain","title_match":false,"year":2016},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/mild-behavioral-impairment-is-associated-with-amyloid-but-not-tau-or-31914223","doi":"10.1002/alz.12007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"31914223","source_url":"https://pubmed.ncbi.nlm.nih.gov/31914223/","study_design":null,"title":"Mild behavioral impairment is associated with \u03b2-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/18f-av-1451-tau-pet-imaging-correlates-strongly-with-tau-27357347","doi":"10.1093/brain/aww163","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"27357347","source_url":"https://pubmed.ncbi.nlm.nih.gov/27357347/","study_design":null,"title":"18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/segregation-of-functional-networks-is-associated-with-cognitive-33725114","doi":"10.1093/brain/awab112","journal":"Brain : a journal of neurology","n_participants":108,"pmid":"33725114","source_url":"https://pubmed.ncbi.nlm.nih.gov/33725114/","study_design":null,"title":"Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/fluorodeoxyglucose-metabolism-associated-with-tau-amyloid-interaction-28253546","doi":"10.1002/ana.24910","journal":"Annals of neurology","n_participants":null,"pmid":"28253546","source_url":"https://pubmed.ncbi.nlm.nih.gov/28253546/","study_design":null,"title":"Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline","title_match":false,"year":2017},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/depressive-symptoms-and-tau-accumulation-in-the-inferior-temporal-28697559","doi":"10.3233/jad-170001","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"28697559","source_url":"https://pubmed.ncbi.nlm.nih.gov/28697559/","study_design":"cross-sectional","title":"Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/tau-amyloid-and-hypometabolism-in-a-patient-with-posterior-cortical-25448043","doi":"10.1002/ana.24321","journal":"Annals of neurology","n_participants":null,"pmid":"25448043","source_url":"https://pubmed.ncbi.nlm.nih.gov/25448043/","study_design":null,"title":"Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy","title_match":false,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/effect-of-apoe-4-genotype-on-amyloid-and-tau-accumulation-in-33129364","doi":"10.1186/s13195-020-00710-6","journal":"Alzheimer's research & therapy","n_participants":272,"pmid":"33129364","source_url":"https://pubmed.ncbi.nlm.nih.gov/33129364/","study_design":"longitudinal study","title":"Effect of APOE \u03b54 genotype on amyloid-\u03b2 and tau accumulation in Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-accumulation-and-cognitive-decline-in-clinically-normal-older-29782318","doi":"10.3233/jad-179928","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"29782318","source_url":"https://pubmed.ncbi.nlm.nih.gov/29782318/","study_design":null,"title":"Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/fdg-pet-in-tau-negative-amnestic-dementia-resembles-that-of-autopsy-29538658","doi":"10.1093/brain/awy049","journal":"Brain : a journal of neurology","n_participants":15,"pmid":"29538658","source_url":"https://pubmed.ncbi.nlm.nih.gov/29538658/","study_design":null,"title":"FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis","title_match":false,"year":2018},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/predicting-future-rates-of-tau-accumulation-on-pet-33094327","doi":"10.1093/brain/awaa248","journal":"Brain : a journal of neurology","n_participants":203,"pmid":"33094327","source_url":"https://pubmed.ncbi.nlm.nih.gov/33094327/","study_design":null,"title":"Predicting future rates of tau accumulation on PET","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/associations-of-quantitative-susceptibility-mapping-with-alzheimer-s-33035667","doi":"10.1016/j.neuroimage.2020.117433","journal":"NeuroImage","n_participants":421,"pmid":"33035667","source_url":"https://pubmed.ncbi.nlm.nih.gov/33035667/","study_design":null,"title":"Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers","title_match":false,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/amyloid-duration-is-associated-with-preclinical-cognitive-decline-and-32211502","doi":"10.1002/dad2.12007","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":257,"pmid":"32211502","source_url":"https://pubmed.ncbi.nlm.nih.gov/32211502/","study_design":"longitudinal study","title":"Amyloid duration is associated with preclinical cognitive decline and tau PET","title_match":false,"year":2020},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/blood-brain-barrier-opening-in-alzheimer-s-disease-using-mr-guided-30046032","doi":"10.1038/s41467-018-04529-6","journal":"Nature communications","n_participants":null,"pmid":"30046032","source_url":"https://pubmed.ncbi.nlm.nih.gov/30046032/","study_design":null,"title":"Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-australian-imaging-biomarkers-and-lifestyle-aibl-study-of-aging-19470201","doi":"10.1017/s1041610209009405","journal":"International psychogeriatrics","n_participants":1000,"pmid":"19470201","source_url":"https://pubmed.ncbi.nlm.nih.gov/19470201/","study_design":null,"title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/self-reported-sleep-and-amyloid-deposition-in-community-dwelling-24145859","doi":"10.1001/jamaneurol.2013.4258","journal":"JAMA neurology","n_participants":70,"pmid":"24145859","source_url":"https://pubmed.ncbi.nlm.nih.gov/24145859/","study_design":"cross-sectional","title":"Self-reported sleep and \u03b2-amyloid deposition in community-dwelling older adults","title_match":false,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-plaques-disrupt-resting-state-default-mode-network-19833321","doi":"10.1016/j.biopsych.2009.08.024","journal":"Biological psychiatry","n_participants":35,"pmid":"19833321","source_url":"https://pubmed.ncbi.nlm.nih.gov/19833321/","study_design":null,"title":"Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly","title_match":false,"year":2010},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/disruption-of-functional-connectivity-in-clinically-normal-older-19812343","doi":"10.1523/jneurosci.3189-09.2009","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":38,"pmid":"19812343","source_url":"https://pubmed.ncbi.nlm.nih.gov/19812343/","study_design":null,"title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","title_match":false,"year":2009},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/subjective-cognitive-complaints-and-amyloid-burden-in-cognitively-22940426","doi":"10.1016/j.neuropsychologia.2012.08.011","journal":"Neuropsychologia","n_participants":null,"pmid":"22940426","source_url":"https://pubmed.ncbi.nlm.nih.gov/22940426/","study_design":null,"title":"Subjective cognitive complaints and amyloid burden in cognitively normal older individuals","title_match":false,"year":2012},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/apoe4-allele-disrupts-resting-state-fmri-connectivity-in-the-absence-21159973","doi":"10.1523/jneurosci.3987-10.2010","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":100,"pmid":"21159973","source_url":"https://pubmed.ncbi.nlm.nih.gov/21159973/","study_design":"longitudinal study","title":"APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A\u03b242","title_match":false,"year":2010},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/trial-of-solanezumab-in-preclinical-alzheimer-s-disease-37458272","doi":"10.1056/nejmoa2305032","journal":"The New England journal of medicine","n_participants":1169,"pmid":"37458272","source_url":"https://pubmed.ncbi.nlm.nih.gov/37458272/","study_design":"clinical trial","title":"Trial of Solanezumab in Preclinical Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/comparing-positron-emission-tomography-imaging-and-cerebrospinal-23536396","doi":"10.1002/ana.23908","journal":"Annals of neurology","n_participants":374,"pmid":"23536396","source_url":"https://pubmed.ncbi.nlm.nih.gov/23536396/","study_design":"cross-sectional","title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","title_match":false,"year":2013},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/abeta-amyloid-and-glucose-metabolism-in-three-variants-of-primary-18991338","doi":"10.1002/ana.21451","journal":"Annals of neurology","n_participants":15,"pmid":"18991338","source_url":"https://pubmed.ncbi.nlm.nih.gov/18991338/","study_design":null,"title":"Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia","title_match":false,"year":2008},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/regional-variability-of-imaging-biomarkers-in-autosomal-dominant-24194552","doi":"10.1073/pnas.1317918110","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"24194552","source_url":"https://pubmed.ncbi.nlm.nih.gov/24194552/","study_design":"longitudinal study","title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/region-specific-hierarchy-between-atrophy-hypometabolism-and-amyloid-23152610","doi":"10.1523/jneurosci.2170-12.2012","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"23152610","source_url":"https://pubmed.ncbi.nlm.nih.gov/23152610/","study_design":null,"title":"Region-specific hierarchy between atrophy, hypometabolism, and \u03b2-amyloid (A\u03b2) load in Alzheimer's disease dementia","title_match":false,"year":2012},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/a-new-amyloid-beta-variant-favoring-oligomerization-in-alzheimer-s-18300294","doi":"10.1002/ana.21321","journal":"Annals of neurology","n_participants":2121,"pmid":"18300294","source_url":"https://pubmed.ncbi.nlm.nih.gov/18300294/","study_design":null,"title":"A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia","title_match":false,"year":2008},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-deposition-begins-in-the-striatum-of-presenilin-1-mutation-17553989","doi":"10.1523/jneurosci.0730-07.2007","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"17553989","source_url":"https://pubmed.ncbi.nlm.nih.gov/17553989/","study_design":null,"title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","title_match":false,"year":2007},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/anti-amyloid-monoclonal-antibodies-for-the-treatment-of-alzheimer-s-37955845","doi":"10.1007/s40259-023-00633-2","journal":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","n_participants":null,"pmid":"37955845","source_url":"https://pubmed.ncbi.nlm.nih.gov/37955845/","study_design":null,"title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cognition-reserve-and-amyloid-deposition-in-normal-aging-20373347","doi":"10.1002/ana.21904","journal":"Annals of neurology","n_participants":17,"pmid":"20373347","source_url":"https://pubmed.ncbi.nlm.nih.gov/20373347/","study_design":null,"title":"Cognition, reserve, and amyloid deposition in normal aging","title_match":false,"year":2010},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/serotonin-signaling-is-associated-with-lower-amyloid-levels-and-21873225","doi":"10.1073/pnas.1107411108","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"21873225","source_url":"https://pubmed.ncbi.nlm.nih.gov/21873225/","study_design":null,"title":"Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans","title_match":false,"year":2011},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/relationships-between-amyloid-and-functional-connectivity-in-21383234","doi":"10.1093/cercor/bhr025","journal":"Cerebral cortex (New York, N.Y. : 1991)","n_participants":null,"pmid":"21383234","source_url":"https://pubmed.ncbi.nlm.nih.gov/21383234/","study_design":null,"title":"Relationships between \u03b2-amyloid and functional connectivity in different components of the default mode network in aging","title_match":false,"year":2011},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/relationship-between-atrophy-and-beta-amyloid-deposition-in-alzheimer-20373343","doi":"10.1002/ana.21955","journal":"Annals of neurology","n_participants":34,"pmid":"20373343","source_url":"https://pubmed.ncbi.nlm.nih.gov/20373343/","study_design":null,"title":"Relationship between atrophy and beta-amyloid deposition in Alzheimer disease","title_match":false,"year":2010},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/optimizing-the-preclinical-alzheimer-s-cognitive-composite-with-29264389","doi":"10.1016/j.trci.2017.10.004","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":70,"pmid":"29264389","source_url":"https://pubmed.ncbi.nlm.nih.gov/29264389/","study_design":"longitudinal study","title":"Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5","title_match":false,"year":2017},{"alzhub_score":78,"alzhub_url":"https://alzhub.org/study/meta-analysis-of-amyloid-cognition-relations-in-cognitively-normal-23547267","doi":"10.1212/wnl.0b013e31828ab35d","journal":"Neurology","n_participants":7140,"pmid":"23547267","source_url":"https://pubmed.ncbi.nlm.nih.gov/23547267/","study_design":"meta-analysis","title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","title_match":false,"year":2013},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/synergistic-effect-of-amyloid-and-neurodegeneration-on-cognitive-25222039","doi":"10.1001/jamaneurol.2014.2031","journal":"JAMA neurology","n_participants":null,"pmid":"25222039","source_url":"https://pubmed.ncbi.nlm.nih.gov/25222039/","study_design":"longitudinal study","title":"Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","title_match":false,"year":2014},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/decreased-brain-stiffness-in-alzheimer-s-disease-determined-by-21751286","doi":"10.1002/jmri.22707","journal":"Journal of magnetic resonance imaging : JMRI","n_participants":null,"pmid":"21751286","source_url":"https://pubmed.ncbi.nlm.nih.gov/21751286/","study_design":null,"title":"Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography","title_match":false,"year":2011},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-tau-and-ptau-181-increase-with-cortical-amyloid-20049742","doi":"10.1002/emmm.200900048","journal":"EMBO molecular medicine","n_participants":null,"pmid":"20049742","source_url":"https://pubmed.ncbi.nlm.nih.gov/20049742/","study_design":null,"title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/fibre-specific-white-matter-reductions-in-alzheimer-s-disease-and-29309541","doi":"10.1093/brain/awx355","journal":"Brain : a journal of neurology","n_participants":49,"pmid":"29309541","source_url":"https://pubmed.ncbi.nlm.nih.gov/29309541/","study_design":null,"title":"Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment","title_match":false,"year":2018},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/diverging-patterns-of-amyloid-deposition-and-hypometabolism-in-23358601","doi":"10.1093/brain/aws327","journal":"Brain : a journal of neurology","n_participants":17,"pmid":"23358601","source_url":"https://pubmed.ncbi.nlm.nih.gov/23358601/","study_design":null,"title":"Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/binding-of-the-positron-emission-tomography-tracer-pittsburgh-16291932","doi":"10.1523/jneurosci.2990-05.2005","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"16291932","source_url":"https://pubmed.ncbi.nlm.nih.gov/16291932/","study_design":null,"title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain","title_match":true,"year":2005},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/short-chain-fatty-acids-and-lipopolysaccharide-as-mediators-between-33074224","doi":"10.3233/jad-200306","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"33074224","source_url":"https://pubmed.ncbi.nlm.nih.gov/33074224/","study_design":null,"title":"Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/validation-of-amyloid-pet-positivity-thresholds-in-centiloids-a-33971965","doi":"10.1186/s13195-021-00836-1","journal":"Alzheimer's research & therapy","n_participants":62,"pmid":"33971965","source_url":"https://pubmed.ncbi.nlm.nih.gov/33971965/","study_design":"cross-sectional","title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","title_match":true,"year":2021},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-alzheimer-s-disease-a-comparison-of-three-24647577","doi":"10.1007/s00259-014-2753-3","journal":"European journal of nuclear medicine and molecular imaging","n_participants":40,"pmid":"24647577","source_url":"https://pubmed.ncbi.nlm.nih.gov/24647577/","study_design":null,"title":"Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers","title_match":true,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-alzheimer-s-disease-neuroimaging-initiative-2-pet-core-2015-26194311","doi":"10.1016/j.jalz.2015.05.001","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"26194311","source_url":"https://pubmed.ncbi.nlm.nih.gov/26194311/","study_design":"cross-sectional","title":"The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/association-of-lifetime-cognitive-engagement-and-low-amyloid-22271235","doi":"10.1001/archneurol.2011.2748","journal":"Archives of neurology","n_participants":null,"pmid":"22271235","source_url":"https://pubmed.ncbi.nlm.nih.gov/22271235/","study_design":"cross-sectional","title":"Association of lifetime cognitive engagement and low \u03b2-amyloid deposition","title_match":false,"year":2012},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-in-mild-cognitive-impairment-subtypes-19475670","doi":"10.1002/ana.21598","journal":"Annals of neurology","n_participants":null,"pmid":"19475670","source_url":"https://pubmed.ncbi.nlm.nih.gov/19475670/","study_design":"longitudinal study","title":"Amyloid imaging in mild cognitive impairment subtypes","title_match":true,"year":2009},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/11c-pib-pet-imaging-in-alzheimer-disease-and-frontotemporal-lobar-17420404","doi":"10.1212/01.wnl.0000259035.98480.ed","journal":"Neurology","n_participants":12,"pmid":"17420404","source_url":"https://pubmed.ncbi.nlm.nih.gov/17420404/","study_design":null,"title":"11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","title_match":true,"year":2007},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/increased-metabolic-vulnerability-in-early-onset-alzheimer-s-disease-20080878","doi":"10.1093/brain/awp326","journal":"Brain : a journal of neurology","n_participants":21,"pmid":"20080878","source_url":"https://pubmed.ncbi.nlm.nih.gov/20080878/","study_design":null,"title":"Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden","title_match":false,"year":2010},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/hippocampal-subfield-volumetry-in-mild-cognitive-impairment-alzheimer-24179859","doi":"10.1016/j.nicl.2013.08.007","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24179859","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179859/","study_design":null,"title":"Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia","title_match":false,"year":2013},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/subjective-cognition-and-amyloid-deposition-imaging-a-pittsburgh-22332189","doi":"10.1001/archneurol.2011.666","journal":"Archives of neurology","n_participants":null,"pmid":"22332189","source_url":"https://pubmed.ncbi.nlm.nih.gov/22332189/","study_design":"cohort study","title":"Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals","title_match":true,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/phase-1-study-of-the-pittsburgh-compound-b-derivative-18f-19617318","doi":"10.2967/jnumed.109.063305","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"19617318","source_url":"https://pubmed.ncbi.nlm.nih.gov/19617318/","study_design":"clinical trial","title":"Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease","title_match":true,"year":2009},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/longitudinal-association-of-amyloid-beta-and-anxious-depressive-29325447","doi":"10.1176/appi.ajp.2017.17040442","journal":"The American journal of psychiatry","n_participants":270,"pmid":"29325447","source_url":"https://pubmed.ncbi.nlm.nih.gov/29325447/","study_design":"longitudinal study","title":"Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amyloid-vs-fdg-pet-in-the-differential-diagnosis-of-ad-and-ftld-22131541","doi":"10.1212/wnl.0b013e31823b9c5e","journal":"Neurology","n_participants":62,"pmid":"22131541","source_url":"https://pubmed.ncbi.nlm.nih.gov/22131541/","study_design":null,"title":"Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD","title_match":false,"year":2011},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/exercise-and-alzheimer-s-disease-biomarkers-in-cognitively-normal-20818789","doi":"10.1002/ana.22096","journal":"Annals of neurology","n_participants":56,"pmid":"20818789","source_url":"https://pubmed.ncbi.nlm.nih.gov/20818789/","study_design":null,"title":"Exercise and Alzheimer's disease biomarkers in cognitively normal older adults","title_match":false,"year":2010},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/pib-is-a-non-specific-imaging-marker-of-amyloid-beta-abeta-peptide-17698496","doi":"10.1093/brain/awm191","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"17698496","source_url":"https://pubmed.ncbi.nlm.nih.gov/17698496/","study_design":null,"title":"PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis","title_match":false,"year":2007},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/insulin-resistance-predicts-brain-amyloid-deposition-in-late-middle-25043908","doi":"10.1016/j.jalz.2014.03.011","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":186,"pmid":"25043908","source_url":"https://pubmed.ncbi.nlm.nih.gov/25043908/","study_design":"cross-sectional","title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","title_match":false,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/longitudinal-quantitative-assessment-of-amyloid-neuroinflammation-and-17928437","doi":"10.1523/jneurosci.0673-07.2007","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":null,"pmid":"17928437","source_url":"https://pubmed.ncbi.nlm.nih.gov/17928437/","study_design":"longitudinal study","title":"Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/amyloid-burden-is-associated-with-self-reported-sleep-in-nondemented-26059712","doi":"10.1016/j.neurobiolaging.2015.05.004","journal":"Neurobiology of aging","n_participants":null,"pmid":"26059712","source_url":"https://pubmed.ncbi.nlm.nih.gov/26059712/","study_design":null,"title":"Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults","title_match":false,"year":2015},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/novel-18f-labeled-arylquinoline-derivatives-for-noninvasive-imaging-23857514","doi":"10.2967/jnumed.112.117341","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":null,"pmid":"23857514","source_url":"https://pubmed.ncbi.nlm.nih.gov/23857514/","study_design":null,"title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","title_match":false,"year":2013},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/ultrasound-blood-brain-barrier-opening-and-aducanumab-in-alzheimer-s-38169490","doi":"10.1056/nejmoa2308719","journal":"The New England journal of medicine","n_participants":null,"pmid":"38169490","source_url":"https://pubmed.ncbi.nlm.nih.gov/38169490/","study_design":null,"title":"Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/cortical-hubs-revealed-by-intrinsic-functional-connectivity-mapping-19211893","doi":"10.1523/jneurosci.5062-08.2009","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":24,"pmid":"19211893","source_url":"https://pubmed.ncbi.nlm.nih.gov/19211893/","study_design":null,"title":"Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease","title_match":false,"year":2009},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/disruption-of-large-scale-brain-systems-in-advanced-aging-18054866","doi":"10.1016/j.neuron.2007.10.038","journal":"Neuron","n_participants":93,"pmid":"18054866","source_url":"https://pubmed.ncbi.nlm.nih.gov/18054866/","study_design":null,"title":"Disruption of large-scale brain systems in advanced aging","title_match":false,"year":2007},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/functional-alterations-in-memory-networks-in-early-alzheimer-s-disease-20069392","doi":"10.1007/s12017-009-8109-7","journal":"Neuromolecular medicine","n_participants":null,"pmid":"20069392","source_url":"https://pubmed.ncbi.nlm.nih.gov/20069392/","study_design":null,"title":"Functional alterations in memory networks in early Alzheimer's disease","title_match":false,"year":2010},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/retinal-amyloid-pathology-and-proof-of-concept-imaging-trial-in-28814675","doi":"10.1172/jci.insight.93621","journal":"JCI insight","n_participants":37,"pmid":"28814675","source_url":"https://pubmed.ncbi.nlm.nih.gov/28814675/","study_design":null,"title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/retinal-vascular-biomarkers-for-early-detection-and-monitoring-of-23443359","doi":"10.1038/tp.2012.150","journal":"Translational psychiatry","n_participants":null,"pmid":"23443359","source_url":"https://pubmed.ncbi.nlm.nih.gov/23443359/","study_design":null,"title":"Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease","title_match":false,"year":2013},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/identification-of-early-pericyte-loss-and-vascular-amyloidosis-in-32043162","doi":"10.1007/s00401-020-02134-w","journal":"Acta neuropathologica","n_participants":null,"pmid":"32043162","source_url":"https://pubmed.ncbi.nlm.nih.gov/32043162/","study_design":null,"title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina","title_match":false,"year":2020},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/amyloid-load-in-parkinson-s-disease-dementia-and-lewy-body-dementia-18653550","doi":"10.1136/jnnp.2007.127878","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":13,"pmid":"18653550","source_url":"https://pubmed.ncbi.nlm.nih.gov/18653550/","study_design":null,"title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","title_match":false,"year":2008},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-in-cognitively-normal-individuals-at-risk-populations-24179789","doi":"10.1016/j.nicl.2013.02.006","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"24179789","source_url":"https://pubmed.ncbi.nlm.nih.gov/24179789/","study_design":"longitudinal study","title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease","title_match":true,"year":2013},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/aducanumab-appropriate-use-recommendations-34585212","doi":"10.14283/jpad.2021.41","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"34585212","source_url":"https://pubmed.ncbi.nlm.nih.gov/34585212/","study_design":null,"title":"Aducanumab: Appropriate Use Recommendations","title_match":false,"year":2021},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/effects-of-monoclonal-antibodies-against-amyloid-on-clinical-and-33831607","doi":"10.1016/j.arr.2021.101339","journal":"Ageing research reviews","n_participants":12585,"pmid":"33831607","source_url":"https://pubmed.ncbi.nlm.nih.gov/33831607/","study_design":"meta-analysis","title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/imaging-beta-amyloid-plaques-and-neurofibrillary-tangles-in-the-aging-15134570","doi":"10.2174/1381612043384772","journal":"Current pharmaceutical design","n_participants":null,"pmid":"15134570","source_url":"https://pubmed.ncbi.nlm.nih.gov/15134570/","study_design":null,"title":"Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain","title_match":false,"year":2004},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/gantenerumab-reduces-amyloid-plaques-in-patients-with-prodromal-to-31831056","doi":"10.1186/s13195-019-0559-z","journal":"Alzheimer's research & therapy","n_participants":89,"pmid":"31831056","source_url":"https://pubmed.ncbi.nlm.nih.gov/31831056/","study_design":"clinical trial","title":"Gantenerumab reduces amyloid-\u03b2 plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/clinical-amyloid-imaging-in-alzheimer-s-disease-21683932","doi":"10.1016/s1474-4422(11)70123-5","journal":"The Lancet. Neurology","n_participants":null,"pmid":"21683932","source_url":"https://pubmed.ncbi.nlm.nih.gov/21683932/","study_design":"longitudinal study","title":"Clinical amyloid imaging in Alzheimer's disease","title_match":true,"year":2011},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/effect-of-reductions-in-amyloid-levels-on-cognitive-change-in-33632704","doi":"10.1136/bmj.n156","journal":"BMJ (Clinical research ed.)","n_participants":null,"pmid":"33632704","source_url":"https://pubmed.ncbi.nlm.nih.gov/33632704/","study_design":"meta-analysis","title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis","title_match":false,"year":2021},{"alzhub_score":40,"alzhub_url":"https://alzhub.org/study/beta-amyloid-imaging-with-florbetaben-25741488","doi":"10.1007/s40336-015-0102-6","journal":"Clinical and translational imaging","n_participants":null,"pmid":"25741488","source_url":"https://pubmed.ncbi.nlm.nih.gov/25741488/","study_design":null,"title":"Beta-amyloid imaging with florbetaben","title_match":true,"year":2015},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/subthreshold-amyloid-predicts-tau-deposition-in-aging-29686045","doi":"10.1523/jneurosci.0485-18.2018","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","n_participants":71,"pmid":"29686045","source_url":"https://pubmed.ncbi.nlm.nih.gov/29686045/","study_design":"longitudinal study","title":"Subthreshold Amyloid Predicts Tau Deposition in Aging","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-self-identified-non-hispanic-black-33568538","doi":"10.1212/wnl.0000000000011599","journal":"Neurology","n_participants":null,"pmid":"33568538","source_url":"https://pubmed.ncbi.nlm.nih.gov/33568538/","study_design":null,"title":"Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study","title_match":true,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/centiloid-scaling-for-quantification-of-brain-amyloid-with-18-f-30519791","doi":"10.1186/s13550-018-0456-7","journal":"EJNMMI research","n_participants":74,"pmid":"30519791","source_url":"https://pubmed.ncbi.nlm.nih.gov/30519791/","study_design":null,"title":"Centiloid scaling for quantification of brain amyloid with [ 18 F]flutemetamol using multiple processing methods","title_match":true,"year":2018},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/pet-imaging-of-brain-amyloid-in-dementia-a-review-21905095","doi":"10.1002/gps.2640","journal":"International journal of geriatric psychiatry","n_participants":null,"pmid":"21905095","source_url":"https://pubmed.ncbi.nlm.nih.gov/21905095/","study_design":null,"title":"PET imaging of brain amyloid in dementia: a review","title_match":false,"year":2011},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/donanemab-for-alzheimer-s-disease-a-systematic-review-of-clinical-36611492","doi":"10.3390/healthcare11010032","journal":"Healthcare (Basel, Switzerland)","n_participants":396,"pmid":"36611492","source_url":"https://pubmed.ncbi.nlm.nih.gov/36611492/","study_design":"systematic review","title":"Donanemab for Alzheimer's Disease: A Systematic Review of Clinical Trials","title_match":false,"year":2022},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/donanemab-population-pharmacokinetics-amyloid-plaque-reduction-and-36805552","doi":"10.1002/cpt.2875","journal":"Clinical pharmacology and therapeutics","n_participants":null,"pmid":"36805552","source_url":"https://pubmed.ncbi.nlm.nih.gov/36805552/","study_design":null,"title":"Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/alzheimer-disease-anti-amyloid-immunotherapies-imaging-39179297","doi":"10.3174/ajnr.a8469","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"39179297","source_url":"https://pubmed.ncbi.nlm.nih.gov/39179297/","study_design":null,"title":"Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities","title_match":false,"year":2025},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/safety-tolerability-and-pharmacokinetics-of-crenezumab-in-patients-32568196","doi":"10.3233/jad-200134","journal":"Journal of Alzheimer's disease : JAD","n_participants":21,"pmid":"32568196","source_url":"https://pubmed.ncbi.nlm.nih.gov/32568196/","study_design":"open-label trial","title":"Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks","title_match":false,"year":2020},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-lecanemab-for-alzheimer-s-disease-a-systematic-37213538","doi":"10.3389/fnagi.2023.1169499","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"37213538","source_url":"https://pubmed.ncbi.nlm.nih.gov/37213538/","study_design":"systematic review","title":"Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/secondary-prevention-of-alzheimer-s-dementia-neuroimaging-30376881","doi":"10.1186/s13195-018-0438-z","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"30376881","source_url":"https://pubmed.ncbi.nlm.nih.gov/30376881/","study_design":"longitudinal study","title":"Secondary prevention of Alzheimer's dementia: neuroimaging contributions","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-therapy-ad-and-aria-untangling-the-role-of-caa-37959255","doi":"10.3390/jcm12216792","journal":"Journal of clinical medicine","n_participants":null,"pmid":"37959255","source_url":"https://pubmed.ncbi.nlm.nih.gov/37959255/","study_design":null,"title":"Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA","title_match":false,"year":2023},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/monoclonal-therapy-with-lecanemab-in-the-treatment-of-mild-alzheimer-39638097","doi":"10.1016/j.arr.2024.102620","journal":"Ageing research reviews","n_participants":null,"pmid":"39638097","source_url":"https://pubmed.ncbi.nlm.nih.gov/39638097/","study_design":"systematic review","title":"Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/trailblazer-alz-4-a-phase-3-trial-comparing-donanemab-with-aducanumab-40390253","doi":"10.1002/alz.70293","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":148,"pmid":"40390253","source_url":"https://pubmed.ncbi.nlm.nih.gov/40390253/","study_design":"clinical trial","title":"TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-randomized-double-blind-phase-2-study-of-the-effects-of-the-vaccine-29199321","doi":"10.14283/jpad.2016.118","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"29199321","source_url":"https://pubmed.ncbi.nlm.nih.gov/29199321/","study_design":"clinical trial","title":"A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease","title_match":true,"year":2016},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/application-of-meta-analysis-to-evaluate-relationships-among-aria-e-35320578","doi":"10.1007/s43441-022-00390-4","journal":"Therapeutic innovation & regulatory science","n_participants":null,"pmid":"35320578","source_url":"https://pubmed.ncbi.nlm.nih.gov/35320578/","study_design":"meta-analysis","title":"Application of Meta-analysis to Evaluate Relationships Among ARIA-E Rate, Amyloid Reduction Rate, and Clinical Cognitive Response in Amyloid Therapeutic Clinical Trials for Early Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/amyloid-related-imaging-abnormalities-and-other-mri-findings-in-a-36281665","doi":"10.14283/jpad.2022.56","journal":"The journal of prevention of Alzheimer's disease","n_participants":1250,"pmid":"36281665","source_url":"https://pubmed.ncbi.nlm.nih.gov/36281665/","study_design":"cross-sectional","title":"Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid","title_match":false,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/a-systematic-review-of-the-efficacy-and-safety-of-anti-amyloid-40621323","doi":"10.7759/cureus.85377","journal":"Cureus","n_participants":null,"pmid":"40621323","source_url":"https://pubmed.ncbi.nlm.nih.gov/40621323/","study_design":"systematic review","title":"A Systematic Review of the Efficacy and Safety of Anti-amyloid Monoclonal Antibodies in Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/greater-white-matter-hyperintensity-volume-is-associated-with-the-39044495","doi":"10.14283/jpad.2024.139","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"39044495","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044495/","study_design":"longitudinal study","title":"Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/quantitative-systems-pharmacology-based-exploration-of-relevant-anti-38774587","doi":"10.1002/trc2.12474","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"38774587","source_url":"https://pubmed.ncbi.nlm.nih.gov/38774587/","study_design":null,"title":"Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice","title_match":false,"year":2024},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/japanese-subgroup-analyses-from-emerge-and-engage-phase-3-clinical-39350371","doi":"10.14283/jpad.2024.106","journal":"The journal of prevention of Alzheimer's disease","n_participants":121,"pmid":"39350371","source_url":"https://pubmed.ncbi.nlm.nih.gov/39350371/","study_design":"clinical trial","title":"Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/pet-ct-mri-in-clinical-trials-of-alzheimer-s-disease-39422954","doi":"10.3233/jad-240206","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"39422954","source_url":"https://pubmed.ncbi.nlm.nih.gov/39422954/","study_design":null,"title":"PET/CT/MRI in Clinical Trials of Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/anti-amyloid-treatments-in-alzheimer-s-disease-elegance-evidence-and-39698778","doi":"10.17219/acem/198674","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"39698778","source_url":"https://pubmed.ncbi.nlm.nih.gov/39698778/","study_design":null,"title":"Anti-amyloid treatments in Alzheimer's disease: elegance, evidence and ethics","title_match":false,"year":2024},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/higher-phosphorylated-tau-levels-predict-cognitive-decline-and-41276859","doi":"10.1186/s13195-025-01912-6","journal":"Alzheimer's research & therapy","n_participants":234,"pmid":"41276859","source_url":"https://pubmed.ncbi.nlm.nih.gov/41276859/","study_design":"longitudinal study","title":"Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/evaluating-the-effects-of-the-novel-glp-1-analogue-liraglutide-in-30944040","doi":"10.1186/s13063-019-3259-x","journal":"Trials","n_participants":206,"pmid":"30944040","source_url":"https://pubmed.ncbi.nlm.nih.gov/30944040/","study_design":null,"title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-increasing-impact-of-cerebral-amyloid-angiopathy-essential-new-28844070","doi":"10.1136/jnnp-2016-314697","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"28844070","source_url":"https://pubmed.ncbi.nlm.nih.gov/28844070/","study_design":null,"title":"The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/physical-activity-and-amyloid-plasma-and-brain-levels-results-from-22889922","doi":"10.1038/mp.2012.107","journal":"Molecular psychiatry","n_participants":116,"pmid":"22889922","source_url":"https://pubmed.ncbi.nlm.nih.gov/22889922/","study_design":null,"title":"Physical activity and amyloid-\u03b2 plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing","title_match":false,"year":2013},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/smoking-and-increased-alzheimer-s-disease-risk-a-review-of-potential-24924665","doi":"10.1016/j.jalz.2014.04.009","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"24924665","source_url":"https://pubmed.ncbi.nlm.nih.gov/24924665/","study_design":"systematic review","title":"Smoking and increased Alzheimer's disease risk: a review of potential mechanisms","title_match":false,"year":2014},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/18-f-flutemetamol-amyloid-positron-emission-tomography-in-preclinical-26141264","doi":"10.1016/j.jalz.2015.05.018","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":68,"pmid":"26141264","source_url":"https://pubmed.ncbi.nlm.nih.gov/26141264/","study_design":"clinical trial","title":"[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-\u03b2 pathology","title_match":true,"year":2015},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/impact-of-training-method-on-the-robustness-of-the-visual-assessment-26823561","doi":"10.2967/jnumed.115.161927","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":82,"pmid":"26823561","source_url":"https://pubmed.ncbi.nlm.nih.gov/26823561/","study_design":"open-label trial","title":"Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study","title_match":true,"year":2016},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/predicting-cognitive-decline-with-deep-learning-of-brain-metabolism-29454006","doi":"10.1016/j.bbr.2018.02.017","journal":"Behavioural brain research","n_participants":139,"pmid":"29454006","source_url":"https://pubmed.ncbi.nlm.nih.gov/29454006/","study_design":"longitudinal study","title":"Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging","title_match":true,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/down-syndrome-partial-trisomy-21-and-absence-of-alzheimer-s-disease-27983553","doi":"10.3233/jad-160836","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"27983553","source_url":"https://pubmed.ncbi.nlm.nih.gov/27983553/","study_design":null,"title":"Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP","title_match":false,"year":2017},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-pattern-of-amyloid-accumulation-in-the-brains-of-adults-with-down-26362596","doi":"10.1016/j.jalz.2015.07.490","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"26362596","source_url":"https://pubmed.ncbi.nlm.nih.gov/26362596/","study_design":null,"title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","title_match":false,"year":2016},{"alzhub_score":91,"alzhub_url":"https://alzhub.org/study/donanemab-in-preclinical-alzheimer-s-disease-screening-and-baseline-40955720","doi":"10.1002/alz.70662","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":63124,"pmid":"40955720","source_url":"https://pubmed.ncbi.nlm.nih.gov/40955720/","study_design":"longitudinal study","title":"Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3","title_match":false,"year":2025},{"alzhub_score":56,"alzhub_url":"https://alzhub.org/study/effectiveness-safety-and-biomarker-dynamics-of-lecanemab-in-chinese-41823189","doi":"10.1002/alz.71231","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"41823189","source_url":"https://pubmed.ncbi.nlm.nih.gov/41823189/","study_design":null,"title":"Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study","title_match":false,"year":2026},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-brain-derived-ptau217-and-total-ptau217-41770931","doi":"10.1073/pnas.2536792123","journal":"Proceedings of the National Academy of Sciences of the United States of America","n_participants":null,"pmid":"41770931","source_url":"https://pubmed.ncbi.nlm.nih.gov/41770931/","study_design":null,"title":"Head-to-head comparison of brain-derived pTau217 and total pTau217 for brain amyloid and tau pathology classification","title_match":false,"year":2026},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/comparison-of-csf-phosphorylated-tau-181-and-217-for-cognitive-decline-34310832","doi":"10.1002/alz.12415","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":753,"pmid":"34310832","source_url":"https://pubmed.ncbi.nlm.nih.gov/34310832/","study_design":null,"title":"Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline","title_match":false,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-p-tau181-and-a42-predict-amyloid-pet-positivity-in-42163294","doi":"10.1186/s13195-026-02080-x","journal":"Alzheimer's research & therapy","n_participants":1407,"pmid":"42163294","source_url":"https://pubmed.ncbi.nlm.nih.gov/42163294/","study_design":"cohort study","title":"Plasma p-tau217, p-tau181, and A\u03b242 predict amyloid PET positivity in cognitively unimpaired adults","title_match":true,"year":2026},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/plasma-ptau-217-amyloid-1-42-ratio-for-enhanced-accuracy-and-reduced-41562409","doi":"10.1093/brain/awag001","journal":"Brain : a journal of neurology","n_participants":208,"pmid":"41562409","source_url":"https://pubmed.ncbi.nlm.nih.gov/41562409/","study_design":null,"title":"Plasma pTau 217/\u03b2-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology","title_match":false,"year":2026},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau-231-increases-at-one-year-intervals-in-38489191","doi":"10.3233/jad-231479","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"38489191","source_url":"https://pubmed.ncbi.nlm.nih.gov/38489191/","study_design":null,"title":"Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-plasma-p-tau181-p-tau231-and-glial-37268240","doi":"10.1016/j.nbd.2023.106175","journal":"Neurobiology of disease","n_participants":88,"pmid":"37268240","source_url":"https://pubmed.ncbi.nlm.nih.gov/37268240/","study_design":null,"title":"Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-concordance-with-amyloid-pet-among-ethnically-diverse-39021585","doi":"10.1002/dad2.12617","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":239,"pmid":"39021585","source_url":"https://pubmed.ncbi.nlm.nih.gov/39021585/","study_design":null,"title":"Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-p-tau212-identifies-cognitively-unimpaired-individuals-with-41447416","doi":"10.1007/s00415-025-13572-5","journal":"Journal of neurology","n_participants":317,"pmid":"41447416","source_url":"https://pubmed.ncbi.nlm.nih.gov/41447416/","study_design":null,"title":"Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-\u03b2 pathology","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/optimized-plasma-p-tau217-and-p-tau217-a42-cutoffs-enhance-detection-42619350","doi":"10.1002/alz.71763","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":191,"pmid":"42619350","source_url":"https://pubmed.ncbi.nlm.nih.gov/42619350/","study_design":null,"title":"Optimized plasma p-tau217 and p-tau217/A\u03b242 cutoffs enhance detection of pre-clinical Alzheimer's disease across diverse participants","title_match":false,"year":2026},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-improves-diagnostic-accuracy-and-clinician-confidence-42254957","doi":"10.1016/j.xinn.2026.101272","journal":"Innovation (Cambridge (Mass.))","n_participants":null,"pmid":"42254957","source_url":"https://pubmed.ncbi.nlm.nih.gov/42254957/","study_design":"cross-sectional","title":"Plasma p-Tau217 improves diagnostic accuracy and clinician confidence in cognitive disorder classification","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/tau-proteins-in-blood-as-biomarkers-of-alzheimer-s-disease-and-other-35175385","doi":"10.1007/s00702-022-02471-y","journal":"Journal of neural transmission (Vienna, Austria : 1996)","n_participants":null,"pmid":"35175385","source_url":"https://pubmed.ncbi.nlm.nih.gov/35175385/","study_design":"longitudinal study","title":"Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies","title_match":false,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/comparison-of-three-plasma-p-tau217-assays-to-detect-pet-confirmed-41788190","doi":"10.1002/dad2.70294","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":113,"pmid":"41788190","source_url":"https://pubmed.ncbi.nlm.nih.gov/41788190/","study_design":null,"title":"Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies","title_match":false,"year":2026},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/multimorbidity-and-associations-with-cognition-and-alzheimer-s-42083115","doi":"10.1002/ana.78238","journal":"Annals of neurology","n_participants":3808,"pmid":"42083115","source_url":"https://pubmed.ncbi.nlm.nih.gov/42083115/","study_design":null,"title":"Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers","title_match":false,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/combining-plasma-p-tau231-and-glial-fibrillary-acidic-protein-41065027","doi":"10.1002/alz.70796","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"41065027","source_url":"https://pubmed.ncbi.nlm.nih.gov/41065027/","study_design":null,"title":"Combining plasma p-tau231 and glial fibrillary acidic protein produces higher discriminative accuracy for amyloid positivity than other blood-based biomarker combinations","title_match":true,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/a-positive-alzheimer-s-blood-biomarker-is-not-a-diagnosis-the-42866775","doi":"10.1097/ms9.0000000000005661","journal":"Annals of medicine and surgery (2012)","n_participants":null,"pmid":"42866775","source_url":"https://pubmed.ncbi.nlm.nih.gov/42866775/","study_design":null,"title":"A positive Alzheimer's blood biomarker is not a diagnosis: the presence-primacy-permission framework for plasma p-tau217","title_match":false,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-predicts-in-vivo-brain-pathology-and-cognition-in-36571821","doi":"10.1002/alz.12906","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":24,"pmid":"36571821","source_url":"https://pubmed.ncbi.nlm.nih.gov/36571821/","study_design":null,"title":"Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease","title_match":false,"year":2023},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/racial-and-ethnic-differences-in-plasma-p-tau217-ratio-biomarker-40861822","doi":"10.1002/dad2.70164","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":6437,"pmid":"40861822","source_url":"https://pubmed.ncbi.nlm.nih.gov/40861822/","study_design":null,"title":"Racial and ethnic differences in plasma p-tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/biomarker-treatment-effects-in-two-phase-3-trials-of-gantenerumab-39887500","doi":"10.1002/alz.14414","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39887500","source_url":"https://pubmed.ncbi.nlm.nih.gov/39887500/","study_design":"clinical trial","title":"Biomarker treatment effects in two phase 3 trials of gantenerumab","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-performance-of-plasma-p-tau217-in-black-middle-aged-and-older-40410928","doi":"10.1002/alz.70288","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":233,"pmid":"40410928","source_url":"https://pubmed.ncbi.nlm.nih.gov/40410928/","study_design":null,"title":"The performance of plasma p-tau217 in Black middle-aged and older adults","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/impact-of-racialization-on-neuroimaging-and-plasma-biomarkers-of-40631440","doi":"10.1002/alz.70463","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":260,"pmid":"40631440","source_url":"https://pubmed.ncbi.nlm.nih.gov/40631440/","study_design":null,"title":"Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/optimizing-timing-and-cost-effective-use-of-plasma-biomarkers-in-40830505","doi":"10.1186/s13195-025-01851-2","journal":"Alzheimer's research & therapy","n_participants":143,"pmid":"40830505","source_url":"https://pubmed.ncbi.nlm.nih.gov/40830505/","study_design":null,"title":"Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/multicenter-validation-of-plasma-p-tau217-amyloid-beta-1-42-ratio-in-42418465","doi":"10.1002/alz.71644","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":499,"pmid":"42418465","source_url":"https://pubmed.ncbi.nlm.nih.gov/42418465/","study_design":null,"title":"Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/real-world-applicability-of-glial-fibrillary-acidic-protein-and-36072480","doi":"10.3389/fnagi.2022.887498","journal":"Frontiers in aging neuroscience","n_participants":63,"pmid":"36072480","source_url":"https://pubmed.ncbi.nlm.nih.gov/36072480/","study_design":"cross-sectional","title":"Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/clinical-application-of-plasma-neurofilament-light-chain-in-a-memory-35585907","doi":"10.12779/dnd.2022.21.2.59","journal":"Dementia and neurocognitive disorders","n_participants":14,"pmid":"35585907","source_url":"https://pubmed.ncbi.nlm.nih.gov/35585907/","study_design":"longitudinal study","title":"Clinical Application of Plasma Neurofilament Light Chain in a Memory Clinic: A Pilot Study","title_match":false,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-of-alzheimer-s-disease-in-the-continuum-of-dementia-38329197","doi":"10.1002/alz.13653","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38329197","source_url":"https://pubmed.ncbi.nlm.nih.gov/38329197/","study_design":null,"title":"Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies","title_match":false,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-relationship-between-plasma-biomarkers-and-amyloid-pet-in-35872565","doi":"10.1016/j.parkreldis.2022.07.008","journal":"Parkinsonism & related disorders","n_participants":null,"pmid":"35872565","source_url":"https://pubmed.ncbi.nlm.nih.gov/35872565/","study_design":null,"title":"The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/association-of-plasma-biomarkers-with-amyloid-and-tau-pet-in-pre-42084083","doi":"10.1002/alz.71441","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":66,"pmid":"42084083","source_url":"https://pubmed.ncbi.nlm.nih.gov/42084083/","study_design":null,"title":"Association of plasma biomarkers with amyloid and tau PET in pre-dementia stages","title_match":false,"year":2026},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/body-mass-index-and-blood-volume-influence-plasma-biomarkers-and-41074913","doi":"10.1002/alz.70765","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"41074913","source_url":"https://pubmed.ncbi.nlm.nih.gov/41074913/","study_design":null,"title":"Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/plasma-nfl-and-gfap-for-predicting-vci-and-related-brain-changes-in-40566826","doi":"10.1002/alz.70381","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1810,"pmid":"40566826","source_url":"https://pubmed.ncbi.nlm.nih.gov/40566826/","study_design":"longitudinal study","title":"Plasma NfL and GFAP for predicting VCI and related brain changes in community and clinical cohorts","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/the-ptau217-a1-42-plasma-ratio-the-first-fda-cleared-blood-biomarker-40582836","doi":"10.5582/ddt.2025.01055","journal":"Drug discoveries & therapeutics","n_participants":null,"pmid":"40582836","source_url":"https://pubmed.ncbi.nlm.nih.gov/40582836/","study_design":null,"title":"The pTau217/A\u03b21-42 plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/predicting-cognitive-decline-with-amyloid-pet-plasma-p-tau217-a42-40-41117398","doi":"10.1002/alz.70802","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":225,"pmid":"41117398","source_url":"https://pubmed.ncbi.nlm.nih.gov/41117398/","study_design":null,"title":"Predicting cognitive decline with amyloid-PET, plasma p-tau217, A\u03b242/40, and p-tau217/A\u03b242 in a community-based cohort - relevance for clinical trial enrollment","title_match":true,"year":2025},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/real-world-implementation-of-lecanemab-and-donanemab-in-an-italian-41857623","doi":"10.1186/s13195-026-02015-6","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"41857623","source_url":"https://pubmed.ncbi.nlm.nih.gov/41857623/","study_design":"cohort study","title":"Real-world implementation of lecanemab and donanemab in an Italian memory center: a 1-year experience","title_match":false,"year":2026},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-beta-x-42-x-40-ratio-and-cognitive-decline-in-38940303","doi":"10.1002/alz.13909","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38940303","source_url":"https://pubmed.ncbi.nlm.nih.gov/38940303/","study_design":"longitudinal study","title":"Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/clinical-performance-and-robustness-evaluation-of-plasma-amyloid-42-36150024","doi":"10.1002/alz.12801","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36150024","source_url":"https://pubmed.ncbi.nlm.nih.gov/36150024/","study_design":null,"title":"Clinical performance and robustness evaluation of plasma amyloid-\u03b242/40 prescreening","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/association-of-plasma-alzheimer-s-disease-biomarkers-with-cognitive-40883967","doi":"10.1002/alz.70625","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":381,"pmid":"40883967","source_url":"https://pubmed.ncbi.nlm.nih.gov/40883967/","study_design":null,"title":"Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/is-plasma-amyloid-1-42-1-40-a-better-biomarker-for-alzheimer-s-36461122","doi":"10.1186/s12987-022-00390-4","journal":"Fluids and barriers of the CNS","n_participants":null,"pmid":"36461122","source_url":"https://pubmed.ncbi.nlm.nih.gov/36461122/","study_design":null,"title":"Is plasma amyloid-\u03b2 1-42/1-40 a better biomarker for Alzheimer's disease than A\u03b2X-42/X-40?","title_match":false,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/brain-amyloid-deposition-and-blood-biomarkers-in-patients-with-30958377","doi":"10.3233/jad-190056","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30958377","source_url":"https://pubmed.ncbi.nlm.nih.gov/30958377/","study_design":null,"title":"Brain Amyloid-\u03b2 Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease","title_match":false,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/longitudinal-evaluation-of-the-natural-history-of-amyloid-in-plasma-32954297","doi":"10.1093/braincomms/fcaa041","journal":"Brain communications","n_participants":15,"pmid":"32954297","source_url":"https://pubmed.ncbi.nlm.nih.gov/32954297/","study_design":"longitudinal study","title":"Longitudinal evaluation of the natural history of amyloid-\u03b2 in plasma and brain","title_match":false,"year":2020},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-amyloid-subtypes-in-confirmed-frontotemporal-31356209","doi":"10.3233/jad-190344","journal":"Journal of Alzheimer's disease : JAD","n_participants":18,"pmid":"31356209","source_url":"https://pubmed.ncbi.nlm.nih.gov/31356209/","study_design":"post-hoc analysis","title":"Cerebrospinal Fluid Amyloid-\u03b2 Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot Study","title_match":false,"year":2019},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/plasma-a42-40-predicts-progression-from-a-amyloid-negative-to-41478830","doi":"10.1016/j.tjpad.2025.100455","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"41478830","source_url":"https://pubmed.ncbi.nlm.nih.gov/41478830/","study_design":"cohort study","title":"Plasma A\u03b242/40 predicts progression from A\u03b2-amyloid negative to positive PET scans","title_match":true,"year":2026},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-alzheimer-s-disease-biomarker-relationships-with-incident-39989078","doi":"10.1002/alz.14629","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":290,"pmid":"39989078","source_url":"https://pubmed.ncbi.nlm.nih.gov/39989078/","study_design":null,"title":"Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET","title_match":true,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/characteristics-of-discordance-between-amyloid-positron-emission-38341444","doi":"10.1038/s41398-024-02766-6","journal":"Translational psychiatry","n_participants":null,"pmid":"38341444","source_url":"https://pubmed.ncbi.nlm.nih.gov/38341444/","study_design":"cross-sectional","title":"Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-\u03b2 42/40 positivity","title_match":true,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/associations-of-csf-bace1-with-amyloid-pathology-neurodegeneration-38856925","doi":"10.1007/s00401-024-02750-w","journal":"Acta neuropathologica","n_participants":null,"pmid":"38856925","source_url":"https://pubmed.ncbi.nlm.nih.gov/38856925/","study_design":null,"title":"Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/performance-of-the-lumipulse-plasma-a42-40-and-ptau181-immunoassays-38304322","doi":"10.1002/dad2.12545","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":179,"pmid":"38304322","source_url":"https://pubmed.ncbi.nlm.nih.gov/38304322/","study_design":null,"title":"Performance of the Lumipulse plasma A\u03b242/40 and pTau181 immunoassays in the detection of amyloid pathology","title_match":false,"year":2024},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/non-linear-character-of-plasma-amyloid-beta-over-the-course-of-35401142","doi":"10.3389/fnagi.2022.832700","journal":"Frontiers in aging neuroscience","n_participants":449,"pmid":"35401142","source_url":"https://pubmed.ncbi.nlm.nih.gov/35401142/","study_design":null,"title":"Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer's Continuum","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/the-amyloid-beta-42-38-ratio-as-a-plasma-biomarker-of-early-memory-39241563","doi":"10.1016/j.neurobiolaging.2024.08.009","journal":"Neurobiology of aging","n_participants":null,"pmid":"39241563","source_url":"https://pubmed.ncbi.nlm.nih.gov/39241563/","study_design":null,"title":"The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/analytical-and-clinical-performance-of-amyloid-beta-peptides-32087019","doi":"10.1093/clinchem/hvaa012","journal":"Clinical chemistry","n_participants":766,"pmid":"32087019","source_url":"https://pubmed.ncbi.nlm.nih.gov/32087019/","study_design":null,"title":"Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/profiling-of-plasma-biomarkers-in-the-context-of-memory-assessment-in-37491358","doi":"10.1038/s41398-023-02558-4","journal":"Translational psychiatry","n_participants":75,"pmid":"37491358","source_url":"https://pubmed.ncbi.nlm.nih.gov/37491358/","study_design":null,"title":"Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/performance-of-blood-biomarkers-in-internal-jugular-vein-for-41207832","doi":"10.1016/j.scib.2025.10.044","journal":"Science bulletin","n_participants":463,"pmid":"41207832","source_url":"https://pubmed.ncbi.nlm.nih.gov/41207832/","study_design":null,"title":"Performance of blood biomarkers in internal jugular vein for Alzheimer's disease pathologies: the Delta Method study","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/can-the-clinical-sign-head-turning-sign-and-simple-questions-in-39568089","doi":"10.1186/s13195-024-01605-6","journal":"Alzheimer's research & therapy","n_participants":155,"pmid":"39568089","source_url":"https://pubmed.ncbi.nlm.nih.gov/39568089/","study_design":null,"title":"Can the clinical sign \"head-turning sign\" and simple questions in \"Neucop-Q\" predict amyloid \u03b2 pathology?","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/unravelling-the-association-between-amyloid-pet-and-cerebrospinal-34897084","doi":"10.3233/jad-210593","journal":"Journal of Alzheimer's disease : JAD","n_participants":23,"pmid":"34897084","source_url":"https://pubmed.ncbi.nlm.nih.gov/34897084/","study_design":null,"title":"Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-amplified-plasmonic-exosome-a42-platform-33370497","doi":"10.1111/ene.14704","journal":"European journal of neurology","n_participants":68,"pmid":"33370497","source_url":"https://pubmed.ncbi.nlm.nih.gov/33370497/","study_design":null,"title":"Head-to-head comparison of amplified plasmonic exosome A\u03b242 platform and single-molecule array immunoassay in a memory clinic cohort","title_match":false,"year":2021},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/plasma-biomarker-trajectories-across-alzheimer-s-clinical-onset-a-17-42021299","doi":"10.1186/s13195-026-02045-0","journal":"Alzheimer's research & therapy","n_participants":17,"pmid":"42021299","source_url":"https://pubmed.ncbi.nlm.nih.gov/42021299/","study_design":"longitudinal study","title":"Plasma biomarker trajectories across Alzheimer's clinical onset: a 17-year prospective study","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/effects-of-obesity-on-plasma-biomarker-and-amyloid-pet-trajectories-40620424","doi":"10.1002/dad2.70143","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"40620424","source_url":"https://pubmed.ncbi.nlm.nih.gov/40620424/","study_design":"cross-sectional","title":"Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/elecsys-pt181p-immunoassay-clinical-performance-for-ruling-out-42719535","doi":"10.1002/dad2.70439","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":604,"pmid":"42719535","source_url":"https://pubmed.ncbi.nlm.nih.gov/42719535/","study_design":null,"title":"Elecsys pT181p immunoassay: Clinical performance for ruling out amyloid pathology","title_match":false,"year":2026},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/low-serum-phosphorus-correlates-with-cerebral-a-deposition-in-29163142","doi":"10.3389/fnagi.2017.00362","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"29163142","source_url":"https://pubmed.ncbi.nlm.nih.gov/29163142/","study_design":null,"title":"Low Serum Phosphorus Correlates with Cerebral A\u03b2 Deposition in Cognitively Impaired Subjects: Results from the KBASE Study","title_match":false,"year":2017},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-for-alzheimer-s-disease-a-multicenter-based-37500404","doi":"10.1016/j.scib.2023.07.009","journal":"Science bulletin","n_participants":null,"pmid":"37500404","source_url":"https://pubmed.ncbi.nlm.nih.gov/37500404/","study_design":"cross-sectional","title":"Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/blood-biomarkers-of-alzheimer-s-disease-balancing-clinical-relevance-41194436","doi":"10.17219/acem/208917","journal":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","n_participants":null,"pmid":"41194436","source_url":"https://pubmed.ncbi.nlm.nih.gov/41194436/","study_design":null,"title":"Blood biomarkers of Alzheimer's disease: Balancing clinical relevance with improved accessibility and sustainability","title_match":false,"year":2025},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/evaluation-of-blood-based-plasma-biomarkers-as-potential-markers-of-36710683","doi":"10.3233/jad-221118","journal":"Journal of Alzheimer's disease : JAD","n_participants":100,"pmid":"36710683","source_url":"https://pubmed.ncbi.nlm.nih.gov/36710683/","study_design":"cross-sectional","title":"Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/integration-of-amyloid-oligomerization-tendency-as-a-plasma-biomarker-36733444","doi":"10.3389/fneur.2022.1028448","journal":"Frontiers in neurology","n_participants":null,"pmid":"36733444","source_url":"https://pubmed.ncbi.nlm.nih.gov/36733444/","study_design":null,"title":"Integration of amyloid-\u03b2 oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis","title_match":false,"year":2022},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/plasma-p-tau217-quantified-by-the-fully-automated-lumipulse-g-41535718","doi":"10.1038/s41598-025-34241-7","journal":"Scientific reports","n_participants":494,"pmid":"41535718","source_url":"https://pubmed.ncbi.nlm.nih.gov/41535718/","study_design":null,"title":"Plasma p-tau217, quantified by the fully automated LUMIPULSE G platform, outperforms p-tau181 in predicting amyloid pathology in cognitive complaints patients","title_match":false,"year":2026},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-dynamics-and-discordant-amyloid-biomarkers-34844077","doi":"10.1016/j.neurobiolaging.2021.10.017","journal":"Neurobiology of aging","n_participants":null,"pmid":"34844077","source_url":"https://pubmed.ncbi.nlm.nih.gov/34844077/","study_design":null,"title":"Cerebrospinal fluid dynamics and discordant amyloid biomarkers","title_match":false,"year":2022},{"alzhub_score":88,"alzhub_url":"https://alzhub.org/study/brain-mri-signatures-across-sex-and-csf-alzheimer-s-disease-biomarkers-40503330","doi":"10.1093/braincomms/fcaf210","journal":"Brain communications","n_participants":306,"pmid":"40503330","source_url":"https://pubmed.ncbi.nlm.nih.gov/40503330/","study_design":"meta-analysis","title":"Brain MRI signatures across sex and CSF Alzheimer's disease biomarkers","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/predicting-continuous-amyloid-pet-values-with-csf-tau-phosphorylation-39041391","doi":"10.1002/alz.14132","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":346,"pmid":"39041391","source_url":"https://pubmed.ncbi.nlm.nih.gov/39041391/","study_design":null,"title":"Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/elecsys-cerebrospinal-fluid-assays-accurately-distinguish-alzheimer-s-35841250","doi":"10.14283/jpad.2022.27","journal":"The journal of prevention of Alzheimer's disease","n_participants":130,"pmid":"35841250","source_url":"https://pubmed.ncbi.nlm.nih.gov/35841250/","study_design":null,"title":"Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-biomarkers-for-the-diagnosis-and-classification-33200589","doi":"10.3346/jkms.2020.35.e361","journal":"Journal of Korean medical science","n_participants":null,"pmid":"33200589","source_url":"https://pubmed.ncbi.nlm.nih.gov/33200589/","study_design":null,"title":"Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-cerebrospinal-fluid-biomarkers-predict-driving-27128959","doi":"10.1097/wad.0000000000000154","journal":"Alzheimer disease and associated disorders","n_participants":129,"pmid":"27128959","source_url":"https://pubmed.ncbi.nlm.nih.gov/27128959/","study_design":null,"title":"Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals","title_match":true,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/concordance-of-lumipulse-cerebrospinal-fluid-t-tau-a42-ratio-with-31914216","doi":"10.1002/alz.12000","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":138,"pmid":"31914216","source_url":"https://pubmed.ncbi.nlm.nih.gov/31914216/","study_design":null,"title":"Concordance of Lumipulse cerebrospinal fluid t-tau/A\u03b242 ratio with amyloid PET status","title_match":true,"year":2020},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/the-spectrum-of-alzheimer-s-disease-41332870","doi":"10.1101/2025.11.17.25340406","journal":"medRxiv : the preprint server for health sciences","n_participants":872,"pmid":"41332870","source_url":"https://pubmed.ncbi.nlm.nih.gov/41332870/","study_design":null,"title":"The spectrum of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/comparison-between-amyloid-pet-and-csf-amyloid-biomarkers-in-a-30735665","doi":"10.1016/j.cca.2019.02.005","journal":"Clinica chimica acta; international journal of clinical chemistry","n_participants":null,"pmid":"30735665","source_url":"https://pubmed.ncbi.nlm.nih.gov/30735665/","study_design":null,"title":"Comparison between amyloid-PET and CSF amyloid-\u03b2 biomarkers in a clinical cohort with memory deficits","title_match":true,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/correlation-between-decreased-csf-synuclein-and-a142-in-parkinson-25212463","doi":"10.1016/j.neurobiolaging.2014.07.043","journal":"Neurobiology of aging","n_participants":null,"pmid":"25212463","source_url":"https://pubmed.ncbi.nlm.nih.gov/25212463/","study_design":null,"title":"Correlation between decreased CSF \u03b1-synuclein and A\u03b2\u2081\u208b\u2084\u2082 in Parkinson disease","title_match":false,"year":2015},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/differences-between-ante-mortem-alzheimer-s-disease-biomarkers-in-36840620","doi":"10.1002/alz.12997","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":100,"pmid":"36840620","source_url":"https://pubmed.ncbi.nlm.nih.gov/36840620/","study_design":null,"title":"Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/neurofilament-relates-to-white-matter-microstructure-in-older-adults-30036759","doi":"10.1016/j.neurobiolaging.2018.06.023","journal":"Neurobiology of aging","n_participants":77,"pmid":"30036759","source_url":"https://pubmed.ncbi.nlm.nih.gov/30036759/","study_design":null,"title":"Neurofilament relates to white matter microstructure in older adults","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/florbetapir-positron-emission-tomography-and-cerebrospinal-fluid-25916563","doi":"10.1016/j.jalz.2015.03.002","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"25916563","source_url":"https://pubmed.ncbi.nlm.nih.gov/25916563/","study_design":"cross-sectional","title":"Florbetapir positron emission tomography and cerebrospinal fluid biomarkers","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/obesity-impacts-brain-metabolism-and-structure-independently-of-32743041","doi":"10.1002/dad2.12052","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":201,"pmid":"32743041","source_url":"https://pubmed.ncbi.nlm.nih.gov/32743041/","study_design":null,"title":"Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly","title_match":false,"year":2020},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/correlation-between-amyloid-pet-imaging-and-discordant-cerebrospinal-38143353","doi":"10.3233/jad-230744","journal":"Journal of Alzheimer's disease : JAD","n_participants":62,"pmid":"38143353","source_url":"https://pubmed.ncbi.nlm.nih.gov/38143353/","study_design":null,"title":"Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/csf-biomarker-concordance-with-amyloid-pet-in-phase-3-studies-of-36795603","doi":"10.1002/alz.12919","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36795603","source_url":"https://pubmed.ncbi.nlm.nih.gov/36795603/","study_design":"clinical trial","title":"CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/apoe-effect-on-alzheimer-s-disease-biomarkers-in-older-adults-with-25960448","doi":"10.1016/j.jalz.2015.03.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"25960448","source_url":"https://pubmed.ncbi.nlm.nih.gov/25960448/","study_design":null,"title":"APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern","title_match":false,"year":2015},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/apoe-differentially-moderates-cerebrospinal-fluid-and-plasma-36780762","doi":"10.1016/j.neurobiolaging.2022.10.016","journal":"Neurobiology of aging","n_participants":727,"pmid":"36780762","source_url":"https://pubmed.ncbi.nlm.nih.gov/36780762/","study_design":null,"title":"APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition","title_match":false,"year":2023},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/polygenic-effect-on-tau-pathology-progression-in-alzheimer-s-disease-36571564","doi":"10.1002/ana.26588","journal":"Annals of neurology","n_participants":85,"pmid":"36571564","source_url":"https://pubmed.ncbi.nlm.nih.gov/36571564/","study_design":"longitudinal study","title":"Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/pathway-specific-polygenic-risk-scores-correlate-with-clinical-status-37661888","doi":"10.3233/jad-230548","journal":"Journal of Alzheimer's disease : JAD","n_participants":1411,"pmid":"37661888","source_url":"https://pubmed.ncbi.nlm.nih.gov/37661888/","study_design":null,"title":"Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers","title_match":false,"year":2023},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/genetic-drivers-of-progression-in-alzheimer-s-disease-are-distinct-41332834","doi":"10.1101/2025.11.17.25340247","journal":"medRxiv : the preprint server for health sciences","n_participants":222,"pmid":"41332834","source_url":"https://pubmed.ncbi.nlm.nih.gov/41332834/","study_design":"meta-analysis","title":"Genetic drivers of progression in Alzheimer's disease are distinct from disease risk","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/coping-with-brain-amyloid-genetic-heterogeneity-and-cognitive-33757599","doi":"10.1186/s40478-021-01154-1","journal":"Acta neuropathologica communications","n_participants":null,"pmid":"33757599","source_url":"https://pubmed.ncbi.nlm.nih.gov/33757599/","study_design":"longitudinal study","title":"Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology","title_match":false,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/cross-ancestry-genome-wide-association-study-identifies-implications-40175353","doi":"10.1038/s41467-025-57751-4","journal":"Nature communications","n_participants":null,"pmid":"40175353","source_url":"https://pubmed.ncbi.nlm.nih.gov/40175353/","study_design":"meta-analysis","title":"Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition","title_match":false,"year":2025},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/genetic-risk-scores-enhance-the-diagnostic-value-of-plasma-biomarkers-37279785","doi":"10.1093/brain/awad196","journal":"Brain : a journal of neurology","n_participants":962,"pmid":"37279785","source_url":"https://pubmed.ncbi.nlm.nih.gov/37279785/","study_design":null,"title":"Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/the-dian-study-24101429","doi":null,"journal":"Brain and nerve = Shinkei kenkyu no shinpo","n_participants":null,"pmid":"24101429","source_url":"https://pubmed.ncbi.nlm.nih.gov/24101429/","study_design":null,"title":"[The DIAN study]","title_match":false,"year":2013},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/psen2-thr421met-mutation-in-a-patient-with-early-onset-alzheimer-s-36362122","doi":"10.3390/ijms232113331","journal":"International journal of molecular sciences","n_participants":null,"pmid":"36362122","source_url":"https://pubmed.ncbi.nlm.nih.gov/36362122/","study_design":null,"title":"PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/progressive-cognitive-impairment-and-familial-spastic-paraparesis-due-35438347","doi":"10.1007/s00415-022-11125-8","journal":"Journal of neurology","n_participants":null,"pmid":"35438347","source_url":"https://pubmed.ncbi.nlm.nih.gov/35438347/","study_design":null,"title":"Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization","title_match":false,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/autosomal-dominantly-inherited-alzheimer-disease-analysis-of-genetic-32284705","doi":"10.1016/j.inffus.2020.01.001","journal":"An international journal on information fusion","n_participants":null,"pmid":"32284705","source_url":"https://pubmed.ncbi.nlm.nih.gov/32284705/","study_design":"longitudinal study","title":"Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-novel-psen1-mutation-i238m-associated-with-early-onset-alzheimer-s-24413619","doi":"10.3233/jad-131844","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"24413619","source_url":"https://pubmed.ncbi.nlm.nih.gov/24413619/","study_design":null,"title":"A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman","title_match":false,"year":2014},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/18f-mk-6240-tau-pet-in-genetic-frontotemporal-dementia-34664612","doi":"10.1093/brain/awab392","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"34664612","source_url":"https://pubmed.ncbi.nlm.nih.gov/34664612/","study_design":null,"title":"18F-MK-6240 tau-PET in genetic frontotemporal dementia","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/18f-av-1451-positron-emission-tomography-in-neuropathological-33578418","doi":"10.1093/brain/awaa383","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"33578418","source_url":"https://pubmed.ncbi.nlm.nih.gov/33578418/","study_design":"cross-sectional","title":"18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome","title_match":false,"year":2021},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/tau-pet-imaging-with-18f-av-1451-in-primary-progressive-apraxia-of-29353121","doi":"10.1016/j.cortex.2017.12.021","journal":"Cortex; a journal devoted to the study of the nervous system and behavior","n_participants":14,"pmid":"29353121","source_url":"https://pubmed.ncbi.nlm.nih.gov/29353121/","study_design":"cross-sectional","title":"Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech","title_match":false,"year":2018},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/18f-pi-2620-tau-pet-signal-across-the-aging-and-alzheimer-s-disease-40800508","doi":"10.1162/imag_a_00329","journal":"Imaging neuroscience (Cambridge, Mass.)","n_participants":49,"pmid":"40800508","source_url":"https://pubmed.ncbi.nlm.nih.gov/40800508/","study_design":null,"title":"[18F]PI-2620 Tau PET signal across the aging and Alzheimer's disease clinical spectrum","title_match":false,"year":2024},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/spare-tau-a-flortaucipir-machine-learning-derived-early-predictor-of-36327215","doi":"10.1371/journal.pone.0276392","journal":"PloS one","n_participants":587,"pmid":"36327215","source_url":"https://pubmed.ncbi.nlm.nih.gov/36327215/","study_design":"cross-sectional","title":"SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/patterns-of-tau-pathology-identified-with-18-f-mk-6240-pet-imaging-34057284","doi":"10.1002/alz.12384","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":101,"pmid":"34057284","source_url":"https://pubmed.ncbi.nlm.nih.gov/34057284/","study_design":null,"title":"Patterns of tau pathology identified with 18 F-MK-6240 PET imaging","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/flortaucipir-tau-pet-imaging-in-semantic-variant-primary-progressive-28986472","doi":"10.1136/jnnp-2017-316409","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"28986472","source_url":"https://pubmed.ncbi.nlm.nih.gov/28986472/","study_design":null,"title":"Flortaucipir tau PET imaging in semantic variant primary progressive aphasia","title_match":false,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cortical-18-f-pi-2620-binding-differentiates-corticobasal-syndrome-33951244","doi":"10.1002/mds.28624","journal":"Movement disorders : official journal of the Movement Disorder Society","n_participants":null,"pmid":"33951244","source_url":"https://pubmed.ncbi.nlm.nih.gov/33951244/","study_design":null,"title":"Cortical [18 F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/generative-adversarial-network-enhanced-ultra-low-dose-18f-pi-2620-37591771","doi":"10.3174/ajnr.a7961","journal":"AJNR. American journal of neuroradiology","n_participants":null,"pmid":"37591771","source_url":"https://pubmed.ncbi.nlm.nih.gov/37591771/","study_design":null,"title":"Generative Adversarial Network-Enhanced Ultra-Low-Dose [18F]-PI-2620 \u03c4 PET/MRI in Aging and Neurodegenerative Populations","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/harmonizing-tau-positron-emission-tomography-in-alzheimer-s-disease-39041435","doi":"10.1002/alz.13908","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39041435","source_url":"https://pubmed.ncbi.nlm.nih.gov/39041435/","study_design":null,"title":"Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/assessment-of-perfusion-deficit-with-early-phases-of-18f-pi-2620-tau-36572740","doi":"10.1007/s00259-022-06087-y","journal":"European journal of nuclear medicine and molecular imaging","n_participants":64,"pmid":"36572740","source_url":"https://pubmed.ncbi.nlm.nih.gov/36572740/","study_design":null,"title":"Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings","title_match":true,"year":2023},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/amyloid-dependent-and-amyloid-independent-effects-of-tau-in-34617688","doi":"10.1002/acn3.51457","journal":"Annals of clinical and translational neurology","n_participants":154,"pmid":"34617688","source_url":"https://pubmed.ncbi.nlm.nih.gov/34617688/","study_design":null,"title":"Amyloid-dependent and amyloid-independent effects of Tau in individuals without dementia","title_match":false,"year":2021},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/metacognition-cortical-thickness-and-tauopathy-in-aging-35868093","doi":"10.1016/j.neurobiolaging.2022.06.007","journal":"Neurobiology of aging","n_participants":151,"pmid":"35868093","source_url":"https://pubmed.ncbi.nlm.nih.gov/35868093/","study_design":null,"title":"Metacognition, cortical thickness, and tauopathy in aging","title_match":false,"year":2022},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/18f-pi-2620-tau-pet-is-associated-with-cognitive-and-motor-impairment-39741783","doi":"10.1093/braincomms/fcae458","journal":"Brain communications","n_participants":29,"pmid":"39741783","source_url":"https://pubmed.ncbi.nlm.nih.gov/39741783/","study_design":null,"title":"18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/evaluation-of-a-visual-interpretation-method-for-tau-pet-with-18f-33313377","doi":"10.1002/dad2.12133","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":274,"pmid":"33313377","source_url":"https://pubmed.ncbi.nlm.nih.gov/33313377/","study_design":null,"title":"Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/evaluation-of-tau-deposition-using-18f-pi-2620-pet-in-mci-and-early-35897078","doi":"10.1186/s13195-022-01048-x","journal":"Alzheimer's research & therapy","n_participants":74,"pmid":"35897078","source_url":"https://pubmed.ncbi.nlm.nih.gov/35897078/","study_design":"clinical trial","title":"Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/localized-intense-uptake-in-the-skull-on-18-f-flortaucipir-pet-ct-40263752","doi":"10.1097/rlu.0000000000005848","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"40263752","source_url":"https://pubmed.ncbi.nlm.nih.gov/40263752/","study_design":null,"title":"Localized Intense Uptake in the Skull on 18 F-Flortaucipir PET/CT","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/atypical-alzheimer-s-disease-phenotypes-with-normal-or-borderline-pet-36001141","doi":"10.1007/s00415-022-11330-5","journal":"Journal of neurology","n_participants":null,"pmid":"36001141","source_url":"https://pubmed.ncbi.nlm.nih.gov/36001141/","study_design":null,"title":"Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles","title_match":false,"year":2022},{"alzhub_score":42,"alzhub_url":"https://alzhub.org/study/multicenter-18f-pi-2620-pet-for-in-vivo-braak-staging-of-tau-35327650","doi":"10.3390/biom12030458","journal":"Biomolecules","n_participants":null,"pmid":"35327650","source_url":"https://pubmed.ncbi.nlm.nih.gov/35327650/","study_design":null,"title":"Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/multimodal-in-vivo-and-postmortem-assessments-of-tau-in-lewy-body-33002767","doi":"10.1016/j.neurobiolaging.2020.08.003","journal":"Neurobiology of aging","n_participants":20,"pmid":"33002767","source_url":"https://pubmed.ncbi.nlm.nih.gov/33002767/","study_design":null,"title":"Multimodal in vivo and postmortem assessments of tau in Lewy body disorders","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/locus-coeruleus-catecholamines-link-neuroticism-and-vulnerability-to-36191755","doi":"10.1016/j.neuroimage.2022.119658","journal":"NeuroImage","n_participants":47,"pmid":"36191755","source_url":"https://pubmed.ncbi.nlm.nih.gov/36191755/","study_design":null,"title":"Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-practical-overview-of-the-use-of-amyloid-pet-centiloid-values-in-40101674","doi":"10.1016/j.nicl.2025.103765","journal":"NeuroImage. Clinical","n_participants":null,"pmid":"40101674","source_url":"https://pubmed.ncbi.nlm.nih.gov/40101674/","study_design":null,"title":"A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research","title_match":true,"year":2025},{"alzhub_score":80,"alzhub_url":"https://alzhub.org/study/donanemab-ly3002813-phase-1b-study-in-alzheimer-s-disease-rapid-and-34585215","doi":"10.14283/jpad.2021.56","journal":"The journal of prevention of Alzheimer's disease","n_participants":18,"pmid":"34585215","source_url":"https://pubmed.ncbi.nlm.nih.gov/34585215/","study_design":null,"title":"Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging","title_match":true,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/beta-amyloid-imaging-in-dementia-31620564","doi":"10.12701/yujm.2018.35.1.1","journal":"Yeungnam University journal of medicine","n_participants":null,"pmid":"31620564","source_url":"https://pubmed.ncbi.nlm.nih.gov/31620564/","study_design":null,"title":"Beta-amyloid imaging in dementia","title_match":true,"year":2018},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/a-new-centiloid-method-for-18f-florbetaben-and-18f-flutemetamol-pet-31834446","doi":"10.1007/s00259-019-04596-x","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"31834446","source_url":"https://pubmed.ncbi.nlm.nih.gov/31834446/","study_design":null,"title":"A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB","title_match":true,"year":2020},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/florbetaben-amyloid-pet-acquisition-time-influence-on-centiloids-and-38962867","doi":"10.1002/alz.13893","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":245,"pmid":"38962867","source_url":"https://pubmed.ncbi.nlm.nih.gov/38962867/","study_design":null,"title":"Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation","title_match":true,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-standard-procedures-and-semiquantification-38427194","doi":"10.1007/978-1-0716-3774-6_11","journal":"Methods in molecular biology (Clifton, N.J.)","n_participants":null,"pmid":"38427194","source_url":"https://pubmed.ncbi.nlm.nih.gov/38427194/","study_design":null,"title":"Amyloid PET Imaging: Standard Procedures and Semiquantification","title_match":true,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/18-f-florbetaben-a-review-in-amyloid-pet-imaging-in-cognitive-26175116","doi":"10.1007/s40263-015-0258-7","journal":"CNS drugs","n_participants":null,"pmid":"26175116","source_url":"https://pubmed.ncbi.nlm.nih.gov/26175116/","study_design":null,"title":"[(18)F]Florbetaben: a review in \u03b2-amyloid PET imaging in cognitive impairment","title_match":true,"year":2015},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/hybrid-pet-mri-with-flutemetamol-and-fdg-in-alzheimer-s-disease-38050727","doi":"10.2174/0115672050243131230925034334","journal":"Current Alzheimer research","n_participants":null,"pmid":"38050727","source_url":"https://pubmed.ncbi.nlm.nih.gov/38050727/","study_design":null,"title":"Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum","title_match":true,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/decreased-imaging-time-of-amyloid-pet-using-18f-florbetapir-can-35239129","doi":"10.1007/s12194-022-00653-7","journal":"Radiological physics and technology","n_participants":null,"pmid":"35239129","source_url":"https://pubmed.ncbi.nlm.nih.gov/35239129/","study_design":null,"title":"Decreased imaging time of amyloid PET using [18F]florbetapir can maintain quantitative accuracy","title_match":true,"year":2022},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/imaging-amyloid-using-18-f-flutemetamol-positron-emission-tomography-26440450","doi":"10.1007/s00259-015-3208-1","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"26440450","source_url":"https://pubmed.ncbi.nlm.nih.gov/26440450/","study_design":null,"title":"Imaging \u03b2-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis","title_match":true,"year":2016},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/amyloid-pet-ordering-practices-in-a-memory-disorders-clinic-35992217","doi":"10.1002/trc2.12333","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"35992217","source_url":"https://pubmed.ncbi.nlm.nih.gov/35992217/","study_design":null,"title":"Amyloid PET ordering practices in a memory disorders clinic","title_match":true,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/early-detection-of-amyloid-load-using-18f-florbetaben-pet-33773598","doi":"10.1186/s13195-021-00807-6","journal":"Alzheimer's research & therapy","n_participants":287,"pmid":"33773598","source_url":"https://pubmed.ncbi.nlm.nih.gov/33773598/","study_design":null,"title":"Early detection of amyloid load using 18F-florbetaben PET","title_match":true,"year":2021},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/expression-of-regional-brain-amyloid-deposition-with-18f-flutemetamol-38676749","doi":"10.1007/s00234-024-03364-5","journal":"Neuroradiology","n_participants":null,"pmid":"38676749","source_url":"https://pubmed.ncbi.nlm.nih.gov/38676749/","study_design":null,"title":"Expression of regional brain amyloid-\u03b2 deposition with [18F]Flutemetamol in Centiloid scale -a multi-site study","title_match":true,"year":2024},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/florbetapir-pet-to-diagnose-cerebral-amyloid-angiopathy-a-prospective-27605173","doi":"10.1212/wnl.0000000000003197","journal":"Neurology","n_participants":null,"pmid":"27605173","source_url":"https://pubmed.ncbi.nlm.nih.gov/27605173/","study_design":null,"title":"Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study","title_match":true,"year":2016},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/serial-amyloid-pet-demonstrates-marked-reduction-in-amyloid-burden-42507054","doi":"10.1007/s11604-026-02054-x","journal":"Japanese journal of radiology","n_participants":12,"pmid":"42507054","source_url":"https://pubmed.ncbi.nlm.nih.gov/42507054/","study_design":null,"title":"Serial amyloid PET demonstrates marked reduction in amyloid burden following donanemab treatment: a real-world cohort study","title_match":true,"year":2026},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/exploring-centiloid-robustness-impact-of-sample-size-and-image-41130790","doi":"10.2967/jnumed.125.270607","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":157,"pmid":"41130790","source_url":"https://pubmed.ncbi.nlm.nih.gov/41130790/","study_design":null,"title":"Exploring Centiloid Robustness: Impact of Sample Size and Image Resolution on Centiloid Conversion Accuracy","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/centiloid-method-evaluation-for-amyloid-pet-of-subcortical-vascular-29176753","doi":"10.1038/s41598-017-16236-1","journal":"Scientific reports","n_participants":null,"pmid":"29176753","source_url":"https://pubmed.ncbi.nlm.nih.gov/29176753/","study_design":null,"title":"Centiloid method evaluation for amyloid PET of subcortical vascular dementia","title_match":true,"year":2017},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/clinical-significance-of-focal-amyloid-deposition-measured-by-18f-31901233","doi":"10.1186/s13195-019-0577-x","journal":"Alzheimer's research & therapy","n_participants":310,"pmid":"31901233","source_url":"https://pubmed.ncbi.nlm.nih.gov/31901233/","study_design":"longitudinal study","title":"Clinical significance of focal \u00df-amyloid deposition measured by 18F-flutemetamol PET","title_match":true,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/predicting-continuous-amyloid-pet-values-with-csf-and-plasma-a42-a40-36874595","doi":"10.1002/dad2.12405","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"36874595","source_url":"https://pubmed.ncbi.nlm.nih.gov/36874595/","study_design":null,"title":"Predicting continuous amyloid PET values with CSF and plasma A\u03b242/A\u03b240","title_match":true,"year":2023},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/prospective-flutemetamol-positron-emission-tomography-and-24296542","doi":"10.1159/000355256","journal":"Neuro-degenerative diseases","n_participants":17,"pmid":"24296542","source_url":"https://pubmed.ncbi.nlm.nih.gov/24296542/","study_design":null,"title":"Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus","title_match":true,"year":2014},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/agreement-of-amyloid-pet-and-csf-biomarkers-for-alzheimer-s-disease-31464088","doi":"10.1002/acn3.50873","journal":"Annals of clinical and translational neurology","n_participants":35,"pmid":"31464088","source_url":"https://pubmed.ncbi.nlm.nih.gov/31464088/","study_design":null,"title":"Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse","title_match":true,"year":2019},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/cerebral-perfusion-and-amyloidosis-in-the-oldest-old-39535349","doi":"10.1002/alz.14357","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":113,"pmid":"39535349","source_url":"https://pubmed.ncbi.nlm.nih.gov/39535349/","study_design":"case-control study","title":"Cerebral perfusion and amyloidosis in the oldest-old","title_match":false,"year":2024},{"alzhub_score":49,"alzhub_url":"https://alzhub.org/study/diagnostic-impact-of-18f-flutemetamol-pet-in-early-onset-dementia-28093088","doi":"10.1186/s13195-016-0228-4","journal":"Alzheimer's research & therapy","n_participants":211,"pmid":"28093088","source_url":"https://pubmed.ncbi.nlm.nih.gov/28093088/","study_design":null,"title":"Diagnostic impact of [18F]flutemetamol PET in early-onset dementia","title_match":true,"year":2017},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/amyloid-pet-and-cognitive-decline-in-cognitively-normal-individuals-31026622","doi":"10.1016/j.neurobiolaging.2019.02.020","journal":"Neurobiology of aging","n_participants":null,"pmid":"31026622","source_url":"https://pubmed.ncbi.nlm.nih.gov/31026622/","study_design":"longitudinal study","title":"Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project","title_match":true,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-18f-florbetaben-and-18f-flutemetamol-in-32474468","doi":"10.3233/jad-200079","journal":"Journal of Alzheimer's disease : JAD","n_participants":107,"pmid":"32474468","source_url":"https://pubmed.ncbi.nlm.nih.gov/32474468/","study_design":null,"title":"Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions","title_match":true,"year":2020},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-with-18-f-florbetaben-in-the-27913818","doi":"10.1007/s00115-016-0249-z","journal":"Der Nervenarzt","n_participants":33,"pmid":"27913818","source_url":"https://pubmed.ncbi.nlm.nih.gov/27913818/","study_design":null,"title":"[Amyloid positron-emission-tomography with [18 F]-florbetaben in the diagnostic workup of dementia patients]","title_match":true,"year":2017},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/a-universal-neocortical-mask-for-centiloid-quantification-37492802","doi":"10.1002/dad2.12457","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":147,"pmid":"37492802","source_url":"https://pubmed.ncbi.nlm.nih.gov/37492802/","study_design":null,"title":"A universal neocortical mask for Centiloid quantification","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/correlation-between-two-methods-of-florbetapir-pet-quantitative-28721302","doi":null,"journal":"American journal of nuclear medicine and molecular imaging","n_participants":183,"pmid":"28721302","source_url":"https://pubmed.ncbi.nlm.nih.gov/28721302/","study_design":null,"title":"Correlation between two methods of florbetapir PET quantitative analysis","title_match":true,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/optimized-dual-time-window-protocols-for-quantitative-18f-30919133","doi":"10.1186/s13550-019-0499-4","journal":"EJNMMI research","n_participants":null,"pmid":"30919133","source_url":"https://pubmed.ncbi.nlm.nih.gov/30919133/","study_design":"longitudinal study","title":"Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies","title_match":true,"year":2019},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/semiquantitative-approach-to-amyloid-positron-emission-tomography-36923983","doi":"10.1055/s-0042-1757290","journal":"World journal of nuclear medicine","n_participants":null,"pmid":"36923983","source_url":"https://pubmed.ncbi.nlm.nih.gov/36923983/","study_design":null,"title":"Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice","title_match":true,"year":2023},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/predicting-amyloid-pet-positivity-using-plasma-p-tau181-and-other-38026758","doi":"10.1002/dad2.12502","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"38026758","source_url":"https://pubmed.ncbi.nlm.nih.gov/38026758/","study_design":"cohort study","title":"Predicting amyloid PET positivity using plasma p-tau181 and other blood-based biomarkers","title_match":true,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/comparison-of-amyloid-pet-acquired-through-standardized-and-40983958","doi":"10.1002/alz.70697","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40983958","source_url":"https://pubmed.ncbi.nlm.nih.gov/40983958/","study_design":null,"title":"Comparison of amyloid PET acquired through standardized and unstandardized protocols","title_match":true,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/feasibility-of-in-vivo-18f-florbetaben-pet-mr-imaging-of-human-28321471","doi":"10.1007/s00259-017-3651-2","journal":"European journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"28321471","source_url":"https://pubmed.ncbi.nlm.nih.gov/28321471/","study_design":null,"title":"Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-\u03b2","title_match":true,"year":2017},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/investigating-tau-and-amyloid-tracer-skull-binding-in-studies-of-35953305","doi":"10.2967/jnumed.122.263948","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":152,"pmid":"35953305","source_url":"https://pubmed.ncbi.nlm.nih.gov/35953305/","study_design":"longitudinal study","title":"Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/utility-of-amyloid-pet-imaging-in-a-memory-clinic-37561943","doi":"10.1097/wad.0000000000000575","journal":"Alzheimer disease and associated disorders","n_participants":74,"pmid":"37561943","source_url":"https://pubmed.ncbi.nlm.nih.gov/37561943/","study_design":null,"title":"Utility of amyloid PET Imaging in a Memory Clinic","title_match":true,"year":2023},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/amyloid-pet-in-neurodegenerative-diseases-with-dementia-29776894","doi":"10.1016/j.remn.2018.03.004","journal":"Revista espanola de medicina nuclear e imagen molecular","n_participants":null,"pmid":"29776894","source_url":"https://pubmed.ncbi.nlm.nih.gov/29776894/","study_design":null,"title":"Amyloid PET in neurodegenerative diseases with dementia","title_match":true,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/development-and-clinical-validation-of-ct-based-regional-modified-36266688","doi":"10.1186/s13195-022-01099-0","journal":"Alzheimer's research & therapy","n_participants":63,"pmid":"36266688","source_url":"https://pubmed.ncbi.nlm.nih.gov/36266688/","study_design":null,"title":"Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET","title_match":true,"year":2022},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/18f-florbetaben-pet-ct-to-assess-alzheimer-s-disease-a-new-analysis-30714241","doi":"10.1111/jon.12601","journal":"Journal of neuroimaging : official journal of the American Society of Neuroimaging","n_participants":44,"pmid":"30714241","source_url":"https://pubmed.ncbi.nlm.nih.gov/30714241/","study_design":null,"title":"18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification","title_match":true,"year":2019},{"alzhub_score":44,"alzhub_url":"https://alzhub.org/study/post-mortem-histopathology-underlying-amyloid-pet-imaging-following-27955679","doi":"10.1186/s40478-016-0399-z","journal":"Acta neuropathologica communications","n_participants":null,"pmid":"27955679","source_url":"https://pubmed.ncbi.nlm.nih.gov/27955679/","study_design":null,"title":"Post-mortem histopathology underlying \u03b2-amyloid PET imaging following flutemetamol F 18 injection","title_match":true,"year":2016},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/depression-and-alzheimer-s-disease-biomarkers-predict-driving-decline-30400098","doi":"10.3233/jad-180564","journal":"Journal of Alzheimer's disease : JAD","n_participants":131,"pmid":"30400098","source_url":"https://pubmed.ncbi.nlm.nih.gov/30400098/","study_design":null,"title":"Depression and Alzheimer's Disease Biomarkers Predict Driving Decline","title_match":false,"year":2018},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/alzheimer-s-biomarkers-in-daily-practice-abide-project-rationale-and-28239639","doi":"10.1016/j.dadm.2017.01.003","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":200,"pmid":"28239639","source_url":"https://pubmed.ncbi.nlm.nih.gov/28239639/","study_design":null,"title":"Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/prognostic-value-of-amyloid-pet-scan-in-normal-pressure-hydrocephalus-29128930","doi":"10.1007/s00415-017-8650-5","journal":"Journal of neurology","n_participants":31,"pmid":"29128930","source_url":"https://pubmed.ncbi.nlm.nih.gov/29128930/","study_design":null,"title":"Prognostic value of amyloid PET scan in normal pressure hydrocephalus","title_match":true,"year":2018},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/deep-residual-inception-encoder-decoder-network-for-amyloid-pet-35142053","doi":"10.1002/alz.12564","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":92,"pmid":"35142053","source_url":"https://pubmed.ncbi.nlm.nih.gov/35142053/","study_design":null,"title":"Deep residual inception encoder-decoder network for amyloid PET harmonization","title_match":true,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/matching-clinical-diagnosis-and-amyloid-biomarkers-in-alzheimer-s-33466854","doi":"10.3390/jpm11010047","journal":"Journal of personalized medicine","n_participants":148,"pmid":"33466854","source_url":"https://pubmed.ncbi.nlm.nih.gov/33466854/","study_design":null,"title":"Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer's Disease and Frontotemporal Dementia","title_match":false,"year":2021},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/identifying-brain-connectivity-using-network-based-statistics-in-30497273","doi":"10.1177/1533317518813556","journal":"American journal of Alzheimer's disease and other dementias","n_participants":35,"pmid":"30497273","source_url":"https://pubmed.ncbi.nlm.nih.gov/30497273/","study_design":null,"title":"Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by \u03b2-Amyloid Positivity","title_match":true,"year":2019},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-positron-emission-tomography-and-cognitive-reserve-26753062","doi":"10.4329/wjr.v7.i12.475","journal":"World journal of radiology","n_participants":null,"pmid":"26753062","source_url":"https://pubmed.ncbi.nlm.nih.gov/26753062/","study_design":null,"title":"Amyloid positron emission tomography and cognitive reserve","title_match":true,"year":2015},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/quantification-of-18-f-florbetaben-amyloid-pet-imaging-in-a-mixed-36478646","doi":"10.1002/alz.12886","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":157,"pmid":"36478646","source_url":"https://pubmed.ncbi.nlm.nih.gov/36478646/","study_design":"longitudinal study","title":"Quantification of [18 F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project","title_match":true,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-applications-beyond-alzheimer-s-disease-25741489","doi":"10.1007/s40336-014-0098-3","journal":"Clinical and translational imaging","n_participants":null,"pmid":"25741489","source_url":"https://pubmed.ncbi.nlm.nih.gov/25741489/","study_design":null,"title":"Amyloid PET imaging: applications beyond Alzheimer's disease","title_match":true,"year":2015},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/temporal-and-anatomical-distribution-of-18f-flutemetamol-uptake-in-31952531","doi":"10.1186/s12917-020-2240-y","journal":"BMC veterinary research","n_participants":null,"pmid":"31952531","source_url":"https://pubmed.ncbi.nlm.nih.gov/31952531/","study_design":null,"title":"Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography","title_match":true,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/visual-interpretation-of-18f-florbetaben-pet-supported-by-deep-32990807","doi":"10.1007/s00259-020-05044-x","journal":"European journal of nuclear medicine and molecular imaging","n_participants":121,"pmid":"32990807","source_url":"https://pubmed.ncbi.nlm.nih.gov/32990807/","study_design":null,"title":"Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden","title_match":true,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/early-phase-18f-florbetapir-and-18f-flutemetamol-images-as-proxies-of-35863896","doi":"10.2967/jnumed.122.264256","journal":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","n_participants":94,"pmid":"35863896","source_url":"https://pubmed.ncbi.nlm.nih.gov/35863896/","study_design":null,"title":"Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting","title_match":true,"year":2022},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/automatic-lesion-detection-and-segmentation-in-18f-flutemetamol-36539779","doi":"10.1186/s12938-022-01058-8","journal":"Biomedical engineering online","n_participants":null,"pmid":"36539779","source_url":"https://pubmed.ncbi.nlm.nih.gov/36539779/","study_design":null,"title":"Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning","title_match":true,"year":2022},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/quantitative-comparative-analysis-of-amyloid-pet-images-using-three-36749463","doi":"10.1007/s12149-023-01824-1","journal":"Annals of nuclear medicine","n_participants":605,"pmid":"36749463","source_url":"https://pubmed.ncbi.nlm.nih.gov/36749463/","study_design":null,"title":"Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals","title_match":true,"year":2023},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/defining-a-centiloid-scale-threshold-predicting-long-term-progression-32601802","doi":"10.1007/s00259-020-04942-4","journal":"European journal of nuclear medicine and molecular imaging","n_participants":37,"pmid":"32601802","source_url":"https://pubmed.ncbi.nlm.nih.gov/32601802/","study_design":null,"title":"Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study","title_match":true,"year":2021},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/centiloid-cut-off-values-for-optimal-agreement-between-pet-and-csf-30902090","doi":"10.1186/s13195-019-0478-z","journal":"Alzheimer's research & therapy","n_participants":205,"pmid":"30902090","source_url":"https://pubmed.ncbi.nlm.nih.gov/30902090/","study_design":null,"title":"Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers","title_match":true,"year":2019},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/use-of-amyloid-pet-ct-with-18f-florbetaben-in-the-management-of-31802055","doi":null,"journal":"Hellenic journal of nuclear medicine","n_participants":38,"pmid":"31802055","source_url":"https://pubmed.ncbi.nlm.nih.gov/31802055/","study_design":null,"title":"Use of amyloid PET/CT with 18F-Florbetaben in the management of patients with Alzheimer's disease","title_match":true,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/automated-semi-quantitative-amyloid-pet-analysis-technique-without-mr-35821311","doi":"10.1007/s12149-022-01769-x","journal":"Annals of nuclear medicine","n_participants":null,"pmid":"35821311","source_url":"https://pubmed.ncbi.nlm.nih.gov/35821311/","study_design":null,"title":"Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease","title_match":true,"year":2022},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/added-value-of-amyloid-pet-in-individualized-risk-predictions-for-mci-31388557","doi":"10.1016/j.dadm.2019.04.011","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":411,"pmid":"31388557","source_url":"https://pubmed.ncbi.nlm.nih.gov/31388557/","study_design":null,"title":"Added value of amyloid PET in individualized risk predictions for MCI patients","title_match":true,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/florbetapir-18f-for-brain-amyloid-positron-emission-tomography-24418060","doi":"10.1016/j.jalz.2013.09.007","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"24418060","source_url":"https://pubmed.ncbi.nlm.nih.gov/24418060/","study_design":null,"title":"Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval","title_match":true,"year":2014},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/development-of-software-for-measuring-brain-amyloid-accumulation-37287410","doi":"10.1002/brb3.3092","journal":"Brain and behavior","n_participants":null,"pmid":"37287410","source_url":"https://pubmed.ncbi.nlm.nih.gov/37287410/","study_design":null,"title":"Development of software for measuring brain amyloid accumulation using 18 F-florbetapir PET and calculating global Centiloid scale and regional Z-score values","title_match":true,"year":2023},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/immediate-reactions-to-amyloid-pet-disclosure-in-japanese-older-41425086","doi":"10.1002/trc2.70167","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":null,"pmid":"41425086","source_url":"https://pubmed.ncbi.nlm.nih.gov/41425086/","study_design":null,"title":"Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/white-matter-lesions-rather-than-amyloid-burden-are-associated-with-39956952","doi":"10.1177/13872877251316516","journal":"Journal of Alzheimer's disease : JAD","n_participants":47,"pmid":"39956952","source_url":"https://pubmed.ncbi.nlm.nih.gov/39956952/","study_design":null,"title":"White matter lesions rather than amyloid-\u03b2 burden are associated with cognitive decline in Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/quantification-of-18f-florbetapir-a-test-retest-tracer-kinetic-29897009","doi":"10.1177/0271678x18783628","journal":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","n_participants":null,"pmid":"29897009","source_url":"https://pubmed.ncbi.nlm.nih.gov/29897009/","study_design":null,"title":"Quantification of [18F]florbetapir: A test-retest tracer kinetic modelling study","title_match":true,"year":2019},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/quantitative-amyloid-pet-in-alzheimer-s-disease-the-amypad-prognostic-32281303","doi":"10.1002/alz.12069","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":2000,"pmid":"32281303","source_url":"https://pubmed.ncbi.nlm.nih.gov/32281303/","study_design":"cohort study","title":"Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study","title_match":true,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/using-amyloid-pet-imaging-to-diagnose-alzheimer-s-disease-in-patients-32556533","doi":"10.1007/s00415-020-09969-z","journal":"Journal of neurology","n_participants":null,"pmid":"32556533","source_url":"https://pubmed.ncbi.nlm.nih.gov/32556533/","study_design":null,"title":"Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/amyloid-tracers-binding-sites-in-autosomal-dominant-and-sporadic-27693181","doi":"10.1016/j.jalz.2016.08.006","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"27693181","source_url":"https://pubmed.ncbi.nlm.nih.gov/27693181/","study_design":null,"title":"Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease","title_match":false,"year":2017},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/longitudinal-validity-of-pet-based-staging-of-regional-amyloid-32648624","doi":"10.1002/hbm.25121","journal":"Human brain mapping","n_participants":403,"pmid":"32648624","source_url":"https://pubmed.ncbi.nlm.nih.gov/32648624/","study_design":"cross-sectional","title":"Longitudinal validity of PET-based staging of regional amyloid deposition","title_match":false,"year":2020},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/development-and-evaluation-of-an-automated-quantification-tool-for-32990884","doi":"10.1186/s40658-020-00329-4","journal":"EJNMMI physics","n_participants":166,"pmid":"32990884","source_url":"https://pubmed.ncbi.nlm.nih.gov/32990884/","study_design":null,"title":"Development and evaluation of an automated quantification tool for amyloid PET images","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/implementing-the-centiloid-transformation-for-11c-pib-and-amyloid-18f-30130643","doi":"10.1016/j.neuroimage.2018.08.044","journal":"NeuroImage","n_participants":null,"pmid":"30130643","source_url":"https://pubmed.ncbi.nlm.nih.gov/30130643/","study_design":null,"title":"Implementing the centiloid transformation for 11C-PiB and \u03b2-amyloid 18F-PET tracers using CapAIBL","title_match":true,"year":2018},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/amyloid-imaging-in-alzheimer-s-disease-comparison-of-florbetapir-and-22791901","doi":"10.1136/jnnp-2012-302548","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"22791901","source_url":"https://pubmed.ncbi.nlm.nih.gov/22791901/","study_design":null,"title":"Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography","title_match":true,"year":2012},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/amyloid-pet-positivity-in-different-primary-progressive-aphasia-29504965","doi":"10.1097/rlu.0000000000002018","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"29504965","source_url":"https://pubmed.ncbi.nlm.nih.gov/29504965/","study_design":null,"title":"Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes","title_match":true,"year":2018},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/clinical-use-of-amyloid-positron-emission-tomography-neuroimaging-27239516","doi":"10.1016/j.dadm.2015.06.006","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"27239516","source_url":"https://pubmed.ncbi.nlm.nih.gov/27239516/","study_design":null,"title":"Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations","title_match":false,"year":2015},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/comparison-of-18f-florbetaben-quantification-results-using-the-31101517","doi":"10.1016/j.jalz.2019.02.005","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"31101517","source_url":"https://pubmed.ncbi.nlm.nih.gov/31101517/","study_design":null,"title":"Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL\u00ae approaches: Validation against histopathology","title_match":true,"year":2019},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/medicare-and-amyloid-pet-imaging-the-battle-over-evidence-27285978","doi":"10.1080/08959420.2016.1198970","journal":"Journal of aging & social policy","n_participants":null,"pmid":"27285978","source_url":"https://pubmed.ncbi.nlm.nih.gov/27285978/","study_design":null,"title":"Medicare and Amyloid PET Imaging: The Battle Over Evidence","title_match":true,"year":2017},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/csf-biomarkers-and-amyloid-pet-concordance-and-diagnostic-accuracy-in-30847669","doi":"10.1007/s13760-019-01112-8","journal":"Acta neurologica Belgica","n_participants":31,"pmid":"30847669","source_url":"https://pubmed.ncbi.nlm.nih.gov/30847669/","study_design":null,"title":"CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort","title_match":true,"year":2019},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/deep-learning-based-amyloid-pet-harmonization-to-predict-cognitive-41059393","doi":"10.1093/radadv/umae019","journal":"Radiology advances","n_participants":1050,"pmid":"41059393","source_url":"https://pubmed.ncbi.nlm.nih.gov/41059393/","study_design":null,"title":"Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly","title_match":true,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/amypad-diagnostic-and-patient-management-study-rationale-and-design-30339801","doi":"10.1016/j.jalz.2018.09.003","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"30339801","source_url":"https://pubmed.ncbi.nlm.nih.gov/30339801/","study_design":null,"title":"AMYPAD Diagnostic and Patient Management Study: Rationale and design","title_match":false,"year":2019},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/software-development-for-quantitative-analysis-of-brain-amyloid-pet-35134278","doi":"10.1002/brb3.2499","journal":"Brain and behavior","n_participants":null,"pmid":"35134278","source_url":"https://pubmed.ncbi.nlm.nih.gov/35134278/","study_design":null,"title":"Software development for quantitative analysis of brain amyloid PET","title_match":true,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/adaptive-template-generation-for-amyloid-pet-using-a-deep-learning-29752765","doi":"10.1002/hbm.24210","journal":"Human brain mapping","n_participants":null,"pmid":"29752765","source_url":"https://pubmed.ncbi.nlm.nih.gov/29752765/","study_design":null,"title":"Adaptive template generation for amyloid PET using a deep learning approach","title_match":true,"year":2018},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-in-clinical-practice-32973035","doi":"10.1136/practneurol-2019-002468","journal":"Practical neurology","n_participants":null,"pmid":"32973035","source_url":"https://pubmed.ncbi.nlm.nih.gov/32973035/","study_design":null,"title":"Amyloid PET imaging in clinical practice","title_match":true,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/post-mortem-analyses-of-pib-and-flutemetamol-in-diffuse-and-cored-32772265","doi":"10.1007/s00401-020-02175-1","journal":"Acta neuropathologica","n_participants":null,"pmid":"32772265","source_url":"https://pubmed.ncbi.nlm.nih.gov/32772265/","study_design":null,"title":"Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-\u03b2 plaques in Alzheimer's disease","title_match":true,"year":2020},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/defining-patient-centered-amyloid-pet-thresholds-for-the-onset-of-41485137","doi":"10.1002/alz.71064","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":301,"pmid":"41485137","source_url":"https://pubmed.ncbi.nlm.nih.gov/41485137/","study_design":null,"title":"Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease","title_match":true,"year":2026},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/apoe4-potentiates-the-relationship-between-amyloid-and-tau-pathologies-32161362","doi":"10.1038/s41380-020-0688-6","journal":"Molecular psychiatry","n_participants":211,"pmid":"32161362","source_url":"https://pubmed.ncbi.nlm.nih.gov/32161362/","study_design":null,"title":"APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and tau pathologies","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/cross-sectional-comparison-of-small-animal-18f-florbetaben-amyloid-25706990","doi":"10.1371/journal.pone.0116678","journal":"PloS one","n_participants":82,"pmid":"25706990","source_url":"https://pubmed.ncbi.nlm.nih.gov/25706990/","study_design":"longitudinal study","title":"Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models","title_match":true,"year":2015},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/the-impact-of-amyloid-beta-positivity-with-18f-florbetaben-pet-on-32977481","doi":"10.3390/metabo10100380","journal":"Metabolites","n_participants":23,"pmid":"32977481","source_url":"https://pubmed.ncbi.nlm.nih.gov/32977481/","study_design":null,"title":"The Impact of Amyloid-Beta Positivity with 18F-Florbetaben PET on Neuropsychological Aspects in Parkinson's Disease Dementia","title_match":true,"year":2020},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/amyloid-pet-imaging-standardization-and-integration-with-other-29512074","doi":"10.1007/978-1-4939-7704-8_13","journal":"Methods in molecular biology (Clifton, N.J.)","n_participants":null,"pmid":"29512074","source_url":"https://pubmed.ncbi.nlm.nih.gov/29512074/","study_design":null,"title":"Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers","title_match":true,"year":2018},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/cortical-hypometabolism-reflects-local-atrophy-and-tau-pathology-in-34373896","doi":"10.1093/brain/awab294","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"34373896","source_url":"https://pubmed.ncbi.nlm.nih.gov/34373896/","study_design":null,"title":"Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/chinese-preclinical-alzheimer-s-disease-study-c-pas-design-and-37357299","doi":"10.14283/jpad.2023.49","journal":"The journal of prevention of Alzheimer's disease","n_participants":4386,"pmid":"37357299","source_url":"https://pubmed.ncbi.nlm.nih.gov/37357299/","study_design":"longitudinal study","title":"Chinese Preclinical Alzheimer's Disease Study (C-PAS): Design and Challenge from PET Acceptance","title_match":false,"year":2023},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/dual-phase-18f-florbetaben-pet-ct-unsuspected-thalamic-infarction-34739400","doi":"10.1097/rlu.0000000000003955","journal":"Clinical nuclear medicine","n_participants":null,"pmid":"34739400","source_url":"https://pubmed.ncbi.nlm.nih.gov/34739400/","study_design":null,"title":"Dual-Phase 18F-Florbetaben PET/CT: Unsuspected Thalamic Infarction Mimicking Alzheimer Disease","title_match":true,"year":2022},{"alzhub_score":63,"alzhub_url":"https://alzhub.org/study/prevalence-of-amyloid-positron-emission-tomographic-positivity-in-27539301","doi":"10.1161/strokeaha.116.013778","journal":"Stroke","n_participants":178,"pmid":"27539301","source_url":"https://pubmed.ncbi.nlm.nih.gov/27539301/","study_design":"prospective cohort","title":"Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment","title_match":true,"year":2016},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/fibt-versus-florbetaben-and-pib-a-preclinical-comparison-study-with-25918674","doi":"10.1186/s13550-015-0090-6","journal":"EJNMMI research","n_participants":null,"pmid":"25918674","source_url":"https://pubmed.ncbi.nlm.nih.gov/25918674/","study_design":null,"title":"FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice","title_match":true,"year":2015},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/modeling-autosomal-dominant-alzheimer-s-disease-with-machine-learning-33480178","doi":"10.1002/alz.12259","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"33480178","source_url":"https://pubmed.ncbi.nlm.nih.gov/33480178/","study_design":"longitudinal study","title":"Modeling autosomal dominant Alzheimer's disease with machine learning","title_match":false,"year":2021},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/an-easy-way-to-increase-confidence-in-beta-amyloid-pet-evaluation-30900240","doi":"10.5603/nmr.2017.0019","journal":"Nuclear medicine review. Central & Eastern Europe","n_participants":null,"pmid":"30900240","source_url":"https://pubmed.ncbi.nlm.nih.gov/30900240/","study_design":null,"title":"An easy way to increase confidence in beta-amyloid PET evaluation","title_match":true,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/tau-and-the-fractionated-default-mode-network-in-atypical-alzheimer-s-35356035","doi":"10.1093/braincomms/fcac055","journal":"Brain communications","n_participants":null,"pmid":"35356035","source_url":"https://pubmed.ncbi.nlm.nih.gov/35356035/","study_design":null,"title":"Tau and the fractionated default mode network in atypical Alzheimer's disease","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/brain-amyloid-burden-and-resting-state-functional-connectivity-in-33123070","doi":"10.3389/fneur.2020.529930","journal":"Frontiers in neurology","n_participants":null,"pmid":"33123070","source_url":"https://pubmed.ncbi.nlm.nih.gov/33123070/","study_design":null,"title":"Brain Amyloid Burden and Resting-State Functional Connectivity in Late Middle-Aged Hispanics","title_match":false,"year":2020},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/predicting-brain-age-from-functional-connectivity-in-symptomatic-and-35452806","doi":"10.1016/j.neuroimage.2022.119228","journal":"NeuroImage","n_participants":null,"pmid":"35452806","source_url":"https://pubmed.ncbi.nlm.nih.gov/35452806/","study_design":null,"title":"Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease","title_match":false,"year":2022},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/default-mode-network-lateralization-and-memory-in-healthy-aging-and-30412488","doi":"10.3233/jad-180541","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30412488","source_url":"https://pubmed.ncbi.nlm.nih.gov/30412488/","study_design":null,"title":"Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease","title_match":false,"year":2018},{"alzhub_score":54,"alzhub_url":"https://alzhub.org/study/assessing-outer-retinal-and-choroidal-changes-in-scd-potential-for-41315191","doi":"10.1038/s41398-025-03781-x","journal":"Translational psychiatry","n_participants":57,"pmid":"41315191","source_url":"https://pubmed.ncbi.nlm.nih.gov/41315191/","study_design":null,"title":"Assessing outer retinal and choroidal changes in scd: potential for high-risk screening using SS-OCTA","title_match":false,"year":2025},{"alzhub_score":61,"alzhub_url":"https://alzhub.org/study/eligibility-for-lecanemab-and-donanemab-in-korea-under-appropriate-41225766","doi":"10.1002/alz.70875","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":2726,"pmid":"41225766","source_url":"https://pubmed.ncbi.nlm.nih.gov/41225766/","study_design":null,"title":"Eligibility for lecanemab and donanemab in Korea under Appropriate Use Recommendations","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/lecanemab-appropriate-use-recommendations-for-clinical-practice-in-41390238","doi":"10.1136/jnnp-2025-336597","journal":"Journal of neurology, neurosurgery, and psychiatry","n_participants":null,"pmid":"41390238","source_url":"https://pubmed.ncbi.nlm.nih.gov/41390238/","study_design":null,"title":"Lecanemab appropriate use recommendations for clinical practice in the UK","title_match":false,"year":2026},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/aducanumab-for-the-treatment-of-alzheimer-s-disease-a-systematic-36775284","doi":"10.1111/psyg.12944","journal":"Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society","n_participants":null,"pmid":"36775284","source_url":"https://pubmed.ncbi.nlm.nih.gov/36775284/","study_design":"meta-analysis","title":"Aducanumab for the treatment of Alzheimer's disease: a systematic review","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/maximizing-the-benefit-and-managing-the-risk-of-anti-amyloid-40118715","doi":"10.1016/j.neurot.2025.e00570","journal":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","n_participants":null,"pmid":"40118715","source_url":"https://pubmed.ncbi.nlm.nih.gov/40118715/","study_design":null,"title":"Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/donanemab-another-anti-alzheimer-s-drug-with-risk-and-uncertain-38830549","doi":"10.1016/j.arr.2024.102348","journal":"Ageing research reviews","n_participants":null,"pmid":"38830549","source_url":"https://pubmed.ncbi.nlm.nih.gov/38830549/","study_design":null,"title":"Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/anti-amyloid-antibody-therapies-for-alzheimer-s-disease-38932758","doi":"10.1007/s13139-024-00848-3","journal":"Nuclear medicine and molecular imaging","n_participants":null,"pmid":"38932758","source_url":"https://pubmed.ncbi.nlm.nih.gov/38932758/","study_design":"clinical trial","title":"Anti-amyloid Antibody Therapies for Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":73,"alzhub_url":"https://alzhub.org/study/regional-effects-of-gantenerumab-on-neuroimaging-biomarkers-in-the-40660741","doi":"10.1002/alz.70347","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40660741","source_url":"https://pubmed.ncbi.nlm.nih.gov/40660741/","study_design":null,"title":"Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial","title_match":false,"year":2025},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-long-term-gantenerumab-treatment-in-dominantly-40120616","doi":"10.1016/s1474-4422(25)00024-9","journal":"The Lancet. Neurology","n_participants":53,"pmid":"40120616","source_url":"https://pubmed.ncbi.nlm.nih.gov/40120616/","study_design":"clinical trial","title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","title_match":false,"year":2025},{"alzhub_score":89,"alzhub_url":"https://alzhub.org/study/japanese-participant-data-from-three-gantenerumab-trials-in-early-40302041","doi":"10.1002/alz.70192","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1965,"pmid":"40302041","source_url":"https://pubmed.ncbi.nlm.nih.gov/40302041/","study_design":"clinical trial","title":"Japanese participant data from three gantenerumab trials in early Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/how-donanemab-data-address-the-coverage-with-evidence-development-38323738","doi":"10.1002/alz.13700","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38323738","source_url":"https://pubmed.ncbi.nlm.nih.gov/38323738/","study_design":null,"title":"How donanemab data address the coverage with evidence development questions","title_match":false,"year":2024},{"alzhub_score":77,"alzhub_url":"https://alzhub.org/study/at-home-administration-of-gantenerumab-by-care-partners-to-people-38706270","doi":"10.14283/jpad.2024.60","journal":"The journal of prevention of Alzheimer's disease","n_participants":149,"pmid":"38706270","source_url":"https://pubmed.ncbi.nlm.nih.gov/38706270/","study_design":"clinical trial","title":"At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-amyloid-hypothesis-and-antibody-therapy-melting-glaciers-38612701","doi":"10.3390/ijms25073892","journal":"International journal of molecular sciences","n_participants":null,"pmid":"38612701","source_url":"https://pubmed.ncbi.nlm.nih.gov/38612701/","study_design":null,"title":"Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?","title_match":false,"year":2024},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/lecanemab-for-treatment-of-individuals-with-early-alzheimer-s-disease-41689888","doi":"10.1016/j.tjpad.2026.100507","journal":"The journal of prevention of Alzheimer's disease","n_participants":1795,"pmid":"41689888","source_url":"https://pubmed.ncbi.nlm.nih.gov/41689888/","study_design":"clinical trial","title":"Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E \u03b54 (ApoE \u03b54) non-carriers or heterozygotes","title_match":false,"year":2026},{"alzhub_score":70,"alzhub_url":"https://alzhub.org/study/real-world-application-of-lecanemab-in-early-stage-alzheimer-s-41250246","doi":"10.1186/s13195-025-01886-5","journal":"Alzheimer's research & therapy","n_participants":14,"pmid":"41250246","source_url":"https://pubmed.ncbi.nlm.nih.gov/41250246/","study_design":"cohort study","title":"Real-world application of lecanemab in early-stage alzheimer's disease: a single-center prospective cohort analysis","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/symptomatic-amyloid-related-imaging-abnormalities-in-an-apoe-4-4-33072846","doi":"10.1002/dad2.12101","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"33072846","source_url":"https://pubmed.ncbi.nlm.nih.gov/33072846/","study_design":null,"title":"Symptomatic amyloid-related imaging abnormalities in an APOE \u03b54/\u03b54 patient treated with aducanumab","title_match":false,"year":2020},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/passive-alzheimer-s-immunotherapy-a-promising-or-uncertain-option-37414156","doi":"10.1016/j.arr.2023.101996","journal":"Ageing research reviews","n_participants":null,"pmid":"37414156","source_url":"https://pubmed.ncbi.nlm.nih.gov/37414156/","study_design":null,"title":"Passive Alzheimer's immunotherapy: A promising or uncertain option?","title_match":false,"year":2023},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/safety-and-efficacy-of-crenezumab-in-cognitively-unimpaired-carriers-41579901","doi":"10.1016/s1474-4422(25)00426-0","journal":"The Lancet. Neurology","n_participants":85,"pmid":"41579901","source_url":"https://pubmed.ncbi.nlm.nih.gov/41579901/","study_design":null,"title":"Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial","title_match":false,"year":2026},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/effects-of-cognitive-reserve-in-alzheimer-s-disease-and-cognitively-35197838","doi":"10.3389/fnagi.2021.784054","journal":"Frontiers in aging neuroscience","n_participants":null,"pmid":"35197838","source_url":"https://pubmed.ncbi.nlm.nih.gov/35197838/","study_design":"longitudinal study","title":"Effects of Cognitive Reserve in Alzheimer's Disease and Cognitively Unimpaired Individuals","title_match":false,"year":2021},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/brain-reserve-contributes-to-distinguishing-preclinical-alzheimer-s-36855049","doi":"10.1186/s13195-023-01187-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"36855049","source_url":"https://pubmed.ncbi.nlm.nih.gov/36855049/","study_design":"longitudinal study","title":"Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2","title_match":false,"year":2023},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cognitive-reserve-and-clinical-expression-of-alzheimer-s-disease-24795838","doi":null,"journal":"American journal of nuclear medicine and molecular imaging","n_participants":null,"pmid":"24795838","source_url":"https://pubmed.ncbi.nlm.nih.gov/24795838/","study_design":null,"title":"Cognitive reserve and clinical expression of Alzheimer's disease: evidence and implications for brain PET imaging","title_match":false,"year":2014},{"alzhub_score":39,"alzhub_url":"https://alzhub.org/study/cognitive-reserve-in-midlife-is-not-associated-with-amyloid-30775981","doi":"10.3233/jad-180785","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"30775981","source_url":"https://pubmed.ncbi.nlm.nih.gov/30775981/","study_design":null,"title":"Cognitive Reserve in Midlife is not Associated with Amyloid-\u03b2 Deposition in Late-Life","title_match":false,"year":2019},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/clinical-criteria-for-limbic-predominant-age-related-tdp-43-39807681","doi":"10.1002/alz.14202","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39807681","source_url":"https://pubmed.ncbi.nlm.nih.gov/39807681/","study_design":null,"title":"Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy","title_match":false,"year":2025},{"alzhub_score":68,"alzhub_url":"https://alzhub.org/study/associations-between-misfolded-alpha-synuclein-aggregates-and-39258841","doi":"10.1002/alz.14225","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":2315,"pmid":"39258841","source_url":"https://pubmed.ncbi.nlm.nih.gov/39258841/","study_design":"cross-sectional","title":"Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-from-molecular-mechanisms-to-promising-41096712","doi":"10.3390/ijms26199444","journal":"International journal of molecular sciences","n_participants":null,"pmid":"41096712","source_url":"https://pubmed.ncbi.nlm.nih.gov/41096712/","study_design":null,"title":"Alzheimer's Disease: From Molecular Mechanisms to Promising Therapeutic Strategies","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/ubiquitin-proteasome-system-in-the-different-stages-of-dominantly-39108475","doi":"10.21203/rs.3.rs-4202125/v1","journal":"Research square","n_participants":null,"pmid":"39108475","source_url":"https://pubmed.ncbi.nlm.nih.gov/39108475/","study_design":null,"title":"Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease","title_match":false,"year":2024},{"alzhub_score":46,"alzhub_url":"https://alzhub.org/study/reasons-for-undergoing-amyloid-imaging-among-diverse-enrollees-in-the-39041310","doi":"10.1002/alz.14077","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39041310","source_url":"https://pubmed.ncbi.nlm.nih.gov/39041310/","study_design":null,"title":"Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study","title_match":true,"year":2024},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/cost-effectiveness-of-florbetapir-pet-in-alzheimer-s-disease-a-26231002","doi":null,"journal":"The journal of mental health policy and economics","n_participants":null,"pmid":"26231002","source_url":"https://pubmed.ncbi.nlm.nih.gov/26231002/","study_design":null,"title":"Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective","title_match":true,"year":2015},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/long-term-cost-effectiveness-of-a-more-accurate-diagnostic-work-up-41195193","doi":"10.1002/dad2.70210","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":440,"pmid":"41195193","source_url":"https://pubmed.ncbi.nlm.nih.gov/41195193/","study_design":null,"title":"Long-term cost-effectiveness of a more accurate diagnostic work-up for dementia","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/blood-based-biomarkers-across-the-alzheimer-s-disease-continuum-in-650383db","doi":"10.64898/2026.10.27.26366659","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.27.26366659","study_design":"cross-sectional","title":"Blood-based biomarkers across the Alzheimer's disease continuum in older Korean population","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/detection-of-tau-spatial-extent-using-mk6240-and-flortaucipir-pet-5c9de0fb","doi":"10.64898/2026.10.26.26366488","journal":"medRxiv","n_participants":682,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.26.26366488","study_design":null,"title":"Detection of tau spatial extent using MK6240 and flortaucipir PET","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/soluble-amyloid-composition-links-proximal-app-processing-fibrillar-415c6827","doi":"10.21203/rs.3.rs-10955863/v1","journal":"Research Square","n_participants":91,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10955863/v1","study_design":null,"title":"Soluble amyloid composition links proximal APP processing, fibrillar burden and the p-tau181 response","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/synuclein-seed-amplification-status-modifies-the-relationship-between-af4554ea","doi":"10.21203/rs.3.rs-11271891/v1","journal":"Research Square","n_participants":193,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-11271891/v1","study_design":"cross-sectional","title":"\u03b1-Synuclein Seed Amplification Status Modifies the Relationship Between Plasma p-tau217, Amyloid and Fibrillar Tau","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/performance-boundaries-of-plasma-centred-prediction-across-pet-and-c9526c45","doi":"10.64898/2026.10.15.26365631","journal":"medRxiv","n_participants":1097,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.15.26365631","study_design":"post-hoc analysis","title":"Performance boundaries of plasma-centred prediction across PET- and MRI-defined AT(N): QC-first internal validation in ADNI with separate axis-specific assessments","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/tau-pet-subtype-modifies-the-association-between-plasma-p-tau217-and-ada7a142","doi":"10.64898/2026.09.25.26363629","journal":"medRxiv","n_participants":396,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.25.26363629","study_design":"cross-sectional","title":"Tau-PET subtype modifies the association between plasma p-tau217 and memory in Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/white-matter-slow-4-falff-as-a-complementary-marker-in-the-multimodal-23883748","doi":"10.64898/2026.09.17.752468","journal":"bioRxiv","n_participants":108,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.17.752468","study_design":null,"title":"White Matter Slow-4 fALFF as a Complementary Marker in the Multimodal Alzheimer\u2019s Disease Biomarker Landscape","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/does-csf-testing-add-value-after-an-indeterminate-plasma-p-tau217-632475b0","doi":"10.21203/rs.3.rs-10754560/v1","journal":"Research Square","n_participants":283,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10754560/v1","study_design":null,"title":"Does CSF testing add value after an indeterminate plasma p-tau217 result?","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/effect-of-prior-traumatic-brain-injury-on-alzheimers-disease-blood-9b971246","doi":"10.64898/2026.01.13.26344009","journal":"medRxiv","n_participants":93,"pmid":null,"source_url":"https://doi.org/10.64898/2026.01.13.26344009","study_design":"cohort study","title":"Effect of prior traumatic brain injury on Alzheimer\u2019s disease blood biomarkers in Vietnam Veterans","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/amplitude-of-physiological-brain-pulsations-in-alzheimers-disease-fae5adec","doi":"10.21203/rs.3.rs-9725762/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-9725762/v1","study_design":null,"title":"Amplitude of physiological brain pulsations in Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-plasma-apoe-proteotyping-for-alzheimers-disease-4dfb2d6c","doi":"10.64898/2026.10.08.26364972","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.08.26364972","study_design":"cross-sectional","title":"Clinical utility of plasma APOE proteotyping for Alzheimer\u2019s disease risk and prognosis","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/tau-ctfp-a-connectome-informed-continuous-time-first-passage-model-05365979","doi":"10.64898/2026.10.26.761855","journal":"bioRxiv","n_participants":168,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.26.761855","study_design":null,"title":"Tau-CTFP: A connectome-informed continuous-time first-passage model for forecasting the onset of regional tau PET abnormality","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/mri-derived-periventricular-diffusivity-contextualizes-plasma-ptau217-1e5483ae","doi":"10.21203/rs.3.rs-10895317/v1","journal":"Research Square","n_participants":602,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10895317/v1","study_design":null,"title":"MRI-derived periventricular diffusivity contextualizes plasma pTau217 associations with Alzheimer pathology: a discovery\u2013validation study","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/clinical-expression-beyond-measured-alzheimer-disease-molecular-f99a3bc7","doi":"10.21203/rs.3.rs-10847343/v1","journal":"Research Square","n_participants":436,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10847343/v1","study_design":"longitudinal study","title":"Clinical expression beyond measured Alzheimer disease molecular pathology: a discovery and external evaluation study","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/estimating-amyloid-deposition-using-brain-perfusion-spect-in-6cc54487","doi":"10.21203/rs.3.rs-10624411/v1","journal":"Research Square","n_participants":88,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10624411/v1","study_design":null,"title":"Estimating amyloid-\u03b2 deposition using brain perfusion SPECT in Alzheimer's disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/mapping-amyloid-pet-uptake-in-the-white-matter-in-alzheimers-disease-7b7b99fe","doi":"10.21203/rs.3.rs-10277565/v1","journal":"Research Square","n_participants":320,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10277565/v1","study_design":null,"title":"Mapping Amyloid-PET Uptake in the White Matter in Alzheimer\u2019s Disease","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/current-gaps-in-downstream-applications-of-fmri-foundation-models-51eea5af","doi":"10.64898/2026.10.22.26366227","journal":"medRxiv","n_participants":343,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.22.26366227","study_design":null,"title":"Current gaps in downstream applications of fMRI foundation models: lessons learned from BrainLM & BrainHarmonix on Prevent-AD","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/continuous-amyloid-staging-complements-global-amyloid-burden-in-early-a13aaacf","doi":"10.64898/2026.10.03.756367","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.03.756367","study_design":"longitudinal study","title":"Continuous amyloid staging complements global amyloid burden in early Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/when-is-amyloid-really-cleared-substantial-discordance-between-fc03ab7d","doi":"10.64898/2026.10.03.26364642","journal":"medRxiv","n_participants":15,"pmid":null,"source_url":"https://doi.org/10.64898/2026.10.03.26364642","study_design":null,"title":"When Is Amyloid Really Cleared? Substantial Discordance Between Centiloid Quantitation and Visual Reads of Amyloid PET after Amyloid-Targeting Therapy","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/divergent-amyloid-trajectories-distinguish-normal-aging-from-20e069b5","doi":"10.64898/2026.09.08.748727","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.08.748727","study_design":"longitudinal study","title":"Divergent amyloid trajectories distinguish normal aging from Alzheimer's disease progression","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/multivariate-blood-biomarkers-capture-resilience-and-resistance-0f2be5f0","doi":"10.64898/2026.08.03.26359415","journal":"medRxiv","n_participants":1009,"pmid":null,"source_url":"https://doi.org/10.64898/2026.08.03.26359415","study_design":null,"title":"Multivariate blood biomarkers capture resilience and resistance phenotypes across the Alzheimer\u2019s disease spectrum","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/regional-cerebrospinal-fluid-motility-as-a-key-determinant-of-soluble-89aedc92","doi":"10.21203/rs.3.rs-10530209/v1","journal":"Research Square","n_participants":502,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10530209/v1","study_design":null,"title":"Regional Cerebrospinal Fluid Motility as a Key Determinant of Soluble Amyloid-\u03b2 Levels and Kinetics","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/determining-the-metabolic-profile-measured-using-ultra-high-pressure-fe58168b","doi":"10.21203/rs.3.rs-10065374/v1","journal":"Research Square","n_participants":59,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10065374/v1","study_design":null,"title":"Determining the metabolic profile measured using ultra-high pressure liquid chromatography associated with Beta Amyloid burden in the brain in individuals with mild cognitive impairment","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/altered-t1w-t2w-flair-ratio-in-white-matter-hyperintensities-as-an-b5f25332","doi":"10.64898/2026.07.28.26359139","journal":"medRxiv","n_participants":71,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.28.26359139","study_design":"cross-sectional","title":"Altered T1w/T2w-FLAIR Ratio in White Matter Hyperintensities as an Indicator of Structural Integrity Loss: Association with Alzheimer\u2019s Disease and Vascular Dementia","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/deep-nanoparticle-protein-corona-plasma-proteomics-resolves-a-stage-7fb049ee","doi":"10.64898/2026.07.25.740710","journal":"bioRxiv","n_participants":90,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.25.740710","study_design":null,"title":"Deep nanoparticle protein corona plasma proteomics resolves a stage-specific peripheral signature of Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/biomarker-variability-limits-individualized-amyloid-time-estimation-d4682f47","doi":"10.64898/2026.07.08.737258","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.08.737258","study_design":null,"title":"Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/investigating-the-amyloid-tau-neurodegeneration-framework-in-b01fb94a","doi":"10.64898/2025.12.11.25341830","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2025.12.11.25341830","study_design":null,"title":"Investigating the Amyloid-Tau-Neurodegeneration Framework in Alzheimer\u2019s Disease Using Semi-Supervised Multimodal Imaging Data Fusion","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/night-to-night-rem-sleep-variability-a-relevant-marker-of-early-7a89a129","doi":"10.64898/2025.12.19.25342684","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2025.12.19.25342684","study_design":"longitudinal study","title":"Night-to-night REM sleep variability: a relevant marker of early amyloid-\u03b2 deposition","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cognitive-screening-biases-in-a-secondary-prevention-alzheimers-a28a08bc","doi":"10.64898/2025.11.28.25341235","journal":"medRxiv","n_participants":6669,"pmid":null,"source_url":"https://doi.org/10.64898/2025.11.28.25341235","study_design":null,"title":"Cognitive screening biases in a secondary prevention Alzheimer\u2019s disease clinical trial","title_match":false,"year":2025},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/plasma-emtbr-tau-as-a-robust-biomarker-for-alzheimers-disease-tangle-09101ef3","doi":"10.64898/2026.09.29.26363951","journal":"medRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.09.29.26363951","study_design":null,"title":"Plasma eMTBR-tau as a robust biomarker for Alzheimer\u2019s disease tangle pathology up to 10 years before death","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/functional-assessment-improves-discrimination-of-clinical-and-eee5059c","doi":"10.64898/2026.07.29.26359236","journal":"medRxiv","n_participants":603,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.29.26359236","study_design":null,"title":"Functional assessment improves discrimination of clinical and biomarker-defined Alzheimer\u2019s disease","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/episodic-memory-erps-reflect-preclinical-alzheimers-disease-c6276936","doi":"10.64898/2026.07.11.737503","journal":"bioRxiv","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.64898/2026.07.11.737503","study_design":null,"title":"Episodic memory ERPs reflect preclinical Alzheimer\u2019s disease progression","title_match":false,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/vocal-acoustic-biomarkers-predict-amyloid-positivity-in-non-demented-976d25d7","doi":"10.21203/rs.3.rs-10848194/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10848194/v1","study_design":"cross-sectional","title":"Vocal acoustic biomarkers predict amyloid positivity in non-demented individuals","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/cross-sectional-and-longitudinal-associations-between-sleep-ffe430e6","doi":"10.64898/2026.01.15.26344227","journal":"medRxiv","n_participants":131,"pmid":null,"source_url":"https://doi.org/10.64898/2026.01.15.26344227","study_design":"cross-sectional","title":"Cross-sectional and longitudinal associations between sleep disturbances and psycho-affective symptoms in older adults: influence of amyloid positivity","title_match":true,"year":2026},{"alzhub_score":16,"alzhub_url":"https://alzhub.org/study/automated-plasma-phospho-tau217-assays-for-the-diagnosis-of-down-763c19f0","doi":"10.21203/rs.3.rs-7359108/v1","journal":"Research Square","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.21203/rs.3.rs-7359108/v1","study_design":null,"title":"Automated Plasma Phospho-tau217 Assays for the diagnosis of Down Syndrome-Related Alzheimer's Disease","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/population-based-blood-screening-for-pre-clinical-alzheimers-disease-ab059739","doi":"10.1136/jnnp-2022-abn.297","journal":"Journal of Neurology Neurosurgery & Psychiatry","n_participants":543,"pmid":null,"source_url":"https://doi.org/10.1136/jnnp-2022-abn.297","study_design":null,"title":"Population-based blood screening for pre-clinical Alzheimer\u2019s disease: a British birth cohort at age 70","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/gwas-of-longitudinal-amyloid-accumulation-on18f-florbetapir-pet-in-26268530","doi":"10.1093/brain/awv231","journal":"Brain","n_participants":null,"pmid":"26268530","source_url":"https://pubmed.ncbi.nlm.nih.gov/26268530/","study_design":"longitudinal study","title":"GWAS of longitudinal amyloid accumulation on18F-florbetapir PET in Alzheimer\u2019s disease implicates microglial activation geneIL1RAP","title_match":true,"year":2015},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/association-between-tau-deposition-and-antecedent-amyloid-28334939","doi":"10.1093/brain/awx046","journal":"Brain","n_participants":null,"pmid":"28334939","source_url":"https://pubmed.ncbi.nlm.nih.gov/28334939/","study_design":"cross-sectional","title":"Association between tau deposition and antecedent amyloid-\u03b2 accumulation rates in normal and early symptomatic individuals","title_match":false,"year":2017},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/tau-covariance-patterns-in-alzheimer-s-disease-patients-match-31077982","doi":"10.1016/j.nicl.2019.101848","journal":"NeuroImage Clinical","n_participants":63,"pmid":"31077982","source_url":"https://pubmed.ncbi.nlm.nih.gov/31077982/","study_design":null,"title":"Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain","title_match":false,"year":2019},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/entorhinal-cortex-tau-amyloid-cortical-thickness-and-memory-30759182","doi":"10.1093/brain/awz025","journal":"Brain","n_participants":null,"pmid":"30759182","source_url":"https://pubmed.ncbi.nlm.nih.gov/30759182/","study_design":null,"title":"Entorhinal cortex tau, amyloid-\u03b2, cortical thickness and memory performance in non-demented subjects","title_match":false,"year":2019},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/pet-imaging-of-tau-pathology-and-relationship-to-amyloid-longitudinal-28946567","doi":"10.3233/jad-170390","journal":"Journal of Alzheimer s Disease","n_participants":null,"pmid":"28946567","source_url":"https://pubmed.ncbi.nlm.nih.gov/28946567/","study_design":"cohort study","title":"PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/using-pet-with-18f-av-45-florbetapir-to-quantify-brain-amyloid-load-22252372","doi":"10.1007/s00259-011-2021-8","journal":"European Journal of Nuclear Medicine and Molecular Imaging","n_participants":46,"pmid":"22252372","source_url":"https://pubmed.ncbi.nlm.nih.gov/22252372/","study_design":null,"title":"Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment","title_match":true,"year":2012},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/open-peer-commentary-to-failure-to-demonstrate-efficacy-of-aducanumab-33135288","doi":"10.1002/alz.12235","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":"33135288","source_url":"https://pubmed.ncbi.nlm.nih.gov/33135288/","study_design":"clinical trial","title":"Open Peer Commentary to \u201cFailure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019\u201d","title_match":false,"year":2020},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/o40405-aducanumab-biib037-an-antiamyloid-beta-monoclonal-antibody-in-204cb97e","doi":"10.1016/j.jalz.2015.07.367","journal":"Alzheimer s & Dementia","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2015.07.367","study_design":null,"title":"O4\u201004\u201005: Aducanumab (BIIB037), an anti\u2010amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double\u2010blind, placebo\u2010controlled, phase 1b study","title_match":false,"year":2015},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/music-memory-and-mechanisms-in-alzheimers-disease-figure-1-26205838","doi":"10.1093/brain/awv148","journal":"Brain","n_participants":null,"pmid":"26205838","source_url":"https://pubmed.ncbi.nlm.nih.gov/26205838/","study_design":null,"title":"Music, memory and mechanisms in Alzheimer\u2019s disease: Figure 1","title_match":false,"year":2015},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/trailblazer-alz-4-topline-study-results-directly-comparing-donanemab-7521651f","doi":"10.1192/bjo.2023.227","journal":"BJPsych Open","n_participants":148,"pmid":null,"source_url":"https://doi.org/10.1192/bjo.2023.227","study_design":"clinical trial","title":"TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/p2003-clinical-trial-design-of-cread-a-randomized-doubleblind-916a25c5","doi":"10.1016/j.jalz.2016.06.1207","journal":"Alzheimer s & Dementia","n_participants":500,"pmid":null,"source_url":"https://doi.org/10.1016/j.jalz.2016.06.1207","study_design":"clinical trial","title":"P2\u2010003: Clinical Trial Design of Cread: A Randomized, Double\u2010Blind, Placebo\u2010Controlled, Parallel\u2010Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal\u2010To\u2010Mild Alzheimer\u2019s Disease","title_match":false,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau181-predicts-cognitive-and-functional-decline-68271e02","doi":"10.1002/acn3.51695","journal":"Annals of Clinical and Translational Neurology","n_participants":91,"pmid":null,"source_url":"https://doi.org/10.1002/acn3.51695","study_design":null,"title":"Plasma phosphorylated tau181 predicts cognitive and functional decline","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/donanemab-ly3002813-doseescalation-study-in-alzheimer-s-disease-3ffcda2a","doi":"10.1002/trc2.12112","journal":"Alzheimer's & Dementia: Translational Research & Clinical Interventions","n_participants":null,"pmid":null,"source_url":"https://doi.org/10.1002/trc2.12112","study_design":null,"title":"Donanemab (LY3002813) dose\u2010escalation study in Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/revised-criteria-for-diagnosis-and-staging-of-alzheimer-s-disease-38934362","doi":"10.1002/alz.13859","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38934362","source_url":"https://pubmed.ncbi.nlm.nih.gov/38934362/","study_design":null,"title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","title_match":false,"year":2024},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/clinical-validation-of-the-precivityad2-blood-test-a-mass-38491912","doi":"10.1002/alz.13764","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":583,"pmid":"38491912","source_url":"https://pubmed.ncbi.nlm.nih.gov/38491912/","study_design":null,"title":"Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and A\u03b242/40 ratio to identify presence of brain amyloid","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/diagnostic-accuracy-of-phosphorylated-tau217-in-detecting-alzheimer-s-39711334","doi":"10.1002/alz.14458","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39711334","source_url":"https://pubmed.ncbi.nlm.nih.gov/39711334/","study_design":null,"title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis","title_match":false,"year":2025},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-between-plasma-p-tau217-and-flortaucipir-pet-37740209","doi":"10.1186/s13195-023-01302-w","journal":"Alzheimer's research & therapy","n_participants":85,"pmid":"37740209","source_url":"https://pubmed.ncbi.nlm.nih.gov/37740209/","study_design":"longitudinal study","title":"Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment","title_match":true,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/phospho-tau-with-subthreshold-tau-pet-predicts-increased-tau-36084009","doi":"10.1093/brain/awac329","journal":"Brain : a journal of neurology","n_participants":231,"pmid":"36084009","source_url":"https://pubmed.ncbi.nlm.nih.gov/36084009/","study_design":"longitudinal study","title":"Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals","title_match":true,"year":2023},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/longitudinal-phospho-tau217-predicts-amyloid-positron-emission-39044490","doi":"10.14283/jpad.2024.134","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"39044490","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044490/","study_design":"longitudinal study","title":"Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease","title_match":true,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/plasma-ptau217-predicts-continuous-brain-amyloid-levels-in-38940656","doi":"10.1002/alz.14073","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38940656","source_url":"https://pubmed.ncbi.nlm.nih.gov/38940656/","study_design":null,"title":"Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/longitudinal-plasma-phosphorylated-tau217-and-other-related-38970274","doi":"10.1002/alz.14100","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"38970274","source_url":"https://pubmed.ncbi.nlm.nih.gov/38970274/","study_design":"longitudinal study","title":"Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/population-pharmacokinetic-pharmacodynamic-analyses-of-amyloid-36165093","doi":"10.1002/psp4.12862","journal":"CPT: pharmacometrics & systems pharmacology","n_participants":null,"pmid":"36165093","source_url":"https://pubmed.ncbi.nlm.nih.gov/36165093/","study_design":null,"title":"Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease","title_match":true,"year":2022},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/concordance-of-csf-measures-of-alzheimer-s-pathology-with-amyloid-pet-33598527","doi":"10.1002/dad2.12131","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":63,"pmid":"33598527","source_url":"https://pubmed.ncbi.nlm.nih.gov/33598527/","study_design":null,"title":"Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays","title_match":true,"year":2021},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/plasma-biomarkers-of-amyloid-tau-axonal-and-neuroinflammation-38961441","doi":"10.1186/s13195-024-01502-y","journal":"Alzheimer's research & therapy","n_participants":104,"pmid":"38961441","source_url":"https://pubmed.ncbi.nlm.nih.gov/38961441/","study_design":null,"title":"Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies","title_match":false,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/tau-pathology-is-associated-with-synaptic-density-and-longitudinal-38589563","doi":"10.1038/s41380-024-02501-z","journal":"Molecular psychiatry","n_participants":null,"pmid":"38589563","source_url":"https://pubmed.ncbi.nlm.nih.gov/38589563/","study_design":"cross-sectional","title":"Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/skeletal-muscle-mitochondrial-function-predicts-cognitive-impairment-37530130","doi":"10.1002/alz.13388","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"37530130","source_url":"https://pubmed.ncbi.nlm.nih.gov/37530130/","study_design":null,"title":"Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration","title_match":false,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/plasma-phosphorylated-tau181-predicts-cognitive-and-functional-decline-36518085","doi":"10.1002/acn3.51695","journal":"Annals of clinical and translational neurology","n_participants":91,"pmid":"36518085","source_url":"https://pubmed.ncbi.nlm.nih.gov/36518085/","study_design":null,"title":"Plasma phosphorylated tau181 predicts cognitive and functional decline","title_match":false,"year":2023},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau217-distinguishes-amyloid-positive-from-40047958","doi":"10.1007/s00415-025-12996-3","journal":"Journal of neurology","n_participants":null,"pmid":"40047958","source_url":"https://pubmed.ncbi.nlm.nih.gov/40047958/","study_design":"systematic review","title":"Blood phosphorylated Tau217 distinguishes amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum. A systematic review and meta-analysis","title_match":true,"year":2025},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau-181-as-a-biomarker-for-amyloid-burden-on-35491781","doi":"10.3233/jad-215639","journal":"Journal of Alzheimer's disease : JAD","n_participants":18,"pmid":"35491781","source_url":"https://pubmed.ncbi.nlm.nih.gov/35491781/","study_design":null,"title":"Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults","title_match":false,"year":2022},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/metabotropic-glutamate-receptor-5-mglur5-is-associated-with-38217040","doi":"10.1186/s13195-024-01385-z","journal":"Alzheimer's research & therapy","n_participants":27,"pmid":"38217040","source_url":"https://pubmed.ncbi.nlm.nih.gov/38217040/","study_design":null,"title":"Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [18F]PSS232 PET/MRI study","title_match":false,"year":2024},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/plasma-p-tau-lt-sub-gt-217-lt-sub-gt-and-neurofilament-p-tau-lt-sub-39776166","doi":"10.1002/alz.14482","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":374,"pmid":"39776166","source_url":"https://pubmed.ncbi.nlm.nih.gov/39776166/","study_design":"cohort study","title":"Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/associations-among-plasma-mri-and-amyloid-pet-biomarkers-of-alzheimer-38747525","doi":"10.1002/alz.13835","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":299,"pmid":"38747525","source_url":"https://pubmed.ncbi.nlm.nih.gov/38747525/","study_design":null,"title":"Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort","title_match":true,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/plasma-ptau217-ratio-predicts-continuous-regional-brain-tau-39575854","doi":"10.1002/alz.14411","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39575854","source_url":"https://pubmed.ncbi.nlm.nih.gov/39575854/","study_design":null,"title":"Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease","title_match":true,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/performance-of-plasma-a42-40-measured-using-a-fully-automated-37667408","doi":"10.1186/s13195-023-01296-5","journal":"Alzheimer's research & therapy","n_participants":174,"pmid":"37667408","source_url":"https://pubmed.ncbi.nlm.nih.gov/37667408/","study_design":null,"title":"Performance of plasma A\u03b242/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status","title_match":false,"year":2023},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/the-correlations-between-plasma-fibrinogen-with-amyloid-beta-and-tau-33551734","doi":"10.3389/fnins.2020.625844","journal":"Frontiers in neuroscience","n_participants":null,"pmid":"33551734","source_url":"https://pubmed.ncbi.nlm.nih.gov/33551734/","study_design":null,"title":"The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer's Disease","title_match":false,"year":2020},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-plasma-p-tau217-in-identifying-abnormal-brain-39807654","doi":"10.1002/alz.14502","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":142,"pmid":"39807654","source_url":"https://pubmed.ncbi.nlm.nih.gov/39807654/","study_design":null,"title":"Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/association-of-microplastics-in-human-cerebrospinal-fluid-with-40435616","doi":"10.1016/j.jhazmat.2025.138748","journal":"Journal of hazardous materials","n_participants":null,"pmid":"40435616","source_url":"https://pubmed.ncbi.nlm.nih.gov/40435616/","study_design":null,"title":"Association of microplastics in human cerebrospinal fluid with Alzheimer's disease-related changes","title_match":false,"year":2025},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/evaluation-of-plasma-p-tau217-for-detecting-amyloid-pathology-in-a-40613474","doi":"10.1002/alz.70426","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":598,"pmid":"40613474","source_url":"https://pubmed.ncbi.nlm.nih.gov/40613474/","study_design":null,"title":"Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort","title_match":false,"year":2025},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/diagnostic-performance-of-plasma-p-tau217-in-a-memory-clinic-cohort-40140924","doi":"10.1186/s13195-025-01719-5","journal":"Alzheimer's research & therapy","n_participants":493,"pmid":"40140924","source_url":"https://pubmed.ncbi.nlm.nih.gov/40140924/","study_design":null,"title":"Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform","title_match":false,"year":2025},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/relationship-between-plasma-p-tau217-and-amyloid-pet-in-racial-and-39044491","doi":"10.14283/jpad.2024.124","journal":"The journal of prevention of Alzheimer's disease","n_participants":1018,"pmid":"39044491","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044491/","study_design":null,"title":"Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4","title_match":true,"year":2024},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/neuropsychiatric-symptoms-in-alzheimer-s-continuum-and-their-38159651","doi":"10.1016/j.jad.2023.12.062","journal":"Journal of affective disorders","n_participants":53,"pmid":"38159651","source_url":"https://pubmed.ncbi.nlm.nih.gov/38159651/","study_design":"cross-sectional","title":"Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers","title_match":false,"year":2024},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/alzheimer-s-disease-diagnostic-accuracy-by-fluid-and-neuroimaging-atn-37438991","doi":"10.1111/cns.14357","journal":"CNS neuroscience & therapeutics","n_participants":2340,"pmid":"37438991","source_url":"https://pubmed.ncbi.nlm.nih.gov/37438991/","study_design":"longitudinal study","title":"Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework","title_match":false,"year":2024},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/head-to-head-comparison-of-plasma-and-pet-imaging-atn-markers-in-37381042","doi":"10.1186/s40035-023-00365-x","journal":"Translational neurodegeneration","n_participants":137,"pmid":"37381042","source_url":"https://pubmed.ncbi.nlm.nih.gov/37381042/","study_design":null,"title":"Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-relationship-of-insulin-resistance-and-diabetes-to-tau-pet-suvr-36932429","doi":"10.1186/s13195-023-01180-2","journal":"Alzheimer's research & therapy","n_participants":280,"pmid":"36932429","source_url":"https://pubmed.ncbi.nlm.nih.gov/36932429/","study_design":null,"title":"The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/accuracy-and-clinical-applicability-of-plasma-tau-181-and-217-for-39849125","doi":"10.1007/s00415-025-12897-5","journal":"Journal of neurology","n_participants":468,"pmid":"39849125","source_url":"https://pubmed.ncbi.nlm.nih.gov/39849125/","study_design":null,"title":"Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer's disease diagnosis in a memory clinic cohort","title_match":false,"year":2025},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-and-neuroimaging-biomarkers-to-predict-cognitive-38755703","doi":"10.1186/s13195-024-01478-9","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"38755703","source_url":"https://pubmed.ncbi.nlm.nih.gov/38755703/","study_design":null,"title":"Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients","title_match":false,"year":2024},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/potential-utility-of-plasma-p-tau-and-neurofilament-light-chain-as-36878697","doi":"10.1212/wnl.0000000000207115","journal":"Neurology","n_participants":257,"pmid":"36878697","source_url":"https://pubmed.ncbi.nlm.nih.gov/36878697/","study_design":"longitudinal study","title":"Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-cerebrospinal-fluid-biomarkers-measured-by-36321325","doi":"10.1002/acn3.51681","journal":"Annals of clinical and translational neurology","n_participants":null,"pmid":"36321325","source_url":"https://pubmed.ncbi.nlm.nih.gov/36321325/","study_design":null,"title":"Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE\u00ae system","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/cut-points-and-gray-zones-the-challenges-of-integrating-alzheimer-s-40145267","doi":"10.1002/alz.70113","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40145267","source_url":"https://pubmed.ncbi.nlm.nih.gov/40145267/","study_design":null,"title":"Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice","title_match":false,"year":2025},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/development-of-thresholds-and-a-visualization-tool-for-use-of-a-blood-39096164","doi":"10.1002/alz.14088","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":1199,"pmid":"39096164","source_url":"https://pubmed.ncbi.nlm.nih.gov/39096164/","study_design":null,"title":"Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice","title_match":false,"year":2024},{"alzhub_score":66,"alzhub_url":"https://alzhub.org/study/plasma-levels-of-phosphorylated-tau-181-are-associated-with-cerebral-33959711","doi":"10.1093/braincomms/fcab073","journal":"Brain communications","n_participants":389,"pmid":"33959711","source_url":"https://pubmed.ncbi.nlm.nih.gov/33959711/","study_design":"cross-sectional","title":"Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals","title_match":true,"year":2021},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/comparison-of-plasma-p-tau217-and-p-tau181-in-predicting-amyloid-40044785","doi":"10.1038/s41598-025-90232-8","journal":"Scientific reports","n_participants":121,"pmid":"40044785","source_url":"https://pubmed.ncbi.nlm.nih.gov/40044785/","study_design":null,"title":"Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients","title_match":true,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/cross-cultural-validation-of-plasma-p-tau217-and-p-tau181-as-39877979","doi":"10.1002/alz.14565","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":270,"pmid":"39877979","source_url":"https://pubmed.ncbi.nlm.nih.gov/39877979/","study_design":null,"title":"Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea","title_match":true,"year":2025},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/predicting-cognitive-stage-transition-using-p-tau181-centiloid-and-36988152","doi":"10.1002/alz.13054","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36988152","source_url":"https://pubmed.ncbi.nlm.nih.gov/36988152/","study_design":null,"title":"Predicting cognitive stage transition using p-tau181, Centiloid, and other measures","title_match":true,"year":2023},{"alzhub_score":71,"alzhub_url":"https://alzhub.org/study/plasma-ptau181-and-ptau217-predict-asymptomatic-amyloid-accumulation-39051027","doi":"10.1093/braincomms/fcae162","journal":"Brain communications","n_participants":75,"pmid":"39051027","source_url":"https://pubmed.ncbi.nlm.nih.gov/39051027/","study_design":"cohort study","title":"Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET","title_match":true,"year":2024},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/profiling-plasma-biomarkers-particularly-ptau217-and-ptau217-a42-and-40785395","doi":"10.1111/jnc.70182","journal":"Journal of neurochemistry","n_participants":80,"pmid":"40785395","source_url":"https://pubmed.ncbi.nlm.nih.gov/40785395/","study_design":null,"title":"Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/A\u03b242, and Their Relation to Cognition in Memory Clinic Patients","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/precivityad2tm-blood-test-analytical-validation-of-an-lc-ms-ms-assay-39202226","doi":"10.3390/diagnostics14161739","journal":"Diagnostics (Basel, Switzerland)","n_participants":null,"pmid":"39202226","source_url":"https://pubmed.ncbi.nlm.nih.gov/39202226/","study_design":null,"title":"PrecivityAD2\u2122 Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-\u03b242/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology","title_match":false,"year":2024},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/biofluid-based-staging-of-alzheimer-s-disease-40095069","doi":"10.1007/s00401-025-02863-w","journal":"Acta neuropathologica","n_participants":219,"pmid":"40095069","source_url":"https://pubmed.ncbi.nlm.nih.gov/40095069/","study_design":null,"title":"Biofluid-based staging of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/blood-phosphorylated-tau181-reliably-differentiates-amyloid-positive-39822285","doi":"10.1002/dad2.70068","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":null,"pmid":"39822285","source_url":"https://pubmed.ncbi.nlm.nih.gov/39822285/","study_design":"systematic review","title":"Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysis","title_match":true,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-neurofilament-light-chain-as-a-biomarker-of-alzheimer-s-35288777","doi":"10.1007/s00415-022-11055-5","journal":"Journal of neurology","n_participants":110,"pmid":"35288777","source_url":"https://pubmed.ncbi.nlm.nih.gov/35288777/","study_design":null,"title":"Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment","title_match":false,"year":2022},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/positron-emission-tomography-imaging-and-clinical-progression-in-21149866","doi":"10.1093/brain/awq349","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"21149866","source_url":"https://pubmed.ncbi.nlm.nih.gov/21149866/","study_design":null,"title":"Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease","title_match":true,"year":2011},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/the-dynamics-of-biomarkers-across-the-clinical-spectrum-of-alzheimer-32534594","doi":"10.1186/s13195-020-00636-z","journal":"Alzheimer's research & therapy","n_participants":2014,"pmid":"32534594","source_url":"https://pubmed.ncbi.nlm.nih.gov/32534594/","study_design":"longitudinal study","title":"The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease","title_match":false,"year":2020},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/detection-of-amyloid-positivity-in-alzheimer-s-disease-neuroimaging-33842885","doi":"10.1093/braincomms/fcab008","journal":"Brain communications","n_participants":null,"pmid":"33842885","source_url":"https://pubmed.ncbi.nlm.nih.gov/33842885/","study_design":null,"title":"Detection of \u03b2-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers","title_match":true,"year":2021},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/plasma-a-lt-sub-gt-42-lt-sub-gt-a-lt-sub-gt-40-lt-sub-gt-is-sensitive-39713875","doi":"10.1002/alz.14442","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"39713875","source_url":"https://pubmed.ncbi.nlm.nih.gov/39713875/","study_design":"cross-sectional","title":"Plasma A\u03b242/A\u03b240 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum","title_match":false,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/prevalence-and-clinical-implications-of-a-amyloid-negative-tau-37523162","doi":"10.1001/jamaneurol.2023.2338","journal":"JAMA neurology","n_participants":7679,"pmid":"37523162","source_url":"https://pubmed.ncbi.nlm.nih.gov/37523162/","study_design":"cohort study","title":"Prevalence and Clinical Implications of a \u03b2-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease","title_match":true,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/diagnostic-value-of-cerebrospinal-fluid-a-ratios-in-preclinical-26677842","doi":"10.1186/s13195-015-0159-5","journal":"Alzheimer's research & therapy","n_participants":38,"pmid":"26677842","source_url":"https://pubmed.ncbi.nlm.nih.gov/26677842/","study_design":null,"title":"Diagnostic value of cerebrospinal fluid A\u03b2 ratios in preclinical Alzheimer's disease","title_match":false,"year":2015},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/assessment-of-the-concordance-and-diagnostic-accuracy-between-elecsys-33746733","doi":"10.3389/fnagi.2021.604119","journal":"Frontiers in aging neuroscience","n_participants":34,"pmid":"33746733","source_url":"https://pubmed.ncbi.nlm.nih.gov/33746733/","study_design":null,"title":"Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest","title_match":false,"year":2021},{"alzhub_score":79,"alzhub_url":"https://alzhub.org/study/prospective-biomarkers-of-alzheimer-s-disease-a-systematic-review-and-35905816","doi":"10.1016/j.arr.2022.101699","journal":"Ageing research reviews","n_participants":70,"pmid":"35905816","source_url":"https://pubmed.ncbi.nlm.nih.gov/35905816/","study_design":"meta-analysis","title":"Prospective biomarkers of Alzheimer's disease: A systematic review and meta-analysis","title_match":false,"year":2022},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/clinical-performance-of-an-antibody-free-assay-for-plasma-a42-a40-to-36604729","doi":"10.1186/s13195-022-01143-z","journal":"Alzheimer's research & therapy","n_participants":200,"pmid":"36604729","source_url":"https://pubmed.ncbi.nlm.nih.gov/36604729/","study_design":"cohort study","title":"Clinical performance of an antibody-free assay for plasma A\u03b242/A\u03b240 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/performance-of-the-plasma-a42-a40-ratio-measured-with-a-novel-hplc-ms-34686209","doi":"10.1186/s13195-021-00911-7","journal":"Alzheimer's research & therapy","n_participants":134,"pmid":"34686209","source_url":"https://pubmed.ncbi.nlm.nih.gov/34686209/","study_design":null,"title":"Performance of the plasma A\u03b242/A\u03b240 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort","title_match":true,"year":2021},{"alzhub_score":38,"alzhub_url":"https://alzhub.org/study/fluid-biomarker-based-molecular-phenotyping-of-alzheimer-s-disease-31699324","doi":"10.1016/bs.pmbts.2019.07.006","journal":"Progress in molecular biology and translational science","n_participants":null,"pmid":"31699324","source_url":"https://pubmed.ncbi.nlm.nih.gov/31699324/","study_design":null,"title":"Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings","title_match":false,"year":2019},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/fully-automated-and-highly-specific-plasma-amyloid-immunoassays-35739591","doi":"10.1186/s13195-022-01029-0","journal":"Alzheimer's research & therapy","n_participants":197,"pmid":"35739591","source_url":"https://pubmed.ncbi.nlm.nih.gov/35739591/","study_design":"clinical trial","title":"Fully automated and highly specific plasma \u03b2-amyloid immunoassays predict \u03b2-amyloid status defined by amyloid positron emission tomography with high accuracy","title_match":true,"year":2022},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/independent-study-demonstrates-amyloid-probability-score-accurately-36975407","doi":"10.1002/acn3.51763","journal":"Annals of clinical and translational neurology","n_participants":13,"pmid":"36975407","source_url":"https://pubmed.ncbi.nlm.nih.gov/36975407/","study_design":null,"title":"Independent study demonstrates amyloid probability score accurately indicates amyloid pathology","title_match":false,"year":2023},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/blood-derived-amyloid-biomarkers-for-alzheimer-s-disease-prevention-35098969","doi":"10.14283/jpad.2021.70","journal":"The journal of prevention of Alzheimer's disease","n_participants":null,"pmid":"35098969","source_url":"https://pubmed.ncbi.nlm.nih.gov/35098969/","study_design":"cross-sectional","title":"Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention","title_match":false,"year":2022},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/regional-disconnection-in-alzheimer-dementia-and-amyloid-positive-33073602","doi":"10.1089/brain.2020.0785","journal":"Brain connectivity","n_participants":67,"pmid":"33073602","source_url":"https://pubmed.ncbi.nlm.nih.gov/33073602/","study_design":null,"title":"Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism","title_match":true,"year":2020},{"alzhub_score":60,"alzhub_url":"https://alzhub.org/study/characterization-of-plasma-at-n-biomarkers-among-a-racial-and-39975470","doi":"10.1002/trc2.70045","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":764,"pmid":"39975470","source_url":"https://pubmed.ncbi.nlm.nih.gov/39975470/","study_design":null,"title":"Characterization of plasma AT(N) biomarkers among a racial and ethnically diverse community-based cohort: an HABS-HD study","title_match":false,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/concordance-between-cerebrospinal-fluid-biomarkers-with-alzheimer-s-29171991","doi":"10.3233/jad-170128","journal":"Journal of Alzheimer's disease : JAD","n_participants":77,"pmid":"29171991","source_url":"https://pubmed.ncbi.nlm.nih.gov/29171991/","study_design":null,"title":"Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms","title_match":false,"year":2018},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/clinical-utility-of-plasma-a42-40-ratio-by-lc-ms-ms-in-alzheimer-s-38595851","doi":"10.3389/fneur.2024.1364658","journal":"Frontiers in neurology","n_participants":null,"pmid":"38595851","source_url":"https://pubmed.ncbi.nlm.nih.gov/38595851/","study_design":null,"title":"Clinical utility of plasma A\u03b242/40 ratio by LC-MS/MS in Alzheimer's disease assessment","title_match":false,"year":2024},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/blood-brain-barrier-breakdown-is-linked-to-tau-pathology-and-neuronal-37283062","doi":"10.1177/0271678x231180035","journal":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","n_participants":62,"pmid":"37283062","source_url":"https://pubmed.ncbi.nlm.nih.gov/37283062/","study_design":null,"title":"Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition","title_match":false,"year":2023},{"alzhub_score":83,"alzhub_url":"https://alzhub.org/study/risk-of-conversion-to-mild-cognitive-impairment-or-dementia-among-38610055","doi":"10.1186/s13195-024-01455-2","journal":"Alzheimer's research & therapy","n_participants":7793,"pmid":"38610055","source_url":"https://pubmed.ncbi.nlm.nih.gov/38610055/","study_design":"systematic review","title":"Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/definition-of-a-threshold-for-the-plasma-a42-a40-ratio-measured-by-38256246","doi":"10.3390/ijms25021173","journal":"International journal of molecular sciences","n_participants":88,"pmid":"38256246","source_url":"https://pubmed.ncbi.nlm.nih.gov/38256246/","study_design":null,"title":"Definition of a Threshold for the Plasma A\u03b242/A\u03b240 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia","title_match":false,"year":2024},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/apoe-4-modulates-the-association-among-plasma-a-lt-sub-gt-42-lt-sub-35351867","doi":"10.1038/s41398-022-01899-w","journal":"Translational psychiatry","n_participants":null,"pmid":"35351867","source_url":"https://pubmed.ncbi.nlm.nih.gov/35351867/","study_design":"longitudinal study","title":"APOE-\u03b54 modulates the association among plasma A\u03b242/A\u03b240, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults","title_match":false,"year":2022},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/association-of-csf-proteins-with-tau-and-amyloid-levels-in-33653397","doi":"10.1186/s13195-021-00789-5","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"33653397","source_url":"https://pubmed.ncbi.nlm.nih.gov/33653397/","study_design":"cohort study","title":"Association of CSF proteins with tau and amyloid \u03b2 levels in asymptomatic 70-year-olds","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/comparative-analysis-of-different-definitions-of-amyloid-positivity-33336227","doi":"10.14283/jpad.2020.51","journal":"The journal of prevention of Alzheimer's disease","n_participants":368,"pmid":"33336227","source_url":"https://pubmed.ncbi.nlm.nih.gov/33336227/","study_design":null,"title":"Comparative Analysis of Different Definitions of Amyloid-\u03b2 Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer","title_match":false,"year":2021},{"alzhub_score":67,"alzhub_url":"https://alzhub.org/study/predicting-longitudinal-cognitive-decline-and-alzheimer-s-conversion-38994939","doi":"10.3390/cells13131085","journal":"Cells","n_participants":50,"pmid":"38994939","source_url":"https://pubmed.ncbi.nlm.nih.gov/38994939/","study_design":"cohort study","title":"Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers","title_match":false,"year":2024},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/the-associations-between-synaptic-density-and-a-t-n-biomarkers-in-38295871","doi":"10.1177/0271678x241230733","journal":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","n_participants":97,"pmid":"38295871","source_url":"https://pubmed.ncbi.nlm.nih.gov/38295871/","study_design":null,"title":"The associations between synaptic density and \"A/T/N\" biomarkers in Alzheimer's disease: An 18F-SynVesT-1 PET/MR study","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/plasma-core-alzheimer-s-disease-biomarkers-predict-amyloid-deposition-36547971","doi":"10.1021/acschemneuro.2c00636","journal":"ACS chemical neuroscience","n_participants":null,"pmid":"36547971","source_url":"https://pubmed.ncbi.nlm.nih.gov/36547971/","study_design":null,"title":"Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline","title_match":false,"year":2023},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/cognitively-unimpaired-individuals-with-a-low-burden-of-a-pathology-34315519","doi":"10.1186/s13195-021-00863-y","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"34315519","source_url":"https://pubmed.ncbi.nlm.nih.gov/34315519/","study_design":"cross-sectional","title":"Cognitively unimpaired individuals with a low burden of A\u03b2 pathology have a distinct CSF biomarker profile","title_match":false,"year":2021},{"alzhub_score":74,"alzhub_url":"https://alzhub.org/study/association-of-weight-change-with-cerebrospinal-fluid-biomarkers-and-33597012","doi":"10.1186/s13195-021-00781-z","journal":"Alzheimer's research & therapy","n_participants":2743,"pmid":"33597012","source_url":"https://pubmed.ncbi.nlm.nih.gov/33597012/","study_design":"cohort study","title":"Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease","title_match":true,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-levels-of-amyloid-40-and-amyloid-42-are-31286708","doi":"10.3988/jcn.2019.15.3.353","journal":"Journal of clinical neurology (Seoul, Korea)","n_participants":null,"pmid":"31286708","source_url":"https://pubmed.ncbi.nlm.nih.gov/31286708/","study_design":null,"title":"Cerebrospinal Fluid Levels of \u03b2-Amyloid 40 and \u03b2-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients","title_match":true,"year":2019},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/diagnostic-value-of-isolated-plasma-biomarkers-and-its-combination-in-38588788","doi":"10.1016/j.cca.2024.118784","journal":"Clinica chimica acta; international journal of clinical chemistry","n_participants":92,"pmid":"38588788","source_url":"https://pubmed.ncbi.nlm.nih.gov/38588788/","study_design":null,"title":"Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study","title_match":false,"year":2024},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-association-of-subjective-sleep-characteristics-and-plasma-36806992","doi":"10.1007/s00415-023-11626-0","journal":"Journal of neurology","n_participants":335,"pmid":"36806992","source_url":"https://pubmed.ncbi.nlm.nih.gov/36806992/","study_design":null,"title":"The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-\u03b2 burden","title_match":false,"year":2023},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/accuracy-of-plasma-biomarkers-to-detect-alzheimer-s-disease-40108829","doi":"10.1002/alz.14570","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":304,"pmid":"40108829","source_url":"https://pubmed.ncbi.nlm.nih.gov/40108829/","study_design":"cohort study","title":"Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia","title_match":false,"year":2025},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/evaluation-of-bcg-vaccination-and-plasma-amyloid-a-prospective-pilot-35208878","doi":"10.3390/microorganisms10020424","journal":"Microorganisms","n_participants":null,"pmid":"35208878","source_url":"https://pubmed.ncbi.nlm.nih.gov/35208878/","study_design":"open-label trial","title":"Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer's Disease","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/blood-acetylcholinesterase-level-is-a-potential-biomarker-for-the-30316049","doi":"10.1016/j.neurobiolaging.2018.09.001","journal":"Neurobiology of aging","n_participants":407,"pmid":"30316049","source_url":"https://pubmed.ncbi.nlm.nih.gov/30316049/","study_design":null,"title":"Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals","title_match":false,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/predicting-alzheimer-disease-from-a-blood-based-biomarker-profile-a-27534714","doi":"10.1212/wnl.0000000000003094","journal":"Neurology","n_participants":74,"pmid":"27534714","source_url":"https://pubmed.ncbi.nlm.nih.gov/27534714/","study_design":null,"title":"Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up","title_match":false,"year":2016},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/plasma-apolipoprotein-j-as-a-potential-biomarker-for-alzheimer-s-27239546","doi":"10.1016/j.dadm.2015.12.001","journal":"Alzheimer's & dementia (Amsterdam, Netherlands)","n_participants":833,"pmid":"27239546","source_url":"https://pubmed.ncbi.nlm.nih.gov/27239546/","study_design":null,"title":"Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging","title_match":false,"year":2016},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/apoe-4-gene-dose-effect-on-imaging-and-blood-biomarkers-of-37016464","doi":"10.1186/s13195-023-01209-6","journal":"Alzheimer's research & therapy","n_participants":19,"pmid":"37016464","source_url":"https://pubmed.ncbi.nlm.nih.gov/37016464/","study_design":null,"title":"APOE \u03b54 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly","title_match":false,"year":2023},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/prognostic-plasma-protein-panel-for-a-deposition-in-the-brain-in-31605717","doi":"10.1016/j.pneurobio.2019.101690","journal":"Progress in neurobiology","n_participants":107,"pmid":"31605717","source_url":"https://pubmed.ncbi.nlm.nih.gov/31605717/","study_design":null,"title":"Prognostic plasma protein panel for A\u03b2 deposition in the brain in Alzheimer's disease","title_match":false,"year":2019},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/use-of-a-blood-biomarker-test-improves-economic-utility-in-the-38546435","doi":"10.1089/pop.2023.0309","journal":"Population health management","n_participants":null,"pmid":"38546435","source_url":"https://pubmed.ncbi.nlm.nih.gov/38546435/","study_design":null,"title":"Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment","title_match":false,"year":2024},{"alzhub_score":62,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-beta-oligomer-is-related-to-subjective-cognitive-36324157","doi":"10.1186/s13195-022-01104-6","journal":"Alzheimer's research & therapy","n_participants":126,"pmid":"36324157","source_url":"https://pubmed.ncbi.nlm.nih.gov/36324157/","study_design":"cross-sectional","title":"Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/frontal-variant-of-alzheimer-s-disease-with-asymmetric-presentation-31989779","doi":"10.1002/brb3.1548","journal":"Brain and behavior","n_participants":null,"pmid":"31989779","source_url":"https://pubmed.ncbi.nlm.nih.gov/31989779/","study_design":null,"title":"Frontal variant of Alzheimer's disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review","title_match":false,"year":2020},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/identify-biological-alzheimer-s-disease-using-a-novel-nucleic-acid-39845736","doi":"10.1093/braincomms/fcaf004","journal":"Brain communications","n_participants":397,"pmid":"39845736","source_url":"https://pubmed.ncbi.nlm.nih.gov/39845736/","study_design":null,"title":"Identify biological Alzheimer's disease using a novel nucleic acid-linked protein immunoassay","title_match":false,"year":2025},{"alzhub_score":64,"alzhub_url":"https://alzhub.org/study/prediction-of-longitudinal-synaptic-loss-in-alzheimer-s-disease-using-40432308","doi":"10.1002/alz.70333","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"40432308","source_url":"https://pubmed.ncbi.nlm.nih.gov/40432308/","study_design":"longitudinal study","title":"Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/assessment-of-immunoprecipitation-with-subsequent-immunoassays-for-38316685","doi":"10.1007/s00406-023-01751-2","journal":"European archives of psychiatry and clinical neuroscience","n_participants":32,"pmid":"38316685","source_url":"https://pubmed.ncbi.nlm.nih.gov/38316685/","study_design":null,"title":"Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/longitudinal-trajectory-of-plasma-p-tau217-in-cognitively-unimpaired-39702464","doi":"10.1186/s13195-024-01642-1","journal":"Alzheimer's research & therapy","n_participants":151,"pmid":"39702464","source_url":"https://pubmed.ncbi.nlm.nih.gov/39702464/","study_design":"longitudinal study","title":"Longitudinal trajectory of plasma p-tau217 in cognitively unimpaired subjects","title_match":false,"year":2024},{"alzhub_score":86,"alzhub_url":"https://alzhub.org/study/the-australian-multidomain-approach-to-reduce-dementia-risk-by-38596483","doi":"10.1002/trc2.12466","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":600,"pmid":"38596483","source_url":"https://pubmed.ncbi.nlm.nih.gov/38596483/","study_design":"randomized controlled trial","title":"The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial","title_match":false,"year":2024},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/relationship-of-amyloid-1-42-in-blood-and-brain-amyloid-ginkgo-31998865","doi":"10.1093/braincomms/fcz038","journal":"Brain communications","n_participants":160,"pmid":"31998865","source_url":"https://pubmed.ncbi.nlm.nih.gov/31998865/","study_design":"longitudinal study","title":"Relationship of amyloid-\u03b21-42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study","title_match":false,"year":2020},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/combined-assessment-of-serum-folate-and-hemoglobin-as-biomarkers-of-28406978","doi":"10.1371/journal.pone.0175854","journal":"PloS one","n_participants":null,"pmid":"28406978","source_url":"https://pubmed.ncbi.nlm.nih.gov/28406978/","study_design":null,"title":"Combined assessment of serum folate and hemoglobin as biomarkers of brain amyloid \u03b2 accumulation","title_match":false,"year":2017},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/plasma-amyloid-42-40-and-apolipoprotein-e-for-amyloid-pet-pre-36926368","doi":"10.1093/braincomms/fcad015","journal":"Brain communications","n_participants":null,"pmid":"36926368","source_url":"https://pubmed.ncbi.nlm.nih.gov/36926368/","study_design":null,"title":"Plasma amyloid-\u03b242/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease","title_match":true,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/a-public-resource-of-baseline-data-from-the-alzheimer-s-prevention-36373344","doi":"10.1002/alz.12843","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":null,"pmid":"36373344","source_url":"https://pubmed.ncbi.nlm.nih.gov/36373344/","study_design":null,"title":"A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial","title_match":false,"year":2023},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-clinical-use-of-blood-test-factors-for-alzheimer-s-disease-34108650","doi":"10.1038/s12276-021-00638-3","journal":"Experimental & molecular medicine","n_participants":149,"pmid":"34108650","source_url":"https://pubmed.ncbi.nlm.nih.gov/34108650/","study_design":null,"title":"The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit","title_match":false,"year":2021},{"alzhub_score":72,"alzhub_url":"https://alzhub.org/study/blood-based-biomarker-prescreening-with-different-testing-40065919","doi":"10.1002/trc2.70065","journal":"Alzheimer's & dementia (New York, N. Y.)","n_participants":202,"pmid":"40065919","source_url":"https://pubmed.ncbi.nlm.nih.gov/40065919/","study_design":"cohort study","title":"Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studies","title_match":false,"year":2025},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/everyday-driving-and-plasma-biomarkers-in-alzheimer-s-disease-36938737","doi":"10.3233/jad-221268","journal":"Journal of Alzheimer's disease : JAD","n_participants":142,"pmid":"36938737","source_url":"https://pubmed.ncbi.nlm.nih.gov/36938737/","study_design":null,"title":"Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit","title_match":false,"year":2023},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/efficacy-of-lt-i-gt-ginkgo-biloba-lt-i-gt-as-an-adjunct-to-donepezil-40134691","doi":"10.3389/fneur.2025.1563056","journal":"Frontiers in neurology","n_participants":101,"pmid":"40134691","source_url":"https://pubmed.ncbi.nlm.nih.gov/40134691/","study_design":null,"title":"Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer's patients","title_match":true,"year":2025},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/qualification-of-the-analytical-and-clinical-performance-of-csf-21311900","doi":"10.1007/s00401-011-0808-0","journal":"Acta neuropathologica","n_participants":null,"pmid":"21311900","source_url":"https://pubmed.ncbi.nlm.nih.gov/21311900/","study_design":null,"title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","title_match":false,"year":2011},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/increased-blood-brain-barrier-permeability-is-associated-with-28061383","doi":"10.1016/j.neurobiolaging.2016.11.017","journal":"Neurobiology of aging","n_participants":1015,"pmid":"28061383","source_url":"https://pubmed.ncbi.nlm.nih.gov/28061383/","study_design":null,"title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","title_match":false,"year":2017},{"alzhub_score":45,"alzhub_url":"https://alzhub.org/study/exercise-engagement-as-a-moderator-of-the-effects-of-apoe-genotype-on-22232206","doi":"10.1001/archneurol.2011.845","journal":"Archives of neurology","n_participants":165,"pmid":"22232206","source_url":"https://pubmed.ncbi.nlm.nih.gov/22232206/","study_design":null,"title":"Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition","title_match":false,"year":2012},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/obstructive-sleep-apnea-severity-affects-amyloid-burden-in-29125327","doi":"10.1164/rccm.201704-0704oc","journal":"American journal of respiratory and critical care medicine","n_participants":null,"pmid":"29125327","source_url":"https://pubmed.ncbi.nlm.nih.gov/29125327/","study_design":"longitudinal study","title":"Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study","title_match":false,"year":2018},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/beta-amyloid-in-alzheimer-s-disease-increased-deposition-in-brain-is-19268916","doi":"10.1016/j.biopsych.2009.01.027","journal":"Biological psychiatry","n_participants":30,"pmid":"19268916","source_url":"https://pubmed.ncbi.nlm.nih.gov/19268916/","study_design":null,"title":"Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","title_match":false,"year":2009},{"alzhub_score":50,"alzhub_url":"https://alzhub.org/study/cerebrospinal-fluid-phospho-tau-t217-outperforms-t181-as-a-biomarker-32183883","doi":"10.1186/s13195-020-00596-4","journal":"Alzheimer's research & therapy","n_participants":null,"pmid":"32183883","source_url":"https://pubmed.ncbi.nlm.nih.gov/32183883/","study_design":null,"title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification","title_match":true,"year":2020},{"alzhub_score":36,"alzhub_url":"https://alzhub.org/study/increased-in-vivo-amyloid-42-production-exchange-and-loss-in-23761040","doi":"10.1126/scitranslmed.3005615","journal":"Science translational medicine","n_participants":null,"pmid":"23761040","source_url":"https://pubmed.ncbi.nlm.nih.gov/23761040/","study_design":null,"title":"Increased in vivo amyloid-\u03b242 production, exchange, and loss in presenilin mutation carriers","title_match":false,"year":2013},{"alzhub_score":57,"alzhub_url":"https://alzhub.org/study/sex-differences-in-the-association-between-tau-pet-and-cognitive-37641484","doi":"10.1002/alz.13432","journal":"Alzheimer's & dementia : the journal of the Alzheimer's Association","n_participants":343,"pmid":"37641484","source_url":"https://pubmed.ncbi.nlm.nih.gov/37641484/","study_design":null,"title":"Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD","title_match":false,"year":2024},{"alzhub_score":82,"alzhub_url":"https://alzhub.org/study/change-in-digital-cognitive-test-performance-between-solanezumab-and-39044493","doi":"10.14283/jpad.2024.137","journal":"The journal of prevention of Alzheimer's disease","n_participants":1117,"pmid":"39044493","source_url":"https://pubmed.ncbi.nlm.nih.gov/39044493/","study_design":"longitudinal study","title":"Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study","title_match":false,"year":2024},{"alzhub_score":59,"alzhub_url":"https://alzhub.org/study/concurrent-detection-of-cognitive-impairment-and-amyloid-positivity-41382170","doi":"10.1186/s13195-025-01913-5","journal":"Alzheimer's research & therapy","n_participants":930,"pmid":"41382170","source_url":"https://pubmed.ncbi.nlm.nih.gov/41382170/","study_design":null,"title":"Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment","title_match":true,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/driving-into-diagnosis-leveraging-high-resolution-telematics-and-41393339","doi":"10.1177/25424823251407543","journal":"Journal of Alzheimer's disease reports","n_participants":254,"pmid":"41393339","source_url":"https://pubmed.ncbi.nlm.nih.gov/41393339/","study_design":null,"title":"Driving into diagnosis: Leveraging high-resolution telematics and sensorimotor profiling to identify preclinical Alzheimer's disease","title_match":false,"year":2025},{"alzhub_score":53,"alzhub_url":"https://alzhub.org/study/predicting-brain-amyloid-load-with-digital-and-blood-based-biomarkers-40618175","doi":"10.1186/s13195-025-01801-y","journal":"Alzheimer's research & therapy","n_participants":349,"pmid":"40618175","source_url":"https://pubmed.ncbi.nlm.nih.gov/40618175/","study_design":null,"title":"Predicting brain amyloid load with digital and blood-based biomarkers","title_match":false,"year":2025},{"alzhub_score":76,"alzhub_url":"https://alzhub.org/study/pathway-specific-polygenic-risk-scores-as-predictors-of-amyloid-27662287","doi":"10.3233/jad-160195","journal":"Journal of Alzheimer's disease : JAD","n_participants":1200,"pmid":"27662287","source_url":"https://pubmed.ncbi.nlm.nih.gov/27662287/","study_design":"meta-analysis","title":"Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-\u03b2 Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease","title_match":false,"year":2017},{"alzhub_score":52,"alzhub_url":"https://alzhub.org/study/mutations-in-mme-cause-an-autosomal-recessive-charcot-marie-tooth-26991897","doi":"10.1002/ana.24612","journal":"Annals of neurology","n_participants":303,"pmid":"26991897","source_url":"https://pubmed.ncbi.nlm.nih.gov/26991897/","study_design":null,"title":"Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2","title_match":false,"year":2016},{"alzhub_score":84,"alzhub_url":"https://alzhub.org/study/genome-wide-association-study-of-brain-amyloid-deposition-as-measured-30361487","doi":"10.1038/s41380-018-0246-7","journal":"Molecular psychiatry","n_participants":1000,"pmid":"30361487","source_url":"https://pubmed.ncbi.nlm.nih.gov/30361487/","study_design":"meta-analysis","title":"Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging","title_match":true,"year":2021},{"alzhub_score":69,"alzhub_url":"https://alzhub.org/study/harmonization-of-csf-and-imaging-biomarkers-in-alzheimer-s-disease-38072165","doi":"10.1016/j.nbd.2023.106373","journal":"Neurobiology of disease","n_participants":null,"pmid":"38072165","source_url":"https://pubmed.ncbi.nlm.nih.gov/38072165/","study_design":"meta-analysis","title":"Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification","title_match":false,"year":2024},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/pet-imaging-of-neuroinflammation-in-alzheimer-s-disease-34603323","doi":"10.3389/fimmu.2021.739130","journal":"Frontiers in immunology","n_participants":null,"pmid":"34603323","source_url":"https://pubmed.ncbi.nlm.nih.gov/34603323/","study_design":null,"title":"PET Imaging of Neuroinflammation in Alzheimer's Disease","title_match":false,"year":2021},{"alzhub_score":55,"alzhub_url":"https://alzhub.org/study/the-relationship-of-soluble-trem2-to-other-biomarkers-of-sporadic-34158530","doi":"10.1038/s41598-021-92101-6","journal":"Scientific reports","n_participants":101,"pmid":"34158530","source_url":"https://pubmed.ncbi.nlm.nih.gov/34158530/","study_design":null,"title":"The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease","title_match":false,"year":2021},{"alzhub_score":48,"alzhub_url":"https://alzhub.org/study/the-association-of-enlarged-perivascular-space-with-microglia-related-35577066","doi":"10.1016/j.nbd.2022.105755","journal":"Neurobiology of disease","n_participants":144,"pmid":"35577066","source_url":"https://pubmed.ncbi.nlm.nih.gov/35577066/","study_design":null,"title":"The association of enlarged perivascular space with microglia-related inflammation and Alzheimer's pathology in cognitively normal elderly","title_match":false,"year":2022},{"alzhub_score":47,"alzhub_url":"https://alzhub.org/study/a-microglial-activity-state-biomarker-panel-differentiates-ftd-37775827","doi":"10.1186/s13024-023-00657-w","journal":"Molecular neurodegeneration","n_participants":null,"pmid":"37775827","source_url":"https://pubmed.ncbi.nlm.nih.gov/37775827/","study_design":null,"title":"A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls","title_match":false,"year":2023},{"alzhub_score":43,"alzhub_url":"https://alzhub.org/study/plasma-soluble-trem2-is-associated-with-white-matter-lesions-34515756","doi":"10.1093/brain/awab332","journal":"Brain : a journal of neurology","n_participants":null,"pmid":"34515756","source_url":"https://pubmed.ncbi.nlm.nih.gov/34515756/","study_design":null,"title":"Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau","title_match":false,"year":2021},{"alzhub_score":41,"alzhub_url":"https://alzhub.org/study/examination-of-the-effect-of-rare-variants-in-trem2-abi3-and-plcg2-in-32894242","doi":"10.3233/jad-200019","journal":"Journal of Alzheimer's disease : JAD","n_participants":null,"pmid":"32894242","source_url":"https://pubmed.ncbi.nlm.nih.gov/32894242/","study_design":null,"title":"Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes","title_match":false,"year":2020}]}